Financial Highlights
Fiscal years ended March 31 (Dollars in thousands)
2017
2018
2019
Net Sales (1)
$ 757,338
$ 1,200,181
$ 1,382,818
Adjusted Operating Income* (1)
$ 66,976
$ 142,105
$ 237,235
Stockholders’ Equity (1)
$ 155,569
$ 463,875
$ 639,415
*Adjusted Operating Income and Adjusted EBITDA are reconciled to GAAP measures on pages 56 – 59 in the 2019 Form 10-K.
(1) Fiscal year ended March 31, 2018 and March 31, 2017 adjusted due to the adoption of Accounting Standard Codification (“ASC”) 606, Revenue from
Contracts with Customers (“ASC 606”). Refer to Note 1, “Organization and Significant Accounting Policies” in the 2019 Form 10-K.
Cash and Cash Equivalents
(in Millions)
Working Capital
(in Millions)
Adjusted EBITDA
(in Millions)
450
400
350
300
250
200
150
100
50
0
$287
$208
$110
FY17 FY18 FY19
450
400
350
300
250
200
150
100
50
0
$391
(1)
$364
$248
(1)
FY17 FY18 FY19
450
400
350
300
250
200
150
100
50
0
$290
$192
(1)
$105
(1)
FY17 FY18 FY19
Catalogs and
Technical Data
COMPONENTEDGE
3D Models, Specifications,
and Search
Made for Engineers
by Engineers
search.kemet.com
engineeringcenter.com
DEAR KEMET SHAREHOLDER,
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:70)(cid:72)(cid:79)(cid:72)(cid:69)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:70)(cid:72)(cid:81)(cid:87)(cid:72)(cid:81)(cid:81)(cid:76)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:76)(cid:81)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:3)(cid:69)(cid:92)(cid:3)(cid:71)(cid:72)(cid:79)(cid:76)(cid:89)(cid:72)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:3)(cid:191)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:17)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:182)(cid:86)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:86)(cid:3)(cid:71)(cid:72)(cid:80)(cid:82)(cid:81)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:88)(cid:81)(cid:71)(cid:68)(cid:80)(cid:72)(cid:81)(cid:87)(cid:68)(cid:79)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:81)(cid:74)(cid:87)(cid:75)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:68)(cid:70)(cid:85)(cid:82)(cid:86)(cid:86)(cid:3)(cid:68)(cid:3)(cid:69)(cid:85)(cid:82)(cid:68)(cid:71)(cid:3)(cid:85)(cid:68)(cid:81)(cid:74)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)
(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:81)(cid:76)(cid:70)(cid:86)(cid:3)(cid:86)(cid:72)(cid:74)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:17)(cid:3)(cid:43)(cid:76)(cid:74)(cid:75)(cid:79)(cid:76)(cid:74)(cid:75)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:29)
•(cid:3)(cid:3)(cid:36)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:20)(cid:24)(cid:8)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:86)(cid:68)(cid:79)(cid:72)(cid:86)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:27)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:7)(cid:20)(cid:17)(cid:22)(cid:27)(cid:3)(cid:69)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:68)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:7)(cid:20)(cid:27)(cid:19)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)
•(cid:3)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:74)(cid:85)(cid:82)(cid:86)(cid:86)(cid:3)(cid:80)(cid:68)(cid:85)(cid:74)(cid:76)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:22)(cid:24)(cid:8)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:27)
•(cid:3)(cid:36)(cid:71)(cid:77)(cid:88)(cid:86)(cid:87)(cid:72)(cid:71)(cid:3)(cid:40)(cid:37)(cid:44)(cid:55)(cid:39)(cid:36)(cid:3)(cid:74)(cid:85)(cid:72)(cid:90)(cid:3)(cid:24)(cid:20)(cid:8)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:85)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:27)(cid:3)(cid:87)(cid:82)(cid:3)(cid:7)(cid:21)(cid:28)(cid:19)(cid:3)(cid:80)(cid:76)(cid:79)(cid:79)(cid:76)(cid:82)(cid:81)
•(cid:3)(cid:3)(cid:40)(cid:68)(cid:85)(cid:81)(cid:76)(cid:81)(cid:74)(cid:86)(cid:3)(cid:83)(cid:72)(cid:85)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:90)(cid:72)(cid:85)(cid:72)(cid:3)(cid:88)(cid:83)(cid:3)(cid:20)(cid:19)(cid:22)(cid:8)(cid:3)(cid:87)(cid:82)(cid:3)(cid:7)(cid:22)(cid:17)(cid:24)(cid:23)(cid:3)(cid:82)(cid:81)(cid:3)(cid:68)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:69)(cid:68)(cid:86)(cid:76)(cid:86)(cid:15)(cid:3)
(cid:89)(cid:72)(cid:85)(cid:86)(cid:88)(cid:86)(cid:3)(cid:7)(cid:20)(cid:17)(cid:26)(cid:23)(cid:3)(cid:76)(cid:81)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:27)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:7)(cid:19)(cid:17)(cid:23)(cid:21)(cid:3)(cid:76)(cid:81)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:26)(cid:11)(cid:20)(cid:12)
(cid:36)(cid:79)(cid:79)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:86)(cid:72)(cid:74)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:76)(cid:80)(cid:83)(cid:85)(cid:82)(cid:89)(cid:72)(cid:71)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:3)(cid:76)(cid:81)(cid:3)(cid:51)(cid:82)(cid:79)(cid:92)(cid:80)(cid:72)(cid:85)(cid:3)
(cid:55)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:3)(cid:90)(cid:75)(cid:72)(cid:85)(cid:72)(cid:3)(cid:90)(cid:72)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:3)(cid:79)(cid:72)(cid:68)(cid:71)(cid:72)(cid:85)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:79)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:70)(cid:68)(cid:86)(cid:72)(cid:3)(cid:80)(cid:88)(cid:79)(cid:87)(cid:76)(cid:79)(cid:68)(cid:92)(cid:72)(cid:85)(cid:3)
(cid:70)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:86)(cid:17)(cid:3)(cid:44)(cid:81)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:3)(cid:79)(cid:76)(cid:81)(cid:72)(cid:86)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:72)(cid:91)(cid:83)(cid:68)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:68)(cid:88)(cid:87)(cid:82)(cid:80)(cid:82)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:3)(cid:69)(cid:68)(cid:86)(cid:72)(cid:17)(cid:3)(cid:58)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:72)(cid:87)(cid:72)(cid:71)(cid:15)(cid:3)(cid:55)(cid:50)(cid:46)(cid:44)(cid:49)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:86)(cid:88)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:73)(cid:88)(cid:79)(cid:79)(cid:92)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:74)(cid:85)(cid:68)(cid:87)(cid:72)(cid:71)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:76)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:74)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:86)(cid:92)(cid:81)(cid:72)(cid:85)(cid:74)(cid:76)(cid:72)(cid:86)(cid:17)
Solid Capacitors
(cid:55)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:72)(cid:71)(cid:3)(cid:71)(cid:72)(cid:80)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:79)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:70)(cid:68)(cid:86)(cid:72)(cid:3)(cid:80)(cid:88)(cid:79)(cid:87)(cid:76)(cid:79)(cid:68)(cid:92)(cid:72)(cid:85)(cid:3)(cid:70)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:85)(cid:72)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:68)(cid:3)(cid:69)(cid:85)(cid:76)(cid:74)(cid:75)(cid:87)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)
(cid:82)(cid:88)(cid:85)(cid:3)(cid:38)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:3)(cid:79)(cid:76)(cid:81)(cid:72)(cid:17)(cid:3)(cid:50)(cid:89)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:83)(cid:68)(cid:86)(cid:87)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:72)(cid:81)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:87)(cid:72)(cid:81)(cid:16)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:81)(cid:88)(cid:73)(cid:68)(cid:70)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:86)(cid:83)(cid:72)(cid:70)(cid:76)(cid:191)(cid:70)(cid:3)(cid:84)(cid:88)(cid:68)(cid:81)(cid:87)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:85)(cid:72)(cid:72)(cid:3)(cid:71)(cid:76)(cid:73)(cid:73)(cid:72)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:87)(cid:72)(cid:85)(cid:80)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)
(cid:68)(cid:85)(cid:72)(cid:3)(cid:88)(cid:81)(cid:76)(cid:84)(cid:88)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:92)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:68)(cid:3)(cid:87)(cid:72)(cid:86)(cid:87)(cid:68)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:81)(cid:74)(cid:87)(cid:75)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:75)(cid:76)(cid:83)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:3)
(cid:90)(cid:75)(cid:82)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:74)(cid:81)(cid:76)(cid:93)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:70)(cid:72)(cid:83)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:84)(cid:88)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:182)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:17)(cid:3)(cid:44)(cid:81)(cid:3)(cid:70)(cid:82)(cid:81)(cid:81)(cid:72)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:76)(cid:86)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:81)(cid:72)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:83)(cid:68)(cid:81)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:88)(cid:85)(cid:85)(cid:72)(cid:81)(cid:87)(cid:3)(cid:38)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:17)(cid:3)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:72)(cid:91)(cid:83)(cid:68)(cid:81)(cid:86)(cid:76)(cid:82)(cid:81)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:83)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:92)(cid:3)(cid:69)(cid:92)(cid:3)(cid:23)(cid:23)(cid:8)(cid:3)(cid:90)(cid:75)(cid:76)(cid:79)(cid:72)(cid:3)(cid:72)(cid:81)(cid:86)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:182)(cid:86)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)
(cid:80)(cid:72)(cid:72)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:71)(cid:72)(cid:80)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:79)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:70)(cid:68)(cid:86)(cid:72)(cid:3)(cid:80)(cid:88)(cid:79)(cid:87)(cid:76)(cid:79)(cid:68)(cid:92)(cid:72)(cid:85)(cid:3)(cid:70)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:76)(cid:80)(cid:72)(cid:15)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:76)(cid:86)(cid:87)(cid:72)(cid:81)(cid:70)(cid:92)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:75)(cid:76)(cid:74)(cid:75)(cid:16)(cid:84)(cid:88)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:82)(cid:81)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:3)(cid:85)(cid:72)(cid:79)(cid:92)(cid:17)(cid:3)(cid:55)(cid:75)(cid:76)(cid:86)(cid:3)(cid:76)(cid:86)(cid:3)(cid:68)(cid:3)(cid:78)(cid:72)(cid:92)(cid:3)(cid:90)(cid:76)(cid:81)(cid:3)(cid:76)(cid:81)(cid:3)(cid:38)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)
(cid:83)(cid:82)(cid:87)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:3)(cid:82)(cid:73)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:72)(cid:86)(cid:86)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:83)(cid:85)(cid:72)(cid:16)(cid:86)(cid:82)(cid:79)(cid:71)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)(cid:22)(cid:22)(cid:8)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:92)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:68)(cid:74)(cid:85)(cid:72)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:17)
(cid:50)(cid:88)(cid:85)(cid:3)(cid:51)(cid:82)(cid:79)(cid:92)(cid:80)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:71)(cid:85)(cid:76)(cid:89)(cid:72)(cid:3)(cid:75)(cid:76)(cid:74)(cid:75)(cid:3)(cid:71)(cid:72)(cid:86)(cid:76)(cid:74)(cid:81)(cid:16)(cid:76)(cid:81)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:85)(cid:72)(cid:86)(cid:87)(cid:3)(cid:68)(cid:70)(cid:85)(cid:82)(cid:86)(cid:86)(cid:3)(cid:80)(cid:88)(cid:79)(cid:87)(cid:76)(cid:83)(cid:79)(cid:72)(cid:3)(cid:86)(cid:72)(cid:74)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:72)(cid:91)(cid:83)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:88)(cid:86)(cid:75)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:3)(cid:79)(cid:76)(cid:81)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:83)(cid:83)(cid:79)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:79)(cid:76)(cid:78)(cid:72)(cid:3)(cid:36)(cid:71)(cid:89)(cid:68)(cid:81)(cid:70)(cid:72)(cid:71)(cid:3)(cid:39)(cid:85)(cid:76)(cid:89)(cid:72)(cid:85)(cid:3)
(cid:36)(cid:86)(cid:86)(cid:76)(cid:86)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:54)(cid:92)(cid:86)(cid:87)(cid:72)(cid:80)(cid:86)(cid:15)(cid:3)(cid:68)(cid:88)(cid:87)(cid:82)(cid:81)(cid:82)(cid:80)(cid:82)(cid:88)(cid:86)(cid:3)(cid:71)(cid:85)(cid:76)(cid:89)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:24)(cid:42)(cid:15)(cid:3)(cid:75)(cid:76)(cid:74)(cid:75)(cid:16)(cid:72)(cid:81)(cid:71)(cid:3)(cid:79)(cid:68)(cid:83)(cid:87)(cid:82)(cid:83)(cid:86)(cid:15)(cid:3)(cid:87)(cid:68)(cid:69)(cid:79)(cid:72)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:90)(cid:72)(cid:68)(cid:85)(cid:68)(cid:69)(cid:79)(cid:72)(cid:86)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)
(cid:68)(cid:83)(cid:83)(cid:79)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:75)(cid:76)(cid:74)(cid:75)(cid:72)(cid:85)(cid:3)(cid:73)(cid:85)(cid:72)(cid:84)(cid:88)(cid:72)(cid:81)(cid:70)(cid:76)(cid:72)(cid:86)(cid:15)(cid:3)(cid:75)(cid:68)(cid:85)(cid:86)(cid:75)(cid:3)(cid:72)(cid:81)(cid:89)(cid:76)(cid:85)(cid:82)(cid:81)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:15)(cid:3)(cid:79)(cid:76)(cid:80)(cid:76)(cid:87)(cid:72)(cid:71)(cid:3)(cid:69)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:86)(cid:83)(cid:68)(cid:70)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:72)(cid:81)(cid:75)(cid:68)(cid:81)(cid:70)(cid:72)(cid:71)(cid:3)
(cid:68)(cid:88)(cid:71)(cid:76)(cid:82)(cid:3)(cid:84)(cid:88)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:85)(cid:72)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:83)(cid:79)(cid:68)(cid:70)(cid:72)(cid:3)(cid:68)(cid:3)(cid:75)(cid:76)(cid:74)(cid:75)(cid:3)(cid:89)(cid:68)(cid:79)(cid:88)(cid:72)(cid:3)(cid:82)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:73)(cid:82)(cid:85)(cid:80)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:68)(cid:71)(cid:89)(cid:68)(cid:81)(cid:87)(cid:68)(cid:74)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:51)(cid:82)(cid:79)(cid:92)(cid:80)(cid:72)(cid:85)(cid:3)(cid:55)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:17)
Film and Electrolytic
(cid:44)(cid:81)(cid:3)(cid:45)(cid:68)(cid:81)(cid:88)(cid:68)(cid:85)(cid:92)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:68)(cid:81)(cid:81)(cid:82)(cid:88)(cid:81)(cid:70)(cid:72)(cid:71)(cid:3)(cid:73)(cid:88)(cid:85)(cid:87)(cid:75)(cid:72)(cid:85)(cid:3)(cid:70)(cid:82)(cid:86)(cid:87)(cid:3)(cid:86)(cid:68)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:41)(cid:76)(cid:79)(cid:80)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:79)(cid:92)(cid:87)(cid:76)(cid:70)(cid:3)(cid:87)(cid:82)(cid:3)(cid:76)(cid:80)(cid:83)(cid:85)(cid:82)(cid:89)(cid:72)(cid:3)(cid:74)(cid:85)(cid:82)(cid:86)(cid:86)(cid:3)
(cid:80)(cid:68)(cid:85)(cid:74)(cid:76)(cid:81)(cid:86)(cid:15)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:70)(cid:82)(cid:80)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:192)(cid:82)(cid:90)(cid:17)(cid:3)(cid:55)(cid:75)(cid:72)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:68)(cid:80)(cid:79)(cid:76)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:80)(cid:68)(cid:81)(cid:88)(cid:73)(cid:68)(cid:70)(cid:87)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)
(cid:73)(cid:82)(cid:85)(cid:3)(cid:68)(cid:91)(cid:76)(cid:68)(cid:79)(cid:3)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:79)(cid:92)(cid:87)(cid:76)(cid:70)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:87)(cid:75)(cid:85)(cid:82)(cid:88)(cid:74)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:81)(cid:72)(cid:71)(cid:3)(cid:85)(cid:72)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:54)(cid:90)(cid:72)(cid:71)(cid:72)(cid:81)(cid:3)(cid:87)(cid:82)(cid:3)(cid:51)(cid:82)(cid:85)(cid:87)(cid:88)(cid:74)(cid:68)(cid:79)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)
(cid:68)(cid:79)(cid:79)(cid:82)(cid:90)(cid:3)(cid:88)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:76)(cid:81)(cid:70)(cid:85)(cid:72)(cid:68)(cid:86)(cid:72)(cid:3)(cid:192)(cid:72)(cid:91)(cid:76)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:15)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:72)(cid:87)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:83)(cid:79)(cid:68)(cid:70)(cid:72)(cid:17)(cid:3)(cid:55)(cid:75)(cid:76)(cid:86)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:81)(cid:72)(cid:71)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:68)(cid:81)(cid:88)(cid:73)(cid:68)(cid:70)(cid:87)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:82)(cid:70)(cid:72)(cid:86)(cid:86)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:85)(cid:72)(cid:71)(cid:88)(cid:70)(cid:72)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:82)(cid:86)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:80)(cid:83)(cid:85)(cid:82)(cid:89)(cid:72)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:80)(cid:72)(cid:72)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:74)(cid:76)(cid:81)(cid:74)(cid:3)(cid:71)(cid:72)(cid:80)(cid:68)(cid:81)(cid:71)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:17)(cid:3)
Magnetics, Sensors & Actuators
(cid:58)(cid:72)(cid:3)(cid:86)(cid:68)(cid:90)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:81)(cid:74)(cid:87)(cid:75)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:70)(cid:87)(cid:88)(cid:68)(cid:87)(cid:82)(cid:85)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:74)(cid:82)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:72)(cid:80)(cid:76)(cid:70)(cid:82)(cid:81)(cid:71)(cid:88)(cid:70)(cid:87)(cid:82)(cid:85)(cid:3)(cid:72)(cid:84)(cid:88)(cid:76)(cid:83)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:86)(cid:72)(cid:74)(cid:80)(cid:72)(cid:81)(cid:87)(cid:17)(cid:3)
(cid:44)(cid:81)(cid:3)(cid:68)(cid:71)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:71)(cid:72)(cid:80)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:83)(cid:76)(cid:72)(cid:93)(cid:82)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:88)(cid:80)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:72)(cid:85)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:191)(cid:86)(cid:75)(cid:3)(cid:191)(cid:81)(cid:71)(cid:72)(cid:85)(cid:3)
(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:90)(cid:68)(cid:86)(cid:3)(cid:86)(cid:82)(cid:79)(cid:76)(cid:71)(cid:17)(cid:3)(cid:39)(cid:72)(cid:80)(cid:68)(cid:81)(cid:71)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:80)(cid:72)(cid:87)(cid:68)(cid:79)(cid:3)(cid:80)(cid:68)(cid:87)(cid:72)(cid:85)(cid:76)(cid:68)(cid:79)(cid:86)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:86)(cid:72)(cid:74)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:85)(cid:72)(cid:80)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)
(cid:89)(cid:72)(cid:85)(cid:92)(cid:3)(cid:86)(cid:87)(cid:85)(cid:82)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:72)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:89)(cid:72)(cid:85)(cid:92)(cid:3)(cid:83)(cid:79)(cid:72)(cid:68)(cid:86)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:76)(cid:83)(cid:72)(cid:79)(cid:76)(cid:81)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)
(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:90)(cid:72)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:74)(cid:72)(cid:87)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:75)(cid:68)(cid:81)(cid:81)(cid:72)(cid:79)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:81)(cid:72)(cid:85)(cid:86)(cid:182)(cid:3)(cid:76)(cid:81)(cid:89)(cid:72)(cid:81)(cid:87)(cid:82)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:36)(cid:80)(cid:72)(cid:85)(cid:76)(cid:70)(cid:68)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:40)(cid:88)(cid:85)(cid:82)(cid:83)(cid:72)(cid:68)(cid:81)(cid:3)
(cid:85)(cid:72)(cid:74)(cid:76)(cid:82)(cid:81)(cid:86)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:80)(cid:68)(cid:78)(cid:76)(cid:81)(cid:74)(cid:3)(cid:74)(cid:85)(cid:72)(cid:68)(cid:87)(cid:3)(cid:86)(cid:87)(cid:85)(cid:76)(cid:71)(cid:72)(cid:86)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:85)(cid:82)(cid:86)(cid:86)(cid:16)(cid:86)(cid:72)(cid:79)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:82)(cid:81)(cid:86)(cid:17)
(cid:11)(cid:20)(cid:12)(cid:3)(cid:3)(cid:53)(cid:72)(cid:70)(cid:82)(cid:81)(cid:70)(cid:76)(cid:79)(cid:76)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:87)(cid:82)(cid:3)(cid:81)(cid:82)(cid:81)(cid:16)(cid:42)(cid:36)(cid:36)(cid:51)(cid:3)(cid:191)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:80)(cid:72)(cid:68)(cid:86)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:83)(cid:85)(cid:72)(cid:86)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:83)(cid:68)(cid:74)(cid:72)(cid:86)(cid:3)(cid:24)(cid:25)(cid:3)(cid:177)(cid:3)(cid:24)(cid:28)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:3)(cid:41)(cid:82)(cid:85)(cid:80)(cid:3)(cid:20)(cid:19)(cid:16)(cid:46)(cid:17)
Accelerating Future Growth
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:76)(cid:86)(cid:3)(cid:68)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:3)(cid:87)(cid:85)(cid:68)(cid:70)(cid:78)(cid:3)(cid:85)(cid:72)(cid:70)(cid:82)(cid:85)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:72)(cid:91)(cid:70)(cid:72)(cid:79)(cid:79)(cid:72)(cid:81)(cid:70)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:88)(cid:86)(cid:87)(cid:68)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:191)(cid:87)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:17)(cid:3)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:68)(cid:79)(cid:79)(cid:3)(cid:191)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:76)(cid:86)(cid:3)(cid:86)(cid:87)(cid:85)(cid:82)(cid:81)(cid:74)(cid:17)(cid:3)(cid:55)(cid:75)(cid:76)(cid:86)(cid:3)(cid:72)(cid:81)(cid:68)(cid:69)(cid:79)(cid:72)(cid:86)(cid:3)(cid:88)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:68)(cid:86)(cid:3)(cid:90)(cid:72)(cid:79)(cid:79)(cid:3)(cid:68)(cid:86)(cid:3)(cid:85)(cid:72)(cid:87)(cid:88)(cid:85)(cid:81)(cid:3)(cid:70)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:17)(cid:3)(cid:44)(cid:81)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:15)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:76)(cid:81)(cid:86)(cid:87)(cid:76)(cid:87)(cid:88)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:81)(cid:3)
(cid:68)(cid:81)(cid:81)(cid:88)(cid:68)(cid:79)(cid:76)(cid:93)(cid:72)(cid:71)(cid:3)(cid:70)(cid:68)(cid:86)(cid:75)(cid:3)(cid:71)(cid:76)(cid:89)(cid:76)(cid:71)(cid:72)(cid:81)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:7)(cid:19)(cid:17)(cid:21)(cid:19)(cid:3)(cid:83)(cid:72)(cid:85)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:3)(cid:178)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:191)(cid:85)(cid:86)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:182)(cid:86)(cid:3)(cid:75)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:92)(cid:15)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:85)(cid:72)(cid:87)(cid:88)(cid:85)(cid:81)(cid:3)
(cid:82)(cid:73)(cid:3)(cid:70)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:71)(cid:72)(cid:80)(cid:82)(cid:81)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:81)(cid:75)(cid:68)(cid:81)(cid:70)(cid:76)(cid:81)(cid:74)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:89)(cid:68)(cid:79)(cid:88)(cid:72)(cid:17)
(cid:58)(cid:72)(cid:3)(cid:87)(cid:75)(cid:76)(cid:81)(cid:78)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:76)(cid:70)(cid:68)(cid:79)(cid:79)(cid:92)(cid:3)(cid:68)(cid:69)(cid:82)(cid:88)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:81)(cid:3)(cid:72)(cid:92)(cid:72)(cid:3)(cid:87)(cid:82)(cid:90)(cid:68)(cid:85)(cid:71)(cid:3)(cid:74)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)(cid:3)(cid:80)(cid:72)(cid:74)(cid:68)(cid:87)(cid:85)(cid:72)(cid:81)(cid:71)(cid:86)(cid:3)(cid:178)(cid:3)(cid:68)(cid:81)(cid:3)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:76)(cid:191)(cid:72)(cid:71)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:81)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:90)(cid:82)(cid:85)(cid:79)(cid:71)(cid:15)(cid:3)(cid:72)(cid:81)(cid:72)(cid:85)(cid:74)(cid:92)(cid:3)(cid:72)(cid:73)(cid:191)(cid:70)(cid:76)(cid:72)(cid:81)(cid:70)(cid:92)(cid:15)(cid:3)(cid:86)(cid:68)(cid:73)(cid:72)(cid:87)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:3)(cid:76)(cid:81)(cid:81)(cid:82)(cid:89)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:17)(cid:3)(cid:36)(cid:81)(cid:87)(cid:76)(cid:70)(cid:76)(cid:83)(cid:68)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:81)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:86)(cid:72)(cid:3)(cid:87)(cid:85)(cid:72)(cid:81)(cid:71)(cid:86)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:3)(cid:70)(cid:85)(cid:76)(cid:87)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:68)(cid:86)(cid:3)(cid:90)(cid:72)(cid:3)(cid:70)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:76)(cid:93)(cid:72)(cid:3)(cid:82)(cid:81)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:76)(cid:70)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:82)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:68)(cid:79)(cid:76)(cid:74)(cid:81)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)
(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:87)(cid:85)(cid:72)(cid:81)(cid:74)(cid:87)(cid:75)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:68)(cid:71)(cid:77)(cid:68)(cid:70)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:72)(cid:91)(cid:76)(cid:86)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:17)
(cid:36)(cid:86)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:83)(cid:79)(cid:68)(cid:81)(cid:81)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:87)(cid:68)(cid:85)(cid:74)(cid:72)(cid:87)(cid:86)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:81)(cid:72)(cid:91)(cid:87)(cid:3)(cid:191)(cid:89)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)(cid:76)(cid:81)(cid:70)(cid:79)(cid:88)(cid:71)(cid:72)(cid:29)
•(cid:3)(cid:36)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:81)(cid:3)(cid:82)(cid:85)(cid:74)(cid:68)(cid:81)(cid:76)(cid:70)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:38)(cid:36)(cid:42)(cid:53)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:87)(cid:3)(cid:79)(cid:72)(cid:68)(cid:86)(cid:87)(cid:3)(cid:24)(cid:8)(cid:3)(cid:83)(cid:72)(cid:85)(cid:70)(cid:72)(cid:81)(cid:87)
•(cid:3)(cid:3)(cid:42)(cid:85)(cid:82)(cid:90)(cid:76)(cid:81)(cid:74)(cid:3)(cid:85)(cid:72)(cid:89)(cid:72)(cid:81)(cid:88)(cid:72)(cid:3)(cid:68)(cid:87)(cid:3)(cid:68)(cid:3)(cid:38)(cid:36)(cid:42)(cid:53)(cid:3)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:24)(cid:8)(cid:3)(cid:87)(cid:75)(cid:85)(cid:82)(cid:88)(cid:74)(cid:75)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:68)(cid:87)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:81)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:191)(cid:89)(cid:72)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)
•(cid:3)(cid:39)(cid:72)(cid:89)(cid:72)(cid:79)(cid:82)(cid:83)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:76)(cid:83)(cid:79)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:70)(cid:68)(cid:83)(cid:76)(cid:87)(cid:68)(cid:79)(cid:3)(cid:68)(cid:79)(cid:79)(cid:82)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:72)(cid:81)(cid:75)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:85)(cid:72)(cid:87)(cid:88)(cid:85)(cid:81)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:85)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:182)(cid:86)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:86)(cid:88)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:79)(cid:90)(cid:68)(cid:92)(cid:86)(cid:3)(cid:90)(cid:76)(cid:79)(cid:79)(cid:3)(cid:69)(cid:72)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:71)(cid:76)(cid:86)(cid:70)(cid:76)(cid:83)(cid:79)(cid:76)(cid:81)(cid:72)(cid:71)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:76)(cid:86)(cid:87)(cid:72)(cid:81)(cid:87)(cid:3)(cid:72)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:68)(cid:3)(cid:70)(cid:79)(cid:72)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:86)(cid:87)(cid:85)(cid:68)(cid:87)(cid:72)(cid:74)(cid:92)(cid:17)
Sustainability Leadership
(cid:55)(cid:75)(cid:76)(cid:86)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:88)(cid:71)(cid:79)(cid:92)(cid:3)(cid:83)(cid:88)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:72)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:191)(cid:85)(cid:86)(cid:87)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:54)(cid:88)(cid:86)(cid:87)(cid:68)(cid:76)(cid:81)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:53)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:82)(cid:88)(cid:87)(cid:79)(cid:76)(cid:81)(cid:72)(cid:86)(cid:3)
(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:72)(cid:81)(cid:89)(cid:76)(cid:85)(cid:82)(cid:81)(cid:80)(cid:72)(cid:81)(cid:87)(cid:15)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:90)(cid:75)(cid:72)(cid:85)(cid:72)(cid:3)(cid:90)(cid:72)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:17)(cid:3)
(cid:54)(cid:88)(cid:86)(cid:87)(cid:68)(cid:76)(cid:81)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:75)(cid:68)(cid:86)(cid:3)(cid:69)(cid:72)(cid:72)(cid:81)(cid:3)(cid:68)(cid:3)(cid:79)(cid:68)(cid:85)(cid:74)(cid:72)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:182)(cid:86)(cid:3)(cid:70)(cid:88)(cid:79)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:80)(cid:68)(cid:81)(cid:92)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:85)(cid:72)(cid:83)(cid:82)(cid:85)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:68)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:87)(cid:76)(cid:81)(cid:88)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:86)(cid:87)(cid:68)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)(cid:83)(cid:82)(cid:79)(cid:76)(cid:70)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:70)(cid:82)(cid:81)(cid:71)(cid:88)(cid:70)(cid:87)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:68)(cid:3)(cid:85)(cid:72)(cid:86)(cid:83)(cid:82)(cid:81)(cid:86)(cid:76)(cid:69)(cid:79)(cid:72)(cid:3)(cid:90)(cid:68)(cid:92)(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:88)(cid:86)(cid:72)(cid:86)(cid:3)(cid:81)(cid:72)(cid:68)(cid:85)(cid:79)(cid:92)(cid:3)(cid:75)(cid:68)(cid:79)(cid:73)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:20)(cid:20)(cid:27)(cid:3)(cid:72)(cid:79)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:72)(cid:85)(cid:76)(cid:82)(cid:71)(cid:76)(cid:70)(cid:3)(cid:87)(cid:68)(cid:69)(cid:79)(cid:72)(cid:15)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:80)(cid:82)(cid:85)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:70)(cid:82)(cid:80)(cid:72)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)
(cid:87)(cid:75)(cid:72)(cid:3)(cid:90)(cid:82)(cid:85)(cid:79)(cid:71)(cid:182)(cid:86)(cid:3)(cid:79)(cid:68)(cid:85)(cid:74)(cid:72)(cid:86)(cid:87)(cid:3)(cid:88)(cid:86)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:79)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:26)(cid:22)(cid:15)(cid:3)(cid:87)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:17)(cid:3)(cid:42)(cid:76)(cid:89)(cid:72)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:81)(cid:86)(cid:76)(cid:89)(cid:72)(cid:3)(cid:81)(cid:68)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:85)(cid:72)(cid:86)(cid:82)(cid:88)(cid:85)(cid:70)(cid:72)(cid:3)(cid:72)(cid:91)(cid:87)(cid:85)(cid:68)(cid:70)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:74)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)(cid:3)(cid:73)(cid:82)(cid:82)(cid:87)(cid:83)(cid:85)(cid:76)(cid:81)(cid:87)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:88)(cid:81)(cid:71)(cid:72)(cid:85)(cid:86)(cid:87)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:76)(cid:80)(cid:83)(cid:82)(cid:85)(cid:87)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:83)(cid:85)(cid:82)(cid:80)(cid:82)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:86)(cid:88)(cid:86)(cid:87)(cid:68)(cid:76)(cid:81)(cid:68)(cid:69)(cid:76)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:82)(cid:73)(cid:3)(cid:81)(cid:82)(cid:87)(cid:3)(cid:82)(cid:81)(cid:79)(cid:92)(cid:3)
(cid:82)(cid:88)(cid:85)(cid:3)(cid:71)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)(cid:69)(cid:88)(cid:87)(cid:3)(cid:68)(cid:79)(cid:86)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:88)(cid:83)(cid:83)(cid:79)(cid:92)(cid:3)(cid:70)(cid:75)(cid:68)(cid:76)(cid:81)(cid:17)(cid:3)(cid:58)(cid:72)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:87)(cid:72)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:69)(cid:72)(cid:87)(cid:87)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:68)(cid:73)(cid:72)(cid:85)(cid:15)(cid:3)(cid:80)(cid:82)(cid:85)(cid:72)(cid:3)
(cid:70)(cid:82)(cid:81)(cid:81)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:72)(cid:81)(cid:86)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)(cid:72)(cid:73)(cid:191)(cid:70)(cid:76)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:88)(cid:86)(cid:87)(cid:68)(cid:76)(cid:81)(cid:68)(cid:69)(cid:79)(cid:92)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:87)(cid:17)(cid:3)
(cid:44)(cid:81)(cid:3)(cid:191)(cid:86)(cid:70)(cid:68)(cid:79)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:3)(cid:21)(cid:19)(cid:20)(cid:28)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:85)(cid:72)(cid:71)(cid:88)(cid:70)(cid:72)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:68)(cid:85)(cid:69)(cid:82)(cid:81)(cid:3)(cid:73)(cid:82)(cid:82)(cid:87)(cid:83)(cid:85)(cid:76)(cid:81)(cid:87)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)(cid:21)(cid:22)(cid:8)(cid:3)(cid:82)(cid:89)(cid:72)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:83)(cid:85)(cid:76)(cid:82)(cid:85)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:17)
Celebrating Innovation in This Century and the Next
(cid:58)(cid:72)(cid:3)(cid:87)(cid:68)(cid:78)(cid:72)(cid:3)(cid:74)(cid:85)(cid:72)(cid:68)(cid:87)(cid:3)(cid:83)(cid:85)(cid:76)(cid:71)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:75)(cid:68)(cid:89)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:70)(cid:75)(cid:76)(cid:72)(cid:89)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:80)(cid:76)(cid:79)(cid:72)(cid:86)(cid:87)(cid:82)(cid:81)(cid:72)(cid:3)(cid:73)(cid:72)(cid:90)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:76)(cid:72)(cid:86)(cid:3)(cid:72)(cid:89)(cid:72)(cid:85)(cid:3)(cid:85)(cid:72)(cid:68)(cid:70)(cid:75)(cid:3)(cid:178)(cid:3)(cid:20)(cid:19)(cid:19)(cid:3)(cid:92)(cid:72)(cid:68)(cid:85)(cid:86)(cid:3)
(cid:76)(cid:81)(cid:3)(cid:69)(cid:88)(cid:86)(cid:76)(cid:81)(cid:72)(cid:86)(cid:86)(cid:17)(cid:3)(cid:50)(cid:88)(cid:85)(cid:3)(cid:76)(cid:81)(cid:81)(cid:82)(cid:89)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:72)(cid:81)(cid:68)(cid:69)(cid:79)(cid:72)(cid:71)(cid:3)(cid:86)(cid:82)(cid:80)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:82)(cid:86)(cid:87)(cid:3)(cid:86)(cid:76)(cid:74)(cid:81)(cid:76)(cid:191)(cid:70)(cid:68)(cid:81)(cid:87)(cid:3)(cid:87)(cid:72)(cid:70)(cid:75)(cid:81)(cid:82)(cid:79)(cid:82)(cid:74)(cid:76)(cid:70)(cid:68)(cid:79)(cid:3)(cid:68)(cid:71)(cid:89)(cid:68)(cid:81)(cid:70)(cid:72)(cid:86)(cid:3)
(cid:178)(cid:3)(cid:73)(cid:85)(cid:82)(cid:80)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:89)(cid:68)(cid:70)(cid:88)(cid:88)(cid:80)(cid:3)(cid:87)(cid:88)(cid:69)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:85)(cid:68)(cid:81)(cid:86)(cid:76)(cid:86)(cid:87)(cid:82)(cid:85)(cid:3)(cid:72)(cid:85)(cid:68)(cid:86)(cid:3)(cid:87)(cid:82)(cid:3)(cid:83)(cid:76)(cid:82)(cid:81)(cid:72)(cid:72)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:71)(cid:76)(cid:86)(cid:70)(cid:82)(cid:89)(cid:72)(cid:85)(cid:76)(cid:72)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:21)(cid:20)(cid:86)(cid:87)(cid:3)(cid:38)(cid:72)(cid:81)(cid:87)(cid:88)(cid:85)(cid:92)(cid:17)(cid:3)
(cid:58)(cid:72)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:68)(cid:70)(cid:70)(cid:82)(cid:80)(cid:83)(cid:79)(cid:76)(cid:86)(cid:75)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:76)(cid:86)(cid:3)(cid:87)(cid:75)(cid:85)(cid:82)(cid:88)(cid:74)(cid:75)(cid:3)(cid:68)(cid:81)(cid:3)(cid:88)(cid:81)(cid:90)(cid:68)(cid:89)(cid:72)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:80)(cid:76)(cid:86)(cid:86)(cid:76)(cid:82)(cid:81)(cid:29)(cid:3)(cid:87)(cid:82)(cid:3)(cid:80)(cid:68)(cid:78)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:90)(cid:82)(cid:85)(cid:79)(cid:71)(cid:3)(cid:68)(cid:3)(cid:69)(cid:72)(cid:87)(cid:87)(cid:72)(cid:85)(cid:15)(cid:3)(cid:86)(cid:68)(cid:73)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:82)(cid:85)(cid:72)(cid:3)(cid:70)(cid:82)(cid:81)(cid:81)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)(cid:83)(cid:79)(cid:68)(cid:70)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:79)(cid:76)(cid:89)(cid:72)(cid:17)
(cid:50)(cid:88)(cid:85)(cid:3)(cid:68)(cid:83)(cid:83)(cid:85)(cid:82)(cid:91)(cid:76)(cid:80)(cid:68)(cid:87)(cid:72)(cid:79)(cid:92)(cid:3)(cid:20)(cid:24)(cid:15)(cid:19)(cid:19)(cid:19)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:3)(cid:90)(cid:82)(cid:85)(cid:79)(cid:71)(cid:90)(cid:76)(cid:71)(cid:72)(cid:3)(cid:87)(cid:68)(cid:78)(cid:72)(cid:3)(cid:74)(cid:85)(cid:72)(cid:68)(cid:87)(cid:3)(cid:83)(cid:85)(cid:76)(cid:71)(cid:72)(cid:3)(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:76)(cid:85)(cid:3)(cid:90)(cid:82)(cid:85)(cid:78)(cid:15)(cid:3)(cid:90)(cid:75)(cid:76)(cid:70)(cid:75)(cid:3)(cid:76)(cid:86)(cid:3)(cid:85)(cid:72)(cid:192)(cid:72)(cid:70)(cid:87)(cid:72)(cid:71)(cid:3)
(cid:76)(cid:81)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:84)(cid:88)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:81)(cid:76)(cid:70)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:82)(cid:81)(cid:72)(cid:81)(cid:87)(cid:86)(cid:3)(cid:87)(cid:75)(cid:68)(cid:87)(cid:3)(cid:90)(cid:72)(cid:3)(cid:83)(cid:85)(cid:82)(cid:89)(cid:76)(cid:71)(cid:72)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:87)(cid:85)(cid:68)(cid:81)(cid:86)(cid:83)(cid:82)(cid:85)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:80)(cid:72)(cid:71)(cid:76)(cid:70)(cid:68)(cid:79)(cid:15)(cid:3)(cid:80)(cid:76)(cid:79)(cid:76)(cid:87)(cid:68)(cid:85)(cid:92)(cid:15)(cid:3)
(cid:68)(cid:72)(cid:85)(cid:82)(cid:86)(cid:83)(cid:68)(cid:70)(cid:72)(cid:15)(cid:3)(cid:76)(cid:81)(cid:71)(cid:88)(cid:86)(cid:87)(cid:85)(cid:76)(cid:68)(cid:79)(cid:15)(cid:3)(cid:87)(cid:72)(cid:79)(cid:72)(cid:70)(cid:82)(cid:80)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:70)(cid:82)(cid:81)(cid:86)(cid:88)(cid:80)(cid:72)(cid:85)(cid:3)(cid:83)(cid:85)(cid:82)(cid:71)(cid:88)(cid:70)(cid:87)(cid:3)(cid:76)(cid:81)(cid:71)(cid:88)(cid:86)(cid:87)(cid:85)(cid:76)(cid:72)(cid:86)(cid:17)(cid:3)(cid:38)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:3)(cid:75)(cid:68)(cid:89)(cid:72)(cid:3)(cid:87)(cid:85)(cid:88)(cid:86)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)
(cid:82)(cid:88)(cid:85)(cid:3)(cid:85)(cid:72)(cid:79)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:75)(cid:76)(cid:83)(cid:86)(cid:3)(cid:69)(cid:72)(cid:70)(cid:68)(cid:88)(cid:86)(cid:72)(cid:3)(cid:90)(cid:72)(cid:3)(cid:75)(cid:82)(cid:81)(cid:82)(cid:85)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:81)(cid:87)(cid:85)(cid:68)(cid:70)(cid:87)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:90)(cid:72)(cid:3)(cid:78)(cid:72)(cid:72)(cid:83)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:76)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:86)(cid:17)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:76)(cid:86)(cid:3)(cid:69)(cid:85)(cid:76)(cid:74)(cid:75)(cid:87)(cid:3)(cid:68)(cid:86)(cid:3)(cid:68)(cid:3)(cid:85)(cid:72)(cid:86)(cid:88)(cid:79)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:87)(cid:85)(cid:82)(cid:81)(cid:74)(cid:3)(cid:191)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:76)(cid:81)(cid:3)(cid:76)(cid:81)(cid:81)(cid:82)(cid:89)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:71)(cid:76)(cid:89)(cid:72)(cid:85)(cid:86)(cid:72)(cid:3)(cid:83)(cid:82)(cid:85)(cid:87)(cid:73)(cid:82)(cid:79)(cid:76)(cid:82)(cid:3)(cid:82)(cid:73)(cid:3)(cid:71)(cid:76)(cid:73)(cid:73)(cid:72)(cid:85)(cid:72)(cid:81)(cid:87)(cid:76)(cid:68)(cid:87)(cid:72)(cid:71)(cid:3)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:81)(cid:76)(cid:70)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:82)(cid:81)(cid:72)(cid:81)(cid:87)(cid:3)(cid:86)(cid:82)(cid:79)(cid:88)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:3)(cid:71)(cid:72)(cid:80)(cid:68)(cid:81)(cid:71)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:75)(cid:76)(cid:74)(cid:75)(cid:72)(cid:86)(cid:87)(cid:3)(cid:86)(cid:87)(cid:68)(cid:81)(cid:71)(cid:68)(cid:85)(cid:71)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:84)(cid:88)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:15)(cid:3)(cid:71)(cid:72)(cid:79)(cid:76)(cid:89)(cid:72)(cid:85)(cid:92)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:86)(cid:72)(cid:85)(cid:89)(cid:76)(cid:70)(cid:72)(cid:17)(cid:3)(cid:36)(cid:86)(cid:3)(cid:90)(cid:72)(cid:3)(cid:79)(cid:82)(cid:82)(cid:78)(cid:3)(cid:68)(cid:75)(cid:72)(cid:68)(cid:71)(cid:15)(cid:3)(cid:90)(cid:72)(cid:3)(cid:86)(cid:72)(cid:72)(cid:3)(cid:87)(cid:85)(cid:72)(cid:80)(cid:72)(cid:81)(cid:71)(cid:82)(cid:88)(cid:86)(cid:3)(cid:82)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:88)(cid:81)(cid:76)(cid:87)(cid:92)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:69)(cid:88)(cid:76)(cid:79)(cid:71)(cid:3)(cid:82)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:83)(cid:82)(cid:86)(cid:76)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:80)(cid:82)(cid:80)(cid:72)(cid:81)(cid:87)(cid:88)(cid:80)(cid:15)(cid:3)(cid:71)(cid:85)(cid:76)(cid:89)(cid:72)(cid:3)(cid:79)(cid:82)(cid:81)(cid:74)(cid:16)(cid:87)(cid:72)(cid:85)(cid:80)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:72)(cid:81)(cid:75)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:3)(cid:89)(cid:68)(cid:79)(cid:88)(cid:72)(cid:17)
(cid:50)(cid:81)(cid:3)(cid:69)(cid:72)(cid:75)(cid:68)(cid:79)(cid:73)(cid:3)(cid:82)(cid:73)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:37)(cid:82)(cid:68)(cid:85)(cid:71)(cid:3)(cid:82)(cid:73)(cid:3)(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:87)(cid:72)(cid:68)(cid:80)(cid:15)(cid:3)(cid:44)(cid:3)(cid:90)(cid:68)(cid:81)(cid:87)(cid:3)(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:68)(cid:81)(cid:78)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:72)(cid:80)(cid:83)(cid:79)(cid:82)(cid:92)(cid:72)(cid:72)(cid:86)(cid:15)(cid:3)(cid:70)(cid:88)(cid:86)(cid:87)(cid:82)(cid:80)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)
(cid:86)(cid:88)(cid:83)(cid:83)(cid:79)(cid:76)(cid:72)(cid:85)(cid:86)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:70)(cid:82)(cid:80)(cid:80)(cid:88)(cid:81)(cid:76)(cid:87)(cid:76)(cid:72)(cid:86)(cid:3)(cid:90)(cid:75)(cid:72)(cid:85)(cid:72)(cid:3)(cid:90)(cid:72)(cid:3)(cid:82)(cid:83)(cid:72)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:75)(cid:68)(cid:85)(cid:72)(cid:75)(cid:82)(cid:79)(cid:71)(cid:72)(cid:85)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:89)(cid:76)(cid:87)(cid:68)(cid:79)(cid:3)(cid:85)(cid:82)(cid:79)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:92)(cid:3)(cid:68)(cid:79)(cid:79)(cid:3)(cid:83)(cid:79)(cid:68)(cid:92)(cid:3)
(cid:76)(cid:81)(cid:3)(cid:82)(cid:88)(cid:85)(cid:3)(cid:86)(cid:88)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:17)(cid:3)(cid:44)(cid:87)(cid:3)(cid:76)(cid:86)(cid:3)(cid:72)(cid:91)(cid:70)(cid:76)(cid:87)(cid:76)(cid:81)(cid:74)(cid:3)(cid:87)(cid:82)(cid:3)(cid:75)(cid:72)(cid:79)(cid:83)(cid:3)(cid:86)(cid:75)(cid:68)(cid:83)(cid:72)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:73)(cid:88)(cid:87)(cid:88)(cid:85)(cid:72)(cid:3)(cid:82)(cid:73)(cid:3)(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:81)(cid:76)(cid:70)(cid:86)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:44)(cid:3)(cid:68)(cid:80)(cid:3)(cid:75)(cid:88)(cid:80)(cid:69)(cid:79)(cid:72)(cid:71)(cid:3)(cid:69)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:82)(cid:83)(cid:83)(cid:82)(cid:85)(cid:87)(cid:88)(cid:81)(cid:76)(cid:87)(cid:92)(cid:3)(cid:87)(cid:82)(cid:3)(cid:79)(cid:72)(cid:68)(cid:71)(cid:3)(cid:86)(cid:88)(cid:70)(cid:75)(cid:3)(cid:68)(cid:3)(cid:74)(cid:85)(cid:72)(cid:68)(cid:87)(cid:3)(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:17)
(cid:54)(cid:76)(cid:81)(cid:70)(cid:72)(cid:85)(cid:72)(cid:79)(cid:92)(cid:15)
William M.Lowe, Jr.
(cid:58)(cid:76)(cid:79)(cid:79)(cid:76)(cid:68)(cid:80)(cid:3)(cid:48)(cid:17)(cid:3)(cid:47)(cid:82)(cid:90)(cid:72)(cid:15)(cid:3)(cid:45)(cid:85)(cid:17)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________
FORM 10-K
(Mark One)
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended March 31, 2019
Or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-15491
____________________________________________________________________________
KEMET Corporation
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
KEMET Tower, One East Broward Blvd., Fort
Lauderdale, Florida
(Address of principal executive offices)
57-0923789
(I.R.S. Employer
Identification No.)
33301
(Zip Code)
Registrant’s telephone number, including area code: (954) 766-2800
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of exchange on which registered
Common Stock, par value $0.01
KEM
New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None.
____________________________________________________________________________
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
No
Yes
Yes
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be
submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit such files). Yes
No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act (Check one):
Large Accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes
No
The aggregate market value of voting common stock held by non-affiliates of the registrant as of September 30, 2018
computed by reference to the closing sale price of the registrant’s common stock was approximately $1,021,114,987.
The number of shares of each class of common stock, $0.01 par value, outstanding as of May 27, 2019 was 58,001,480.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive proxy statement to be delivered to stockholders in connection with the Annual Meeting of
Stockholders to be held July 31, 2019 are incorporated by reference into Part III of this report.
Part I
Page No.
Table of Contents
ITEM 1.
BUSINESS
ITEM 1A.
RISK FACTORS
ITEM 1B.
UNRESOLVED STAFF COMMENTS
ITEM 2.
ITEM 3.
ITEM 4.
PROPERTIES
LEGAL PROCEEDINGS
MINE SAFETY DISCLOSURES
ITEM 4A.
INFORMATION ABOUT OUR EXECUTIVE OFFICERS
Part II
ITEM 5.
ITEM 6.
ITEM 7.
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES
SELECTED FINANCIAL DATA
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 8.
ITEM 9.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE
ITEM 9A.
CONTROLS AND PROCEDURES
ITEM 9B.
OTHER INFORMATION
Part III
ITEM 10.
ITEM 11.
ITEM 12.
ITEM 13.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
EXECUTIVE COMPENSATION
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE
ITEM 14.
PRINCIPAL ACCOUNTANT FEES AND SERVICES
Part IV
ITEM 15.
ITEM 16.
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
FORM 10-K SUMMARY
SIGNATURES
4
15
22
23
24
26
26
29
32
33
61
61
61
62
63
64
64
64
64
64
65
136
137
3
ITEM 1. BUSINESS
Background of Company
PART I
KEMET Corporation (“we,” “us,” “our,” “KEMET” and the “Company”), is a global manufacturer of passive
electronic components. We first began manufacturing tantalum capacitors in 1958 as a division of Union Carbide Corporation
(“UCC”) and became a stand-alone legal entity in 1990 following a management buyout from UCC. In 1992, we publicly
issued shares of our common stock. Since then, we have made the following acquisitions:
Segment
Fiscal Year
Business
Solid Capacitors Segment (“Solid Capacitors”)
Film and Electrolytic Segment (“Film and Electrolytic”)
Film and Electrolytic
Film and Electrolytic
Solid Capacitors
Corporate
Corporate
Solid Capacitors and Electro-Magnetic, Sensors, and Actuators
Segment (“MSA”)
2007
2008
2008
2012
2012
2013
2016
2018
Tantalum Business Unit of EPCOS AG
Evox Rifa Group Oyj
Arcotronics Italia S.p.A.
Cornell Dubilier Foil, LLC (renamed
KEMET Foil Manufacturing, LLC
(“KFM”))
Niotan Incorporated (renamed KEMET
Blue Powder Corporation (“KBP”))
34% economic interest in TOKIN
Corporation (“TOKIN”) (1)
IntelliData, Inc. (“IntelliData”)
TOKIN (1)
______________________________________________________________________________
(1) In fiscal year 2013, our subsidiary, KEMET Electronics Corporation (“KEC”) acquired a 34% economic interest in TOKIN as calculated based on the
number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and preferred shares of TOKIN outstanding
as of such date. The Company accounted for its investment in TOKIN using the equity method for a non-consolidated variable interest entity since KEC did not
have the power to direct significant activities of TOKIN. During fiscal year 2018, KEMET entered into a Definitive NEC TOKIN Stock Purchase Agreement
(the “TOKIN Purchase Agreement”) with NEC Corporation (“NEC”), to acquire all of the outstanding shares of common stock and preferred stock of TOKIN
not already held by KEMET. The transaction closed on April 19, 2017 and on that date, TOKIN became a 100% indirect owned subsidiary of KEMET.
Through the above acquisitions and organic growth we have expanded our product base to include multilayer ceramic,
solid and electrolytic aluminum and film capacitors, and electro-magnetics, sensors, and actuators.
Strategy
KEMET is committed to providing its customers with high quality, low cost solutions for their electronic applications
and strives to create shareholder value primarily through the following strategic priorities:
•
•
•
•
leveraging our manufacturing expertise;
strengthening our “Go-to-Market” leadership position;
consistently attracting and retaining exceptional talent; and,
selectively target complementary acquisitions and equity investments.
KEMET measures its progress against these strategic priorities over the long-term based primarily on financial metrics
including revenue growth, profitability, free cash flow, and balance sheet liquidity.
We believe this strategy has successfully transformed the Company and positioned it to capture the growing demand
for custom designed, higher margin electronic components in several industry segments. KEMET's transformation has resulted
in increased and sustainable margins, and has enhanced the durability of our revenue base. In addition, we intend to leverage
KEMET's strong proprietary technology to support future organic growth in key markets.
4
Strategic Highlights
With the completion of the TOKIN acquisition and the vertical integration of KEMET's Solid Capacitors' Tantalum
product line, the Tantalum product line is well positioned to continue its recent success. The Tantalum product line is now
focused on its Polymer technology and is benefiting from operational synergies from the TOKIN acquisition, which reduced
operating costs, improved yields, and provided access to new market segments. In addition, vertical integration of the tantalum
ore supply chain has resulted in savings of approximately $50.0 million per year compared to 2012 and has created stability in
our cost structure. As a result of the enhanced Polymer focus, KEMET’s Polymer Tantalum sales now lead the industry with
greater than 50.0% market share. We believe leveraging KEMET's and TOKIN's manufacturing expertise combined with
vertical integration has successfully transformed KEMET's Tantalum product line and positioned it well for new growth
opportunities across multiple industry segments, especially those segments demanding higher reliability in harsh environment
applications.
KEMET's Solid Capacitors' Ceramic product line is also well positioned for new opportunities. The Ceramic product
line began its transformation in 2008 when it shifted it's focus from consumer markets to business to business markets, across
the automotive defense/aerospace, medical, energy, telecommunications, and industrial sectors. While KEMET's competitors
focused on small case size multi-layer ceramic capacitors (MLCC's), KEMET's Ceramic product line focused on building a
core competency in high-reliability, high-voltage/power, large case size MLCC's. Since 2010, the Cumulative Annual Growth
Rate (CAGR) of KEMET's chosen markets was approximately 17.0%. KEMET's Ceramic MLCC's are in high demand, and
during fiscal year 2019, the Company entered into long-term (10 year) supply agreements with three significant customers that
are projected to account for approximately 33.0% of KEMET's total capacity in fiscal year 2022. KEMET is in the process of
expanding its current MLCC production capacity, which currently is approximately 49 billion pieces per year. The Company
expects to have the ability to produce 72 billion pieces per year by fiscal year 2022. Approximately 24 billion, or 33.0% of
these pieces are committed to the three customers that signed long-term supply agreements. We believe operational and
strategic agility have successfully transformed our Ceramic product line.
The completion of KEMET's acquisition of TOKIN in fiscal year 2018 further diversified KEMET's products and
geographic markets, facilitating cross selling opportunities that support KEMET's "long tail" (see below) selling strategy.
TOKIN's MSA reportable segment added approximately $240.0 million in net sales. The added liquidity from TOKIN's balance
sheet reduced KEMET's consolidated net debt, permitting a debt refinancing arrangement in Japan. This debt refinancing
provides annual interest savings of approximately $21.0 million. Additionally, the acquisition has contributed to the
development of new technology, and as noted above, has created operational synergies and improved yields in KEMET's
existing Tantalum product line.
KEMET's “Go-to-Market” strategy includes four key elements which have contributed to KEMET's success and
supported the structural transformation noted above:
• Global Sales Team
• Design-In Focus
•
Service "Long Tail" (high mix, low volume) Customers
• Customer Digital Engagement Platform
KEMET's global sales team consists of over 100 professionals supporting each region. Sales people, application
engineers and customer service representatives are located close to KEMET's customers allowing frequent face-to-face
conversations. In addition, we partner with all the premier distributors in the electronics industry ensuring we obtain a large
geographical sales presence and can leverage their expertise in stocking and servicing customers.
Adding value to our customers is an important part of our relationship and over the years we have transformed our
product portfolio from a commodity based approach to a customized, design-in approach. To support our design-in strategy, our
global sales team includes field application engineers with degrees in electrical engineering that work directly with our
customers at the early stages of product development to ensure KEMET's products are designed-into the product applications.
As a result, today, we target all the key fast growing applications in the electronic market including, but not limited to, electric
vehicles, industry 4.0, autonomous driving, artificial intelligence, and data storage.
While a global sales team focuses on our larger customers, KEMET has also developed a comprehensive strategy to
serve our “long tail” customers (the smaller customers), which are approximately 180,000 customers that account for
approximately 50.0% of our net sales. This allows us to not only provide world class customer service to our smaller
customers, but also provides KEMET with an improved opportunity to partner with today's smaller companies that are
potentially tomorrow's leading electronic companies. To do so, we have developed an internal culture and supporting business
processes to engage with high-mix/low-volume requirements that are typical from the “long-tail” customer.
5
KEMET supports its global sales initiatives with its market leading customer digital engagement platform. We believe
the electronic component industry is still in the early stages of “digital disruption” (how electronic manufacturers go to market).
We believe our existing and continuously improving component simulation, component search, and component quoting
platforms for buyers are market leading and put KEMET at the forefront of the “digital disruption” that will transform how the
electronic components are sold in the future.
Finally, as strategic opportunities are identified, we will evaluate and possibly pursue them if they would enable us to
enhance our competitive position and expand our market presence. Our strategy is to acquire complementary capacitor and
other related businesses allowing us to leverage our business model, potentially including those involved in other passive
components that are synergistic with our customers’ technologies and our current product offerings.
We believe KEMET's business strategy will allow us to leverage the global mega-trends of an increasingly electrified
and connected world and positions KEMET well for growth, both internally and through acquisitions. Organic revenue is
targeted to grow at an average annual rate of at least five percent over the next five years and revenue through acquisitions is
targeted to grow at an annual rate of five percent by the end of the fifth year. Despite our plan to continue to grow, in part,
through targeted acquisitions, we may be unable to continue to identify, have the financial capabilities to acquire, or
successfully complete transactions with suitable acquisition candidates. Please refer to Item 1A - Risk Factors - for additional
information on risks and uncertainties.
General
While KEMET competes in the passive electronic component industry, our strategic focus is on growth markets,
specialty products requiring high reliability, and, within Ceramic, larger case size capacitors.
Our product line consists of multilayer ceramic, tantalum, film and aluminum (solid and electrolytic) capacitors, and
Electro-Magnetic Compatible (“EMC”) devices, sensors, and actuators. Product offerings include surface mounts, which are
attached directly to the circuit board; leaded capacitors, which are attached to the circuit board using lead wires; and chassis-
mount and other pin-through-hole board-mount capacitors, which utilize attachment methods such as screw terminal and snap-
in. Capacitors are electronic components that store, filter, and regulate electrical energy and current flow. As an essential
passive component used in nearly all circuit boards, capacitors are typically used for coupling, decoupling, filtering, oscillating
and wave shaping and are used in communication systems, servers, personal computers, tablets, cellular phones, automotive
electronic systems, defense and aerospace systems, consumer electronics, power management systems and many other
electronic devices and systems (basically anything that plugs in or has a battery). While our broad product offering allows us to
meet the majority of those needs independent of application and end use, our strategic focus is on high growth and specialty
markets as noted above.
Solid Capacitors' products are commonly used in conjunction with integrated circuits, and the same circuit may
contain both ceramic and tantalum capacitors. Tantalum capacitors are a popular choice because of their ability for high
capacitance in a small volume package. While ceramic capacitors are more cost-effective at lower capacitance values, tantalum
capacitors are more cost-effective at higher capacitance values while solid aluminum capacitors can be more effective in special
applications.
KEMET's Tantalum business continues to transition toward a higher proportion of Polymer technology sales in which
KEMET has market share leadership greater than 50.0%. Growth drivers for this product line include advanced driver
assistance and autonomous driving systems, tablets and PC’s, 5G infrastructure and connectivity, data servers and solid state
drives and power density energy systems.
KEMET's Ceramic business continues to focus on its specialty (value added) and large cap size business. Growth
drivers for Ceramic include electric vehicles, advanced driver assistance and autonomous driving systems, 5G infrastructure
and connectivity, data servers and solid state drives, wireless charging, satellites, radar, and guidance systems.
Film, paper and aluminum electrolytic capacitors can be used to support integrated circuits, but also are used in the
field of power electronics to provide energy for applications such as motor starts, power conditioning, electromagnetic
interference filtering safety, and inverters. Film and Electrolytic's self healing products deliver high reliability solutions for
extreme conditions. Growth drivers for Film and Electrolytic include alternative energy solutions, electric vehicle charging
stations, and hybrid and electric vehicles.
KEMET's MSA business offers a broad line of electrical noise management products that play a key role in
maintaining signal integrity across a number of end markets including telecommunications, mobile computing, automotive and
general industries. Additionally, MSA's sensor and actuator business manufactures products that sense and respond to human
activity, physical vibration, and electric current, which are found in home appliances, consumer devices, and industrial
6
electrical equipment. Growth drivers for MSA include electric vehicles, advanced driver assistance and autonomous driving
systems, industry 4.0, 5G infrastructure and connectivity, and power density and energy efficiency systems.
We believe the long-term demand for the components we offer will grow on a regional and global basis due to a
variety of factors including electric vehicles ("EV"), vehicles with advanced driver assisted electronics, 5G infrastructure,
industry 4.0, alternative energy and energy storage. The 'electrification of everything' is driving growth. We expect growth not
only in end-products, but due to the increasing complexity of electronic products and the additional capacitors required in those
products, we expect strong growth of the products required to support the 'electrification of everything'. KEMET, we believe, is
strategically aligned in its manufacturing operations and in how we go-to-market to serve these growing markets.
Our Industry
We compete with others that manufacture and distribute electronic components both domestically and globally and our
success in the market is influenced by many factors, including price, availability, engineering specifications, quality and
breadth of offering, performance characteristics, customer service and geographic location of our manufacturing sites. As in all
manufacturing industries, improving cost of production is key to staying competitive. KEMET, as well as many of our larger
competitors, have relocated their manufacturing operations to low cost regions and locations in closer proximity to our
respective customers.
Because capacitors are a fundamental component of electronic circuits, demand for capacitors tends to reflect the
general demand for electronic products, as well as integrated circuits, which we believe over time will continue to grow. We
believe growth in the electronics market and the resulting growth in demand for capacitors will be driven primarily by a
number of recent trends which include:
•
industry 4.0:
the development of new products, applications and electronic controls for engines and industrial machinery,
including cyber physical systems, cloud computing, and cognitive computing; security smart phones and
mobile personal computing devices;
•
the “internet-of-things”;
the increase in the electronic content of existing products, such as home appliances and medical equipment,
smart phones and mobile personal computing devices;
•
•
the enhanced functionality, complexity and convergence of electronic devices that use state-of-the-art
microprocessors;
alternative and renewable energy systems;
• EV and advanced driver assisted electronics; and,
•
the development of 5G infrastructure and connectivity.
The acquisition of TOKIN increased our market opportunity through the EMC devices and sensor and actuator
markets.
Markets and Customers
Our products are sold to a variety of OEMs in a broad range of industries including the computer, communications,
automotive, military, consumer, industrial, medical, and aerospace industries. We also sell products to EMS providers, which
serve OEMs in these industries. Electronics distributors are an important channel of distribution in the electronics industry and
represent a large channel through which we sell our capacitors. One electronics distributor, TTI, Inc., accounted for over 10%
of our net sales in fiscal years 2019, 2018 and 2017. If our relationship with this customer were to terminate, we would need to
determine alternative means of delivering our products to the end-customers served by them. In addition, an aggregate of over
10% of our net sales in fiscal year 2019 were driven by sales to EMS providers for incorporation into Apple Inc. products.
Diversification is critical to the success of our business as our products reach a multitude of industries with various
opportunities for growth. As a full-service provider in the capacitor space, KEMET produces approximately 95.0% of the
dielectrics available to serve our customer needs. The TOKIN acquisition has increased KEMET's offering with a larger
product portfolio including magnetics, sensors and actuators, enhancing its ability to deliver specialty and design-in solutions to
the automotive, military, aerospace, medical, energy, communications, and industrial markets. While we are seeing a merging
of major segments as connectivity and “internet-of-things” grow, the following table presents an overview of the diverse
7
industries that incorporate our capacitors into their products and the general nature of those products.
Industry
Automotive
Communications
Computer-related
Industrial
Consumer
Military/Aerospace
Medical
Alternative Energy
Products
Adaptive cruise control, High intensity discharge headlamps, Light emitting
diode electronic modules, Lane departure warning, Camera systems, Audio
systems, Tire pressure monitoring, Power train electronics, Instrumentation,
Airbag systems, Anti-lock braking and stabilization systems, Hybrid and
electric drive vehicles, Electronic engine control modules, Driver comfort
controls, Security systems, Radar, Connectivity systems and Advance driver
assistance gear
Smart phones, Telephones, Switching equipment, Relays, Base stations, and
Wireless infrastructure
Personal computers (laptops, tablets, notebooks), Workstations, Servers,
Mainframes, Computer peripheral equipment, Power supplies, Solid state
drives, and Local area networks
Electronic controls, Measurement equipment, Instrumentation, Solar and wind
energy generation, Down-hole drilling and Medical electronics
Digital media devices, Game consoles, Televisions, Audio devices, and Global
positioning systems
Avionics, Radar, Guidance systems, and Satellite communications
Defibrillators, Diagnostic equipment, Imaging equipment, Cardiac devices,
and Pain management devices
Wind generation systems, Solar generation systems, Geothermal generation
systems, Tidal generation systems and Electric drive vehicles
We produce a small percentage of capacitors under military specification standards sold for both military and
commercial uses. We do not sell any capacitors directly to the United States government. Certain of our customers purchase
capacitors for products in the military and aerospace industries.
The acquisition of TOKIN increased our position in the following industries that incorporate EMC devices, sensors,
and actuators into their products:
Industry
Telecom Infrastructure
Gaming
Consumer
Automotive
Medical
Industrial
Products
Switching equipment, Base stations, and Wireless infrastructure
Consoles, Displays, Power management
Battery chargers/AC adapters, Power supply, Refrigerators, Inductive
cooking and Air conditioning
Infotainment and Power supply
Test and Diagnostic
Semiconductor producing equipment and Measurement equipment
Our customer base includes most of the world’s major electronics original equipment manufacturers (“OEMs”),
electronics manufacturing services providers (“EMSs”) and distributors listed below.
Major OEMs:
• Bosch Group, Cisco Systems Inc., Continental AG, Delphi Technologies PLC, Tesla Inc., and Denso in the automotive
segment.
• Apple Inc., Western Digital Corporation, Dell Inc., Nintendo, and Google LLC in the Computer and consumer
segment.
• ABB Group, Horiba, Yaskawa Electric Inc., and Schlumberger in the industrial and alternative energy segment.
Major EMSs:
•
Flextronics International Ltd., Jabil Circuit Inc., Celestica Inc., and Sanmina-SCI Corporation
Major Distributors:
• TTI, Inc., Arrow Electronics, Inc., Satori Electric Co., Ltd., and Avnet, Inc.
8
KEMET in the United States
Our corporate headquarters is located in Fort Lauderdale, Florida.
Component manufacturing previously located in the United States has been substantially relocated to our lower-cost
manufacturing facilities in Mexico, China, Vietnam, Indonesia, Thailand, and countries in Europe. The vision for KEMET's
foreign subsidiaries is for them to be primarily local operations, with local management and workers, to help achieve our
objective of being a global company. These facilities are responsible for maintaining our tradition of excellence in quality,
service, and delivery, while accelerating cost-reduction efforts and supporting efforts to grow our customer base. Production
remaining in the United States focuses primarily on early-stage manufacturing of new products and other specialty products for
which customers are predominantly located in North America.
On February 21, 2012, we completed the acquisition of all of the outstanding shares of Blue Powder, a leading
manufacturer of tantalum powders. Blue Powder had been a significant supplier of tantalum powder to KEMET for several
years. KBP's principal operating location was in Carson City, Nevada. The Company is currently in the process of modifying its
vertical integration strategy by relocating its tantalum powder facility equipment from Carson City, Nevada to its existing
Matamoros, Mexico plant.
To accelerate the pace of innovations, KEMET maintains an Innovation Center for Solid Capacitors near Greenville,
South Carolina. The primary objectives of the KEMET Innovation Center are to ensure the flow of new product platforms,
material sets, and processes that are expected to keep us at the forefront of our customers’ product designs, while enabling these
products to be transferred rapidly to the most appropriate KEMET manufacturing location in the world for low-cost, high-
volume production.
KEMET in Mexico
We believe our operations in Mexico are among the most cost efficient in the world, and we expect they will continue
to be our primary production facilities supporting North American and European customers for Solid Capacitors. One of the
strengths of KEMET Mexico is that it is a local operation, including local management and workers. These facilities are
responsible for maintaining KEMET’s tradition of excellence in quality, service, and delivery, while driving down costs. The
facilities in Victoria and Matamoros are primarily focused on tantalum capacitors, while the facilities in Monterrey are focused
on ceramic capacitors.
KEMET in Asia Pacific
We have a well-established manufacturing, sales and logistics network in Asia to support our customers’ Asian
operations. We currently manufacture tantalum and aluminum polymer, film, and electrolytic products in China and film
products in Indonesia. As a result of the acquisition of TOKIN on April 19, 2017, we manufacture electromagnetic
compatibility and sensor and actuator products in China, Japan and Vietnam and tantalum capacitors in Thailand. In addition,
we operate one innovation center for Solid Capacitors and one innovation center for MSA in Japan.
KEMET in Europe
We currently have one or more manufacturing locations in each of the following countries: Bulgaria, Finland, Italy,
Macedonia, Portugal, and Sweden. In addition, we operate product innovation centers in Italy, Portugal and Sweden. We
continue to maintain and enhance our strong European sales and customer service infrastructure, allowing us to continue to
meet the local preferences of European customers who remain an important focus for KEMET.
Global Sales and Logistics
KEMET serves the needs of our global customer base through four geographic regions: North America and South
America (“Americas”), Europe, the Middle East and Africa (“EMEA”), Asia and the Pacific Rim (“APAC”) and Japan and
Korea (“JPKO”). We have a global sales team with 33 sales offices located in 11 countries and a global distribution network.
We also have independent sales representatives located in several countries worldwide including: Brazil, Israel, Canada, and
the United States. Our strategic focus is to ensure we have people near our customers to facilitate regular face-to-face
communication. This is critical to ensure that KEMET is included during the design-in phase.
Consequently, in our major markets, we market and sell our products primarily through a direct sales force. With a
global sales organization that is customer-focused, our direct sales personnel from around the world serve on KEMET Global
Account Teams committed to serving any customer location in the world with a dedicated KEMET representative. The
traditional sales team is supported by regional Field Application Engineers who are experts in electronic engineering and
market all of KEMET’s products by assisting customers with the resolution of capacitor application issues. We believe our
direct sales force creates a distinct advantage in the marketplace by enabling us to establish and maintain strong relationships
9
with our customers to efficiently process simple repeat business as well as to consult with customers on new and technically
complex custom applications. In addition, where appropriate, we use independent commissioned representatives. This approach
requires a blend of accountability and responsibility for specific customer locations, guided by an overall account strategy for
each customer. Our sales team works with the customers throughout the entire purchasing process, following opportunities as
they progress through concept, design, validation and, finally, mass production. In Japan, we market and sell directly and
through manufacturers agents. These manufacturers agents create unique custom solutions integrating our products which help
pull our products though the channel.
Electronics distributors are an important distribution channel in the electronics industry and accounted for 42.2%,
39.2%, and 46.8% of our net sales in fiscal years 2019, 2018 and 2017, respectively. A portion of our net sales to distributors
are made under agreements allowing certain rights of return and price protection on unsold merchandise held by distributors. In
addition, our distributor policy includes inventory price protection and “ship-from-stock and debit” (“SFSD”) programs
common in the industry.
Sales by Geography
In fiscal years 2019 and 2018, net sales by region were as follows (dollars in thousands):
Fiscal Year 2019
Fiscal Year 2018
APAC
EMEA
Americas
JPKO
Total
Net Sales
$
533,340
315,535
337,842
196,101
$ 1,382,818
% of
Total
38.6% APAC
22.8% EMEA
24.4% Americas
14.2% JPKO
Total
Net Sales
$
479,987
277,898
259,105
183,191
$ 1,200,181
% of
Total
40.0%
23.1%
21.6%
15.3%
We believe our regional balance of revenues is a benefit to our business. The geographic diversity of our net sales
diminishes the impact of regional sales decreases caused by various holiday seasons. The Americas remains the leading region
in the world for product design in activity where engagement with OEM design engineers determines product placement
independent of the region of the world where the final product is manufactured. Please see Note 7, “Reportable Segment and
Geographic Information” to our Consolidated Financial Statements.
Inventory and Backlog
Our customers often encounter uncertain or changing demand for their products. They historically order products from
us based on their forecast and if demand does not meet their forecasts, they may cancel or reschedule the shipments included in
our backlog, in many instances without penalty. Additionally, many of our customers have started to require shorter lead times
and “just in time” delivery. Consequently, the twelve-month order backlog is not a meaningful trend indicator for us.
Although we manufacture and inventory standardized products, a portion of our products are produced to meet
specific customer requirements. Cancellations by customers of orders already in production could have an impact on
inventories. Historically, however, cancellations have not been significant.
Competition
The capacitor industry, and the electronic industry in general, is characterized by a competitive and growing market
environment. Competitive factors influencing the market for our products include: product quality, customer service, technical
innovation, pricing, and timely delivery. We believe we compete favorably based on each of these factors. Additionally, we
believe our strategic focus positions KEMET well in specific markets within the capacitor industry, aligns with our core
competencies, and allows us to focus on growth and higher profitability markets.
Our major global competitors in the passive electronic component industry include AVX Corporation, Panasonic
Corporation, Murata Manufacturing Co., Ltd., Samsung Electro-Mechanics Co. LTD., Taiyo Yuden Co., Ltd., TDK-EPC
Corporation, Yageo Corporation, Walsin Technology Corporation, LTD., Vishay Intertechnology, Inc. (“Vishay”), Xiamen
Faratronic Co. LTD., Hitachi High-Technologies Corp., Nippon Chemi-Con Corp., Nichicon Corp., and Rubycon Corporation.
We believe the Company's strategic shift over the last few years to more customized, design-in and high reliability
solutions has given it a unique competitive position in the market place and enhanced its durability of revenue base. In the
highly commoditized multi layered ceramic capacitor market KEMET focuses primarily on the large case sizes capacitors and
the growing automotive market segment offering niche products required in high temperature, vibration, and voltage
environments.
10
Raw Materials
The principal raw materials used in the manufacture of our products are tantalum powder, tantalum ore, barium
titanate, calcium zirconate, rare earth oxides, palladium, aluminum, silver, copper, nickel and tin. These materials are
considered commodities and are subject to price volatility. Additionally, any delays in obtaining raw materials for our products
could hinder our ability to manufacture our products, negatively impacting our competitive position and our relationships with
our customers. KEMET is committed to partnerships and close relationships with key suppliers of the critical materials listed
above. We also actively pursue sourcing from multiple manufacturing sites of current suppliers, as well as second sourcing of
critical raw materials to mitigate the risk of supply discontinuity in case of unforeseen geo-political events or natural disasters.
Tantalum is mined principally in the Democratic Republic of Congo, Australia, Brazil, Canada, Ethiopia, Nigeria, and
Rwanda. As a result of our tantalum vertical integration program which began in fiscal year 2012, we have reduced our
exposure to price volatility and supply uncertainty in the tantalum supply chain. Our tantalum ore supply requirements are now
met through our direct sourcing partners of conflict free tantalum, which is then processed into the intermediate product
potassium heptafluorotantalate (commonly known as K-salt) at our own facility in Mexico or at third party locations, before
final processing into tantalum powder at KBP operations in Carson City, Nevada or Matamoros, Mexico. Price increases for
tantalum ore, or for the remaining tantalum powder that we source from third parties, could impact our financial performance
as we may not be able to pass all such price increases on to our customers. We estimate that our vertical integration strategy
has created $50.0 million of cost savings per year.
Silver and aluminum have generally been available in sufficient quantities, and we believe there are enough suppliers
from which we can purchase our requirements. An increase in the price of silver and aluminum that we are unable to pass on to
our customers, could, however, have an adverse effect on our profitability.
Patents and Trademarks
As of March 31, 2019, we held the following number of patents and trademarks:
United States
Foreign
Patents
Trademarks
323
1,025
17
260
Many of our patents and trademarks were obtained as part of the TOKIN acquisition. We believe the success of our
business is not materially dependent on the existence or duration of any individual patent, license, or trademark other than the
trademarks “KEMET,” “KEMET Charged,” and "TOKIN". Our engineering and research and development staffs have
developed and continue to develop proprietary manufacturing processes and equipment designed to enhance our manufacturing
facilities and reduce costs.
Segment Reporting
We are organized into three reportable segments: Solid Capacitors, Film and Electrolytic and Electro-Magnetic,
Sensors, and Actuators. Each reportable segment is responsible for the operations of certain manufacturing sites as well as all
related research and development efforts. The sales, marketing and corporate functions are shared by each of the segments. See
Note 7, “Reportable Segment and Geographic Information” to our Consolidated Financial Statements for other information
regarding the Company's reportable segments, including net sales, operating income, total assets, and financial information
about geographic areas.
Solid Capacitors Reportable Segment
Solid Capacitors operates in ten manufacturing sites in the United States, Mexico and Asia and operates innovation
centers in the United States and Japan. Solid Capacitors primarily produces tantalum, aluminum, polymer and ceramic
capacitors which are sold globally. Solid Capacitors also produces tantalum powder used in the production of tantalum
capacitors. Solid Capacitors employs approximately 8,000 employees worldwide. For fiscal years 2019, 2018 and 2017, Solid
Capacitors had consolidated net sales of $935.8 million, $771.2 million and $575.1 million, respectively.
We continue to make significant investments in tantalum production within Solid Capacitors and, based on net sales,
we believe we are the largest tantalum capacitor manufacturer in the world. We believe we have one of the broadest lines of
tantalum product offerings and are one of the leaders in the growing market for high-frequency low equivalent series resistance
(“ESR”) surface mount tantalum and aluminum polymer capacitors.
We believe KBP, which we acquired in 2012, is the largest production facility for tantalum powder in the western
hemisphere. Since the acquisition of KBP, KEMET has been able to stabilize its tantalum powder costs and significantly
11
improve its operating margin through its vertical integration efforts. The Company continues to streamline its vertical
integration strategy and may take actions to improve the cost structure if the anticipated results are advantageous. The
Company is currently in the process of relocating its tantalum powder facility equipment from Carson City, Nevada to its
existing Matamoros, Mexico plant.
Our tantalum product line has a broad product portfolio with industry leading processes and materials technology, a
global manufacturing base, and on-time delivery capabilities that allow us to serve a wide range of customers in a diverse group
of end markets, including computing, telecommunications, consumer, medical, military, automotive, and general industries.
KEMET is a market leader in Polymer Tantalum, with an estimated market share of greater than 50.0%.
Within our ceramic product line, we are making significant investments to support future MLCC growth. KEMET is a
global and well known MLCC supplier in the automotive, industrial, medical, energy, defense and aerospace markets. Due to
the extended global shortage of ceramic capacitors that began in 2016, customers are looking to KEMET as a long-term stable
MLCC supplier to support their growth. The Company has entered into agreements with three of its largest customers pursuant
to which the customers have agreed to provide interest free loans to the Company in exchange for assurance of future supply.
These interest free loans are being used by the Company to fund the purchase of certain production equipment and to make
other investments and improvements in the Company and its operations in order to increase its overall capacity to produce
various electronic components. We are continuing to work with many of our other customers to help them secure future MLCC
supply.
Our ceramic product line offers an extensive line of MLCC's in a variety of sizes and configurations. Our high voltage,
high temperature and ultra-stable dielectric technology provides us with what we believe to be a significant advantage over
many of our competitors, particularly in the high reliability markets mentioned. We are increasing investments in research and
development to extend our current portfolio, as well as to be able to offer more effective high-density packaging solutions for
connecting multiple components. We are also working with our customers to design-in our products with a focus on the
growing automotive segment.
Film and Electrolytic Reportable Segment
Our Film and Electrolytic Reportable Segment produces film, paper and wet aluminum electrolytic capacitors. In
addition, the segment designs and produces electromagnetic interference filters ("EMI filters"). Film capacitors can be used for
applications requiring high power and high voltages, whereas aluminum electrolytic capacitors can be used for applications
requiring high energy at a reasonable price. EMI filters consist of capacitive and inductive elements that reduce electromagnetic
disturbance in the frequency range desired. We believe we are one of the world’s largest suppliers of film capacitors and one of
the leaders in wet aluminum electrolytic capacitors. Both product families serve industrial and automotive customers, and in
particular, the emerging market for alternative energy and electrical vehicles. For fiscal years 2019, 2018, and 2017, our Film
and Electrolytic segment had consolidated net sales of $206.2 million, $202.0 million, and $182.2 million, respectively. Our
Film and Electrolytic business is mostly concentrated in Europe, and as such, is impacted by the change in the exchange rate
for the Euro to the U.S. dollar.
Our Film and Electrolytic Reportable Segment primarily serves the industrial and automotive markets. We believe our
Film and Electrolytic Segment’s product portfolio, technology and experience allow us to significantly benefit from the
continued growth in alternative energy solutions and energy efficiency solutions within both the automotive and industrial
markets especially for demanding applications such as humidity, temperature, voltage, etc. We operate nine manufacturing sites
throughout Europe and Asia and maintain product innovation centers in Italy, Portugal and Sweden. Our Film and Electrolytic
Segment employs approximately 1,750 employees worldwide.
The Company is in the process of relocating axial electrolytic production from Granna, Sweden to its plant in Evora,
Portugal. The Company is streamlining its manufacturing operations for axial electrolytic capacitors with this relocation,
allowing the Company to increase flexibility, capabilities, and competitiveness in the marketplace.
Electro-Magnetic, Sensors, and Actuators Reportable Segment
MSA operates in four manufacturing sites throughout Asia and operates a product innovation center in Japan. MSA
was a new reportable segment for KEMET in fiscal year 2018 resulting from the acquisition of TOKIN in April 2017. MSA
primarily produces EMC materials and devices, piezo materials and actuators and various types of sensors which are sold
globally. For fiscal years 2019 and 2018, our MSA Segment had consolidated net sales of $240.7 million and $227.0 million,
respectively. MSA is aiming to sell products globally. Currently, most of MSA's net sales come from Japan, Korea, and other
countries in Asia. Our MSA segment employs approximately 3,000 employees worldwide.
The EMC device product line offers a broad line of electrical noise management products. As circuits become more
complex within a device, and the amount of information being communicated between devices increases at a dramatic rate, the
12
quality of electronic signals becomes key to the integrity of the information being communicated. EMC products play a key
role in maintaining signal integrity across a number of end-markets including telecommunications, mobile computing,
automotive and general industries.
The sensor and actuator product line manufactures products that sense and respond to human activity, physical
vibration, and electric current. These products are found in home appliances, consumer devices, and industrial electrical
equipment. In addition, we manufacture electromechanical actuation devices that are critical to the manufacture of
semiconductor devices and the management of industrial and chemical gas flow. Sensors are an important family of devices as
the “internet-of-things” continues to permeate everyday life.
Environmental and Regulatory Compliance
We are subject to various North American, European, and Asian national, state, and local environmental laws and
regulations relating to the protection of the environment, including those governing the handling and management of certain
chemicals and materials used and generated in the manufacturing of electronic components. We do not believe compliance with
these laws and regulations will have a material adverse effect on our capital expenditures, earnings, or competitive position.
However, we believe it is reasonably likely the trend in environmental litigation, laws, and regulations will continue to move
toward stricter standards. Such changes in the laws and regulations may require us to make additional capital expenditures
which, while not currently estimable with certainty, are not presently expected to have a material adverse effect on our financial
condition.
We are strongly committed to economic, environmental, and socially sustainable development. As a result of this
commitment, in 2008 we adopted the Electronic Industry Citizenship Coalition (“EICC”) Code of Conduct, now titled
Responsible Business Alliance ("RBA") Code of Conduct. The RBA Code of Conduct is a comprehensive code of conduct that
addresses all aspects of corporate responsibility including labor, health and safety, the environment, business ethics, and related
management system elements. It outlines standards to ensure working conditions in the electronic industry supply chain are
safe, free from slavery and human trafficking, workers are treated with respect and dignity, manufacturing processes are
environmentally sustainable, materials are sourced responsibly, and business operations are conducted ethically.
Policies, programs, and procedures implemented throughout KEMET are intended to ensure conformity with
applicable legal and regulatory requirements, the content of the RBA Code of Conduct, and customer contractual requirements
related to social and environmental responsibility.
We fully support the position of the RBA, the Responsible Minerals Initiative ("RMI"), and the Tantalum-Niobium
International Study Center (“TIC”) in avoiding the use of conflict minerals which directly or indirectly finance or benefit armed
groups in the Democratic Republic of Congo and its adjoining countries, or in any region determined to be a conflict affected
and high-risk area. In furtherance of this support, we have utilized the Organisation for Economic Co-operation and
Development (“OECD”) Due Diligence Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and
High-Risk Areas as the foundation for KEMET's supply chain policy by implementing the five-step risk-based framework due
diligence in our mineral supply chain. This supply chain policy and requirement has been communicated to all suppliers of
conflict minerals and is communicated publicly on our website. Our tantalum supply base has been and continues to be
validated as conformant to the RMI's Responsible Minerals Assurance Program ("RMAP"). We will continue to work through
the RMI and TIC towards the goal of greater transparency in the supply chain.
In April 2019, KEMET published its first Corporate Sustainability Report (“CSR”), outlining its commitment towards
the environment, its employees, and the communities within it operates.
Summary of Activities to Develop a Transparent Supply Chain
We are actively involved in developing a transparent supply chain through our membership in the RMI. We were a
member of the EICC Global e-Sustainability Initiative (“GeSI”) working group that developed the original Conflict Free
Sourcing Program assessment protocols and we participated in the pilot implementation phase of the OECD Due Diligence
Guidance for Responsible Supply Chains of Minerals from Conflict-Affected and High-Risk Areas. We participate in smelter
engagement to increase the number of conflict-free validated smelters globally, the development of due diligence guidance
documents and the advancement of the industry adopted RMI Conflict Minerals Reporting Template. We rely on the RMAP
independent third-party audits to supplement our internal due diligence of conflict mineral suppliers and are monitoring the
progress of these audits to ensure our supply chain is conflict free. We fully support Section 1502 “Conflict Minerals” of the
Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and are complying with all reporting requirements.
13
Global Code of Conduct and Mission, Vision and Values
KEMET maintains a Global Code of Conduct (“Code of Conduct”), which became effective August 1, 2010 and
updated on May 16, 2019, as well as mission (“Mission”), vision (“Vision”) and values (“Values”) statements along with a set
of core values, which became effective in June 2011. KEMET’s Mission is to help make the world a better, safer, more
connected place to live. KEMET’s Vision is to be the world’s most trusted partner for innovative component solutions.
KEMET’s Values embody the key expectations of how our employees should approach the work they do every day: One
KEMET, Unparalleled Customer Experience, Ethics and Integrity, Talent Oriented, No Politics, The Math Must Work and
Speed. The Code of Conduct and Mission, Vision and Values are applicable to all employees, officers, and directors of the
Company. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or waiver
from a provision of our Code of Conduct, Mission, Vision and Values by posting such information on our website at http://
www.kemet.com.
In April 2019, the Company published its first CSR, outlining its environmental and social commitments towards all
of its stakeholders. Sustainability has been a large part of KEMET's culture for many years, and the new report demonstrates to
all stakeholders the Company's policy of conducting business in a responsible way. Sustainability is integrated throughout
KEMET's global operations, and the Company has implemented programs worldwide in support of the policy. The CSR
highlights these programs, which includes the RBA Code of Conduct, as well as yearly submissions of data to the Carbon
Disclosure Project.
KEMET supports the Kisengo Foundation and certain other charitable endeavors in the Democratic Republic of
Congo with periodic monetary donations. Funds have been used toward building and supporting a new hospital and school as
well as the installation of fresh water wells, solar street lighting, infrastructure improvements and a micro-agriculture project.
Employees
We have approximately 14,350 employees as of March 31, 2019 in the following locations:
Asia
Mexico
Europe
Japan and Korea
United States
5,700
5,600
1,500
900
650
The number of KEMET employees represented by labor organizations in each of the following countries are shown in
the table below. Due to the General Data Protection Regulation (“GDPR”) that became effective in May 2018 in the European
Union, the Company is not permitted to identify employees represented by labor unions in countries that are part of the
European Union.
Mexico
China
Vietnam
Japan
Indonesia
United States
Taiwan
3,737
2,511
1,390
633
319
14
11
In fiscal year 2019, we did not experience any major work stoppages. Our labor costs in Mexico, Asia and various
locations in Europe are denominated in local currencies, and a significant depreciation or appreciation of the United States
dollar against the local currencies would increase or decrease our labor costs.
Securities Exchange Act of 1934 (“Exchange Act”) Reports
We maintain an Internet website at the following address: http://www.kemet.com. KEMET makes available on or
through our Internet website certain reports and amendments to those reports filed or furnished to the Securities and Exchange
Commission (“SEC”) pursuant to Section 13(a) or 15(d) of the Exchange Act. These include annual reports on Form 10-K,
quarterly reports on Form 10-Q, current reports on Form 8-K and beneficial ownership reports on Forms 3, 4 and 5. This
information is available on our website free of charge as soon as reasonably practicable after we electronically file the
information with, or furnish it to, the SEC.
14
ITEM 1A. RISK FACTORS.
This report contains certain statements that are forward-looking within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements are not guarantees of future performance and involve certain risks, uncertainties and
assumptions that are difficult to predict. Actual outcomes and results may differ materially from those expressed in, or implied
by, our forward-looking statements. Words such as “expects,” “anticipates,” “believes,” “estimates” or other similar expressions
and future or conditional verbs such as “will,” “should,” “would” and “could” are intended to identify such forward-looking
statements. Readers of this report should not rely solely on the forward-looking statements and should consider all uncertainties
and risks throughout this report. The statements are representative only as of the date they are made, and we undertake no
obligation to update any forward-looking statement.
All forward-looking statements, by their nature, are subject to risks and uncertainties. Our actual future results may
differ materially from those set forth in our forward-looking statements. We face risks that are inherent in the businesses and
the market places in which we operate. While management believes these forward-looking statements are accurate and
reasonable, uncertainties, risks and factors, including those described below, could cause actual results to differ materially from
those reflected in the forward-looking statements.
Factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, these
forward-looking statements include, but are not necessarily limited to, the following: (i) adverse economic conditions could
impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect
our liquidity and ability to continue to operate and could cause a write down of long-lived assets or goodwill; (ii) an increase in
the cost or a decrease in the availability of our principal or single-sourced purchased raw materials; (iii) changes in the
competitive environment; (iv) uncertainty of the timing of customer product qualifications in heavily regulated industries; (v)
economic, political, or regulatory changes in the countries in which we operate; (vi) difficulties, delays, or unexpected costs in
completing the Company’s restructuring plans; (vii) acquisitions and other strategic transactions expose us to a variety of risks,
including the ability to successfully integrate and maintain adequate internal controls over financial reporting in compliance
with applicable regulations; (viii) our acquisition of TOKIN Corporation may not achieve all of the anticipated results; (ix) our
business could be negatively impacted by increased regulatory scrutiny and litigation; (x) difficulties associated with retaining,
attracting, and training effective employees and management; (xi) the need to develop innovative products to maintain
customer relationships and offset potential price erosion in older products; (xii) exposure to claims alleging product defects;
(xiii) the impact of laws and regulations that apply to our business, including those relating to environmental matters, data
protection, cyber security and privacy; (xiv) the impact of international laws relating to trade, export controls and foreign
corrupt practices; (xv) changes impacting international trade and corporate tax provisions related to the global manufacturing
and sales of our products may have an adverse effect on our financial condition and results of operations; (xvi) volatility of
financial and credit markets affecting our access to capital; (xvii) default or failure of one or more of our counterparty financial
institutions could cause us to incur significant losses; (xviii) the need to reduce the total costs of our products to remain
competitive; (xix) potential limitation on the use of net operating losses to offset possible future taxable income; (xx)
restrictions in our debt agreements that could limit our flexibility in operating our business; (xxi) failure to maintain effective
internal controls over financial reporting; (xxii) service interruption, misappropriation of data, or breaches of security as it
relates to our information systems could cause a disruption in our operations, financial losses, and damage to our reputation;
(xxiii) economic and demographic experience for pension and other post-retirement benefit plans could be less favorable than
our assumptions; (xxiv) fluctuation in distributor sales could adversely affect our results of operations; (xxv) earthquakes and
other natural disasters could disrupt our operations and have a material adverse effect on our financial condition and results of
operations; and (xxvi) volatility in our stock price.
Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our
business operations and could cause actual results to differ materially from those included, contemplated or implied by the
forward-looking statements made in this report, and the reader should not consider the above list of factors to be a complete set
of all potential risks or uncertainties.
Adverse economic conditions could impact our ability to realize operating plans if the demand for our products
declines; and such conditions could adversely affect our liquidity and ability to continue to operate and could cause the
write down of long-lived assets or goodwill.
While our operating plans provide for cash generated from operations to be sufficient to cover our future operating
requirements, many factors, including reduced demand for our products, currency exchange rate fluctuations, increased raw
material costs, and other adverse market conditions we cannot predict could cause a shortfall in net cash generated from
operations. As an example, the electronics industry is a cyclical industry with demand for capacitors reflecting the demand for
products in the electronics market. Customers’ requirements for our capacitors fluctuate as a result of changes in general
economic activity and other factors affecting the demand for their end-products. During periods of increasing demand for their
products, they typically seek to increase their inventory of our products to avoid production bottlenecks. When demand for their
15
products peaks and begins to decline, they may rapidly decrease orders for our products while they use accumulated inventory.
Business cycles vary somewhat in different geographical regions, such as Asia, and within customer industries. We are also
vulnerable to general economic events beyond our control and our sales and profits may suffer in periods of weak demand.
Our ability to realize operating plans is also dependent upon meeting our payment obligations. If cash generated from
operating, investing and financing activities is insufficient to pay for operating requirements and to cover interest payment
obligations under debt instruments, planned operating and capital expenditures may need to be reduced.
Additionally, long-lived assets and intangible assets subject to amortization are reviewed for impairment whenever
events or changes in circumstances indicate the carrying amount of a long-lived asset or group of assets may not be
recoverable. Also, goodwill is reviewed for impairment annually and whenever events or changes in circumstances indicate the
carrying amount of goodwill may not be recoverable. In the event the tests show the carrying value of certain long-lived assets,
intangible assets, or goodwill are impaired, we would be required to take an impairment charge to earnings under U.S.
generally accepted accounting principles. However, such a charge would have no direct effect on our cash. If the economic
conditions decline we could incur impairment charges in the future.
An increase in the cost or decrease in the availability of our principal or single-sourced purchased raw materials
could adversely affect profitability.
The principal raw materials used in the manufacture of our products include tantalum powder, tantalum ore,
palladium, aluminum, silver, copper, nickel and tin. These materials are considered commodities and are subject to price
volatility. Additionally, any delays in obtaining raw materials for our products could hinder our ability to manufacture our
products, negatively impacting our competitive position and our relationships with our customers.
Tantalum is mined principally in the Democratic Republic of Congo, Australia, Brazil, Canada, Ethiopia, Nigeria, and
Rwanda. As a result of our tantalum vertical integration program which began in fiscal year 2012, we have reduced our
exposure to price volatility and supply uncertainty in the tantalum supply chain. Our tantalum ore supply requirements are now
met through our direct sourcing partners of conflict free tantalum, which is then processed into the intermediate product
potassium heptafluorotantalate (commonly known as K-salt) at our own facility in Mexico or at third party locations, before
final processing into tantalum powder at KBP operations in Carson City, Nevada or Matamoros, Mexico. Price increases for
tantalum ore, or for the remaining tantalum powder that we source from third parties, could impact our financial performance
as we may not be able to pass all such price increases on to our customers.
Silver and aluminum have generally been available in sufficient quantities, and we believe there are enough suppliers
from which we can purchase our requirements. An increase in the price of silver and aluminum that we are unable to pass on to
our customers, could, however, have an adverse effect on our profitability.
Changes in the competitive environment could harm our business.
The capacitor business is competitive worldwide, with low transportation costs and few import barriers. Competition
is based on factors such as product quality and reliability, availability, customer service, technical innovation, timely delivery
and price. The industry has become increasingly consolidated and global in recent years, and our primary U.S. and non-U.S.
competitors, some of which are larger than us, have significant financial resources. The greater financial resources of such
competitors may enable them to commit larger amounts of capital in response to changing market conditions. Some
competitors may also have the ability to use profits from other operations to subsidize losses sustained in their businesses with
which we compete. Certain competitors may also develop product or service innovations that could put us at a disadvantage.
Uncertainty of the timing of customer product qualifications in heavily regulated industries could affect the timing
of product revenues and profitability arising from these industries.
Our capacitors are incorporated into products used in diverse industries. Certain of these industries, such as military,
aerospace and medical, are heavily regulated, with long and sometimes unpredictable product approval and qualification
processes. Due to such regulatory compliance issues, there can be no assurances as to the timing of product revenues and
profitability arising from our product development and sales efforts in these industries.
We manufacture many capacitors in Europe, Mexico and Asia and economic, political or regulatory changes in
any of these regions could adversely affect our profitability.
Our international operations are subject to a number of special risks, in addition to the same risks as our domestic
business. These risks include currency exchange rate fluctuations, differing protections of intellectual property, trade barriers,
labor unrest, exchange controls, regional economic uncertainty, differing (and possibly more stringent) labor regulation, risk of
governmental expropriation, domestic and foreign customs and tariffs, current and changing regulatory regimes, differences in
16
the availability and terms of financing, political instability and potential increases in taxes. These factors could impact our
production capability or adversely affect our results of operations or financial condition.
We may experience difficulties, delays or unexpected costs in completing our restructuring plans and may not
realize all of the expected benefits from our restructuring plans.
We may not realize, in full or in part, the anticipated benefits of our restructuring plans without encountering
difficulties, which may include complications in the transfer of production knowledge, loss of key employees and/or customers,
the disruption of ongoing business, possible inconsistencies in standards, controls and procedures and potential difficulty in
meeting customer demand in the event the market dramatically improves. We are a party to collective bargaining agreements in
certain jurisdictions in which we operate, which could potentially prevent or delay execution of parts of our restructuring plans.
Acquisitions and other strategic transactions expose us to a variety of operational and financial risks.
Our ability to realize the anticipated benefits of acquisitions depends, to a large extent, on our ability to integrate the
acquired companies with our own. Our management devotes significant attention and resources to these efforts, which may
disrupt the business of each of the companies involved and, if executed ineffectively, could preclude realization of the full
benefits we expect. Failure to realize the anticipated benefits of our acquisitions could cause an interruption of, or a loss of
momentum in, the operations of the acquired company. In addition, the efforts required to realize the benefits of our
acquisitions may result in material unanticipated problems, expenses, liabilities, competitive responses, loss of customer
relationships, the diversion of management’s attention, and may cause our stock price to decline.
Management is responsible for establishing and maintaining adequate internal control over financial reporting and
failure to timely integrate acquired businesses into our Company’s operating and internal control structures may increase the
risk of failure to prevent misstatements in their financial records and in our consolidated financial statements.
Additionally, we may finance acquisitions or future payments with cash from operations, additional indebtedness and/
or the issuance of additional securities, any of which may impair the operation of our business or present additional risks, such
as reduced liquidity or increased interest expense. Such acquisition financing could result in a decrease of our ratio of earnings
to fixed charges. We may also seek to restructure our business in the future by disposing of certain of our assets, which may
harm our future operating results, divert significant managerial attention from our operations and/or require us to accept non-
cash consideration, the market value of which may fluctuate.
Furthermore, expansions or acquisitions into new geographic markets and services may require us to comply with new
and unfamiliar legal and regulatory requirements, which could impose substantial obligations on us and our management, cause
us to expend additional time and resources and increase our exposure to penalties or fines for non-compliance with such
requirements. Failure to implement our acquisition strategy, including successfully integrating acquired businesses, could have
an adverse effect on our business, financial condition and results of operations.
We may not realize the anticipated cross-selling synergies and revenue expansion expected to result from the
acquisition of TOKIN and we may experience difficulties in integrating TOKIN’s business which may adversely affect our
financial performance.
There can be no assurance we will realize the anticipated operating synergies, tax benefits and revenue expansion from
the acquisition of TOKIN or we will not experience difficulties in integrating the operations of TOKIN with our operations. For
example, the integration of TOKIN will require the experience and expertise of certain of our key managers and key managers
of TOKIN. There can be no assurance, however, that these managers will remain with us for the time period necessary to
successfully integrate the operations of TOKIN with our operations. In addition, the acquisition of TOKIN may present
significant challenges for our management due to the increased time and resources required to properly integrate our
management, employees, information systems, accounting controls, personnel and administrative functions with those of
TOKIN and to manage the combined company on a going forward basis. There can be no assurance we will be able to
successfully integrate and streamline overlapping functions or, if successfully accomplished, that such integration will not be
more costly to accomplish than presently contemplated or that we will not encounter difficulties in managing the combined
company due to its increased size and scope.
Furthermore, there can be no assurance that, as a combined company, we will continue to maintain all of the supplier
and customer relationships we and TOKIN maintained as separate companies. As a combined company, we may encounter
difficulties managing relationships with our suppliers and our customers due to our increased size and scope and to the
increased number of relationships we will have with suppliers and customers.
17
We are currently subject to increased regulatory scrutiny and litigation that may negatively impact our business.
The growth of our Company and our expansion into a variety of new products expose us to a variety of new regulatory
issues, and we have experienced increased regulatory scrutiny as we have grown. We are subject to various federal, foreign and
state laws, including antitrust laws, violations of which can involve civil or criminal sanctions. Furthermore, as a result of our
acquisition of TOKIN, we assumed all liabilities assessed against TOKIN that may arise as a result of litigation to which
TOKIN is a party. Refer to “Item 3. Legal Proceedings” for a summary of the Company's material litigation and investigations.
The impact of these proceedings could have a material adverse effect on our financial position, liquidity, and results of
operations.
If we are unable to attract, train or retain key employees, management or a highly skilled and diverse workforce, it
could have a negative impact on our business, financial condition or results of operations.
Our success depends upon the continued contributions of our executive officers and certain other employees, many of
whom have many years of experience with us and would be extremely difficult to replace. We must also attract and retain
experienced and highly skilled engineering, sales and marketing and managerial personnel. Competition for qualified personnel
is intense in our industry, and we may not be successful in hiring and retaining these people. If we lost the services of our
executive officers or our other highly qualified and experienced employees or cannot attract and retain other qualified
personnel, our business could suffer through less effective management due to loss of accumulated knowledge of our business
or through less successful products due to a reduced ability to design, manufacture and market our products.
We must continue to develop innovative products to maintain relationships with our customers and to offset
potential price erosion in older products.
While most of the fundamental technologies used in the passive components industry have been available for a long
time, the market is nonetheless characterized by rapid changes in product designs and technological advances allowing for
better performance, smaller size and/or lower cost. New applications are frequently found for existing technologies, and new
technologies occasionally replace existing technologies for some applications or create new business opportunities in other
areas of application. We believe successful innovation is critical for maintaining profitability to offset potential erosion of
selling prices for existing products and to ensure the flow of new products and robust manufacturing processes that will keep us
at the forefront of our customers’ product designs. Non-customized products are especially vulnerable to price pressure, but
customized products have also experienced price pressure in recent years. Developing and marketing new products requires
start-up costs that may not be recouped if these products or production techniques are not successful. There are numerous risks
inherent in product development, including the risks we will be unable to anticipate the direction of technological change or we
will be unable to develop and market new products and applications in a timely fashion to satisfy customer demands. If this
occurs, we could lose customers and experience adverse effects on our results of operations.
We may be exposed to claims alleging product defects.
Our business exposes us to claims alleging product defects or nonconformance with product specifications. We may be
held liable for, or incur costs related to, such claims if any of our products, or products in which our products are incorporated,
are found to have caused end market product application failures, product recalls, property damage or personal injury.
Provisions in our customer and distributor agreements are designed to limit our exposure to potential material product defect
claims, including warranty, indemnification, waiver and limitation of liability provisions, but such provisions may not be
effective under the laws of some jurisdictions. If we cannot successfully defend ourselves against product defect claims, we
may incur substantial liabilities. Regardless of the merits or eventual outcome, defect claims could entail substantial expense
and require the time and attention of key management personnel.
Our insurance program may not be adequate to cover all liabilities arising out of product defect claims and, at any
time, insurance coverage may not be available on commercially reasonable terms or at all. If liability coverage is insufficient, a
product defect claim could result in liability to us, which could materially and adversely affect our results of operations or
financial condition. Even if we have adequate insurance coverage, product defect claims, or recalls could result in negative
publicity or force us to devote significant time and attention to those matters.
Various laws and regulations that apply to our business, including those relating to conflict minerals and
environmental matters, could limit our ability to operate as we are currently and could result in additional costs.
We are subject to various laws and regulations of national, state and local authorities in the countries in which we
operate regarding a wide variety of matters, including conflict minerals, environmental, employment, land use, antitrust, and
others that affect the day-to-day operations of our business. The liabilities and requirements associated with the laws and
regulations that affect us may be costly and time-consuming. There can be no assurance we have been or will be at all times in
compliance with such applicable laws and regulations. Failure to comply may result in the assessment of administrative, civil
18
and criminal penalties, the issuance of injunctions to limit or cease operations, the suspension or revocation of permits and
other enforcement measures that could have the effect of limiting our operations. If we are pursued for sanctions, costs or
liabilities in respect of these matters, our operations and, as a result, our profitability could be materially and adversely affected.
The SEC requires issuers for whom tantalum, tin, tungsten and gold are necessary to the functionality or production of
a product manufactured, or contracted to be manufactured, by such person to conduct certain diligence procedures and make
certain disclosures annually regarding whether any of those minerals originated in the Democratic Republic of Congo or an
adjoining country. As defined by the SEC, tantalum, tin, tungsten and gold are commonly referred to as “conflict minerals” or
“3TG”. If an issuer’s conflict minerals originated in those countries, the rule requires the issuer to submit a report to the SEC
that includes a description of the measures it took to exercise due diligence on the conflict minerals’ source and chain of
custody. We use tantalum, tin and, to a lesser degree, other of the 3TG minerals in our production processes and in our
products. We have exercised due diligence on the source and chain of custody during the reporting period and, as required
under the rule, have disclosed a description of these measures and certain of our findings in a special disclosure on Form SD.
Disclosure in accordance with the rule may cause changes to the pricing of 3TG minerals, which could adversely affect our
profitability. In addition, it is possible some of our disclosures pursuant to the rule related to our inquiries and supply chain
custody diligence could cause reputational harm and cause the company to lose customers or sales.
In addition, we are subject to a variety of U.S. federal, state and local, as well as foreign, environmental laws and
regulations relating, among other things, to wastewater discharge, air emissions, handling of hazardous materials, disposal of
solid and hazardous wastes, and remediation of soil and groundwater contamination. We use a number of chemicals or similar
substances and generate waste that are considered hazardous. We are required to hold environmental permits to conduct many
of our operations. Violations of environmental laws and regulations could result in substantial fines, penalties, and other
sanctions. Changes in environmental laws or regulations (or in their enforcement) affecting or limiting, for example, our
chemical uses, certain of our manufacturing processes, or our disposal practices, could restrict our ability to operate as we are
currently operating or impose additional costs. In addition, we may experience releases of certain chemicals or discover
existing contamination, which could cause us to incur material cleanup costs or other damages.
Our international sales and operations are subject to applicable laws relating to trade, export controls and foreign
corrupt practices, the violation of which could adversely affect our operations.
We must comply with all applicable export control laws and regulations of the United States and other countries.
United States laws and regulations applicable to us include the Arms Export Control Act, the International Traffic in Arms
Regulations (“ITAR”), the Export Administration Regulations (“EAR”) and the trade and trade sanctions laws and regulations
administered by the Office of the United States Trade Representative (“OFTR”) and the United States Department of the
Treasury’s Office of Foreign Assets Control (“OFAC”). The import and export of our products from each of our United States
and international manufacturing facilities and distribution hubs are subject to international trade agreements, the modification
or repeal of which could impact our business. We must comply with the requirements of OFTR and non-U.S. trade
representative offices to benefit from existing trade agreements. EAR restricts the export of dual-use products and technical
data to certain countries, while ITAR restricts the export of defense products, technical data and defense services. The U.S.
government agencies responsible for administering EAR and ITAR have significant discretion in the interpretation and
enforcement of these regulations. We also cannot provide services to certain countries subject to United States trade sanctions
unless we first obtain the necessary authorizations from OFAC. In addition, we are subject to the Foreign Corrupt Practices Act
and other anti-bribery laws that, generally, bar bribes or unreasonable gifts to foreign governments or officials.
Violations of these laws or regulations could result in significant additional sanctions including fines, more onerous
compliance requirements, more extensive debarments from export privileges, loss of authorizations needed to conduct aspects
of our international business and criminal penalties and may harm our ability to enter contracts with customers who have
contracts with the U.S. government. A violation of the laws or the regulations enumerated above could materially adversely
affect our business, financial condition and results of operations.
Changes impacting international trade and corporate tax provisions related to the global manufacturing and sales
of our products may have an adverse effect on our financial condition and results of operations.
A significant portion of our business activities are conducted in foreign countries, including Mexico and China. Our
business benefits from free trade agreements such as the North American Free Trade Agreement (“NAFTA”) and we also rely
on various U.S. corporate tax provisions related to international commerce as we build, market and sell our products globally.
Changes in trade treaties and corporate tax policy could impact U.S. trade relations with other countries such as Mexico, and
adversely affect our financial condition and results of operations.
19
Volatility of financial and credit markets could affect our access to capital.
Uncertainty in the global financial and credit markets could impact our ability to implement new financial
arrangements or to modify our existing financial arrangements. An inability to obtain new financing or to further modify
existing financing could adversely impact the execution of our restructuring plans and delay the realization of the expected cost
reductions. Our ability to generate adequate liquidity will depend on our ability to execute our operating plans and to manage
costs in light of developing economic conditions. An unanticipated decrease in sales, or other factors that would cause the
actual outcome of our plans to differ from expectations, could create a shortfall in cash available to fund our liquidity needs.
Being unable to access new capital, experiencing a shortfall in cash from operations to fund our liquidity needs and the failure
to implement an initiative to offset the shortfall in cash would likely have a material adverse effect on our business.
Default by or failure of one or more of our counterparty financial institutions could cause us to incur significant
losses.
As part of our hedging activities, we enter into transactions involving derivative financial instruments with a financial
institution. In addition, we have significant amounts of cash, cash equivalents and other investments on deposit or in accounts
with banks or other financial institutions in the United States and abroad. As a result, we are exposed to the risk of default by or
failure of counterparty financial institutions. The risk of counterparty default or failure may be heightened during economic
downturns and periods of uncertainty in the financial markets. If one of our counterparties were to become insolvent or file for
bankruptcy, our ability to recover losses incurred as a result of default or to retrieve our assets that are deposited or held in
accounts with such counterparty may be limited by the counterparty's liquidity or the applicable laws governing any related
financial institution's insolvency or bankruptcy proceedings. In the event of default by or failure of one or more of our
counterparties, we could incur significant losses, which could negatively impact our results of operations and financial
condition.
We must consistently reduce the total costs of our products to remain competitive.
Our industry is intensely competitive and prices for existing products tend to decrease steadily over their life cycle.
There is substantial and continuing pressure from customers to reduce the total cost of capacitors. To remain competitive, we
must achieve continuous cost reductions through process and product improvements.
We must also be in a position to minimize our customers’ shipping and inventory financing costs and to meet their
other goals for rationalization of supply and production. Our growth and the profit margins of our products will suffer if our
competitors are more successful in reducing the total cost to customers of their products than we are. We must also continue to
introduce new products that offer performance advantages over our existing products and can thereby achieve premium prices,
offsetting the price declines in our more mature products.
Our use of net operating losses to offset possible future taxable income could be limited by ownership changes.
In addition to the general limitations on the carryback and carryforward of net operating losses under Section 172 of
the Internal Revenue Code (the “Code”), Section 382 of the Code imposes further limitations on the utilization of net operating
losses by a corporation following ownership changes which result in more than a 50-percentage point change in ownership of a
corporation within a three-year period. If Section 382 applies, the post-ownership change utilization of our net operating losses
may be subject to limitation for federal income tax purposes related to regular and alternative minimum tax. While we do not
believe we have experienced an ownership change to date, the application of Section 382 of the Code now or in the future
could limit a substantial part of our future utilization of available net operating losses. Such limitation could require us to pay
substantial additional income taxes and adversely affect our liquidity and financial position.
Even if we have not experienced an ownership change to date, we could experience an ownership change in the near
future if there are significant purchases of our common stock or other events outside our control.
Our debt agreements contain restrictions that could limit our flexibility in operating our business.
Our debt agreements contain various covenants that, subject to exceptions, may limit our ability to, among other
things: incur additional indebtedness; create liens on assets; make capital expenditures; engage in mergers, consolidations,
liquidations and dissolutions; sell assets (including pursuant to sale leaseback transactions); pay dividends and distributions on
or repurchase capital stock; make investments (including acquisitions), loans, or advances; prepay certain junior indebtedness;
engage in certain transactions with affiliates; enter into restrictive agreements; amend material agreements governing certain
junior indebtedness; and change lines of business. The agreement governing our revolving credit facility also includes a fixed
charge coverage ratio covenant that we must satisfy if an event of default occurs or in the event we do not meet certain excess
availability requirements under our revolving credit facility. Our ability to comply with these covenants is dependent on our
future performance, which may be subject to many factors, some of which are beyond our control.
20
Our controls and procedures may fail or be circumvented, which may result in a material adverse effect on our
business, financial condition, and results of operations.
Management regularly reviews and updates our internal controls, disclosure controls and procedures, and corporate
governance policies and procedures. Any system of controls, however well designed and operated, is based in part on certain
assumptions and can provide only reasonable, not absolute, assurance that the objectives of the system are met. Any failure or
circumvention of the controls and procedures or failure to comply with regulations related to controls and procedures could
have a material adverse effect on our business, results of operations and financial condition.
As disclosed in Part II - Item 9A. “Controls and Procedures” of this Form 10-K in the section “Management’s Report
on Internal Control Over Financial Reporting,” a material weakness was identified in our internal control over financial
reporting resulting from certain control deficiencies in our internal control over financial reporting pertaining to the initiation
and recording of net sales and accounts receivable, net at March 31, 2019. The specific issues leading to these conclusions are
described in that section. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial
reporting, such that there is a reasonable possibility that a material misstatement of a company’s annual or interim financial
statements will not be prevented or detected on a timely basis.
The material weakness identified in Item 9A did not result in any misstatement of the Company’s Consolidated
Financial Statements for any period presented. The Company has already commenced efforts to remediate the material
weakness and expects for the material weakness to be remediated this year. However, our remedial measures to address the
material weakness may be insufficient and we may in the future discover areas of our internal controls that need improvement.
Failure to maintain effective controls or to timely implement any necessary improvement of our internal and disclosure controls
could, among other things, result in losses from errors, harm our reputation or cause investors to lose confidence in the reported
financial information, all of which could have a material adverse effect on our results of operations and financial condition.
If we are unable to protect our information systems against service interruption, misappropriation of data, or
breaches of security, our operations could be disrupted, we may suffer financial losses, and our reputation may be damaged.
As a global company we rely on networks and information systems and other technology (“information systems”),
including the internet and third-party hosted services, to support our business. Any inability to successfully manage the
procurement, development, implementation, execution or maintenance of our information systems, including matters related to
system and data security, reliability, compliance or performance could have an adverse effect on our business including our
results of operation and timeliness of financial reporting.
Because information systems are critical to many of the Company's operating activities, our business may be impacted
by system shutdowns, service disruptions or security breaches. These incidents may be caused by failures during routine
operations such as system upgrades or by user errors, as well as network or hardware failures, malicious or disruptive software,
unintentional or malicious actions of employees or contractors, cyberattacks by common hackers, criminal groups or nation-
state organizations or social-activist (hacktivist) organizations, geopolitical events, natural disasters, failures or impairments of
telecommunications networks, or other catastrophic events. In addition, such incidents could result in unauthorized or
accidental disclosure of material confidential information of the Company or its customers, or regulated individual personal
data. If our information systems suffer severe damage, disruption or shutdown and our business continuity plans do not
effectively resolve the issues in a timely manner, we could experience delays in reporting our financial results, and we may lose
revenue and profits as a result of our inability to timely manufacture, distribute, invoice and collect payments for products. The
loss or disclosure of misappropriated confidential information could have the following implications: loss of intellectual
property, disruption to key business operations, and diversion of management’s attention from key business operations and key
informational technology resources. The Company could also be required to spend significant financial and other resources to
remedy the damage caused by a security breach or to repair or replace networks and information systems
In addition, we are subject to federal defense procurement regulations relating to the effectiveness of our cybersecurity
operations, and to laws, rules, and regulations in the U.S., U.K., European Union, and other countries relating to the collection,
use, and security of user data. Our ability to execute transactions and to possess and use personal information and data in
conducting our business subjects us to legislative and regulatory burdens that may require us to notify vendors, customers, or
employees of a data security breach, potentially damaging our brand and reputation. If we fail to comply with applicable
federal, state, or international cybersecurity, privacy-related, or data protection laws or regulations, we may incur a loss of
business (including defense-related business) and/or penalties or significant legal liability or be subject to proceedings by
government entities.
If economic and demographic experience for pension and other post-retirement benefit plans are less favorable
than our assumptions (e.g., discount rates or return on investments), then it may affect our financial condition and results
of operations.
21
The measurement of our obligations, costs, and liabilities associated with benefits pursuant to our pension and other
post-retirement benefit plans requires that we estimate the present value of projected future payments to all participants. We use
many assumptions in calculating these estimates, including assumptions related to discount rates, return on investments on
designated plan assets, and demographic experience (e.g. mortality and retirement rates). To the extent actual results are less
favorable than our assumptions, there could be a substantial adverse impact on our financial condition and results of operations.
For instance, significant decreases in market interest rates could lead to increases in annual pension expense. Further, decreases
in the value of plan assets could lead to an increased use of cash for plan contributions. For discussion of our assumptions, see
“Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in
Item 7 and Note 9 to the consolidated financial statements.
Sales to distribution channel customers may fluctuate and adversely affect our results of operations.
From time-to-time, if end customer demand decreases, our sales to distributors also decrease while the distributors
reduce their inventory levels. In addition, a single customer, a distributor, accounted for over 10% of our net sales in fiscal
years 2019, 2018 and 2017. If our relationship with this customer were to terminate, we would need to determine alternative
means of delivering our products to the end-customers served by it.
Earthquakes and other natural disasters could disrupt our operations and have a material adverse effect on our
financial condition and results of operations.
Several of our facilities in Japan are located in regions that could be subject to earthquakes and other natural disasters.
Our production facilities located in Japan are in areas with above average seismic activity and some have been affected by other
natural disasters such as tsunami. If any of our facilities in Japan or elsewhere were to experience a catastrophic earthquake or
other natural disaster, such event could disrupt our operations, delay production, shipments, and revenue, and result in large
expenses to repair or replace the facility or facilities. While KEMET has property insurance to partially reimburse it for losses
caused by windstorm and earth movement, such insurance would not cover all possible losses. In addition, our existing disaster
recovery and business continuity plans (including those relating to our information technology systems) may not be fully
responsive to, or minimize losses associated with, catastrophic events.
Our stock price can be volatile.
The market price for our common stock has been volatile historically. Our stock price may be significantly affected by
factors including those described elsewhere in "Part 1, Item 1A. Risk Factors," as well as the following:
•
•
•
•
•
•
general market and economic conditions;
quarterly fluctuations in our operating results compared to market expectations;
investors' perceptions of the electronic component industry;
changes in financial estimates by us or securities analysts and recommendations by securities analysts;
the composition of our stockholders, particularly the presence of "short sellers" trading our stock; and
a decline in our credit rating.
ITEM 1B. UNRESOLVED STAFF COMMENTS.
None.
22
ITEM 2. PROPERTIES.
We are headquartered in Fort Lauderdale, Florida, and, as of March 31, 2019, we had 23 manufacturing plants
located in North America, Europe and Asia. Our manufacturing and research facilities include approximately 4.9 million
square feet of floor space and use proprietary manufacturing processes and equipment.
Our facilities in Mexico operate under the Maquiladora program. In general, a company that operates under this
program is afforded certain duty and tax preferences and incentives on products brought into the United States. Our
manufacturing standards, including compliance with worker safety laws and regulations, are essentially identical in North
America, Europe and Asia. Our operations in Mexico, Europe and Asia, similar to our United States operations, have won
numerous quality, environmental and safety awards.
We believe substantially all of our property and equipment is in good condition, and overall, we have sufficient capacity to
meet our current and projected manufacturing and distribution needs. The following table provides certain information
regarding our principal facilities:
Location
Fort Lauderdale, Florida, U.S.A
Solid Capacitor Reportable Segment
Simpsonville, South Carolina, U.S.A.
Matamoros, Mexico
Monterrey, Mexico (1)
Suzhou, China (1)
Ciudad Victoria, Mexico
Carson City, Nevada, U.S.A.
Nyuzen, Toyama, Japan
Chachoengsao, Thailand
Film and Electrolytic Reportable Segment
Evora, Portugal
Skopje, Macedonia
Granna, Sweden
Suomussalmi, Finland
Batam, Indonesia
Kyustendil, Bulgaria (2)
Pontecchio, Italy
Anting, China (3)
Farjestaden, Sweden
Electro-Magnetic, Sensors, and Actuators
Segment Reportable Segment
Shiroishi, Miyagi, Japan
Sendai, Miyagi, Japan
Bien Hoa City, Dong Nai Province, Vietnam
Xiamen, China
Square
Footage
(in
thousands)
Type of
Interest
61
Leased
Headquarters
Description of Use
Owned
Innovation Center, Advanced Tantalum
Manufacturing
Owned Manufacturing
Owned Manufacturing
Leased Manufacturing
Owned Manufacturing
Owned Manufacturing
Owned Manufacturing and Innovation Center
Owned Manufacturing
Owned Manufacturing and Innovation Center
Owned Manufacturing
Owned Manufacturing
Leased Manufacturing
Owned Manufacturing
(2)
(2)
382
286
532
353
265
87
209
170
233
126
132
56
68
86
226
Owned Manufacturing and Innovation Center
73
28
524
378
174
432
(3)
(3)
Leased Manufacturing and Innovation Center
Owned Manufacturing
Owned Manufacturing and Innovation Center
Owned Manufacturing
Owned Manufacturing
_______________________________________________________________________________
(1) Includes two manufacturing facilities.
(2) Includes one owned manufacturing facility and one leased warehouse facility.
(3) Includes one owned manufacturing facility and one leased manufacturing facility.
23
ITEM 3. LEGAL PROCEEDINGS.
We or our subsidiaries may at any one time be parties to lawsuits arising out of our respective operations, including
workers’ compensation or work place safety cases, some of which involve claims of substantial damages. Although there can be
no assurance, based upon information known to us, we do not believe that any liability which might result from an adverse
determination of such lawsuits would have a material adverse effect on our financial condition or results of operations.
As previously reported, KEMET and KEC, along with more than 20 other capacitor manufacturers and subsidiaries
(including TOKIN, as described below), are defendants in a purported antitrust class action complaint, In re: Capacitors
Antitrust Litigation, No. 3:14-cv-03264-JD, filed on December 4, 2014 with the United States District Court, Northern District
of California (the “U.S. Class Action Complaint”). The complaint alleges a violation of Section 1 of the Sherman Act, for
which it seeks injunctive and equitable relief and money damages. The complaint is currently nearing the end of the expert
merits discovery phase. In addition, KEMET and KEC, along with more than 20 other capacitor manufacturers and
subsidiaries, have been named as defendants in two suits by plaintiffs who have chosen not to participate in the U.S. Class
Action Complaint (collectively with the U.S. Class Action Complaint, the “U.S. Complaints”): AASI Beneficiaries’ Trust v. AVX
Corporation, et al., filed on August 29, 2016 in the United States District Court, Southern District of Florida, and Benchmark
Electronics, Inc., et al. v. AVX Corporation, et al., filed on April 18, 2017 in the United States District Court, Southern District
of Texas. The AASI and Benchmark complaints allege generally the same violations as the U.S. Class Action Complaint.
In addition, as previously reported, KEMET and KEC, along with certain other capacitor manufacturers and
subsidiaries (including TOKIN, as described below), were named as defendants in several additional suits that were filed in
Canada (collectively, the “Canadian Complaints”): Badamshin v. Panasonic Corporation, et al., filed August 6, 2014 in the
Superior Court, Province of Quebec, District of Montreal; Herard v. Panasonic Corporation, et al., filed August 6, 2014 in the
Superior Court, Province of Quebec, District of Montreal; Cygnus Electronics Corporation v. Panasonic Corporation, et al.,
filed August 6, 2014 in the Superior Court of Justice, Province of Ontario; LeClaire v. Panasonic Corporation, et al., filed
August 6, 2014 in the Superior Court, Province of Quebec, District of Montreal; Taylor v Panasonic Corporation, et al., filed
August 11, 2014 in the Superior Court of Justice, Province of Ontario; Ramsay v. Panasonic Corporation, et al., filed August
14, 2014 in the Supreme Court, Province of British Columbia; Martin v. Panasonic Corporation, et al., filed September 25,
2014 in the Superior Court, Province of Quebec, District of Montreal; Parikh v. Panasonic Corporation, et al., filed October 3,
2014 in the Superior Court of Justice, Province of Ontario; Fraser v. Panasonic Corporation, et al., filed October 3, 2014 in the
Court of Queen’s Bench, Province of Saskatchewan; Pickering v. Panasonic Corporation, et al., filed October 6, 2014 in the
Supreme Court, Province of British Columbia; McPherson v Panasonic Corporation et al., filed on November 6, 2014 in the
Court of Queen’s Bench, Province of Manitoba; and Allott v AVX Corporation, et al., filed on May 13, 2016 in the Superior
Court of Justice, Province of Ontario. The Canadian Complaints generally allege the same unlawful acts as in the U.S.
Complaints, assert claims under Canada’s Competition Act as well as various civil and common law causes of action, and seek
injunctive and equitable relief and money damages.
There have been no material updates to the proceedings described in the immediately preceding paragraph except that
the claims against KEMET and KEC in Leclaire were dismissed on December 6, 2018. In addition, Parikh and Taylor have
been stayed in favor of Cygnus, and Badamshin, Martin and Herard have been stayed in favor of LeClaire. Further, on
November 18, 2018, the Ontario Supreme Court of Justice temporarily stayed Cygnus pending the outcome of a matter on
appeal concerning class certification, and the Ramsay plaintiffs voluntarily suspended that proceeding until class certification
for Cygnus has been determined.
Except for the TOKIN accrual described below and certain attorneys’ fees, the Company has not recorded any accrual
concerning the U.S. Complaints and the Canadian Complaints.
TOKIN-Specific Legal Proceedings
In July 2013, TOKIN was named as one of eight defendants in two purported U.S. class action antitrust lawsuits (In
Re: Lithium Ion Batteries Antitrust Litigation, 13-MD-02420-YGR, United States District Court, Northern District of
California) (the “Battery Class Action Suits”) regarding the sale of lithium ion batteries brought on behalf of direct product
purchasers and indirect product purchasers. On March 2, 2018, TOKIN entered into a settlement agreement, which, subject to
court approval, provides for the release of TOKIN and its subsidiaries from claims asserted in the Battery Class Action Suits, in
consideration of which, TOKIN agreed to pay $2.0 million to the settlement class of indirect product purchasers. TOKIN paid
the settlement amount into an escrow account on January 25, 2019. On May 16, 2018, the Court granted final approval to a
settlement agreement by which, in consideration of the release of TOKIN and its subsidiaries from claims asserted in the
Battery Class Action Suits, TOKIN agreed to pay $4.95 million to the settlement class of direct product purchasers. Prior to
final court approval, TOKIN had paid the settlement amount into an escrow account on January 18, 2018.
24
Beginning in March 2014, TOKIN and certain of its subsidiaries received inquiries, requests for information and other
communications from government authorities in China, the United States, the European Commission, Japan, South Korea,
Taiwan, Singapore, and Brazil concerning alleged anti-competitive activities within the capacitor industry.
On September 2, 2015, the United States Department of Justice announced a plea agreement with TOKIN in which
TOKIN agreed to plead guilty to a one-count felony charge of unreasonable restraint of interstate and foreign trade and
commerce in violation of Section 1 of the Sherman Act, and to pay a criminal fine of $13.8 million. The plea agreement was
approved by the United States District Court, Northern District of California, on January 21, 2016. The fine is payable over 5
years in six installments of $2.3 million each, plus accrued interest. The first four payments were made in February 2016,
January 2017, January 2018, and January 2019, while the next payment is due in January 2020.
On December 9, 2015, the Taiwan Fair Trade Commission (“TFTC”) publicly announced that TOKIN would be fined
1.2 billion New Taiwan dollars (“NTD”) (approximately $39.5 million) for violations of the Taiwan Fair Trade Act.
Subsequently, the TFTC indicated the fine would be reduced to NTD 609.1 million (approximately $19.8 million). In February
2016, TOKIN commenced an administrative suit in Taiwan, challenging the validity of the amount of the fine. On August 23,
2018, the Taipei High Administrative Court revoked the TFTC decision, finding that the decision had been time-barred by
applicable statute. On September 21, 2018, the TFTC filed an appeal against the High Administrative Court's decision. Payment
of the TFTC fine is not stayed during the administrative appeals; TOKIN has made installment payments of the fine
aggregating to approximately NTD 152.3 million (approximately $4.9 million) as of March 31, 2019.
On March 29, 2016, the Japan Fair Trade Commission published an order by which TOKIN was fined JPY 127.2
million (approximately U.S. $1.1 million) for violation of the Japanese Antimonopoly Act. Payment of the fine was made on
October 31, 2016.
On July 15, 2016, TOKIN entered into definitive settlement agreements in two antitrust suits filed with the United
States District Court, Northern District of California as In re: Capacitors Antitrust Litigation, No. 3:14-cv-03264-JD (the
“Capacitor Class Action Suits”). Pursuant to the terms of the settlement, in consideration of the release of TOKIN and its
subsidiaries (including TOKIN America, Inc.) from claims asserted in the Capacitor Class Action Suits, TOKIN will pay an
aggregate $37.3 million to a settlement class of direct purchasers of capacitors and a settlement class of indirect purchasers of
capacitors. Each of the respective class payments is payable in five installments, four of which were paid on or before the
respective due dates of July 29, 2016, May 15, 2017, May 15, 2018, and May 15, 2019. The final payment is due by December
31, 2019.
On July 27, 2016, Brazil’s Administrative Council for Economic Defense approved a cease and desist agreement with
TOKIN in which TOKIN made a financial contribution of Brazilian Real 0.6 million (approximately $0.2 million) to Brazil’s
Fund for Defense of Diffuse Rights.
On March 21, 2018, the European Commission announced a decision by which TOKIN was fined EUR 8.8 million
directly (approximately $10.3 million) and EUR 5.0 million (approximately $5.9 million) jointly and severally with NEC
Corporation, for violation of the competition laws of the European Union. Payment of the fines were made on June 28, 2018.
On June 4, 2018, TOKIN filed an appeal with the General Court of the European Union, seeking annulment and/or reduction of
the fines.
As noted above, TOKIN, along with KEMET and certain of its other subsidiaries, were named as defendants in the
Canadian Complaints. On May 30, 2018, TOKIN entered into definitive settlement agreement with the plaintiffs in the
Canadian Complaints Pursuant to the terms of the settlement, in consideration of the release of TOKIN and its subsidiaries
(including TOKIN America, Inc.) from claims asserted in the Canadian Complaints, TOKIN paid CAD 2.9 million
(approximately $2.2 million) to a settlement class of purchasers of aluminum and tantalum electrolytic capacitors and
purchasers of products containing such capacitors. The settlement payment was made on June 27, 2018. The settlement
agreement has been approved by the Quebec and Ontario courts; approval by the Supreme Court of British Columbia is
pending.
On November 30, 2018, the Korean Fair Trade Commission (“KFTC”) notified TOKIN of its decision to impose an
administrative fine on TOKIN of KRW 8.1 billion (approximately $7.2 million) for violation of South Korea's Monopoly
Regulation and Fair Trade Law. TOKIN filed its appeal of the KFTC's decision with the Seoul High Court on December 28,
2018. Payment of the fine is not stayed during appeal; TOKIN paid the full fine amount on February 1, 2019.
On July 2, 2018, TOKIN and TOKIN America Inc. were named as two of 20 defendants in a purported U.S. class
action antitrust lawsuit, In re: Inductors Antitrust Litigation, No. 5:18-cv-00198-EJD-NC, filed in the United States District
Court, Northern District of California, regarding the sale of inductors brought on behalf of direct product purchasers and
indirect product purchasers. The complaint alleges violations of Sections 1 and 3 of the Sherman Act, for which it seeks
injunctive and equitable relief and money damages.
25
As of March 31, 2019, TOKIN’s accrual for antitrust and civil litigation claims totaled $37.7 million which is stated in
the following line items, “Account payable” ($15.0 million), “Accrued expenses” ($9.5 million) and “Other non-current
obligations” ($13.2 million) on the Consolidated Balance Sheets. This amount includes the best estimate of losses which may
result from the ongoing antitrust investigations, civil litigation and claims. However, the actual outcomes could differ from
what has been accrued.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 4A. INFORMATION ABOUT OUR EXECUTIVE OFFICERS
The name, age, business experience, positions and offices held, and period served in such positions or offices for each
of the executive officers and certain key employees of the Company are listed below. There are no family relationships among
our executive officers and directors or any other arrangement or understanding pursuant to which any person was selected as an
officer.
Name
Age
Position
William M. Lowe, Jr.
66 Chief Executive Officer and Director
Gregory C. Thompson
63 Executive Vice President and Chief Financial Officer
Charles C. Meeks, Jr.
Shigenori (Sean) Oyama
57 Executive Vice President, Solid Capacitors-Tantalum
62 Executive Vice President, Magnetics, Sensors, and Actuators
R. James Assaf
Claudio Lollini
Stefano Vetralla
Susan B. Barkal
59 Senior Vice President, General Counsel and Secretary
39 Senior Vice President of Global Sales and Marketing
56 Senior Vice President and Chief Human Resources Officer
56 Senior Vice President Quality, Chief Compliance Officer and Chief of Staff
Dr. Phillip M. Lessner
60 Senior Vice President and Chief Technology Officer
Andreas Meier
51 Senior Vice President, Film and Electrolytic
Robert S. Willoughby
58 Senior Vice President, Solid Capacitors-Ceramics
Michael L. Raynor
Richard J. Vatinelle
Executive Officers
53 Vice President and Corporate Controller
55 Vice President and Treasurer
Years with
Company
11
—
35
37
11
14
11
19
23
21
33
12
6
William M. Lowe, Jr., Chief Executive Officer and Director, was named such in December 2018. Mr. Lowe joined
KEMET in July 2008 as its Executive Price President and Chief Financial Officer. Before joining KEMET, Mr. Lowe was the
Vice President, Chief Operating Officer and Chief Financial Officer of Unifi, Inc., a producer and processor of textured
synthetic yarns from January 2004 to October 2007. Prior to holding that position, he was Executive Vice President and Chief
Financial Officer for Metaldyne, an automotive components manufacturer. He also held various financial management
positions with ArvinMeritor, Inc., a premier global supplier of integrated automotive components. He received his B.S. degree
in business administration with a major in accounting from Tri-State University and was certified as a Certified Public
Accountant in the state of Ohio (current license status inactive).
Gregory C. Thompson, Executive Vice President and Chief Financial Officer, joined KEMET in such capacity in
December 2018. Earlier that month, Mr. Thompson joined KEMET as its Executive Vice President-Finance. Mr. Thompson
previously served as Executive Vice President of Axiall Corporation, a Delaware corporation, from July 2015 until October
2016 and Chief Financial Officer from February 2008 until October 2016. Before beginning at Axiall in 2008, Mr. Thompson
served as the Senior Vice President and Chief Financial Officer of Invacare Corporation, a medical equipment manufacturer.
Prior thereto, he served in various financial management positions with Sensormatic Electronics Corporation, Wang
Laboratories, Inc. and Price Waterhouse. He is a Certified Public Accountant and is a Member of the American Institute of
Certified Public Accountants. He holds a Bachelor of Science degree in Accounting from Virginia Tech.
Charles C. Meeks, Jr., Executive Vice President, Solid Capacitors-Tantalum, was named such in July 2017. He joined
KEMET in December 1983 in the position of Process Engineer, and has held various positions of increased responsibility
including the positions of Plant Manager and Director of Operations, Ceramic Product Line. He was named Vice President,
Ceramic Product Line in June 2005, Senior Vice President, Ceramic Product Line in October 2007, Senior Vice President,
Ceramic and Film and Electrolytics in March 2010, Executive Vice President Ceramic and Film and Electrolytics in May 2011,
26
and Executive Vice President, Solid Capacitors in July 2017 prior to his appointment to his current position. In addition, since
January 2000, Mr. Meeks has served as President of Top Notch Inc., a private company that offers stress management therapy
services. Mr. Meeks received a Masters of Business Administration degree and a Bachelor of Science degree in Ceramic
Engineering from Clemson University.
Shigenori (Sean) Oyama, Executive Vice President, Magnetics, Sensors, and Actuators, was named such in July 2017
after the Company's acquisition of TOKIN. Mr. Oyama joined TOKIN in 1982. He moved to California in 1989 and held
various management roles in Field Application Engineering, Sales and Marketing at TOKIN America Inc. Mr. Oyama returned
to TOKIN Japan and was appointed General Manager of Product Marketing for Energy Devices in 2003, General Manager and
Vice President for the EMC Division in 2005, Senior Vice President of all Business Groups in 2010, followed by his
appointment to President of TOKIN in 2012. Mr. Oyama holds a B.S. degree in Electrical Engineering from Tohoku University.
R. James Assaf, Senior Vice President, General Counsel and Secretary, was named such in February 2014. Mr. Assaf
joined KEMET as Vice President, General Counsel in March 2008, and was appointed Vice President, General Counsel and
Secretary in July 2008 prior to his appointment to his current position. Before joining KEMET, Mr. Assaf served as General
Manager for InkSure Inc., a start-up seller of product authentication solutions. He had also previously held several positions
with Sensormatic Electronics Corporation, including Associate General Counsel and Director of Business Development,
Mergers and Acquisitions. Prior to Sensormatic, Mr. Assaf served as an Associate Attorney with the international law firm
Squire Sanders and Dempsey. Mr. Assaf received his Bachelor of Arts degree from Kenyon College and his Juris Doctor degree
from Case Western Reserve University School of Law.
Claudio Lollini, Senior Vice President of Global Sales and Marketing, was named such in July 2015. He joined
KEMET in October 2007 through the Company’s acquisition of Arcotronics Italia S.p.A., where he served as Manager, Sales-
Greater China. Mr. Lollini was appointed Director of Product Management for Film and Electrolytic in January 2009, Director
of Sales Taiwan in June 2012, and Vice President, Sales-Asia Pacific in May 2013 prior to his appointment to his current
position. Mr. Lollini holds a Bachelor of Science degree in Engineering Management from the University of Bologna and a
Master of Business Administration from the Kellogg School of Management and is a 2011 graduate of the KEMET Leadership
Forum.
Stefano Vetralla, Senior Vice President and Chief Human Resources Officer, was named such in July 2015. He joined
KEMET in May 2008 as Director-HR, Film and Electrolytic Business Group. Mr. Vetralla was appointed Director-HR, Global
Sales and Film and Electrolytic Business Group in January 2011; Senior Director HR, Global Sales and Film and Electrolytic
Business Group in January 2012; Senior Director-HR, Field in September 2012; Vice President-Global HR Operations in
September 2013; and Vice President-Global HR and Chief Human Resources Officer in May 2014 prior to his current
appointment. Prior to KEMET, he held Human Resources positions of increasing responsibility in international corporations
including Hewlett-Packard Company, 3Com Corporation and Telindus /Belgacom. Mr. Vetralla holds a Law Degree from the
State University of Milan and is a 2011 graduate of the KEMET Leadership Forum.
Robert S. Willoughby, Senior Vice President, Solid Capacitors-Ceramics, was named such in July 2017. He joined
KEMET in December 1985 and has held positions of increasing responsibility within Diagnostic, Quality, New Product and
Process Engineering. Mr. Willoughby served as Director-Ceramic Operations from July 2007 until March 2010; served as Vice
President of Operations-Film and Electrolytic Business Unit from March 2010 until May 2013; served as Vice President, Film
and Electrolytic Business Group from May 2013 through December 2014; and served as Senior Vice President-Film and
Electrolytic Business Group from January 2015 through April 2016. Mr. Willoughby was named Senior Vice President-Global
Supply Chain in May 2016, prior to his appointment to his current position. He holds a Bachelor of Science degree in Industrial
Engineering from Clemson University and is a 2007 graduate of the KEMET Leadership Forum.
Other Key Employees
Susan B. Barkal, Senior Vice President Quality, Chief Compliance Officer and Chief of Staff, was named such in
February 2014. Ms. Barkal joined KEMET in November 1999 and has served as Quality Manager for the Tantalum Business
Group (now a part of Solid Capacitors), Technical Product Manager for all Tantalum product lines and Director of Tantalum
Product Management. Ms. Barkal was appointed Vice President of Quality and Chief Compliance Officer in December 2008
prior to her appointment to her current position. Ms. Barkal holds a B.S. degree in Chemical Engineering from Clarkson
University, a Master of Science degree in Mechanical Engineering from California Polytechnic University and is a 2007
graduate of the KEMET Leadership Forum.
Dr. Philip M. Lessner, Senior Vice President and Chief Technology Officer, was named such in February 2014. He
joined KEMET in March 1996 as a Technical Associate in the Tantalum Technology Group. He has held several positions of
increasing responsibility in the Technology and Product Management areas including Senior Technical Associate, Director
Tantalum Technology, Director Technical Marketing Services and Vice President Tantalum Technology. Dr. Lessner was named
27
Vice President, Chief Technology Officer and Chief Scientist in December 2006, Senior Vice President, Chief Technology
Officer and Chief Scientist in May 2011 and Senior Vice President and Chief Technology and Marketing Officer in November
2012 prior to his appointment to his current position. Dr. Lessner received a PhD in Chemical Engineering from the University
of California, Berkeley and a B.S. in Chemical Engineering from Cooper Union.
Andreas Meier, Senior Vice President-Film and Electrolytic, was named such in May 2016. Mr. Meier joined KEMET
in January 1998 and has held several positions of increasing responsibility in the Sales and Product Management areas. Mr.
Meier was named Vice President-Product Management, Film and Electrolytics in January, 2010 and Vice President, Sales-
EMEA in December, 2012 prior to his appointment to his current position. Mr. Meier holds a degree in Electronic Engineering
from the University of Paderborn in Germany.
Michael L. Raynor, Vice President and Corporate Controller, was named such in November 2012. Mr. Raynor joined
the Company in July 2007 as the Assistant Corporate Controller; in November of 2008 Mr. Raynor was named Director of
Financial Planning and Analysis prior to his appointment to his current position. Prior to joining KEMET, Mr. Raynor held
various controller level positions with distribution and manufacturing companies. Mr. Raynor received a Bachelor of Arts
degree in Economics and a Masters of Accounting from the University of North Carolina at Chapel Hill, is a Certified Public
Accountant in the state of North Carolina and is a 2015 graduate of the KEMET Leadership Forum.
Richard J. Vatinelle, Vice President and Treasurer, was named such in March 2014. Mr. Vatinelle joined the Company
in November 2012 as Controller-Tantalum Business Group. Prior to joining KEMET, Mr. Vatinelle served for two years as
Regional Controller-Latin America for Leo Pharma A/S, a global manufacturer of pharmaceutical products. From 2007 to 2009
he served as Director of Finance, Policies and Reporting, for Stiefel Laboratories, a pharmaceutical company specialized in
dermatology. Mr. Vatinelle’s career in finance includes eight years with Conagra Foods Inc., where he held various
international finance roles, and eleven years with Banque Sudameris, an international banking group where he began his career.
Mr. Vatinelle holds a Bachelor of Science degree in Finance and International Management from Georgetown University and is
a 2015 graduate of the KEMET Leadership Forum.
28
PART II
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND
ISSUER PURCHASES OF EQUITY SECURITIES.
Market for Common Stock of the Company
Our common stock trades on the NYSE under the ticker symbol “KEM.” We had 72 stockholders of record as of
May 27, 2019.
Dividend Policy
Between the date of our initial public offering in October 1992 and until fiscal year 2019, we had not declared or paid
any cash dividends on our common stock. Beginning in the third quarter of fiscal year 2019, we announced our intention to pay
regular quarterly cash dividends to holders of our common stock. Cash dividends of $0.05 per share were paid to holders of our
common stock during the third and fourth quarters of fiscal year 2019. On May 16, 2019, the Company announced a cash
dividend of $0.05 per share of the Company's common stock. Payment will be made on June 10, 2019 to shareholders of record
at the close of business on May 30, 2019.
Any future determination to pay dividends will be at the discretion of our Board and will depend upon, among other
factors, the capital requirements, operating results, and our financial condition. In addition, under the terms of the Revolving
Line of Credit (as hereinafter defined), we are restricted from paying cash dividends in an amount greater than $15.0 million in
the aggregate per year.
29
PERFORMANCE GRAPH
The following graph compares our cumulative total stockholder return for the past five fiscal years, beginning on
March 31, 2014, with the Russell 3000 and a peer group (the “Peer Group”) comprised of certain companies which we consider
to be peers because they either manufacture capacitors or other electronic components, or compete in the same market
segments in which we compete. The Peer Group is comprised of AVX Corporation, Littelfuse, Inc., and Vishay
Intertechnology, Inc.
*$100 invested on March 31, 2014 in stock or index, including reinvestment of dividends
RETURNS
Years Ending March 31,
KEMET Corporation
Russell 3000
Peer Group
2014
2015
2016
2017
2018
2019
$
$
100.00
100.00
100.00
$
71.26
120.53
104.50
$
33.22
132.33
109.80
$
206.54
128.45
146.25
$
312.05
149.09
182.00
293.77
166.05
170.47
Unregistered Sales of Equity Securities
We did not sell any of our equity securities during fiscal year 2019 that were not registered under the Securities Act of
1933, as amended (the “Securities Act”).
30
Repurchase of Equity Securities
The following table provides information relating to our purchase of shares of our common stock during the quarter
ended March 31, 2019:
Periods
January 1 to January 31, 2019
February 1 to February 28, 2019
March 1 to March 31, 2019
Total for Quarter Ended March 31, 2019
(a) Total
Number of
Shares
Purchased (1)
(b) Average
Price Paid
per Share
(c) Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs (2)
— $
447
21,190
21,637 $
—
18.31
17.51
17.53
—
—
—
(d) Maximum
Number of Shares
that may yet be
Purchased Under the
Plan or Programs (2)
—
—
—
_______________________________________________________________________________
(1) Represents shares withheld by the Company upon vesting of restricted stock to pay taxes due. The Company does not currently have a publicly announced
share repurchase plan or program.
(2) The Company does not currently have a publicly announced share repurchase plan or program.
Equity Compensation Plan Disclosure
The following table summarizes equity compensation plans approved by stockholders and equity compensation plans
that were not approved by stockholders as of March 31, 2019:
Plan category
Equity compensation plans approved by stockholders
Equity compensation plans not approved by stockholders
Total
(a)
(b)
(c)
Number of
securities to be
issued upon
exercise of
outstanding
options, warrants,
and rights
1,962,361(1)
—
1,962,361
Weighted-average
exercise
price of
outstanding
options,
warrants,
and rights
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (a))
$
$
6.37
—
6.37
4,284,048
—
4,284,048
_______________________________________________________________________________
(1) Includes 419,985 shares subject to outstanding LTIP Awards (time-based), 208,442 shares subject to outstanding LTIP Awards (performance-based) and
1,178,817 outstanding non-vested restricted shares of Common Stock; the weighted-average exercise price does not take into account these shares as they have
no exercise price.
31
ITEM 6. SELECTED FINANCIAL DATA.
The following table summarizes our selected historical consolidated financial information for each of the last five years. The
selected financial information under the captions “Summary of Operations,” “Per Share Data,” “Balance Sheet Data,” and
“Other Data” shown below has been derived from our audited Consolidated Financial Statements. This table should be read in
conjunction with other consolidated financial information of KEMET, including “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” and the Consolidated Financial Statements, included elsewhere herein. The
data set forth below may not be indicative of our future financial condition or results of operations (see Item 1A, “Risk
Factors”) (amounts in thousands except per share amounts):
Summary of Operations:
Net sales (1)
Operating income (1)
Interest income
Interest expense
Income (loss) from continuing operations (1)
Income from discontinued operations, net of income tax
expense (benefit)
Net income (1)
Per Share Data (1):
Net income (loss) from continuing operations per basic
share
Net income from discontinued operations, net of
income tax expense (benefit) per basic share
Net income (loss) per basic share
Net income (loss) from continuing operations per
diluted share
Net income from discontinued operations, net of
income tax expense (benefit) per diluted share
Net income (loss) per diluted share
Dividends declared per share
Balance Sheet Data:
Total assets (1)
Working capital
Long-term debt, less current portion
Other non-current obligations
Stockholders’ equity (2)
Other Data:
Fiscal Years Ended March 31,
2019
2018
2017
2016
2015
$1,382,818
$1,200,181
$ 757,338
$ 734,823
$ 823,192
200,849
(2,035)
21,239
206,587
112,852
(809)
32,882
254,127
34,968
(24)
39,755
47,157
—
—
—
206,587
254,127
47,157
33,833
(14)
39,605
(53,629)
—
(53,629)
23,832
(15)
40,701
(19,522)
5,379
(14,143)
$
3.57
$
4.81
$
1.01
$
(1.17) $
(0.43)
—
3.57
3.50
—
3.50
0.10
—
4.81
4.33
—
4.33
—
—
1.01
0.85
—
0.85
—
—
(1.17)
0.12
(0.31)
(1.17)
(0.43)
—
(1.17)
—
0.12
(0.31)
—
$1,318,095
$1,222,923
$ 739,439
$ 699,780
$ 742,604
363,580
266,041
125,360
639,415
391,295
304,083
152,249
463,875
248,252
386,211
60,707
155,569
228,793
385,833
74,892
112,481
228,478
386,320
57,131
164,682
Cash flow provided by (used in) operating activities
$ 131,731
$ 120,761
$
71,667
$
32,365
$
24,402
Capital expenditures
Research and development expenses(1)
_______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of Accounting Standard Codification ("ASC") 606, Revenue from Contracts with
Customers (“ASC 606”).
(2) Fiscal years ended March 31 ,2018 and 2017 adjusted due to the adoption of ASC 606.
146,056
20,469
24,613
65,004
25,617
39,114
44,612
26,693
22,232
25,513
32
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS.
The following discussion and analysis provide information that we believe is useful in understanding our operating
results, cash flows, and financial condition for the three fiscal years ended March 31, 2019, 2018, and 2017. The discussion
should be read in conjunction with, and is qualified in its entirety by reference to, the consolidated financial statements and
related notes appearing elsewhere in this report. The discussions in this document contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties. Our actual future
results could differ materially from those discussed here. Factors that could cause or contribute to such differences include, but
are not limited to, those discussed under the Item 1A, “Risk Factors” and, from time to time, in our other filings with the
Securities and Exchange Commission.
Our Competitive Strengths
We believe that our Company benefits from the following competitive strengths:
Strong Customer Relationships
We have a large and diverse customer base. We believe that our emphasis on quality control and our performance
history establishes loyalty with OEMs, EMSs and distributors. Our customer base includes most of the world’s major
electronics OEMs (including Bosch Group, Cisco Systems, Inc., Continental AG, Dell Inc., Apple Inc., Google LLC, Nintendo,
Tesla Inc., Delphi Technologies PLC, ABB Group, and Horiba), EMSs (including Celestica Inc., Flextronics International LTD,
Jabil Circuit, Inc., and Sanmina-SCI Corporation) and distributors (including TTI, Inc., Arrow Electronics, Inc., Satori Electric
Co., and Avnet, Inc.). Our strong, extensive and efficient worldwide distribution network is one of our differentiating factors.
We believe our ability to provide innovative and flexible service offerings, superior customer support and focus on speed-to-
market results in a more rewarding customer experience, earning us a high degree of customer loyalty.
Breadth of Our Diversified Product Offering and Markets
We believe that we have the most complete line of primary capacitor types spanning a full spectrum of dielectric
materials including tantalum, multilayer ceramic, solid and electrolytic aluminum and film capacitors. As discussed below, our
acquisition of (and previous private label partnership with) TOKIN, has expanded our product offerings and markets. As a
result, we believe we can satisfy virtually all of our customers’ capacitance needs, thereby strengthening our position as their
supplier of choice. In addition, through our acquisition of TOKIN, we have products to assist in the management of electronic
noise within a device and in communications between devices, as well as products that can sense and respond to human
activity, physical vibration, and electric current. We sell our products into a wide range of end-markets, including computing,
industrial, telecommunications, transportation, consumer, defense and healthcare across all geographical regions. No single end
market industry accounted for more than 30% of net sales; although, one customer, an electronics distributor, accounted for
more than 10% of our net sales in fiscal year 2019. No single end-use direct customer accounted for more than 5% of our net
sales in fiscal year 2019. We believe that well-balanced product, geographic and customer diversification helps us mitigate
some of the negative financial impact through economic cycles.
Leading Market Positions and Operating Scale
Based on net sales, we believe that we are the largest manufacturer of tantalum capacitors in the world and one of the
largest manufacturers of direct current film capacitors in the world and have a substantial market position in the specialty
ceramic and custom wet aluminum electrolytic markets. KEMET's Polymer Tantalum sales now lead the industry with greater
than 50.0% market share. As discussed below, our acquisition of (and previous private label partnership with) TOKIN allows us
to achieve true scale in operations to manage raw materials sourcing as well as maximize efficiencies. We believe that our
leading market positions and operating scale allow us to realize production efficiencies, leverage economies of scale and
capitalize on growth opportunities in the global capacitor market.
Strong Presence in Specialty Products
We engage in design collaboration with our customers in order to meet their specific needs and provide them with
customized products satisfying their engineering specifications. Whether at the concept or design stage, KEMET provides
engineering tools and samples to our customers to enable them to make the best product selections. KEMET’s Field
Application Engineers (experts in electrical circuits) and Technical Product Managers (experts in product applications) assist
our Sales team as they navigate the product selection process with our customers. During fiscal years 2019 and 2018,
respectively, specialty products accounted for 39.4% and 41.8% of our revenue. By allocating an increasing portion of our
management resources and research and development (“R&D”) investment particularly through our acquisition of (and
previous partnership with) TOKIN to specialty products, we have established ourselves as one of the leading innovators in this
33
fast growing, emerging segment of the market, including healthcare, renewable energy, telecommunication infrastructure and
oil and gas.
Low-Cost and Strategic Locations
We believe our manufacturing plants located in Mexico, China, Vietnam, Indonesia, Thailand, Bulgaria, and
Macedonia provide some of the lowest cost production facilities in the industry. Many of our key customers relocated or added
production facilities to Asia, particularly China. We believe our manufacturing production footprint is essential to best meet our
customers' demands, production needs, and total value proposition.
Our Brand
Founded by Union Carbide in 1919 as KEMET Laboratories, we believe that we have established a reputation as a
high quality, efficient and affordable partner that sets our customers’ needs as the top priority. This has allowed us to
successfully attract loyal clientele and enable us to expand our operations and market share over the past few years. We believe
our commitment to addressing the needs of the industry in which we operate has differentiated us from our competitors. In
addition to our traditional reputation of being the “Easy-To-Buy-From” company by providing excellent customer service and
on-time delivery, we have now evolved to be the “Easy-To-Design-In” company with the addition of technical resources like
KEMET’s online Engineering Center and capacitor selection simulation tools.
Our People
We believe that we have successfully developed a unique corporate culture based on innovation, customer focus and
commitment. We have a strong, highly experienced and committed team in each of our markets. Many of our professionals
have developed unparalleled experience in building leadership positions in new markets, as well as successfully integrating
acquisitions. Our 21-member senior management team has an average of 18 years of experience with us and an average of 28
years of experience in the manufacturing industry.
Business Strategy
Our strategy is to use our position as a leading, high-quality manufacturer of electronic components and materials to
capitalize on the increasingly demanding requirements of our customers. Refer to “Item 1. Business” for KEMET's strategic
highlights. Other important elements of our strategy include:
One KEMET Campaign.
We continue to focus on improving our commercial and technological capabilities through various initiatives that all
fall under our One KEMET campaign. The One KEMET campaign aims to ensure that we, as a company, are focused on the
same goals and working with the same processes and systems to ensure consistent quality and service that allow us to provide
our customers with the technologies they require at a competitive “total cost of ownership.” This effort was launched to ensure
that, as we continue to grow, we not only remain grounded in our core principles but that we also use those principles,
operating procedures and systems as the foundation from which to expand. These initiatives include our Lean and Six Sigma
culture evolution, our global customer accounts management program and our evolution toward a philosophy of being “easy to
design-in.”
Develop Our Significant Customer Relationships and Industry Presence.
We continue to focus on our responsiveness to our customers’ needs and requirements by making order entry and
fulfillment easier, faster, more flexible and more reliable for our customers. This will be accomplished by focusing on building
products around customers’ needs and by giving decision-making authority to customer-facing personnel and by providing
purpose-built systems and processes.
Leverage Our Technological Competence and Expand Our Leadership in Specialty Products
We continue to leverage our technological competence and our acquisition of TOKIN, by introducing new products in
a timely and cost-efficient manner. This allows us to generate an increasing portion of our sales from new and customized
solutions that meet our customers’ varied and evolving electronic component needs, as well as to improve our financial
performance. We believe that by continuing to build on our strength in the higher growth and higher margin specialty segments
of the capacitor, electro-magnetic, sensor and actuator markets, we will be well-positioned to achieve our long-term growth
objectives while also improving our profitability. During fiscal year 2019, we introduced 31,902 new products of which 336
were first to market, and specialty products accounted for 39.4% of our revenue over this period.
34
Further Expand Our Broad Capacitance Capabilities
We identify ourselves as the "Electronic Components" company and strive to be the supplier of choice for all our
customers' capacitance needs across the full spectrum of dielectric materials including tantalum, multilayer ceramic, solid and
electrolytic aluminum, film and paper. While we believe we have the most complete line of capacitor technologies across these
primary capacitor types, we intend to continue to research and pursue additional capacitance technologies and solutions to
maximize the breadth of our product offerings. As discussed below through our acquisition of TOKIN, we have further
expanded our product offerings to electric double layer capacitors, electro-magnetic devices, sensors, and actuators. This
expansion of product offerings is a continuation of our focus on the higher margin specialty segments of the market.
Selectively Target Complementary Acquisitions and Equity Investments
As strategic opportunities are identified, we will evaluate and possibly pursue them if they would enable us to enhance
our competitive position and expand our market presence. Our strategy is to acquire complementary capacitor and other related
businesses allowing us to leverage our business model, potentially including those involved in other passive components that
are synergistic with our customers’ technologies and our current product offerings. For example, in fiscal year 2012, we
acquired KBP, which has allowed us to vertically integrate certain manufacturing processes within Solid Capacitors. Further, as
described below, in fiscal year 2018 we acquired TOKIN, a manufacturer of tantalum capacitors and electro-magnetic devices.
In fiscal year 2018, we entered into a Joint Venture Agreement for the formation of KEMET Jianghai Electronic
Components Co. Ltd., a limited liability company located in Nantong, China with Jianghai (Nantong) Film Capacitor Co., Ltd,
a subsidiary of Nantong Jianghai Capacitor Co. Ltd ("Jianghai"). KEMET Jianghai Electronic Components manufactures axial
electrolytic, (H)EV Film DC brick, solid aluminum electrolytic, and hybrid aluminum electrolytic capacitors for distribution
through the KEMET and Jianghai sales channels.
Also, during fiscal year 2018, the Company invested in Novasentis' Series-D round of funding. Novasentis makes the
world's thinnest, electro mechanical polymer-based actuators that provide rich haptic feedback for a variety of applications,
including augmented/virtual reality and wearables. Novasentis supplies its "smart" film and KEMET applies its expertise in
manufacturing film capacitors to the development and commercial production of the actuators.
Promote the KEMET Brand Globally
We are focused on promoting the KEMET brand globally by highlighting the high-quality and high reliability of our
products and our superior customer service. We will continue to market our products to new and existing customers around the
world to expand our business. We continue to be recognized by our customers as a leading global supplier. For example, in
calendar years 2015, 2016, and 2017, we received the “Global Operations Excellence Award” from TTI, Inc.
On June 29, 2018, we received the “Supplier of the Year Award” in the “Consistent Supply Chain ” category for
calendar year 2018 from Elektronika Sales Pvt. Ltd and on March 22, 2019 TTI, Inc. announced that KEMET won the 2018
“Supplier Excellence Award.”
Global Sales & Marketing Strategy
Our motto “Think Global, Act Local” describes our approach to sales and marketing. Each of our four sales regions
(Americas, EMEA, JPKO and APAC) have account managers, field application engineers and strategic marketing managers. In
addition, we also have local customer and quality-control support in each region. This organizational structure allows us to
respond to the needs of our customers on a timely basis and in their native language. The regions are managed locally and
report to a senior manager who is on the KEMET Leadership Team. Furthermore, this organizational structure ensures the
efficient communication of our global goals and strategies and allows us to serve the language, cultural and other region-
specific needs of our customers. Our customer base is approximately 180,000 strong, with our top 1,000 customers accounting
for about 50.0% of our revenues. Our go-to-market strategy includes a combination of strong engagement face to face with
those top customers and an industry leading state of the art digital platform to engage the remaining customers. In addition, we
partner with all the premier distributors in the electronics industry to ensure we obtain the biggest reach and leverage their
expertise in stocking and servicing those customers.
TOKIN Acquisition
Through our acquisition of TOKIN and the previous cross licensing agreement and Amended and Restated Private
Label Agreement with TOKIN, we have expanded product offerings and markets for both KEMET and TOKIN. KEMET’s
strong presence in the western hemisphere and TOKIN's excellent position in Japan and Asia significantly enhanced our
customer reach and has created cross-selling opportunities. Through TOKIN we believe we can achieve true scale in operations
allowing us to manage raw materials sourcing as well as maximize efficiencies and best practices in manufacturing and product
development. We believe that the international management team of KEMET and TOKIN allows us to be more sensitive and
35
aware of region-specific business needs compared to our competitors. Combining our R&D capabilities and university
relationships allows us to be on the forefront of new developments and technological advancements in the capacitor industry.
Leveraging R&D investment in both Japan and the U.S. enables KEMET to diversify beyond capacitors in the passives market
as a result of the TOKIN acquisition.
Since the acquisition of TOKIN, the Company has been able to improve its cash balance, net debt, and interest
expense. The purchase of TOKIN gave the Company access to the Japanese capital markets, which allowed the Company to
refinance its U.S. based debt with a Japanese bank. Interest rates in Japan are significantly less than in the U.S., which
contributed to the lower interest expense in fiscal year 2019 compared to fiscal years 2018 and 2017.
Recent Developments and Trends
TOKIN
On April 19, 2017, the Company completed its acquisition of TOKIN, which at that time it became a 100% owned
indirect subsidiary of KEMET. As such, the results for fiscal year 2017 and the first 19 days of fiscal year 2018 do not include
TOKIN's sales and expenses. See Note 2, "Acquisitions" to the Consolidated Financial Statements for further discussion on the
TOKIN acquisition.
Tax Cuts and Jobs Act
The Tax Cuts and Jobs Act (the “Act”) was enacted on December 22, 2017. The Act reduced the US federal corporate
tax rate from 35% to 21%, required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that
were previously tax deferred, and created new taxes on certain foreign-sourced earnings.
In fiscal year 2018, the Company recorded provisional amounts for certain enactment-date effects of the Act by
applying the guidance in SAB 118, because the Company had not yet completed its accounting for all of the tax effects of the
Act. Certain provisions of the Act did not impact the Company until the fiscal year 2019. These provisions include, but are not
limited to, the base erosion anti-abuse tax (“BEAT”), the provision designed to tax global intangible low-taxed income
(“GILTI”), the foreign-derived intangible income (“FDII”) provision, the expansion of the IRC Sec. 162(m) limitation, and the
provision designed to limit interest expense deductions.
In fiscal year 2019, the Company completed its accounting for the enactment-date income tax effects of the Act, based
on legislative updates relating to the Act currently available. These tax effects related to the one-time transition tax, the reduced
corporate tax rate, and an additional limitation for executive compensation under IRC Sec. 162(m). For further information on
the impact of the Act on the Company, refer to Note 11, “Income Taxes.”
Tariffs
On July 6, 2018, the United States government-imposed tariffs according to Section 301 of the Trade Act, on
particular products that are imported into the United States from China. The Company primarily imports film, tantalum
Polymer, and MSA products into the United States from China. The impact on the Company's future results from these tariffs is
expected to be minimal as the Company does not import a significant number of products into the United States from China,
and the Company expects to pass the entire cost of the tariffs onto its direct customers and distributors.
Long-term debt
On October 29, 2018, the Company entered into a JPY 33.0 billion Term Loan Agreement (the “TOKIN Term Loan
Facility”) by and among TOKIN, the lenders party thereto (the “Lenders”) and Sumitomo Mitsui Trust Bank, Limited in its
capacity as agent (the “Agent”), arranger and Lender. Funding for the TOKIN Term Loan Facility occurred on November 7,
2018. The proceeds, which were net of an arrangement fee withheld from the funding amount, were JPY 32.1 billion, or
approximately $283.9 million using the exchange rate as of November 7, 2018.
The proceeds from the TOKIN Term Loan Facility were used by TOKIN to make intercompany loans (the
“Intercompany Loans”) to the Company. The proceeds, along with other cash on hand, were used to prepay in full the
outstanding amounts under the Company's Term Loan Credit Agreement with Bank of America, N.A. of $323.4 million and a
prepayment premium of 1.0%. For further information, refer to Note 3, “Debt.”
Dividends
During fiscal year 2019, the Company announced its intention to pay regular quarterly cash dividends to holders of
our common stock. During the fiscal year, the Company declared and paid two quarterly cash dividends of $0.05 per share of
its common stock. On May 16, 2019, the Company announced a cash dividend of $0.05 per share of the Company's common
stock. Payment will be made on June 10, 2019 to shareholders of record at the close of business on May 30, 2019.
36
Any future determination to pay dividends will be at the discretion of the Company’s Board and will depend upon,
among other factors, the capital requirements, operating results, and financial condition of the Company.
Restructuring
The Company has implemented restructuring plans which include programs to increase competitiveness by removing
excess capacity, relocating production to lower cost locations, relocating corporate functions to the new headquarters, and
eliminating unnecessary costs throughout the Company. Significant restructuring plans which include personnel reduction costs
that occurred during fiscal year ended March 31, 2019 are summarized below:
Restructuring Plan
Segment
TOKIN operational &
overhead function
reduction in force
MSA, Corporate,
& Solid
Capacitors
Total expected to be
incurred
Incurred during year
ended March 31, 2019
Cumulative incurred to
date
Personnel
Reduction
Costs
Relocation
& Exit
Costs
Personnel
Reduction
Costs
Relocation
& Exit
Costs
Personnel
Reduction
Costs
Relocation
& Exit
Costs
$
5,339 $
— $
942 $
— $
5,339 $
—
Tantalum powder facility
relocation (1)
Axial electrolytic
production relocation from
Granna to Evora
Solid Capacitors
850
2,468
Film and
Electrolytic
879
3,232
—
—
Reorganization due to
decline of MnO2 Products Solid Capacitors
All Other (2)
Corporate, Film
and Electrolytic
1,798
—
1,585
296
3,355
2,296
—
305
—
—
1,585
3,355
2,296
—
___________________________________________
(1) The Company expects to recover approximately $0.9 million related to tantalum reclaim, which would decrease the cumulative expenses incurred to date for
relocation and exit costs upon the completion of reclaim activities.
(2) The Company incurred $0.6 million in restructuring charges for minor projects not included in the table above during fiscal year ended March 31, 2019,
consisting of $0.3 million each in personal reduction costs and relocation and exit costs.
Off-Balance Sheet Arrangements
As of March 31, 2019, other than operating lease commitments as described in Note 15, “Commitments and
Contingencies”, we are not a party to any off-balance sheet financing arrangements that have, or are reasonably likely to have,
a current or future material effect on our financial condition, revenues, expenses, results of operations, liquidity, capital
expenditures or capital resources.
Critical Accounting Policies
Our accounting policies are summarized in Note 1, “Organization and Significant Accounting Policies” to the
consolidated financial statements. The following identifies a number of policies which require significant judgments and
estimates or are otherwise deemed critical to our financial statements.
Our estimates and assumptions are based on historical data and other assumptions that we believe are reasonable.
These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during
the reporting period.
Our judgments are based on our assessment as to the effect certain estimates, assumptions, or future trends or events
may have on the financial condition and results of operations reported in the consolidated financial statements. Readers should
understand that actual future results could differ from these estimates, assumptions, and judgments.
A quantitative sensitivity analysis is provided where that information is reasonably available, can be reliably estimated
and provides material information to investors. The amounts used to assess sensitivity (i.e., 1%, 10%, etc.) are included to
allow readers of this Annual Report on Form 10-K to understand a general cause and effect of changes in the estimates and do
not represent our predictions of variability. For these estimates, it should be noted that future events rarely develop exactly as
forecast, and estimates require regular review and adjustment. We believe the following critical accounting policies contain the
most significant judgments and estimates used in the preparation of the consolidated financial statements:
REVENUE RECOGNITION. The Company recognizes revenue under the guidance provided in ASC 606.
Consistent with the terms of ASC 606, the Company records revenue on product sales in the period in which the Company
37
satisfies its performance obligation by transferring control over a product to a customer. The amount of revenue recognized
reflects the consideration the Company expects to receive in exchange for transferring products to a customer.
The Company sells its products to distributors, OEMs, and EMS providers, and the sales price may include
adjustments for sales discounts, price adjustments, and sales allowances. The Company has elected the practical expedient
under ASC 606-10-10-4 and evaluates these sales-related adjustments on a portfolio basis. The principle forms of these
adjustments include:
•
Inventory price protection and ship-from-stock and debit (“SFSD”) programs,
• Distributor rights of returns,
•
Sales allowances, and
• Limited assurance warranties
The Company's inventory price protection and SFSD programs provide authorized distributors with the flexibility to
meet marketplace prices by allowing them, upon a pre-approved case-by-case basis, to adjust their purchased inventory cost to
correspond with current market demand. KEMET's SFSD program is specific to certain distributors within the Americas and
EMEA regions. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment
quote from their local KEMET sales representative, and apply only to a specific customer, part, specified special price amount,
specified quantity, and are only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with
current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain
accounting assumptions, all of which are reviewed quarterly. We believe this methodology enables us to make reliable
estimates of future adjustments under the SFSD program. If the historical SFSD run rates used in our calculation changed by
1% in fiscal year 2019, net sales would be impacted by $1.3 million.
Select distributors have the right to return a certain portion of their purchased inventory to KEMET from the previous
fiscal quarter. The Company estimates future returns based on historical return patterns and records a corresponding right of
return asset and refund liability as a component of the line items, “Inventories, net” and “Accrued expenses,” respectively, on
the Consolidated Balance Sheets. The Company also offers volume-based rebates on a case-by-case basis to certain customers
in each of the Company’s sales channels.
The Company's sales allowances are recognized as a reduction in the line item “Net sales” on the Consolidated
Statements of Operations, while the associated reserves are included in the line item “Accounts receivable, net” on the
Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but
is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the
effects of technological change, and other variables that might result in changes to the Company’s estimates.
INVENTORIES. Inventories are valued at the lower of cost or net realizable value. For most of the inventory, cost
is determined under the first-in, first-out method. For tool crib, a component of our raw material inventory, cost is determined
under the average cost method. The valuation of inventories requires us to make estimates. We also must assess the prices at
which we believe the finished goods inventory can be sold compared to its cost. A sharp decrease in demand could adversely
impact earnings as the reserve estimates could increase.
Excess and obsolete inventories are based on a combination of usage, age, order requirements, and sales history. Raw
materials and tool crib obsolescence reserves are based on usage over one and two years, respectively, and the Company
maintains reserves for raw materials and tool cribs that exceed these ages. Finished goods obsolescence reserves are either
based on product age limits determined by market requirements, and/or based on excess quantities that exceed product orders
and historical product sales.
PENSION AND POST-RETIREMENT BENEFITS. Our management, with the assistance of actuarial firms,
performs actuarial valuations of the fair values of our pension and post-retirement plans’ benefit obligations. We make certain
assumptions that have a significant effect on the calculated fair value of the obligations such as the:
•
•
discount rate—used to arrive at the net present value of the obligation; and
salary increases—used to calculate the impact future pay increases will have on post-retirement
obligations.
We understand that these assumptions directly impact the actuarial valuation of the obligations recorded on the
Consolidated Balance Sheets and the income or expense that flows through the Consolidated Statements of Operations.
We base our assumptions on either historical or market data that we consider reasonable. Variations in these
assumptions could have a significant effect on the amounts reported in Consolidated Balance Sheets and the Consolidated
38
Statements of Operations. The most critical assumption relates to the discount rate. A 25 basis point increase or decrease in the
weighted average discount rate would result in changes to the projected benefit obligation of ($4.0) million and $4.4 million,
respectively.
GOODWILL AND LONG-LIVED ASSETS. Goodwill, which represents the excess of purchase price over fair
value of net assets acquired, and intangible assets with indefinite useful lives are tested for impairment at least on an annual
basis. We perform our impairment test during the fourth quarter of each fiscal year and when otherwise warranted.
We evaluate our goodwill on a reporting unit basis. This requires us to estimate the fair value of the reporting units
based on the future net cash flows expected to be generated. The impairment test involves a comparison of the fair value of
each reporting unit, with the corresponding carrying amounts. If the reporting unit’s carrying amount exceeds its fair value,
then an indication exists that the reporting unit’s goodwill may be impaired. The impairment to be recognized is measured by
the amount by which the carrying value of the reporting unit’s goodwill being measured exceeds its implied fair value. The
implied fair value of goodwill is the excess of the fair value of the reporting unit over the sum of the amounts assigned to
identified net assets. As a result, the implied fair value of goodwill is generally the residual amount that results from subtracting
the value of net assets including all tangible assets and identified intangible assets from the fair value of the reporting unit’s fair
value. We determine the fair value of our reporting units using an income-based, discounted cash flow (“DCF”) analysis, and
market-based approaches (Guideline Publicly Traded Company Method and Guideline Transaction Method) which examine
transactions in the marketplace involving the sale of the stocks of similar publicly-owned companies, or the sale of entire
companies engaged in operations similar to KEMET. In addition to the above described reporting unit valuation techniques, our
goodwill impairment assessment also considers our aggregate fair value based upon the value of our outstanding shares of
common stock.
Our goodwill balance of $40.3 million is comprised of $35.6 million related to KBP, which is within the Tantalum
product line of the Solid Capacitors reportable segment, and $4.7 million related to IntelliData, which is a corporate asset. As
part of our annual impairment testing, we determine the fair value of the relevant reporting unit(s) using an income-based, DCF
analysis for KBP at the Tantalum product line level, and an internal rate of return analysis for IntelliData.
Significant assumptions used in the DCF analysis are:
•
•
•
the discount rate based on the weighted average cost of capital (“WACC”),
estimated sales growth rates, and
the estimated market price and production cost for tantalum products
Our WACC is determined through market comparisons combined with small stock and equity risk premiums.
Tantalum’s sales growth rates are estimated through KEMET’s three-year strategic plan.
Long-lived assets and intangible assets subject to amortization are reviewed for impairment whenever events or
changes in circumstances indicate that the carrying amount of a long-lived asset or group of assets may not be recoverable. A
long-lived asset classified as held for sale is initially measured and reported at the lower of its carrying amount or fair value
less cost to sell.
Long-lived assets to be disposed of other than by sale are classified as held and used until the long-lived asset is
disposed of.
Tests for the recoverability, when necessary, of a long-lived asset to be held and used are performed by comparing the
carrying amount of the long-lived asset to the sum of the estimated future undiscounted cash flows expected to be generated by
the asset. In estimating the future undiscounted cash flows, we use future projections of cash flows directly associated with, and
which are expected to arise as a direct result of, the use and eventual disposition of the assets. These assumptions include,
among other estimates, periods of operation and projections of sales and cost of sales. Changes in any of these estimates could
have a material effect on the estimated future undiscounted cash flows expected to be generated by the asset. If it is determined
that the book value of a long-lived asset is not recoverable, an impairment loss would be calculated equal to the excess of the
carrying amount of the long-lived asset over its fair value. The fair value is calculated as the discounted cash flows of the
underlying assets.
We evaluate the value of our other indefinite-lived intangible assets (trademarks) using an income-based, relief from
royalty analysis.
The Company completed its impairment test on goodwill and intangible assets with indefinite useful lives as of
January 1, 2019 and concluded that goodwill and indefinite-lived assets were not impaired nor were they at risk of failing step
one of the impairment test as the fair value of each of the assets exceeds the carrying value. The type of events that could result
in a future goodwill impairment could include an increase of over 100 basis points in the Company's derived weighted-average
39
cost of capital, which could be driven by stock price volatility, increases in government or corporate bond market rates, or other
factors. A one percent increase or decrease in the discount rate used in the goodwill and indefinite-lived assets valuation would
have resulted in changes in fair value in the following amounts, and would not have resulted in an impairment charge:
Goodwill - KBP
Goodwill - IntelliData
Trademarks
Discount Rate Sensitivity, in millions
Fair Value in
Excess of
Carrying Value,
%
+1%
-1%
92.6% $
118.1%
609.3%
(56.0) $
(0.9)
(7.7)
64.0
1.0
9.0
INCOME TAXES. Tax law requires items to be included in the tax return at different times than when these items
are reflected in the consolidated financial statements. As a result, the annual effective tax rate reflected in our consolidated
financial statements is different from that reported in our tax return (our cash tax rate). Some of these differences are
permanent, such as expenses that are not deductible in our tax return, and some differences reverse over time, such as
depreciation expense. These timing differences create deferred tax assets and liabilities. Income taxes are accounted for under
the asset and liability method. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to
taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. The Company
periodically evaluates its net deferred tax assets based on an assessment of historical performance, ability to forecast future
events, and the likelihood that the Company will realize the benefits through future taxable income. Valuation allowances are
recorded to reduce the net deferred tax assets to the amount that is more likely than not to be realized. For interim reporting
purposes, the Company records income taxes based on the expected annual effective income tax rate, taking into consideration
global forecasted tax results and the effect of discrete tax events. The Company makes certain estimates and judgments in the
calculation for the provision for income taxes, in the resulting tax liabilities, and in the recoverability of deferred tax assets. All
deferred tax assets are reported as noncurrent in the Consolidated Balance Sheets.
We believe that it is more likely than not that a portion of the deferred tax assets in various jurisdictions will not be
realized, based on the scheduled reversal of deferred tax liabilities, the recent history of cumulative losses, and the insufficient
evidence of projected future taxable income to overcome the loss history. We have provided a valuation allowance related to
any benefits from income taxes resulting from the application of a statutory tax rate to the deferred tax assets. We continue to
have net deferred tax assets (future tax benefits) in several jurisdictions which we expect to realize, assuming, based on certain
estimates and assumptions, sufficient taxable income can be generated to utilize these deferred tax benefits. If these estimates
and related assumptions change in the future, we may be required to reduce the value of the deferred tax assets resulting in
additional tax expense. The amount of future income required for the Company to realize its net deferred tax assets is $227.1
million.
Differences between the provision for income taxes on earnings from continuing operations and the amount computed
using the U.S. Federal statutory income tax rate are primarily due to the changes in the U.S. and foreign valuation allowances,
tax non-deductible permanent differences, and differences due to U.S. and foreign tax law changes.
The accounting rules require that we recognize, in our financial statements, the impact of a tax position, if that position
is “more likely than not” of not being sustained on audit, based on the technical merits of the position. Any accruals for
estimated interest and penalties would be recorded as a component of income tax expense.
To the extent that the provision for income taxes changed by 1.0% of income before income taxes, consolidated net
income would have changed by $1.7 million in fiscal year 2019.
40
Results of Operations
Historically, revenues and earnings may or may not be representative of future operating results due to various
economic and other factors. The following table sets forth the Consolidated Statements of Operations for the periods indicated
(amounts in thousands):
Net sales (1)
Operating costs and expenses:
Cost of sales (1)
Selling, general and administrative expenses
Research and development (1)
Restructuring charges
(Gain) loss on write down and disposal of long-lived assets
Total operating costs and expenses
Operating income (1)
Non-operating (income) expense:
Interest income
Interest expense
Acquisition (gain) loss
Change in value of TOKIN options
Other (income) expense, net (1)
Income before income taxes and equity income (loss) from equity
method investments (1)
Income tax expense (benefit) (1)
Income before equity income (loss) from equity method
investments (1)
Equity income (loss) from equity method investments
Net income (1)
$
______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
Consolidated Comparison of Fiscal Year 2019 to Fiscal Year 2018
Net Sales
Fiscal Years Ended March 31,
2019
2018
2017
$ 1,382,818
$ 1,200,181
$
757,338
924,276
202,642
44,612
8,779
1,660
1,181,969
200,849
(2,035)
21,239
—
—
11,214
170,431
(39,460)
209,891
(3,304)
206,587
860,744
173,620
39,114
14,843
(992)
1,087,329
112,852
(809)
32,882
(130,880)
—
24,592
187,067
9,132
177,935
76,192
$
254,127
$
571,944
107,658
26,693
5,404
10,671
722,370
34,968
(24)
39,755
—
(10,700)
(3,871)
9,808
4,294
5,514
41,643
47,157
Net sales of $1.4 billion in fiscal year 2019 increased 15.2% from $1.2 billion in fiscal year 2018 primarily due to an
increased in Solid Capacitor net sales $164.6 million. In addition, Film and Electrolytic net sales increased by $4.3 million, and
MSA net sales increased by $13.8 million.
The increase in Solid Capacitors net sales was primarily driven by a $111.8 million increase in distributor sales across
the Americas, APAC, and EMEA regions. The $111.8 million increase consisted of a $72.8 million increase in Ceramic product
line sales and a $39.0 million increase in Tantalum product line sales. Also contributing to the increase in net sales was a $30.6
million increase in OEM sales across the APAC, EMEA, and JPKO regions, and a $28.0 million increase in EMS sales across
all regions. These increases in net sales were partially offset by a $3.2 million decrease in distributor sales in the JPKO region
and a $2.7 million decrease in OEM sales in the Americas region. In addition, Solid Capacitors net sales was unfavorably
impacted by $0.5 million from foreign currency exchange due to the change in the value of the Euro compared to the U.S.
dollar.
The increase in Film and Electrolytic net sales was primarily driven by a $10.5 million increase in distributor sales
across the Americas and EMEA regions. Also contributing to the increase in net sales was $1.7 million increase in EMS sales in
the Americas region and a $0.8 million increase in OEM sales in the JPKO region. These increases in net sales were partially
offset by a $5.6 million decrease in OEM sales across the APAC and EMEA regions and a $3.1 million decrease in distributor
sales across the APAC and JPKO regions. In addition, there was an unfavorable impact of $0.1 million from foreign currency
exchange primarily due to the change in the value of the Euro compared to the U.S. dollar.
41
The increase in MSA net sales was primarily driven by a $15.0 million increase in OEM sales in the JPKO region.
Also contributing to the increase in net sales was a $4.3 million increase in EMS sales across all regions and a $3.7 million
increase in distributor sales across the Americas and EMEA regions. These increase in net sales were partially offset by a $5.5
million decrease in distributor sales across the APAC and JPKO regions and a $3.8 million decrease in OEM sales across the
Americas, APAC, and JPKO regions.
In fiscal years 2019 and 2018, net sales by channel and the percentages of net sales by region to total net sales were as
follows (dollars in thousands):
APAC
EMEA
Americas
JPKO
Total
Fiscal Year 2019
Fiscal Year 2018
Net Sales
533,340
315,535
337,842
196,101
1,382,818
$
$
% of
Total
38.6% $
22.8%
24.4%
14.2%
$
Net Sales
479,987
277,898
259,105
183,191
1,200,181
% of
Total
40.0%
23.1%
21.6%
15.3%
In fiscal years 2019 and 2018, the percentages of net sales by channel to total net sales were as follows (dollars in
thousands):
OEM
Distributor
EMS
Total
Gross Margin
Fiscal Year 2019
Fiscal Year 2018
Net Sales
% of Total
Net Sales
% of Total
$
$
598,306
584,618
199,894
1,382,818
43.3% $
42.2%
14.5%
$
563,495
470,324
166,362
1,200,181
46.9%
39.2%
13.9%
Gross margin for the fiscal year ended March 31, 2019 of $458.5 million (33.2% of net sales) increased $119.1 million
or 35.1% from $339.4 million (28.3% of net sales) in the prior fiscal year. Gross margin as a percentage of net sales improved
490 basis points.
Solid Capacitors gross margin increased $118.4 million, or 43.1% primarily due to an increase in net sales, as well as
continued margin improvement due to our restructuring activities, vertical integration, and manufacturing process
improvements resulting from our cost reduction activities.
Film and Electrolytic gross margin increased $4.8 million, or 31.6% primarily due to an increase in net sales, as well
as continued margin improvement due to our restructuring activities and manufacturing process improvements resulting from
our cost reduction activities.
MSA gross margin decreased $4.1 million, or 8.4% primarily due to a change in the sales mix to lower margin
products.
Selling, General and Administrative Expenses (“SG&A”)
SG&A expenses of $202.6 million (14.7% of net sales) for fiscal year 2019 increased $29.0 million, or 16.7%
compared to $173.6 million (14.5% of net sales) for fiscal year 2018. The increase was primarily attributable to a $11.8 million
increase in payroll and related expenses, primarily consisting of salaries and incentive-based compensation, a $8.7 million
increase in ERP integration and technology transition costs, a $4.0 million increase in rent and software costs, and a $2.8
million increase in consulting expenses. Additionally, $2.5 million of the overall increase was attributed to 19 additional days
of ownership of our TOKIN subsidiary during the fiscal year ended March 31, 2019, compared to the fiscal year ended March
31, 2018. Partially offsetting these increases was a $1.5 million decrease in legal fees incurred defending anti-trust litigation
claims.
42
Research and Development
R&D expenses of $44.6 million (3.2% of net sales) for fiscal year 2019 increased $5.5 million or 14.1% compared to
$39.1 million (3.3% of net sales). The increase was primarily related to an increase in payroll and related expenses of $4.9
million, a $0.8 million increase in expenses related to supplies, and a $0.6 million increase in costs attributed to the 19
additional days of ownership of our TOKIN subsidiary during the fiscal year ended March 31, 2019, compared to the fiscal
year ended March 31, 2018.
(Gain) Loss on Write Down and Disposal of Long-Lived Assets
During fiscal year 2019, KEMET recorded a net loss on the write down and disposal of long-lived assets of $1.7
million, which was comprised of $0.7 million in impairment charges and $1.0 million in net losses on the sale and disposal of
long-lived assets. The impairment charges were primarily related to the write down of idle land and machinery of $0.5 million
and $0.2 million, respectively, at TOKIN. The $1.0 million net loss on write down and disposal of long-lived assets primarily
consisted of the disposal of furniture and fixtures resulting from the Company relocation of its corporate headquarters to Fort
Lauderdale, Florida and the disposal of old machinery throughout the Company that was no longer being used.
During fiscal year 2018, the Company recorded a net gain on the write down and disposal of long-lived assets of $1.0
million, which was comprised of $1.2 million in net gains on the sale and disposal of long-lived assets offset by $0.2 million in
impairment charges. The net gains on the sale and disposal of long-lived assets were primarily related to the sale of equipment,
land, and buildings from KFM, which was shut down in fiscal year 2017. On March 13, 2018, the Company sold KFM's land
and buildings to a third party for a gross sales price of $3.6 million. The net proceeds realized by the Company were
approximately $3.4 million after payment of $0.2 million in closing costs. The Company realized a gain on the sale of the land
and buildings of approximately $1.9 million during the year ended March 31, 2019 as a result of the sale. In addition, the
Company sold KFM's equipment for a $1.4 million gain. These gains were partially offset by MSA's loss on disposals of assets
of $1.3 million primarily related to equipment and buildings used for discontinued products and Solid Capacitors' loss of
approximately $0.6 million related to the relocation of its K-Salt operations from a leased facility to its existing Matamoros,
Mexico facility.
Restructuring Charges
Restructuring charges of $8.8 million in fiscal year 2019 decreased $6.1 million or 40.9% from $14.8 million in fiscal
year 2018.
The Company incurred $8.8 million in restructuring charges in the fiscal year ended March 31, 2019 comprised of
$2.8 million in personnel reduction costs and $6.0 million in relocation and exit costs. The personnel reduction costs of $2.8
million were primarily due to $0.9 million in costs related to headcount reductions in the TOKIN legacy group across various
internal and operational functions, and $1.6 million in costs related to reorganization in the Solid Capacitors reportable
segment due to a permanent structural change driven by the decline of MnO2 products, $0.3 million in severance charges
related to personnel reductions in the Film and Electrolytic reportable segment resulting from a reorganization of the segment's
management structure.
The relocation and exits costs of $6.0 million were primarily due to $3.4 million in costs related to the relocation of its
tantalum powder equipment from Carson City, Nevada to its plant in Matamoros, Mexico and $2.3 million in costs related to
the relocation of axial electrolytic production equipment from Granna, Sweden to its plant in Evora, Portugal.
The Company incurred $14.8 million in restructuring charges in the fiscal year ended March 31, 2018, comprised of
$12.6 million related to personnel reduction costs and $2.3 million of relocation and exit costs.
The personnel reduction costs of $12.6 million were due to $5.2 million related to a voluntary reduction in force in the
Film and Electrolytic reportable segment's Italian operations; $4.4 million related to a headcount reduction in the TOKIN
legacy group across various internal and operational functions; $2.7 million in severance charges across various overhead
functions in the Simpsonville, South Carolina office as these functions were relocated to the Company's new corporate
headquarters in Fort Lauderdale, Florida; and $0.2 million in headcount reductions related to a European sales reorganization.
The relocation and exit costs of $2.3 million included $0.9 million in lease termination penalties related to the
relocation of global marketing, finance and accounting, and information technology functions to the Company's Fort
Lauderdale office, $0.8 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico
plant, $0.4 million in exit costs related to the shut-down of operations for KFM, and $0.1 million related to the transfer of
certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico.
43
Operating Income
Operating income for fiscal year 2019 of $200.8 million increased $87.9 million compared to operating income of
$112.9 million in fiscal year 2018. The improvement was primarily due to a $119.1 million increase in gross margin and a $6.1
million decrease in restructuring charges. These improvements to operating income were partially offset by a $29.0 million
increase in SG&A expenses, a $5.5 million increase in R&D expenses, and a $2.7 million unfavorable impact from (gain) loss
on write down and disposal of long-lived assets.
Non-Operating (Income) Expense, net
Non-operating expense, net was $30.4 million in fiscal year 2019 compared to non-operating income, net of $74.2
million in fiscal year 2018. The $104.6 million unfavorable change was primarily attributable to the acquisition gain of $130.9
million recognized during fiscal year 2018, compared to no such gain in fiscal year 2019. In addition, the Company recognized
a $15.9 million loss on the early extinguishment of debt in fiscal year 2019. Partially offsetting these unfavorable changes were
the following favorable items which occurred during the fiscal year 2019 versus fiscal year 2018: a $12.9 million decrease in
net interest expense, a $3.3 million decrease in anti-trust litigation fines, a $4.5 million gain related to research and
development grant reimbursements from the Japanese and Italian governments, and a $20.3 million net favorable change in
foreign currency exchange gain, which was primarily due to the change in the value of the Chinese Yuan Renminbi, Thai Baht,
British Pound, and the Euro.
Income Taxes
Income tax benefit of $39.5 million for fiscal year 2019 decreased by $48.6 million compared to income tax expense
of $9.1 million in fiscal year 2018. The fiscal year 2019 income tax benefit was primarily comprised of $50.1 million related to
the partial release of valuation allowances in the U.S. and Japan, offset in part by $10.4 million in income tax expense related to
foreign operations and $0.2 million in income tax expense related to U.S. operations.
Fiscal year 2018 income tax expense of $9.1 million was comprised of 9.7 million in foreign income tax expense and
a $0.6 million U.S. federal income tax benefit. The U.S. federal benefit of $0.6 million included an estimated $0.8 million tax
benefit resulting from the Tax Cuts and Jobs Act of 2017.
Equity Income (Loss) from Equity Method Investments
Equity loss from equity method investments of $3.3 million in fiscal year 2019 had an unfavorable change of $79.5
million compared to $76.2 million in fiscal year 2018. The change was primarily related to the TOKIN acquisition that
occurred in the first quarter of fiscal year 2018. The Company recognized equity income of $84.2 million related to our 34%
economic interest in TOKIN for the 19-day period ended April 19, 2017 for the sale of TOKIN's electrical-mechanical devices
("EMD") business and a $9.0 million unfavorable removal of the cost basis of the portion of equity investment related to the
EMD division. TOKIN is now a fully owned subsidiary of the Company and there were no such gains from our equity method
investments in fiscal year 2019. In fiscal year 2019, the Company impaired its investment in Novasentis by $2.7 million.
44
Reportable Segment Comparison of Fiscal Year 2019 to Fiscal Year 2018
The following table sets forth the operating income (loss) for each of our reportable segments for the fiscal years 2019
and 2018. The table also sets forth each of the reportable segments’ net sales as a percentage of total net sales and total
operating income as a percentage of total net sales (amounts in thousands, except percentages):
Net sales
Solid Capacitors
Film and Electrolytic (1)
MSA
Total (1)
Operating income (loss)
Solid Capacitors
Film and Electrolytic (1)
MSA
Corporate
Total (1)
For the Fiscal Years Ended
March 31, 2019
March 31, 2018
Amount
% of Total
Sales
Amount
% of Total
Sales
$
935,838
206,240
240,740
67.7% $
14.9%
17.4%
771,240
201,977
226,964
$
1,382,818
100.0% $
1,200,181
64.3 %
16.8 %
18.9 %
100.0 %
$
348,150
$
234,473
8,183
22,546
(178,030)
200,849
$
3,622
15,694
(140,937)
112,852
14.5% $
9.4 %
_______________________________________________
(1) Fiscal year ending March 31, 2018 adjusted due to the adoption of ASC 606.
Solid Capacitors
The table below sets forth net sales, operating income and operating income as a percentage of net sales for our Solid
Capacitors reportable segment for fiscal years 2019 and 2018 (amounts in thousands, except percentages):
Tantalum product line net sales
Ceramic product line net sales
Solid Capacitors net sales
Solid Capacitors operating income
Net Sales
For the Fiscal Years Ended
March 31, 2019
March 31, 2018
Amount
% to Net
Sales
Amount
% to Net
Sales
$
$
$
563,255
372,583
935,838
348,150
$
$
37.2% $
495,114
276,126
771,240
234,473
30.4%
Solid Capacitors net sales of $935.8 million in fiscal year 2019 increased $164.6 million or 21.3% from $771.2
million in fiscal year 2018. Tantalum product line net sales of $563.3 million in fiscal year 2019 increased $68.1 million or
13.8% from $495.1 million in fiscal year 2018. Ceramic product line net sales of $372.6 million in fiscal year 2019 increased
$96.5 million or 34.9% from $276.1 million in fiscal year 2018.
The increase in Solid Capacitors net sales was primarily driven by a $111.8 million increase in distributor sales across
the Americas, APAC, and EMEA regions. The $111.8 million increase consisted of a $72.8 million increase in Ceramic product
line sales and a $39.0 million increase in Tantalum product line sales. Also contributing to the increase in net sales was a $30.6
million increase in OEM sales across the APAC, EMEA, and JPKO regions, and a $28.0 million increase in EMS sales across
all regions. These increases in net sales were partially offset by a $3.2 million decrease in distributor sales in the JPKO region
and a $2.7 million decrease in OEM sales in the Americas region. In addition, Solid Capacitors net sales was unfavorably
impacted by $0.5 million from foreign currency exchange due to the change in the value of the Euro compared to the U.S.
dollar.
45
Reportable Segment Operating Income
Segment operating income of $348.2 million for fiscal year 2019 increased $113.7 million or 48.5% from $234.5
million for fiscal year 2018. The increase in operating income was primarily attributable to an increase in gross margin of
$118.4 million, which was driven by an increase in net sales, as well as continued margin improvement due to our restructuring
activities, vertical integration, and manufacturing process improvements resulting from our cost reduction activities. Also
contributing to the increase in operating income was a $2.5 million decrease in SG&A expenses and a $0.5 million decrease in
net loss on write down and disposal of long-lived assets. Partially offsetting these improvements was a $3.9 million increase in
restructuring charges and a $3.8 million increase in R&D expenses.
Film and Electrolytic
The table below sets forth net sales, operating income and operating income as a percentage of net sales for our Film
and Electrolytic reportable segment for the fiscal years 2019 and 2018 (amounts in thousands, except percentages):
Net sales (1)
Segment operating income (1)
______________________________________________
(1) Fiscal year ending March 31, 2018 adjusted due to the adoption of ASC 606.
Net Sales
For the Fiscal Years Ended
March 31, 2019
March 31, 2018
Amount
$
206,240
% to Net
Sales
Amount
$
201,977
% to Net
Sales
8,183
4.0%
3,622
1.8%
Film and Electrolytic net sales of $206.2 million in fiscal year 2019 increased $4.3 million or 2.1% from $202.0
million in fiscal year 2018. The increase in net sales was primarily driven by a $10.5 million increase in distributor sales across
the Americas and EMEA regions. Also contributing to the increase in net sales was $1.7 million increase in EMS sales in the
Americas region and a $0.8 million increase in OEM sales in the JPKO region. These increases in net sales were partially offset
by a $5.6 million decrease in OEM sales across the APAC and EMEA regions and a $3.1 million decrease in distributor sales
across the APAC and JPKO regions. In addition, there was an unfavorable impact of $0.1 million from foreign currency
exchange primarily due to the change in the value of the Euro compared to the U.S. dollar.
Reportable Segment Operating Income
Segment operating income of $8.2 million in fiscal year 2019 increased $4.6 million from $3.6 million in fiscal year
2018. The increase in operating income was primarily attributable to a $4.8 million increase in gross margin driven by an
increase in net sales, as well as continued margin improvement due to our restructuring activities and manufacturing process
improvements resulting from our cost reduction activities. The increase was also attributed to a $3.1 million decrease in
restructuring charges and a $0.6 million decrease in SG&A expenses. These improvements were partially offset by a $3.3
million decrease in net gain on write down and disposal of long-lived assets and a $0.6 million increase in R&D expenses.
Electro-Magnetic, Sensors, and Actuators
The following table sets forth net sales, operating income, and operating income as a percentage of net sales for our
MSA reportable segment in fiscal years 2019 and 2018 (amounts in thousands, except percentages).
Net sales
Segment operating income
Net Sales
For the Fiscal Years Ended
March 31, 2019
March 31, 2018
Amount
$
240,740
% to Net
Sales
Amount
$
226,964
% to Net
Sales
22,546
9.4%
15,694
6.9%
MSA net sales of $240.7 million in fiscal year 2019 increased $13.8 million or 6.1% from $227.0 million in fiscal year
2018. The increase in net sales was primarily driven by a $15.0 million increase in OEM sales in the JPKO region. Also
contributing to the increase in net sales was a $4.3 million increase in EMS sales across all regions and a $3.7 million increase
in distributor sales across the Americas and EMEA regions. These increase in net sales were partially offset by a $5.5 million
46
decrease in distributor sales across the APAC and JPKO regions and a $3.8 million decrease in OEM sales across the Americas,
APAC, and JPKO regions.
Reportable Segment Operating Income
Segment operating income of $22.5 million in fiscal year 2019 increased $6.9 million from $15.7 million in fiscal year
2018. The increase in operating income was primarily due to a $6.6 million decrease in SG&A expenses resulting from a
decrease in payroll expenses that was caused by a reduction in head count. Also contributing to the increase in operating
income was a $2.9 million decrease in restructuring charges, a $1.3 million decrease in net loss on write down and disposal of
long-lived assets, and a $0.2 million decrease in R&D expenses. Partially offsetting these improvements was a $4.1 million
decrease in gross margin, which was primarily driven by a change in the sales mix to lower margin products.
Consolidated Comparison of Fiscal Year 2018 to Fiscal Year 2017
Net sales
Net sales of $1.2 billion for fiscal year 2018 increased 58.5% from $757.3 million for fiscal year 2017. Solid
Capacitor and Film and Electrolytic sales increased by $196.1 million and $19.7 million, respectively and net sales for MSA,
our new reportable segment in fiscal year 2018, was $227.0 million. Prior to the acquisition of TOKIN on April 19, 2017, the
Company did not have any MSA sales.
The increase in Solid Capacitors net sales was primarily driven by the addition of net sales of $133.8 million resulting
from the TOKIN acquisition and an increase in net sales to the legacy products distributor channel of $81.7 million. To a lesser
degree, an increase in legacy Ceramic products' net sales of $6.0 million in the EMS channel across all regions and $10.2
million in the OEM channel in the EMEA and APAC regions also contributed to the increase in Solid Capacitors net sales.
These increases were partially offset by a $28.0 million decrease in net sales in the OEM channel for legacy Tantalum products
across all regions. In addition, Solid Capacitors net sales was favorably impacted by $6.1 million from foreign currency
exchange due to the change in the value of the Euro compared to the U.S. dollar.
The increase in Film and Electrolytic net sales was driven by an increase in net sales in the distributor channel across
the APAC and EMEA regions of $13.7 million, and to a lesser degree, a $3.3 million increase in net sales in the OEM channel
of the EMEA region and a $4.2 million increase in the EMS channel across the Americas, EMEA, and APAC regions. These
increases were partially offset by a decrease in net sales of $1.2 million in the OEM channel across the Americas, APAC, and
JPKO regions. In addition, there was a favorable impact of $7.6 million from foreign currency exchange primarily due to the
change in the value of the Euro compared to the U.S. dollar.
In fiscal years 2018 and 2017, net sales by region were as follows (dollars in thousands):
APAC
EMEA
Americas
JPKO
Total
Fiscal Year 2018
Fiscal Year 2017
Net Sales
% of Total
Net Sales
% of Total
$
$
479,987
277,898
259,105
183,191
1,200,181
40.0% $
23.1%
21.6%
15.3%
$
288,764
237,437
224,056
7,081
757,338
38.1%
31.4%
29.6%
0.9%
In fiscal years 2018 and 2017, the percentages of net sales by channel to total net sales were as follows:
OEM
Distributors
EMS
Total
Gross Margin
Fiscal Year 2018
Fiscal Year 2017
Net Sales
% of Total
Net Sales
% of Total
$
$
563,495
470,324
166,362
1,200,181
46.9% $
39.2%
13.9%
$
246,397
354,639
156,302
757,338
32.5%
46.8%
20.7%
Gross margin for the fiscal year ended March 31, 2018 of $339.4 million (28.3% of net sales) increased $154.0 million
or 83.1% from $185.4 million (24.5% of net sales) in the prior fiscal year. Gross margin as a percentage of net sales improved
380 basis points.
47
Solid Capacitors gross margin increased $100.4 million, or 57.5% due to an increase in net sales, cost improvements
in vertical integration, favorable foreign currency impact to manufacturing costs, and manufacturing process improvements
resulting from annual cost reduction activities, as well as our acquisition of TOKIN. TOKIN contributed $47.0 million to Solid
Capacitors gross margin in fiscal year 2018.
Film and Electrolytic gross margin increased $4.3 million, or 39.9% due an increase in net sales, as well as the benefit
of completed restructuring activities.
MSA gross margin was $49.3 million for the fiscal year ended March 31, 2018.
SG&A
SG&A expenses of $173.6 million (14.5% of net sales) for fiscal year 2018 increased $66.0 million or 61.3%
compared to $107.7 million (14.2% of net sales) for fiscal year 2017. The increase was primarily attributable to $41.9 million
in SG&A expenses incurred by TOKIN for the fiscal year ended March 31, 2018. In addition, the increase was related to $15.7
million in increased payroll-related expenses and benefits, a $9.1 million increase in office related expenses and rent, a $4.1
million increase in professional fees and a $2.4 million increase in travel related expenses. These increases were partially offset
by a $7.0 million decrease in ERP integration and technology transition costs and a $0.4 million decrease in legal expenses.
Research and Development
R&D expenses of $39.1 million (3.3% of net sales) for fiscal year 2018 increased $12.4 million or 46.5% compared to
$26.7 million (3.5% of net sales). The increase was primarily related to $10.1 million in R&D expenses incurred by TOKIN for
fiscal year 2018 and $2.2 million in increased payroll-related expenses.
(Gain) Loss on Write Down and Disposal of Long-Lived Assets
During fiscal year 2018, the Company recorded a net gain on the write down and disposal of long-lived assets of $1.0
million, which was comprised of $1.2 million in net gains on the sale and disposal of long-lived assets offset by $0.2 million in
impairment charges. The net gains on the sale and disposal of long-lived assets were primarily related to the sale of equipment,
land, and buildings from KFM, which was shut down in fiscal year 2017. On March 13, 2018, the Company sold KFM's land
and buildings to a third party for a gross sales price of $3.6 million. The net proceeds realized by the Company were
approximately $3.4 million after payment of $0.2 million in closing costs. The Company realized a gain on the sale of the land
and buildings of approximately $1.9 million during the year ended March 31, 2018 as a result of the sale. In addition, the
Company sold KFM's equipment for a $1.4 million gain. These gains were partially offset by MSA's loss on disposals of assets
of $1.3 million primarily related to equipment and buildings used for discontinued products and Solid Capacitors' loss of
approximately $0.6 million related to the relocation of its K-Salt operations from a leased facility to its existing Matamoros,
Mexico facility.
During fiscal year 2017, the Company recorded a net loss on write down and disposal of long-lived assets of $10.7
million, which was comprised of $10.3 million in impairment charges and $0.4 million in net losses on the sale and disposal of
long-lived assets. In fiscal year 2017, Film and Electrolytic incurred impairment charges totaling $8.2 million. The impairment
charges consisted of the following two actions.
On August 31, 2016, KEMET Electronics Corporation, a wholly-owned subsidiary of KEMET made the decision to
shut-down operations of its wholly-owned subsidiary, KFM. Operations at KFM’s Knoxville, Tennessee plant ceased as of
October 31, 2016. The Company recorded impairment charges related to KFM totaling $4.1 million comprised of $3.0 million
for the write down of property plant and equipment and $1.1 million for the write down of intangible assets.
The Company also recorded impairment charges of $4.1 million related to a decline in real estate market conditions
surrounding its vacated Sasso Marconi, Italy manufacturing facility.
In fiscal year 2017, Solid Capacitors incurred impairment charges totaling $2.1 million related to the relocation of our
leased K-salt facility to our existing Matamoros, Mexico facility.
Restructuring Charges
Restructuring charges of $14.8 million in fiscal year 2018 increased $9.4 million or 174.7% from $5.4 million in fiscal
year 2017.
The Company incurred $14.8 million in restructuring charges in the fiscal year ended March 31, 2018, comprised of
$12.6 million related to personnel reduction costs and $2.3 million of relocation and exit costs.
48
The personnel reduction costs of $12.6 million were due to $5.2 million related to a voluntary reduction in force in the
Film and Electrolytic reportable segment's Italian operations; $4.4 million related to a headcount reduction in the TOKIN
legacy group across various internal and operational functions; $2.7 million in severance charges across various overhead
functions in the Simpsonville, South Carolina office as these functions were relocated to the Company's new corporate
headquarters in Fort Lauderdale, Florida; and $0.2 million in headcount reductions related to a European sales reorganization.
The relocation and exit costs of $2.3 million included $0.9 million in lease termination penalties related to the
relocation of global marketing, finance and accounting, and information technology functions to the Company's Fort
Lauderdale office, $0.8 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico
plant, $0.4 million in exit costs related to the shut-down of operations for KFM, and $0.1 million related to the transfer of
certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico.
The Company incurred $5.4 million in restructuring charges in the fiscal year ended March 31, 2017, including $2.2
million related to personnel reduction costs and $3.2 million of relocation and exit costs.
The personnel reduction costs of $2.2 million corresponded with the following: $0.3 million related to the
consolidation of certain Solid Capacitor manufacturing in Matamoros, Mexico; $0.4 million for headcount reductions related to
the shut-down of operations for KFM; $0.3 million related to headcount reductions in Europe (primarily Italy and Landsberg,
Germany) corresponding with the relocation of certain production lines and laboratories to lower cost regions; $0.3 million for
overhead reductions in Sweden; $0.3 million in U.S. headcount reductions related to the relocation of global marketing
functions to the Company’s Fort Lauderdale, Florida office; $0.3 million in headcount reductions related to the transfer of
certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico; $0.2 million in overhead reductions for
the relocation of research and development operations from Weymouth, England to Evora, Portugal; and $0.1 million in
manufacturing headcount reductions related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant.
The relocation and exit costs of $3.2 million included $1.9 million in expenses related to contract termination costs
related to the shut-down of operations for KFM; $0.6 million in expenses related to the relocation of the K-Salt operations to
the existing Matamoros, Mexico plant; $0.6 million for transfers of Film and Electrolytic production lines and R&D functions
to lower cost regions; and $0.1 million related to the transfer of certain Tantalum production from Simpsonville, South Carolina
to Victoria, Mexico.
Operating Income
Operating income for fiscal year 2018 of $112.9 million increased $77.9 million compared to operating income of
$35.0 million in fiscal year 2017. The improvement was primarily due a $154.0 million increase in gross margin and an $11.7
million improvement in (gain) loss on write down and disposal of long-lived assets. These improvements to operating income
were partially offset by a $66.0 million increase in SG&A expenses, a $12.4 million increase in R&D expenses, and a $9.4
million increase in restructuring charges.
Non-Operating (Income) Expense, net
Non-operating income, net was $74.2 million in fiscal year 2018 compared to a net expense of $25.2 million in fiscal
year 2017. The $99.4 million improvement was primarily due to a $130.9 million gain on acquisition in fiscal 2018 and a $7.7
million decrease in net interest and amortization expense under the Term Loan and Credit Agreement for fiscal year 2018 as
compared to net interest and amortization expense under the Senior Notes in fiscal year 2017. Partially offsetting these
favorable changes were the following unfavorable changes: a $16.9 million net unfavorable change in foreign currency
exchange gain/(loss), which was primarily due to the change in the value of the Chinese Yuan Renminbi, Euro, Great Britain
Pound, Thai Baht, and Japanese Yen, compared to the U.S. dollar; a $10.7 million decrease in gains related to the TOKIN
Option as there was no such gain recorded in fiscal year 2018 compared to fiscal year 2017; $11.3 million in antitrust litigation
fines recorded in fiscal year 2018, $1.1 million in integration expenses incurred by TOKIN in fiscal year 2018, and $0.6 million
increase in net other operating expenses.
Income Taxes
Income tax expense of $9.1 million in fiscal year 2018 increased $4.8 million compared to income tax expense of $4.3
million in fiscal year 2017. The increase was primarily driven by income tax expense from foreign operations. Of the $4.8
million increase, $3.3 million related income tax expense from operations of newly acquired subsidiaries.
Fiscal year 2018 income tax expense of $9.1 million was comprised of 9.7 million in income tax expense related to
foreign operations and a $0.6 million of U.S. federal income tax benefit. The U.S. federal benefit of $0.6 million included an
estimated $0.8 million tax benefit resulting from the Tax Cuts and Jobs Act of 2017.
49
Fiscal year 2017 income tax expense of $4.3 million was comprised of $4.3 million in foreign income tax expense. No
U.S. federal income tax expense benefit was recognized for the U.S. taxable loss for fiscal year 2017 due to a valuation
allowance provided for U.S. net operating losses.
Equity Income (Loss) from Equity Method Investments
In fiscal year 2018, we incurred equity income related to our equity method investments of $76.2 million compared to
$41.6 million in fiscal year 2017. The increase was primarily due to equity income of $84.2 million related to our 34%
economic interest in TOKIN for the 19-day period ended April 19, 2017, which included the gain on the sale of the EMD
business. The increase was also due to $0.8 million and $0.4 million of income from TOKIN's equity method investments,
Nippon Yttrium Co., Ltd ("NYC") and NT Sales Co., Ltd ("NTS"), respectively. Partially offsetting these favorable items was a
$9.0 million removal of the balance of the cost basis of the portion of equity investment related to the EMD division which was
established at the time of initial acquisition of 34% of TOKIN, as well as $0.1 million of loss from our joint venture with
Novasentis.
Reportable Segment Comparison of Fiscal Year 2018 to Fiscal Year 2017
The following table sets forth the operating income (loss) for each of our reportable segments for the fiscal years 2018
and 2017. The table also sets forth each of the reportable segments’ net sales as a percentage of total net sales and the operating
income components as a percentage of total net sales (amounts in thousands, except percentages):
Net sales
Solid Capacitors
Film and Electrolytic (1)
MSA
Total (1)
Operating income (loss)
Solid Capacitors
Film and Electrolytic (1)
MSA (2)
Corporate (1)
Total
For the Fiscal Years Ended
March 31, 2018
March 31, 2017
Amount
% of Total
Sales
Amount
% of Total
Sales
$
771,240
201,977
226,964
64.3% $
16.8%
18.9%
575,110
182,228
—
$
1,200,181
100.0% $
757,338
75.9%
24.1%
—%
100.0%
$
234,473
$
3,622
15,694
(140,937)
112,852
$
9.4% $
147,662
(9,028)
—
(103,666)
34,968
4.6%
_______________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) After the TOKIN acquisition in fiscal year 2018, MSA became a new reportable segment.
Solid Capacitors
The table below sets forth net sales, operating income and operating income as a percentage of net sales for our Solid
Capacitors reportable segment for the fiscal years 2018 and 2017 (amounts in thousands, except percentages):
Tantalum product line net sales
Ceramic product line net sales
Net sales
Segment operating income
For the Fiscal Years Ended
March 31, 2018
March 31, 2017
Amount
% to Net
Sales
Amount
% to Net
Sales
$
$
$
495,114
276,126
771,240
234,473
$
$
30.4% $
342,184
232,926
575,110
147,662
25.7%
50
Net Sales
Solid Capacitors net sales of $771.2 million in fiscal year 2018 increased $196.1 million or 34.1% from $575.1
million in fiscal year 2017. Tantalum product line net sales of $495.1 million in fiscal year 2018 increased $152.9 million or
44.7% from $342.2 million in fiscal year 2017. Ceramic product line net sales of $276.1 million in fiscal year 2018 increased
$43.2 million or 18.5% from $232.9 million in fiscal year 2017.
The increase in Solid Capacitors net sales was primarily driven by the addition of net sales of $133.8 million resulting
from the TOKIN acquisition and an increase in net sales to the legacy products distributor channel of $81.7 million. To a lesser
degree, an increase in legacy Ceramic products' net sales of $6.0 million in the EMS channel across all regions and $10.2
million in the OEM channel in the EMEA and APAC regions also contributed to the increase in Solid Capacitors net sales.
These increases were partially offset by a $28.0 million decrease in net sales in the OEM channel for legacy Tantalum products
across all regions. In addition, Solid Capacitors net sales was favorably impacted by $6.1 million from foreign currency
exchange due to the change in the value of the Euro compared to the U.S. dollar.
Reportable Segment Operating Income
Segment operating income of $234.5 million for fiscal year 2018 increased $86.8 million or 58.8% from $147.7
million for fiscal year 2017. The increase in operating income was primarily attributable to an increase in gross margin of
$100.4 million. TOKIN contributed $47.0 million in additional gross margin in fiscal year 2018. Legacy KEMET gross margin
increased $53.3 million, or 30.6%, primarily driven by an increase in net sales, cost improvements in vertical integration,
favorable foreign currency impact to manufacturing costs, and manufacturing process improvements resulting from our cost
reduction activities. In addition, there was a $1.6 million improvement in (gain) loss on write down and disposal of long-lived
assets. Partially offsetting these improvements were a $10.5 million increase in SG&A expenses and a $5.0 million increase in
R&D expenses. TOKIN accounted for $10.2 million of the increase in SG&A expenses and $4.1 million of the increase in
R&D expenses.
Film and Electrolytic
The table below sets forth net sales, operating income (loss) and operating income (loss) as a percentage of net sales
for our Film and Electrolytic reportable segment for the fiscal years 2018 and 2017 (amounts in thousands, except percentages):
Net sales (1)
Segment operating income (loss) (1)
For the Fiscal Years Ended
March 31, 2018
March 31, 2017
Amount
$
201,977
% to Net
Sales
$
3,622
1.8%
Amount
182,228
(9,028)
% to Net
Sales
(5.0)%
_______________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606
Net Sales
Film and Electrolytic net sales of $202.0 million in fiscal year 2018 increased $19.7 million or 10.8% from $182.2
million in fiscal year 2017. The increase in net sales was primarily driven by an increase in net sales in the distributor channel
across all the APAC and EMEA regions of $13.7 million, a $3.3 million increase in net sales in the OEM channel of the EMEA
region and a $4.2 million increase in the EMS channel across the Americas, EMEA, and APAC regions. These increases were
partially offset by a decrease in net sales of $1.2 million in the OEM channel across the Americas, APAC, and JPKO regions. In
addition, there was a favorable impact of $7.6 million from foreign currency exchange primarily due to the change in the value
of the Euro compared to the U.S. dollar.
Reportable Segment Operating Income (Loss)
Segment operating income of $3.6 million in fiscal year 2018 improved $12.7 million from $9.0 million of operating
loss in fiscal year 2017. The improvement was primarily attributable to a $4.3 million increase in gross margin driven by higher
net sales, as well as the benefit of completed restructuring activities. The increase was also attributed to an $11.7 million
improvement in (gain) loss on the write down and disposal of long-lived assets. These improvements were partially offset by a
$2.1 million increase in restructuring charges, a $0.7 million increase in SG&A expenses, and a $0.6 million increase in R&D
expenses.
51
Liquidity and Capital Resources
Our liquidity needs arise from working capital requirements, acquisitions, capital expenditures, principal and interest
payments on debt, costs associated with the implementation of our restructuring plans, and dividend payments. Historically,
these cash needs have been met by cash flows from operations, borrowings under our loan agreements, and existing cash and
cash equivalents balances.
TOKIN Term Loan Facility
On October 29, 2018, the Company entered into the TOKIN Term Loan Facility and received funding on November 7,
2018. The proceeds, which were net of an arrangement fee withheld from the funding amount, were JPY 32.1 billion, or
approximately $283.9 million using the exchange rate as of November 7, 2018. Net of the arrangement fee, bank issuance
costs, and other indirect issuance costs, the Company's net proceeds from the TOKIN Term Loan Facility was $281.8 million.
The proceeds from the TOKIN Term Loan Facility were used by TOKIN to make Intercompany Loans. The proceeds,
along with other cash on hand, were used to prepay in full the outstanding amounts under the Company’s Term Loan Credit
Agreement of $323.4 million and a prepayment premium of 1.0%.
The TOKIN Term Loan Facility consists of (i) a JPY 16.5 billion (approximately $146.0 million using the exchange
rate as of November 7, 2018) Term Loan A tranche (the “Term Loan A”) and (ii) a JPY 16.5 billion (approximately $146.0
million using the exchange rate as of November 7, 2018) Term Loan B tranche (the “Term Loan B” and, together with the Term
Loan A, collectively, the “Term Loans”). Principal payments under Term Loan A are required semi-annually, in the amount of
JPY 1.4 billion (approximately $12.4 million using the exchange rate as of March 31, 2019), while the principal of Term Loan
B is due in one payment at maturity. At each reporting period, the carrying value of the loan is translated from JPY to U.S.
Dollars (“USD”) using the spot exchange rate as of the end of the reporting period. The carrying value of the TOKIN Term
Loan Facility at March 31, 2019 was $276.8 million.
Interest payments are due semi-annually on the Term Loans, with the interest rate based on a margin over the six-
month Japanese TIBOR. The applicable margin for Term Loan A is 2.00% and for Term Loan B is 2.25%. Japanese TIBOR at
March 31, 2019 was 0.13%. Interest payable related to the TOKIN Term Loan Facility included in the line item “Accrued
expenses” on the Condensed Consolidated Balance Sheets was $0.1 million as of March 31, 2019.
The Term Loans mature on September 30, 2024. KEMET and certain subsidiaries of TOKIN provided guarantees of
the obligations under the Term Loans, which will also be secured by certain assets, properties and equity interests of TOKIN
and its material subsidiaries. The Term Loans contain customary covenants applicable to both the Company and to TOKIN,
including maintenance of a consolidated net leverage ratio, the absence of two consecutive years of consolidated operating
losses and the maintenance of certain required levels of consolidated net assets. The TOKIN Term Loan Facility also contains
customary events of default. The Company may prepay the Term Loans at any time, subject to certain notice requirements and
reimbursement of loan breakage costs.
Revolving Line of Credit
In connection with the closing of the TOKIN Term Loan Facility on October 29, 2018, the Company entered into
Amendment No. 10 to the Loan and Security Agreement, Waiver and Consent (the “Revolver Amendment”), by and among
KEMET, KEC, the other borrowers named therein, the financial institutions party thereto as lenders and Bank of America,
N.A., a national banking association, as agent for the lenders. The Revolver Amendment provides the Company with, among
other things, increased flexibility for certain restricted payments (including dividends), and released certain pledges that
allowed the Company to obtain the TOKIN Term Loan Facility to pay down the Term Loan Credit Agreement. The revolving
line of credit has a facility amount of up to $75.0 million which is based on factors including outstanding eligible accounts
receivable, inventory, and equipment collateral. There were no borrowings under the revolving line of credit during fiscal year
2019, and the Company’s available borrowing capacity under the Loan and Security Agreement was $66.0 million as of
March 31, 2019.
Customer Advances
In September, November, and February of fiscal year 2019, the Company entered into three agreements with different
customers (the “Customers”) pursuant to which the Customers agreed to make advances (collectively, the “Advances”) to the
Company in an aggregate amount of up to $72.0 million (collectively, the “Customer Capacity Agreements”). The Company is
using these Advances to fund the purchase of production equipment and to make other investments and improvements in its
business and operations (the “Investments”) to increase overall capacity to produce various electronic components of the type
and part as may be sold by the Company to the Customers from time to time. The Company retains all rights to the production
equipment purchased with the funds from the Advances. The Advances from the Customers are being made in quarterly
52
installments (“Installments”) over an expected period of 18 to 24 months from the effective date of the Customer Capacity
Agreements.
The Advances will be repaid beginning on the date that production from the Investments is sufficient to meet the
Company's obligations under the agreements with the Customers. Repayments will be made on a quarterly basis as determined
by calculations that generally consider the number of components purchased by the Customers during the quarter. Repayments
based on the calculations will continue until either the Advances are repaid in full, or December 31, 2038 for all three
Customers. The Company has a quarterly repayment cap in the agreement with each of the Customers and is not required to
make any quarterly repayments to the Customers that in the aggregate exceeds $1.8 million. If the Customers do not purchase a
number of components that would require full repayment of the Advances by December 31, 2038, then the Advances shall be
deemed repaid in full. Additionally, if the Customers do not purchase a number of components that would require a payment on
the Advances for a period of 16 consecutive quarters, the Advances shall be deemed repaid in full.
As of March 31, 2019, the Company has received a total of $13.4 million in Advances from these Customers. Since
the debt is non-interest bearing, we have recorded debt discounts on the Advances. These discounts are being amortized over
the expected life of the Advances through interest expense. During fiscal year 2019, the Company had $16.3 million in capital
expenditures related to the Customer Capacity Agreements.
Derivatives
On November 7, 2018, the Company entered into two cross-currency swaps designated as fair value hedges to hedge
the foreign currency risk on the Intercompany Loans. These agreements are contracts to exchange floating-rate payments in
JPY with floating rate payments in USD. The swaps are intended to offset in the same period the remeasurement of the carrying
value of the underlying foreign currency Intercompany Loans. The terms of these cross-currency swaps are as follows:
• An amortizing cross-currency swap with an initial notional value JPY 16.5 billion. The notional amount is amortized
by approximately JPY 1.4 billion every six months and matures on September 30, 2024. The Company receives
interest in JPY on March 31 and September 30 of each year based on the JPY notional value and JPY Libor plus
2.00%. Interest payments are made by the Company in USD on March 31 and September 30 of each year based on the
USD equivalent of the JPY notional value and USD Libor plus 2.70%.
• A non-amortizing cross-currency swap contract with a notional value of JPY 16.5 billion maturing on September 30,
2024. The Company receives interest in JPY on March 31 and September 30 of each year based on the JPY notional
value and JPY Libor plus 2.25%. Interest payments are made by the Company in USD on March 31 and September 30
of each year based on the USD equivalent of the JPY notional value and USD Libor plus 3.15%.
Also, on November 7, 2018, the Company entered into a cross-currency swap designated as a net investment hedge to
hedge the JPY currency exposure of the Company's net investment in TOKIN. This agreement is a contract to exchange fixed-
rate payments in one currency for fixed-rate payments in another currency. The terms of this cross-currency swap are as
follows:
• An amortizing cross-currency swap with an initial notional value of JPY 33.0 billion. The notional amount is
amortized by approximately JPY 1.4 billion every six months and matures on September 30, 2024. Interest payments
are made by the Company in JPY on March 31 and September 30 of each year based on the JPY notional value and a
fixed rate of 2.61%. The Company receives interest in USD on March 31 and September 30 of each year based on the
USD equivalent of the JPY notional value and a fixed rate of 6.25%.
Short-term Liquidity
Cash and cash equivalents of $207.9 million as of March 31, 2019 decreased $78.9 million from $286.8 million as of
March 31, 2018. Our net working capital (current assets less current liabilities) decreased $27.7 million, with the balance as of
March 31, 2019 of $363.6 million compared to $391.3 million of net working capital as of March 31, 2018, with the decrease
primarily driven by the cash holdings of TOKIN. Cash and cash equivalents held by our foreign subsidiaries totaled $139.6
million and $196.8 million at March 31, 2019 and 2018, respectively, with the decrease primarily driven by cash holdings of
TOKIN and Suzhou, China. Our operating income outside the U.S. is no longer deemed to be permanently reinvested in foreign
jurisdictions. However, we currently do not intend nor foresee a need to repatriate cash and cash equivalents held by foreign
subsidiaries. If these funds are needed for our operations in the U.S., we may be required to accrue U.S. withholding taxes on
the distributed foreign earnings.
Based on our current operating plans, we believe domestic cash and cash equivalents, including expected cash
generated from operations, are sufficient to fund our operating requirements for at least the next twelve months, including $6.3
million in interest payments, $28.4 million in debt principal payments, $120.0 million to $135.0 million in capital expenditures,
53
excluding approximately $45.0 million to $50.0 million of customer-funded capacity expansion related to Customer Capacity
Agreements, $1.9 million in restructuring payments, and $11.6 million in expected cash dividends. The Company's expected
capital expenditures in fiscal year 2020 mainly relate to the Company's continued plan of capacity expansion to support future
growth, and to improve our information technology infrastructure around the world. As of March 31, 2019, our borrowing
capacity, which is based on factors including outstanding eligible accounts receivable, inventory and equipment collateral,
under the revolving line of credit was $66.0 million. The revolving line of credit expires on April 28, 2022.
Cash and cash equivalents decreased by $78.9 million during the year ended March 31, 2019, as compared to an
increase of $177.1 million during the year ended March 31, 2018 and an increase of $44.8 million during the year ended
March 31, 2017 as follows (amounts in thousands):
Net cash provided by (used in) operating activities (1)
Net cash provided by (used in) investing activities
Net cash provided by (used in) financing activities
Effect of foreign currency fluctuations on cash (2)
Net increase (decrease) in cash, cash equivalents, and restricted cash
_______________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) Fiscal year ended March 31, 2018 adjusted due to the adoption of ASC 606.
Operating Cash Flow Activities
Fiscal Years Ended March 31,
2019
2018
2017
$
$
$
131,731
(147,012)
(56,657)
(6,990)
(78,928) $
120,761
$
102,364
(55,798)
9,745
177,072
$
71,667
(25,598)
(125)
(1,174)
44,770
During fiscal years 2019, 2018, and 2017, cash provided by operating activities totaled $131.7 million, $120.8 million,
and $71.7 million, respectively. During fiscal year 2019, cash provided by operating activities was positively impacted by our
net income of $206.6 million, a $7.7 million increase in accounts payable, and a $1.0 million decrease in accrued income taxes.
Operating cash flows were negatively impacted by a $70.6 million decrease in other operating liabilities, a $42.8 million
increase in inventories, an $8.9 million increase in accounts receivable, and a $4.4 million increase in prepaid expenses and
other assets. The decrease in other operating liabilities was driven by a $46.3 million decrease in accruals for TOKIN anti-trust
fines and a $7.8 million decrease in restructuring liabilities. The increase in inventory is due to increased customer demand.
During fiscal year 2018, cash provided by operating activities was positively impacted by our net income of $254.1
million. Excluding the acquired balances from TOKIN, operating cash flows were also positively impacted by a $30.2 million
decrease in accounts receivable, a $4.3 million decrease in prepaid expenses and other assets, and a $1.3 million increase in
accrued income taxes. Excluding the acquired balances from TOKIN, operating cash flows were negatively impacted by a
$16.1 million decrease in accounts payable and a $13.8 million increase in inventories.
During fiscal year 2017, cash provided by operating activities was positively impacted by our net income of $47.2
million, a $16.8 million decrease in inventories, a $6.2 million increase in accounts payable, and a $1.7 million increase in
other operating liabilities. Operating cash flows were negatively impacted by a $2.6 million increase in accounts receivable and
a $1.8 million increase in prepaid expenses and other assets.
Investing Cash Flow Activities
During fiscal years 2019, 2018, and 2017, cash provided by (used in) investing activities totaled $(147.0) million,
$102.4 million, and $(25.6) million, respectively. During fiscal year 2019, cash used in investing activities included capital
expenditures of $146.1 million, primarily related to expanding capacity at our manufacturing facilities in Mexico, Portugal,
China, Thailand and Japan, as well as information technology projects in the United States and Mexico. $16.3 million of the
$146.1 million in capital expenditures were related to the Customer Capacity Agreements. Additionally, the Company invested
$4.0 million in the form of capital contributions to KEMET Jianghai and Novasentis. Offsetting these uses of cash, we had
asset sales of $2.3 million and received dividends of $0.8 million.
During fiscal year 2018, cash provided by investing activities was primarily due to $164.0 million in net cash received
attributable to the bargain purchase of TOKIN. Additionally, we had proceeds from asset sales of $3.6 million and received
dividends of $2.7 million. This was partially offset by capital expenditures of $65.0 million, primarily related to expanding
capacity at our manufacturing facilities in Mexico, Portugal, China, Thailand and Japan, as well as for information technology
projects in the United States and Mexico. In addition, the Company invested $3.0 million in the form of capital contributions to
Novasentis.
54
During fiscal year 2017, cash used in investing activities was primarily due to capital expenditures of $25.6 million,
primarily related to expanding capacity at our manufacturing facilities in Mexico, Italy, Portugal, and China.
Financing Cash Flow Activities
During fiscal years 2019, 2018, and 2017, cash used in financing activities totaled $56.7 million, $55.8 million, and
$0.1 million, respectively. During fiscal year 2019, the Company received $281.8 million in proceeds from the TOKIN Term
Loan Facility, net of discount, bank issuance costs, and other indirect issuance costs, $13.4 million in proceeds from advances
from customers, as described in the earlier section titled "Customer Advances", received proceeds on an interest free loan from
the Portuguese Government of $1.1 million, and received $0.5 million in cash proceeds from the exercise of stock options. The
Company made $344.5 million in payments on long term debt, including two quarterly principal payments on the Term Loan
Credit Agreement of $4.3 million, for a total of $8.6 million, $323.4 million to repay the remaining balance on the Term Loan
Credit Agreement, and one principal payment on the TOKIN Term Loan Facility of $12.4 million. An early payment premium
on the Term Loan Credit Agreement used $3.2 million in cash. Lastly, the Company paid two quarterly cash dividends for a
total of $5.8 million.
During fiscal year 2018, cash used in financing activities was impacted by the following payments: (i) $353.0 million
to pay off the remaining outstanding balance of the 10.5% Senior Notes, (ii) $33.9 million to repay the remaining outstanding
balance of the revolving line of credit, and (iii) three quarterly principal payments on the Term Loan Credit Agreement for $4.3
million each, for a total of $12.9 million. The Company received $329.7 million in proceeds from the Term Loan Credit
Agreement, net of discount, bank issuance costs, and other indirect issuance costs, received proceeds from the exercise of stock
warrants and stock options for $8.8 million and $5.2 million, respectively, and received $0.3 million in proceeds on an interest
free loan from the Portuguese Government.
During fiscal year 2017, the Company made $0.1 million in net payments on long-term debt, had cash outflows of
$1.1 million for the purchase of treasury stock, and received $1.1 million from the exercise of stock options.
Commitments
At March 31, 2019, we had contractual obligations in the form of non-cancellable operating leases and debt, including
interest payments (see Note 3, “Debt” and Note 15, “Commitments and Contingencies” to our consolidated financial
statements), European social security, pension benefits, other post-retirement benefits, inventory purchase obligations, fixed
asset purchase obligations, acquisition related obligations, and construction obligations as follows (amounts in thousands):
Contractual obligations
Debt obligations (1)
Interest obligations (1)
Operating lease obligations
Pension and other post-retirement benefits (2)
Employee separation liability
Restructuring liability
Purchase commitments
Capital lease obligations
Anti-trust fines and settlements (3)
Total
Payment Due by Period
Total
Year 1
Years 2 - 3
Years 4 - 5
More than
5 years
$
305,927
$
28,430
$
59,509
$
55,708
$
162,280
28,200
48,311
94,178
7,640
2,181
31,468
2,049
34,880
6,326
10,898
6,758
594
1,869
31,468
993
21,712
11,039
14,302
15,184
674
312
—
888
8,928
9,402
18,024
674
—
—
168
10,203
2,965
1,907
13,709
54,212
5,698
—
—
—
—
$
554,834
$
109,048
$
112,111
$
95,869
$
237,806
_______________________________________________________________________________
(1) Refer to Note 3, “Debt” for additional information. Repayment of the Customer Capacity Agreements assumes the customers purchase products in a quantity
sufficient to require the maximum permitted debt repayment amount per quarter.
(2) Reflects expected benefit payments through fiscal year 2029.
(3) In addition to amounts reflected in the table, an additional $2.9 million has been recorded in the line item "Accrued expenses," for which the timing of
payment has not been determined.
Uncertain Income Tax Positions
We have recognized a liability for our unrecognized uncertain income tax positions of approximately $2.4 million as
of March 31, 2019. The ultimate resolution and timing of payment for remaining matters continues to be uncertain and are,
therefore, excluded from the above table.
55
Non-GAAP Financial Measures
To complement our Consolidated Statements of Operations and Cash Flows, we use non-GAAP financial measures of
Adjusted gross margin, Adjusted operating income, Adjusted net income, and Adjusted EBITDA. We believe that Adjusted
gross margin, Adjusted operating income, Adjusted net income, and Adjusted EBITDA are complements to U.S. GAAP
amounts and such measures are useful to investors. The presentation of these non-GAAP measures is not meant to be
considered in isolation or as an alternative to net income as an indicator of our performance, or as an alternative to cash flows
from operating activities as a measure of liquidity.
The following table provides a reconciliation from U.S. GAAP Gross margin to non-GAAP Adjusted gross margin
(amounts in thousands):
Net sales (1)
Cost of sales (1)
Gross Margin (GAAP) (1)
Gross margin as a % of net sales
Non-GAAP adjustments:
Plant start-up costs (2)
Stock-based compensation expense
Adjusted gross margin (non-GAAP) (1)
Adjusted gross margin as a % of net sales
Fiscal Years Ended March 31,
2019
2018
2017
$1,382,818
924,276
458,542
$1,200,181
860,744
339,437
$ 757,338
571,944
185,394
33.2%
28.3%
24.5%
(927)
2,756
$ 460,371
929
1,519
$ 341,885
427
1,384
$ 187,205
33.3%
28.5%
24.7%
_______________________________________________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) $0.9 million in costs incurred during fiscal year 2018 related to the relocation of the Company's tantalum powder facility equipment from Carson City,
Nevada to its existing Matamoros, Mexico plant were reclassified from “Plant start-up costs” to “Restructuring charges” during fiscal year 2019.
The following table provides reconciliation from U.S. GAAP Operating income to non-GAAP Adjusted operating
income (amounts in thousands):
Operating income (GAAP) (1)
Non-GAAP adjustments:
(Gain) loss on write down and disposal of long-lived assets
ERP integration costs/IT transition costs
Stock-based compensation
Restructuring charges (2)
Legal expenses related to antitrust class actions
TOKIN investment-related expenses
Plant start-up costs (2)
Fiscal Years Ended March 31,
2019
2018
2017
$
200,849
$
112,852
$
34,968
1,660
8,813
12,866
8,779
5,195
—
(927)
237,235
(992)
80
7,657
14,843
6,736
—
929
10,671
7,045
4,720
5,404
2,640
1,101
427
Adjusted operating income (non-GAAP) (1)
_______________________________________________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) $0.9 million in costs incurred during fiscal year 2018 related to the relocation of the Company's tantalum powder facility equipment from Carson City,
Nevada to its existing Matamoros, Mexico plant were reclassified from “Plant start-up costs” to “Restructuring charges” during fiscal year 2019.
142,105
$
$
$
66,976
56
The following table provides a reconciliation from U.S. GAAP Net income to non-GAAP Adjusted net income
(amounts in thousands):
Net income (GAAP) (1)
Non-GAAP adjustments:
Equity (income) loss from equity method investments
Acquisition (gain) loss
Change in value of TOKIN options
(Gain) loss on write down and disposal of long-lived assets
Restructuring charges (2)
R&D grant reimbursements and grant income
ERP integration costs/IT transition costs
Stock-based compensation
Legal expenses/fines related to antitrust class actions
Net foreign exchange (gain) loss
TOKIN investment-related expenses
Plant start-up costs (2)
Amortization included in interest expense
Income tax effect of non-GAAP adjustments
Loss on early extinguishment of debt
Fiscal Years Ended March 31,
2019
2018
2017
$
206,587
$ 254,127
$
47,157
3,304
—
—
1,660
8,779
(4,559)
8,813
12,866
11,896
(7,230)
—
(927)
1,872
(50,012)
15,946
(76,192)
(130,880)
—
(992)
14,843
—
80
7,657
16,636
13,145
—
929
2,467
(30)
486
(41,643)
—
(10,700)
10,671
5,404
—
7,045
4,720
2,640
(3,758)
1,101
427
761
(741)
—
Adjusted net income (non-GAAP) (1)
____________________________________________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) $0.9 million in costs incurred during fiscal year 2018 related to the relocation of the Company's tantalum powder facility equipment from Carson City,
Nevada to its existing Matamoros, Mexico plant were reclassified from “Plant start-up costs” to “Restructuring charges” during fiscal year 2019.
$ 102,276
208,995
$
$
23,084
57
The following table provides reconciliation from U.S. GAAP Net income to non-GAAP Adjusted EBITDA (amounts
in thousands):
Net income (U.S. GAAP) (1)
Non-GAAP adjustments:
Income tax expense (benefit)
Interest expense, net
Depreciation and amortization
EBITDA (non-GAAP) (1)
Excluding the following items:
Equity (income) loss from equity method investments
Acquisition (gain) loss
Change in value of TOKIN options
(Gain) loss on write down and disposal of long-lived assets
ERP integration costs/IT transition costs
Stock-based compensation
Restructuring charges (2)
R&D grant reimbursements and grant income
Legal expenses/fines related to antitrust class actions
Net foreign exchange (gain) loss
TOKIN investment-related expenses
Plant start-up costs (2)
Loss on early extinguishment of debt
Fiscal Years Ended March 31,
2019
2018
2017
$
206,587
$
254,127
$
47,157
(39,460)
19,204
52,628
238,959
9,132
32,073
50,661
4,294
39,731
38,151
345,993
129,333
3,304
—
—
1,660
8,813
12,866
8,779
(4,559)
11,896
(7,230)
—
(927)
15,946
(76,192)
(130,880)
—
(992)
80
7,657
14,843
—
16,636
13,145
—
929
486
(41,643)
—
(10,700)
10,671
7,045
4,720
5,404
—
2,640
(3,758)
1,101
427
—
Adjusted EBITDA (non-GAAP) (1)
____________________________________________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) $0.9 million in costs incurred during fiscal year 2018 related to the relocation of the Company's tantalum powder facility equipment from Carson City,
Nevada to its existing Matamoros, Mexico plant were reclassified from “Plant start-up costs” to “Restructuring charges” during fiscal year 2019.
289,507
191,705
$
$
$
105,240
Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the
quantitative reconciliation provided above. Management uses Adjusted gross margin to facilitate our analysis and
understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided above
which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in
ongoing operations. The Company believes that Adjusted gross margin is useful to investors because it provides a supplemental
way to understand the underlying operating performance of the Company. Adjusted gross margin should not be considered as
an alternative to gross margin or any other performance measure derived in accordance with U.S. GAAP.
Adjusted operating income represents operating income, excluding adjustments which are outlined in the quantitative
reconciliation provided above. We use Adjusted operating income to facilitate our analysis and understanding of our business
operations by excluding the items outlined in the quantitative reconciliation provided above which might otherwise make
comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company
believes that Adjusted operating income is useful to investors because it provides a supplemental way to understand the
underlying operating performance of the Company and allows investors to monitor and understand changes in our ability to
generate income from ongoing operations.
Adjusted operating income should not be considered as an alternative to operating income or any other performance
measure derived in accordance with U.S. GAAP.
Adjusted net income represents net income, excluding adjustments which are outlined in the quantitative
reconciliation provided above. We use Adjusted net income to evaluate the Company’s operating performance by excluding the
items outlined in the quantitative reconciliation provided above which might otherwise make comparisons of our ongoing
business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that adjusted net
income is useful to investors because it provides a supplemental way to understand the underlying operating performance of the
Company and allows investors to monitor and understand changes in our ability to generate income from ongoing operations.
58
Adjusted net income should not be considered as an alternative to net income, operating income or any other performance
measures derived in accordance with U.S. GAAP.
Adjusted EBITDA represents net income before income tax expense, interest expense, net, and depreciation and
amortization, excluding adjustments which are outlined in the quantitative reconciliation provided above. We present Adjusted
EBITDA as a supplemental measure of our performance and ability to service debt. We also present adjusted EBITDA because
we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of
companies in our industry.
We believe adjusted EBITDA is an appropriate supplemental measure of debt service capacity because cash
expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense
because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges.
The other items excluded from adjusted EBITDA are excluded to better reflect our continuing operations.
In evaluating adjusted EBITDA, one should be aware that in the future we may incur expenses similar to the
adjustments noted above. Our presentation of adjusted EBITDA should not be construed as an inference that our future results
will be unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under
U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures
derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.
Our adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a
substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:
•
•
•
•
•
•
•
•
it does not reflect our cash expenditures, future requirements for capital expenditures or contractual
commitments;
it does not reflect changes in, or cash requirements for, our working capital needs;
it does not reflect the significant interest expense or the cash requirements necessary to service interest or
principal payments on our debt;
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will
often have to be replaced in the future, and our adjusted EBITDA measure does not reflect any cash
requirements for such replacements;
it is not adjusted for all non-cash income or expense items that are reflected in our Consolidated Statements of
Cash Flows;
it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of
our ongoing operations;
it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and
other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a
comparative measure.
Because of these limitations, adjusted EBITDA should not be considered as a measure of discretionary cash available
to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You
should compensate for these limitations by relying primarily on our U.S. GAAP results and using adjusted EBITDA only
supplementary.
Recent Accounting Pronouncements
In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No. 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service
Contract. This ASU amends the definition of a hosting arrangement and requires a customer in a hosting arrangement that is a
service contract to capitalize certain implementation costs as if the arrangement was an internal-use software project. Under
this ASU, a customer will apply ASC 350-40 to determine whether to capitalize implementation costs of the cloud computing
arrangement that is a service contract or expense them as incurred. This ASU is effective for fiscal years beginning after
December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently
evaluating the impact of the adoption of this guidance on the Company’s Condensed Consolidated Financial Statements.
In March 2018, the FASB issued ASU No. 2018-05, Amendments to SEC Paragraphs Pursuant to SEC Staff
Accounting Bulletin (“SAB”) No. 118. The amendments in this update provide guidance on when to record and disclose
provisional amounts for certain income tax effects of the Tax Cuts and Jobs Act. The amendments also require any provisional
amounts or subsequent adjustments to be included in net income from continuing operations. Additionally, this ASU discusses
required disclosures that an entity must make with regard to the Act. This ASU is effective immediately as new information is
59
available to adjust provisional amounts that were previously recorded. The Company has adopted this standard and has
finalized its accounting for the Act. See Note 11, “Income Taxes” for additional information on the Act.
In August 2017, the FASB issued ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities
(“ASU 2017-12”). The ASU amends and simplifies existing guidance to allow companies to more accurately present the
economic effects of risk management activities in the financial statements. For cash flow hedges existing on the date of
adoption, an entity is required to eliminate the separate measurement of ineffectiveness in earnings by means of a cumulative-
effect adjustment to accumulated other comprehensive income (“AOCI”) with a corresponding adjustment to the opening
balance of retained earnings. ASU 2017-12 becomes effective for fiscal years and interim periods beginning after December 15,
2018 and early adoption is permitted. In the third quarter of fiscal year 2019, the Company entered into new derivative
contracts and elected to early adopt the ASU effective as of October 1, 2018. The adoption of the standard did not result in a
cumulative-effect adjustment since the Company has not previously had any ineffectiveness associated with its cash flows
hedges.
In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain
Cash Receipts and Cash Payments. The update clarifies how cash receipts and cash payments in certain transactions are
presented and classified in the statement of cash flows. The effective date of this update is for fiscal years, and interim periods
within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires retrospective
application to all periods presented but may be applied prospectively if retrospective application is impracticable. The
Company adopted this guidance as of April 1, 2018. In connection with the adoption of this ASU, the Company elected to
account for distributions received from equity method investees using the nature of distributions approach, under which
distributions are classified based on the nature of activity that generated them. The other provisions of this ASU did not have an
impact on the Company's Condensed Consolidated Cash Flows.
In February 2016, the FASB issued ASU No. 2016-02 (“ASU 2016-02”), Leases, as modified by ASU 2017-03,
Transition and Open Effective Date Information, requiring lessees to recognize a right-of-use asset and a lease liability for all
leases. This ASU also requires expanded disclosures to help financial statement users better understand the amount, timing, and
uncertainty of cash flows arising from leases. The standard is effective for fiscal years beginning after December 15, 2018, and
interim periods within those fiscal years and the Company will adopt ASU 2016-02 on April 1, 2019. The Company has
substantially completed its preparation for the adoption of this ASU, and the ASU is expected to have a material impact on
lease assets and lease liabilities on its Consolidated Balance Sheets upon adoption. This ASU is not expected to have a material
effect on the amount of expense recognized in connection with the Company's current practice. The Company plans to elect the
optional transition method that will give companies the option to use the effective date as the date of initial application on
transition, and as a result, we will not adjust our comparative period financial information or make the new required lease
disclosures for periods before the effective date. For information about the Company's future lease commitments as of March
31, 2019, see Note 15, "Commitments and Contingencies."
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which superseded
existing accounting standards for revenue recognition and created a single framework. ASU 2014-09 and its amendments were
included primarily in ASC 606. The core principle of ASC 606 is that an entity should recognize revenue for the transfer of
goods or services equal to an amount that it expects to be entitled to receive for those goods or services. ASC 606 also requires
additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer
contracts, including significant judgments and changes in judgments. The Company adopted the requirements of ASC 606
effective in the first quarter of fiscal year 2019, using the full retrospective method, which required us to restate each prior
reporting period presented. The Company has applied practical expedient ASC 606-10-65-1(f)(3) and notes that all previously
reported historical amounts are adjusted for the impact of ASC 606. See Note 1, “Organization and Significant Accounting
Polices,” for tables showing how the adoption of ASC 606 impacted our previously reported Consolidated Balance Sheet as of
March 31, 2018 and our Consolidated Statements of Operations, Statements of Comprehensive Income, Statements of Changes
in Stockholders' Equity, and Statements of Cash Flows for the fiscal years ended March 31, 2018 and 2017.
There are currently no other accounting standards that have been issued that will have a significant impact on the
Company’s financial position, results of operations or cash flows upon adoption.
Effect of Inflation
Inflation generally affects us by increasing the cost of labor, equipment, and raw materials. We do not believe that
inflation has had any material effect on our business over the past three fiscal years except for the following discussion in
Commodity Price Risk.
60
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
Interest Rate Risk
On October 29, 2018, the Company entered into the TOKIN Term Loan Facility and received funding on November 7,
2018 at an equivalent of $292.0 million using the exchange rate on November 7, 2018. The TOKIN Term Loan Facility has a
variable interest rate and had an outstanding principal balance of $285.5 million as of March 31, 2019. We are exposed to interest
rate risk through the Term Loan Facility, and a 1% change in the interest rate would yield a $2.9 million change in interest expense
on an annualized basis.
Foreign Currency Exchange Rate Risk
Given our international operations and sales, we are exposed to movements in foreign exchange rates. Of these, the
most significant are currently the Euro, Japanese Yen, Thai Baht, Taiwan New Dollar, and Mexican Peso. A portion of our sales
to our customers and operating costs in Europe, Japan, and Thailand are denominated in Euro, Japanese Yen, and Thai Baht,
respectively, creating an exposure to foreign currency exchange rates. Also, a portion of our costs in our operations in Mexico
are denominated in Mexican Pesos, creating an exposure to foreign currency exchange rates. Additionally, certain of our non-
U.S. subsidiaries make sales denominated in U.S. dollars which expose them to foreign currency transaction gains and losses.
Historically, to minimize our exposure, we periodically entered into forward foreign exchange contracts in which the future
cash flows were hedged against the U.S. dollar (see Note 12, “Derivatives” to the Consolidated Financial Statements).
Additionally, during fiscal year 2019, the we entered into cross-currency swaps to hedge the foreign currency risk on
Intercompany Loans and to hedge the JPY currency exposure of the Company's net investment in TOKIN. We use these
derivative financial instruments primarily to reduce our exposure to adverse fluctuations in foreign currency exchange rates. We
do not enter into derivative financial instruments for speculative purposes and our derivative positions are used to reduce risk
by hedging an underlying economic exposure. Because of the high correlation between the hedging instrument and the
underlying exposure, fluctuations in the value of the instruments are generally offset by reciprocal changes in the value of the
underlying exposure.
A 10 percent weakening or strengthening of the U.S. dollar in relation to the foreign currencies we transact in would
result in approximately a $14.2 million increase or a $11.9 million decrease to our net income, respectively.
Raw Material Price Risk
As a result of our tantalum vertical integration efforts which began in fiscal year 2012, we have reduced our exposure
to price volatility and supply uncertainty in the tantalum supply chain. A majority of our tantalum needs are now met through
our direct sourcing of conflict free tantalum ore or tantalum scrap reclaim, which is then processed into the intermediate
product potassium heptafluorotantalate (commonly known as K-salt) at our facility in Mexico, before final processing into
tantalum powder at KBP. Price increases for tantalum ore, or for the remaining tantalum powder that we source from third
parties, could impact our financial performance as we may be unable to pass all such price increases on to our customers.
Silver and aluminum have generally been available in sufficient quantities, and we believe there are enough suppliers
from which we can purchase our requirements. An increase in the price of silver and aluminum that we are unable to pass on to
our customers, however, could have an adverse effect on our profitability.
To evaluate the impact of price changes in precious metals on net income we used the following assumptions: the
selling prices of our products would not be impacted, all the precious metals change in the same direction at the same time, and
we do not have commitment contracts in place. Under these assumptions, a 10 percent increase or decrease in the cost of
precious metals would result in approximately a $11.0 million increase or decrease to our net income. We believe we have
partially mitigated this risk through our vertical integration efforts.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The response to this item is submitted as a separate section of this Form 10-K. See Item 15.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE
None.
61
ITEM 9A. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
As of March 31, 2019, our management, including the Company’s Chief Executive Officer and Chief Financial
Officer, has performed an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in
Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act) in ensuring that the information required to be disclosed in
reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and
reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that information
required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act is accumulated
and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as
appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our management has concluded
that such disclosure controls and procedures were not effective as of March 31, 2019 (the end of the period covered by this
Annual Report on Form 10-K), as a result of a material weakness in internal control over financial reporting, as described in
Management’s Report on Internal Control over Financial Reporting below.
Management's Report on Internal Control over Financial Reporting
The Company’s management is responsible for establishing and maintaining adequate internal control over financial
reporting (as defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act). Internal control over financial
reporting is a process, designed by, or under the supervision of, an entity’s principal executive and principal financial officers,
and effected by an entity’s board of directors, management and other personnel, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of consolidated financial statements for external purposes in accordance
with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures
that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and the
dispositions of the assets of the entity; (2) provide reasonable assurance that transactions are recorded as necessary to permit
preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and
expenditures of the entity are being made only in accordance with authorizations of the management and directors of the entity;
and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition
of the entity’s assets that could have a material effect on its Consolidated Financial Statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive
Officer and Chief Financial Officer, the Company’s management conducted an assessment of the effectiveness of its internal
control over financial reporting based on the criteria set forth in the Internal Control-Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (2013 framework).
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material misstatement of the Company’s Annual or Interim Financial Statements will
not be prevented or detected on a timely basis.
Because of certain control deficiencies in our internal control over financial reporting pertaining to the initiation and
recording of net sales and accounts receivable, net at March 31, 2019, management has concluded that our internal control over
financial reporting was not effective as of March 31, 2019. These control deficiencies create a reasonable possibility that a
material misstatement to the consolidated financial statements would not be prevented or detected on a timely basis, and
management has concluded that the control deficiencies represent a material weakness in internal control over financial
reporting. Therefore, our internal control over financial reporting was not effective as of March 31, 2019.
As a result of the identified material weakness, management performed additional procedures to ensure that our year-
end financial statements are accurate. Notwithstanding the identified material weakness as of March 31, 2019, management,
including our Chief Executive Officer and our Chief Financial Officer, believes that the audited Consolidated Financial
Statements contained in this Annual Report on Form 10-K fairly present, in all material respects, our financial condition, results
of operations and cash flows for the fiscal years presented in conformity with GAAP. Additionally, this material weakness in
our internal control over financial reporting did not identify or result in a material misstatement in the Company’s Consolidated
Financial Statements for the year ended March 31, 2019.
The Company’s independent registered public accounting firm, Ernst & Young LLP, has issued an adverse opinion on
the effectiveness of the Company’s internal control over financial reporting as of March 31, 2019, which is included herein.
They have also audited our Consolidated Financial Statements included in this Annual Report on Form 10-K and have issued
an unqualified opinion.
62
Remediation
Management is addressing the identified control deficiencies and is designing additional processes and controls to
ensure they are remediated. The remediation plan includes identifying and implementing new controls as well as improving
existing controls pertaining to the initiation and recording of net sales and accounts receivable, net, including enhanced
employee training and identifying and implementing an appropriate suite of IT general controls and automated controls within
the IT environments that support revenue initiation and recording.
We will work to remediate these deficiencies prior to the end of fiscal year 2020. However, the deficiencies will not be
considered remediated until the applicable controls operate for a sufficient period of time and management has concluded,
through testing, that the controls are operating effectively.
Changes in Internal Control over Financial Reporting
In addition to the material weakness identified during the quarter and year end described above, as of March 31, 2019,
there were changes in internal control related to the integration of the TOKIN operations acquired in fiscal year 2018,
implementation efforts over new information technology solutions, and the design of internal controls for the implementation
of the new lease standard that becomes effective in fiscal year 2020.
Other than those changes described above, there have been no other changes in the Company’s internal control over
financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended March 31,
2019 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial
reporting.
ITEM 9B. OTHER INFORMATION.
None.
63
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
Other than the information under “Executive Officers” and “Other Key Employees” under Part I, Item 4A, the other
information required by Item 10 is incorporated by reference from the Company’s definitive proxy statement for its annual
stockholders meeting to be held on July 31, 2019 under the headings “Nominees for Board of Directors,” “Continuing
Directors,” “Delinquent Section 16(a) Reports,” "Review, Approval or Ratification of Transactions with Related Persons," and
“Information about the Board of Directors.”
ITEM 11. EXECUTIVE COMPENSATION.
The information required by Item 11 is incorporated by reference from the Company’s definitive proxy statement for
its annual stockholders’ meeting to be held on July 31, 2019 under the headings “Compensation Discussion and Analysis,”
“Summary Compensation Table,” “Grants of Plan-Based Awards Table,” “Outstanding Equity Awards at Fiscal Year-End
Table,” “Option Exercises and Stock Vested Table,” “Nonqualified Deferred Compensation Table,” “Potential Payments Upon
Termination or Change in Control,” “Compensation of Directors,” “Director Compensation Table,” “Report of the
Compensation Committee,” “Compensation Committee Interlocks and Insider Participation,” and "CEO Pay Ratio Table."
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND
RELATED STOCKHOLDER MATTERS.
The information required by Item 12 is incorporated by reference from the Company’s definitive proxy statement for
its annual stockholders’ meeting to be held on July 31, 2019 under the heading “Security Ownership,” and from “Equity
Compensation Plan Disclosure” in Item 5 hereof.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
The information required by Item 13 is incorporated by reference from the Company’s definitive proxy statement for
its annual stockholders’ meeting to be held on July 31, 2019 under the headings “Review, Approval or Ratification of
Transactions with Related Persons” and “Information about the Board of Directors.”
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
The information required by Item 14 is incorporated by reference from the Company’s definitive proxy statement for
its annual stockholders’ meeting to be held on July 31, 2019 under the heading “Audit and Non-Audit Fees.”
64
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
(a)
(1) Financial Statements
The following financial statements are filed as a part of this report:
Report of Independent Registered Public Accounting Firm
Report of Independent Registered Public Accounting Firm
Consolidated Financial Statements:
Page No.
69
70
Consolidated Balance Sheets as of March 31, 2019 and 2018
Consolidated Statements of Operations for the years ended March 31, 2019, 2018 and 2017
Consolidated Statements of Comprehensive Income (Loss) for the years ended March 31, 2019, 2018 and 2017
Consolidated Statements of Changes in Stockholders’ Equity for the years ended March 31, 2019, 2018 and
2017
Consolidated Statements of Cash Flows for the years ended March 31, 2019, 2018 and 2017
Notes to Consolidated Financial Statements
72
73
74
75
76
78
(2) Financial Statement Schedules
Financial statement schedules are omitted because they are not applicable or because the required information is
included in the consolidated financial statements or notes thereto.
(3) List of Exhibits
The following exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the SEC:
2.1
2.2
2.3
2.4
2.5
2.6
3.1
Stock Purchase Agreement, dated as of March 12, 2012, by and among KEMET Electronics Corporation, NEC
Corporation and NEC TOKIN Corporation (incorporated by reference to Exhibit 99.2 to the Company’s Current
Report on Form 8-K (File No. 1-15491) filed on March 15, 2012)
Amendment No. 1 to the Stock Purchase Agreement dated as of December 12, 2012, by and among KEMET
Electronics Corporation, NEC Corporation and NEC TOKIN Corporation (incorporated by reference to
Exhibit 99.1 to the Company’s Current Report on Form 8-K (File No. 1-15491) filed on December 14, 2012)
Definitive NEC TOKIN Stock Purchase Agreement dated as of February 23, 2017, by and between KEMET
Electronics Corporation and NEC Corporation (incorporated by reference to Exhibit 2.1 to the Company's
Current Report on form 8-K (File No. 1-15491) filed on February 23, 2017)
Master Sale and Purchase Agreement, dated February 23, 2017 between NEC TOKIN Corporation, NTJ
Holdings 1 Ltd. and Japan Industrial Partner, Inc. (incorporated by reference to Exhibit 2.1 to the Company's
Current Report on Form 8-K (File No. 1-15491) filed on April 20, 2017)
Amendment, dated April 7, 2017, to the Master Sale and Purchase Agreement between NEC TOKIN
Corporation, NTJ Holdings 1 Ltd. and Japan Industrial Partners, Inc. (incorporated by reference to Exhibit 2.2 to
the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 20, 2017)
Amendment, dated April 14, 2017, to the Master Sale and Purchase Agreement between NEC TOKIN
Corporation, NTJ Holdings 1 Ltd. and Japan Industrial Partners, Inc. (incorporated by reference to Exhibit 2.3 to
the Company's Current Report on Form 8-K (File No. 1-15491) filed on April 20, 2017)
Second Restated Certificate of Incorporation of the Company, as amended to date (incorporated by reference to
Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended June 30,
2011)
65
3.2
Amended and Restated By-laws of KEMET Corporation, effective June 5, 2008 (incorporated by reference to
Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 1-15491) filed on June 5, 2008)
4.1
Description of Capital Stock
10.1
10.2
10.3
10.4
10.5
10.6
10.7
10.8
10.9
10.10
10.11
10.12
10.13
10.14
Registration Agreement, dated as of December 21, 1990, by and among the Company and each of the investors
and executives listed on the schedule of investors and executives attached thereto (incorporated by reference to
Exhibit 10.3 to the Company’s Registration Statement on Form S-1 (Reg. No. 33-48056))
Form of Amendment No. 1 to Registration Agreement, dated as of April 28, 1994 (incorporated by reference to
Exhibit 10.3.1 to the Company’s Registration Statement on Form S-1 (Reg. No. 33-61898))
1995 Executive Stock Option Plan by and between the Company and each of the executives listed on the
schedule attached thereto (incorporated by reference to Exhibit 10.33 to the Company’s Annual Report on
Form 10-K (File No. 1-15491) for the year ended March 31, 1996)*
1992 Key Employee Stock Option Plan (incorporated by reference to Exhibit 10.16 to the Company’s Annual
Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2009)*
Amendment No. 1 to KEMET Corporation 1992 Key Employee Stock Option Plan effective October 23, 2000
(incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q (File No. 1-15491)
for the quarter ended December 31, 2000)*
2004 Long-Term Equity Incentive Plan (incorporated by reference to Exhibit 4.3 to the Company’s Registration
Statement on Form S-8 (Reg. No. 333-123308))*
Form of Indemnification Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K (File No. 1-15491) filed on April 23, 2009)*
Second Amended and Restated KEMET Corporation Deferred Compensation Plan (incorporated by reference to
Exhibit 10.56 to the Company’s Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31,
2009)*
Loan and Security Agreement, dated as of September 30, 2010, by and among KEMET Electronics Corporation,
KEMET Electronics Marketing (S) Pte Ltd., and Bank of America, N.A., as agent and Banc of America
Securities LLC, as lead arranger and bookrunner (incorporated by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K (File No. 1-15491) filed on October 5, 2010)
KEMET Executive Secured Benefit Plan (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly
Report on Form 10-Q (File No. 1-15491) for the quarter ended December 31, 2010)*
Form of Change in Control Severance Compensation Agreement, entered into with executive officers of the
Company (incorporated by reference to Exhibit 10.15 to the Company's Annual Report on Form 10-K (File No.
1-15491) for the year ended March 31, 2016)*
Stockholders’ Agreement, dated as of March 12, 2012, by and among KEMET Electronics Corporation, NEC
Corporation and NEC TOKIN Corporation (incorporated by reference to Exhibit 99.4 to the Company’s Current
Report on Form 8-K (File No. 1-15491) filed on March 15, 2012)
Form of Restricted Stock Unit Grant Agreement for Employees (incorporated by reference to Exhibit 10.61 to
the Company’s Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012)*
Form of Restricted Stock Unit Grant Agreement for Directors (incorporated by reference to Exhibit 10.62 to the
Company’s Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012)*
10.15
Form of Restricted Stock Unit Grant Agreement for Directors for the year ended March 31, 2019.*
10.16
Amendment No. 1 to Loan and Security Agreement, Waiver and Consent, dated as of March 19, 2012, by and
among KEMET Electronics Corporation, KEMET Electronics Marketing (S) Pte Ltd., the financial institutions
party thereto as lenders and Bank of America, N.A., as agent (incorporated by reference to Exhibit 10.63 to the
Company’s Annual Report on Form 10-K (File No. 1-15491) for the year ended March 31, 2012)
66
10.17
10.18
10.19
10.20
10.21
10.22
10.23
10.24
10.25
10.26
10.27
10.28
10.29
Form of Long-Term Incentive Plan Award Agreement (incorporated by reference to Exhibit 10.2 to the
Company's Quarterly Report on Form 10-Q (File No. 1-15491) filed on August 3, 2016)*
Consolidated Amendment to Loan and Security Agreement, dated as of July 8, 2013, by and among KEMET
Electronics Corporation, KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, KEMET
Electronics Marketing (S) PTE LTD., the financial institutions party thereto as lenders and Bank of America,
N.A., as agent (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q
(File No. 1-15491) filed on August 2, 2013)
Amendment No. 5 to Loan and Security Agreement, dated April 30, 2014, among KEMET Electronics
Corporation and its subsidiaries KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, and
KEMET Electronics Marketing (S) PTE LTD., as Borrowers, and Bank of America, N.A., as agent for the
Lenders (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No.
1-15491) filed on May 5, 2014)
KEMET Corporation 2011 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.1 to the
Company's Current Report on Form 8-K (File No. 1-15491) filed on August 2, 2011)*
2014 Amendment and Restatement of the KEMET Corporation 2011 Omnibus Equity Incentive Plan
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 1-15491)
filed on July 24, 2014)*
KEMET Corporation Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company’s
Current Report on Form 8-K (File No. 1-15491) filed on August 2, 2017)*
Incentive Award, Severance and Non-Competition Agreement, dated as of December 1, 2014, between KEMET
Corporation and William M. Lowe, Jr. (incorporated by reference to Exhibit 10.1 to the Company’s Current
Report on Form 8-K (File No. 1-15491) filed on December 5, 2014)*
Incentive Award and Non-Competition Agreement, dated as of December 1, 2014, between KEMET
Corporation and Charles C. Meeks, Jr. (incorporated by reference to Exhibit 10.2 to the Company’s Current
Report on Form 8-K (File No. 1-15491) filed on December 5, 2014)*
Amendment No. 6 to Loan and Security Agreement, Waiver and Consent dated December 19, 2014, among
KEMET Electronics Corporation, KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, The
Forest Electric Company and KEMET Electronics Marketing (S) PTE LTD., as Borrowers, the financial
institutions party thereto, as Lenders, and Bank of America, N.A., as agent for the Lenders (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 1-15491) filed on December
22, 2014)
Amendment No. 7 to Loan and Security Agreement, dated March 27, 2015, among KEMET Electronics
Corporation, KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, The Forest Electric
Company and KEMET Electronics Marketing (S) PTE LTD., as Borrowers, the financial institutions party
thereto, as Lenders, and Bank of America, N.A., as agent for the Lenders (incorporated by reference to Exhibit
10.30 to the Company's Annual Report on Form 10-K (File No. 1-15491) filed for the year ended March 31,
2016)
Amended and Restated Employment Agreement between KEMET Corporation and Per-Olof Lööf, dated April
18, 2018 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No.
1-15491) filed on April 20, 2018)*
Amendment No. 8 to Loan and Security Agreement, dated May 2, 2016, among KEMET Electronics
Corporation, KEMET Foil Manufacturing, LLC, KEMET Blue Powder Corporation, The Forest Electric
Company and KEMET Electronics Marketing (S) PTE LTD., as Borrowers, the financial institutions party
thereto, as Lenders, and Bank of America, N.A., as agent for the Lenders (incorporated by reference to Exhibit
10.1 to the Company’s Current Report on Form 8-K (File No. 1-15491) filed on May 5, 2016)
Employee Transfer Agreement, dated as of December 5, 2016, between KEMET Corporation and Claudio
Lollini (incorporated by reference to Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q (File No.
001-15491) filed on February 2, 2017)*
67
10.30
10.31
10.32
10.33
10.34
10.35
10.36
10.37
Amendment No. 9 to Loan and Security Agreement, Waiver and Consent, dated as of April 28, 2017, by and
among KEMET Corporation, the other borrowers named therein, the financial institutions party thereto as
lenders and Bank of America, N.A., a national banking association, as agent for the lenders (incorporated by
reference to Exhibit 10.3 to the Company's Current Report on Form 8-K (File No. 1-15491) filed on May 1,
2017)
Amended and Restated Employment Agreement between KEMET Corporation and Per-Olof Loof, dated as of
April 18, 2018. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (file
No. 1-15491) filed on April 20, 2018)*
English Translation of the Term Loan Agreement, dated October 29, 2018, by and among TOKIN Corporation,
the Lenders party thereto and Sumitomo Mitsui Trust Bank Limited, in its capacity as agent (incorporated by
reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (file No. 1-15491) filed on October 29,
2018)
Form of Guaranty Agreement, dated October 29, 2018, by and between KEMET Corporation and Sumitomo
Mitsui Trust Bank Limited, in its capacity as agent (incorporated by reference to Exhibit 10.2 to the Company’s
Current Report on Form 8-K (file No. 1-15491) filed on October 29, 2018)
Amendment No. 10 to Loan and Security Agreement, Waiver and Consent, dated as of October 29, 2018, by and
among KEMET, the other borrowers named therein, the financial institutions party thereto as lenders and Bank
of America, N.A., a national banking association, as agent for the lenders (incorporated by reference to Exhibit
10.3 to the Company’s Current Report on Form 8-K (file No. 1-15491) filed on October 29, 2018)
Employment Agreement by and between KEMET Corporation and William M. Lowe, Jr. dated March 20, 2019
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (file No. 1-15491)
filed on March 25, 2019)*
Form of Change in Control Severance Compensation Agreement for fiscal year 2020*
Form of Long-Term Incentive Plan Award Agreement, dated May 18, 2019*
21.1
Subsidiaries of KEMET Corporation
23.1
Consent of Independent Registered Public Accounting Firm, Ernst & Young LLP
31.1
Certification of the Chief Executive Officer Pursuant to Section 302
31.2
Certification of the Chief Financial Officer Pursuant to Section 302
32.1
Certification of the Chief Executive Officer Pursuant to Section 906
32.2
Certification of the Chief Financial Officer Pursuant to Section 906
101
The following financial information from KEMET Corporation’s Annual Report on Form 10-K for the year
ended March 31, 2019, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated
Balance Sheets at March 31, 2019, and March 31, 2018, (ii) Consolidated Statements of Income for the years
ended March 31, 2019, 2018 and 2017, (iii) Consolidated Statements of Comprehensive Income for the years
ended March 31, 2019, 2018 and 2017, (iv) Consolidated Statements of Changes in Stockholders’ Equity for the
years ended March 31, 2019, 2018 and 2017, (v) Consolidated Statements of Cash Flows for the years ended
March 31, 2019, 2018 and 2017 and (vi) the Notes to Consolidated Financial Statements, tagged as blocks of
text
_______________________________________________________________________________
*
Exhibit is a management contract or a compensatory plan or arrangement.
68
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of KEMET Corporation
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of KEMET Corporation and subsidiaries (the
Company) as of March 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income
(loss), changes in stockholders‘ equity and cash flows for each of the three years in the period ended March 31, 2019,
and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the
consolidated financial statements present fairly, in all material respects, the financial position of the Company at March
31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended
March 31, 2019, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), the Company’s internal control over financial reporting as of March 31, 2019, based on
criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations
of the Treadway Commission (2013 framework) and our report dated May 30, 2019 expressed an adverse opinion
thereon.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express
an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with
the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material
misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to
those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in
the financial statements. Our audits also included evaluating the accounting principles used and significant estimates
made by management, as well as evaluating the overall presentation of the financial statements. We believe that our
audits provide a reasonable basis for our opinion.
/s/ Ernst & Young LLP
We have served as the Company’s auditor since 2009.
Boca Raton, FL
May 30, 2019
69
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of KEMET Corporation
Opinion on Internal Control over Financial Reporting
We have audited KEMET Corporation and subsidiaries’ internal control over financial reporting as of March
31, 2019, based on criteria established in Internal Control - Integrated Framework issued by the Committee of
Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, because
of the effect of the material weakness described below on the achievement of objectives of the control criteria, KEMET
Corporation and subsidiaries (the Company) has not maintained effective internal control over financial reporting as
of March 31, 2019, based on the COSO criteria.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial
statements will not be prevented or detected on a timely basis. The following material weakness has been identified
and included in management’s assessment. Management has identified a material weakness in the design and operating
effectiveness of controls pertaining to the initiation and recording of net sales and accounts receivable, net.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board
(United States) (PCAOB), the 2019 consolidated financial statements of the Company. This material weakness was
considered in determining the nature, timing and extent of audit tests applied in our audit of the 2019 consolidated
financial statements, and this report does not affect our report dated May 30, 2019, which expressed an unqualified
opinion thereon.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting
and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying
Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the
Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered
with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting
was maintained in all material respects.
Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based
on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe
that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in
accordance with generally accepted accounting principles. A company’s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable
assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made
only in accordance with authorizations of management and directors of the company; and (3) provide reasonable
assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s
assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls
70
may become inadequate because of changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate.
Boca Raton, FL
May 30, 2019
/s/ Ernst & Young LLP
71
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(Amounts in thousands except per share data)
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net (1)
Inventories, net
Prepaid expenses and other current assets
Total current assets (1)
Property, plant and equipment, net
Goodwill
Intangible assets, net
Equity method investments
Deferred income taxes
Other assets (1)
Total assets (1)
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt
Accounts payable
Accrued expenses (1)
Income taxes payable
Total current liabilities (1)
Long-term debt
Other non-current obligations (1)
Deferred income taxes (1)
Total liabilities (1)
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, par value $0.01, authorized 10,000 shares, none issued
Common stock, par value $0.01, authorized 175,000 shares, issued 57,822 and 56,641 shares
at March 31, 2019 and 2018, respectively
Additional paid-in capital
Retained earnings (1)
Accumulated other comprehensive income (loss) (1)
Total stockholders’ equity (1)
March 31,
2019
2018
$
207,918
$
154,059
241,129
38,947
642,053
495,280
40,294
53,749
12,925
57,024
16,770
286,846
146,561
204,386
41,160
678,953
405,316
40,294
59,907
12,016
13,837
12,600
$
1,318,095
$
1,222,923
$
28,430
$
153,287
93,761
2,995
278,473
266,041
125,360
8,806
678,680
—
578
465,366
204,195
(30,724)
639,415
20,540
139,989
125,119
2,010
287,658
304,083
152,249
15,058
759,048
—
566
462,737
3,370
(2,798)
463,875
Total liabilities and stockholders’ equity (1)
______________________________________________________________________________
(1) Fiscal year ended March 31, 2018 adjusted due to the adoption of Accounting Standard Codification ("ASC") 606, Revenue from Contracts with Customers (“ASC
606”). Refer to Note 1, “Organization and Significant Accounting Policies.”
1,222,923
1,318,095
$
$
See accompanying notes to consolidated financial statements.
72
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(Amounts in thousands except per share data)
Net sales (1)
Operating costs and expenses:
Cost of sales (1)
Selling, general and administrative expenses
Research and development (1)
Restructuring charges
(Gain) loss on write down and disposal of long-lived assets
Total operating costs and expenses (1)
Operating income (1)
Non-operating (income) expense:
Interest income
Interest expense
Acquisition (gain) loss
Change in value of TOKIN options
Other (income) expense, net
Income before income taxes and equity income (loss) from equity
method investments (1)
Income tax expense (benefit) (1)
Income before equity income (loss) from equity method
investments (1)
Equity income (loss) from equity method investments
Net income (1)
Net income per basic share (1)
Net income per diluted share (1)
Dividends declared per share
Weighted-average shares outstanding:
Basic
Diluted
Fiscal Years Ended March 31,
2019
2018
2017
$
1,382,818
$
1,200,181
$
757,338
924,276
202,642
44,612
8,779
1,660
1,181,969
200,849
(2,035)
21,239
—
—
11,214
170,431
(39,460)
209,891
(3,304)
206,587
3.57
3.50
0.10
$
$
$
$
860,744
173,620
39,114
14,843
(992)
1,087,329
112,852
(809)
32,882
(130,880)
—
24,592
187,067
9,132
177,935
76,192
254,127
4.81
4.33
$
$
$
— $
$
$
$
$
571,944
107,658
26,693
5,404
10,671
722,370
34,968
(24)
39,755
—
(10,700)
(3,871)
9,808
4,294
5,514
41,643
47,157
1.01
0.85
—
57,840
59,082
52,798
58,640
46,552
55,389
______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
See accompanying notes to consolidated financial statements.
73
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Comprehensive Income (Loss)
(Amounts in thousands)
Net income (1)
Other comprehensive income (loss), net of tax:
Foreign currency translation gains (losses) (2)
Defined benefit pension plans
Defined benefit post-retirement plan adjustments
Equity interest in investee’s other comprehensive income (loss)
Foreign exchange contracts
Excluded component of fair value hedges
Other comprehensive income (loss) (2)
Total comprehensive income (1)
______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) Fiscal year ended March 31, 2018 adjusted due to the adoption of ASC 606.
$
Fiscal Years Ended March 31,
2019
2018
2017
$
206,587
$
254,127
$
47,157
(24,065)
(927)
(86)
(11)
(588)
(2,249)
(27,926)
178,661
35,271
167
(255)
5,584
(1,753)
—
39,014
$
293,141
$
(15,284)
163
20
1,440
3,274
—
(10,387)
36,770
See accompanying notes to consolidated financial statements.
74
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Changes in Stockholders’ Equity
(Amounts in thousands)
Shares
Outstanding
Common
Stock
Additional
Paid-In
Capital
Retained
Earnings
(Deficit)
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Stock
Total
Stockholders’
Equity
45,897
$
465
$ 452,821
$(299,510) $
47,157
—
—
—
—
(10,387)
(31,425) $(9,870) $ 112,481
47,157
—
(10,387)
(128)
4,720
— 9,870
—
—
—
—
—
(10,000)
4,720
Balance at March 31, 2016
Net income (1)
Other comprehensive income (loss)
Issuance of shares
Stock-based compensation
Adoption of ASU's (2)
Balance at March 31, 2017
Net income (1)
Other comprehensive income
Issuance of shares
Stock-based compensation
Offering Fees
—
—
792
—
—
—
—
2
—
—
46,689
467
—
—
9,952
—
—
—
—
99
—
—
447,671
130
1,596
(250,757)
— 254,127
—
8,043
7,657
(634)
462,737
—
—
—
—
3,370
—
—
—
—
—
—
—
—
1,726
155,569
254,127
39,014
8,142
7,657
(634)
463,875
—
(41,812)
—
39,014
—
—
—
(2,798)
—
(27,926)
—
Balance at March 31, 2018
56,641
566
Net income
Other comprehensive income (loss)
Issuance of shares
Cash dividends
Stock-based compensation
Balance at March 31, 2019
—
—
1,181
—
—
—
—
12
—
—
— 206,587
—
(10,237)
—
12,866
—
—
(5,762)
—
57,822
$
578
$ 465,366
$ 204,195
$
—
—
206,587
(27,926)
(10,225)
(5,762)
12,866
—
(30,724) $ — $ 639,415
—
—
—
—
______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) Impact of the adoption of ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting ("ASU No. 2016-09"), ASU No. 2016-16., Income
Taxes - Intra Entity Transfers of Assets Other Than Inventory (“ASU No. 2016-16”), and ASC 606.
See accompanying notes to consolidated financial statements.
75
KEMET CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Amounts in thousands)
Operating activities:
Net income (1)
Adjustments to reconcile net income to net cash provided by (used in)
operating activities, net of effect of acquisitions:
Depreciation and amortization (1)
Equity (income) loss from equity method investments
Acquisition (gain) loss
Non-cash debt and financing costs
Loss on early extinguishment of debt
Stock-based compensation expense
Change in value of TOKIN options
Pension and other post-retirement benefits
Change in deferred income taxes (1)
(Gain) loss on write down and disposal of long-lived assets
Rent receivable
Other, net (1)
Changes in assets and liabilities, net of the effect of acquisitions:
Accounts receivable (1)
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued income taxes
Other operating liabilities (1)
Net cash provided by (used in) operating activities
Investing activities:
Capital expenditures
Contributions to equity method investments
Proceeds from dividend
Acquisitions, net of cash received
Proceeds from sale of assets
Net cash provided by (used in) investing activities
Fiscal Years Ended March 31,
2019
2018
2017
$
206,587
$
254,127
$
47,157
52,628
3,304
—
1,872
15,946
12,866
—
4,938
(49,757)
1,660
—
(285)
(8,910)
(42,806)
(4,381)
7,650
1,046
(70,627)
131,731
(146,056)
(4,000)
776
—
2,268
(147,012)
50,661
(76,192)
(130,880)
2,467
486
7,657
—
4,717
564
(992)
2,645
(680)
30,217
(13,827)
4,330
(16,053)
1,317
197
120,761
(65,004)
(3,000)
2,745
163,985
3,638
102,364
38,151
(41,643)
—
761
—
4,720
(10,700)
2,543
(15)
10,671
—
(392)
(2,630)
16,805
(1,769)
6,170
144
1,694
71,667
(25,617)
—
—
—
19
(25,598)
76
Consolidated Statements of Cash Flows (Continued)
Financing activities:
Proceeds from revolving line of credit
Payments of revolving line of credit
Proceeds from issuance of debt
Payment of long-term debt
Early extinguishment of debt costs
Debt issuance costs
Proceeds from exercise of stock options
Proceeds from exercise of stock warrants
Purchase of treasury stock
Payment of dividends
Net cash provided by (used in) financing activities
Net increase (decrease) in cash, cash equivalents, and restricted cash
Effect of foreign currency fluctuations on cash (2)
Cash, cash equivalents, and restricted cash at beginning of fiscal year
Cash, cash equivalents, and restricted cash at end of fiscal year
Less: Restricted cash at end of year
Cash and cash equivalents at end of year
Supplemental Cash Flow Statement Information:
Interest paid, net of capitalized interest
Income taxes paid
Fiscal Years Ended March 31,
2019
2018
2017
—
—
298,336
(344,461)
(3,234)
(2,021)
485
—
—
(5,762)
(56,657)
(71,938)
(6,990)
286,846
207,918
—
—
(33,881)
334,978
(365,938)
—
(5,002)
5,207
8,838
—
—
(55,798)
167,327
9,745
109,774
286,846
—
12,000
(12,000)
2,314
(2,428)
—
—
1,133
—
(1,144)
—
(125)
45,944
(1,174)
65,004
109,774
—
$
$
$
207,918
$
286,846
$
109,774
11,965
10,863
$
$
44,905
7,120
$
$
38,922
4,153
_____________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) Fiscal year ended March 31, 2018 adjusted due to the adoption of ASC 606.
See accompanying notes to consolidated financial statements.
77
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
Note 1: Organization and Significant Accounting Policies
Nature of Business and Organization
KEMET Corporation, which together with its subsidiaries is referred to herein as “KEMET” or the “Company” is a
leading manufacturer of tantalum capacitors, multilayer ceramic capacitors, film capacitors, electrolytic capacitors, paper
capacitors and solid aluminum capacitors, and Electro-Magnetic Compatible ("EMC") devices, sensors, and actuators. The
Company is headquartered in Fort Lauderdale, Florida and has manufacturing plants and distribution centers located in the
United States, Mexico, Europe and Asia. Additionally, the Company has wholly-owned foreign subsidiaries which primarily
provide sales support for KEMET’s products in foreign markets.
KEMET is organized into three reportable segments: the Solid Capacitor Reportable Segment (“Solid Capacitors”), the
Film and Electrolytic Reportable Segment (“Film and Electrolytic”) and the Electro-Magnetic, Sensors, and Actuators
Reportable Segment ("MSA"). Each reportable segment is responsible for the operations of certain manufacturing sites as well
as related research and development efforts.
Basis of Presentation
Certain amounts for the Consolidated Statements of Operations for fiscal years 2018 and 2017 have been revised to
conform with the fiscal year 2019 presentation.
Principles of Consolidation
The accompanying Consolidated Financial Statements of the Company include the accounts of its wholly-owned
subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Investment in entities in which
the Company can exercise significant influence, but does not own a majority equity interest or otherwise control, are accounted
for using the equity method and are included as equity method investments on the consolidated balance sheets.
Cash Equivalents
Cash equivalents of $60.7 million and $83.9 million at March 31, 2019 and 2018, respectively, consist of money
market accounts and certificates of deposits with original terms of three months or less. The Company considers all liquid debt
instruments with original maturities of three months or less to be cash equivalents.
Inventories
Inventories are stated at the lower of cost or net realizable value. The Company maintains reserves for excess and
slow-moving inventory to reflect a carrying amount for inventory that is stated at the lower of cost or net realizable value. The
inventory reserve is an estimate and is adjusted based on slow moving and excess inventory, historical shipments, customer
forecasts and backlog, and technology developments.
Raw materials and tool crib obsolescence reserves are based on usage over one and two years, respectively, and the
Company maintains reserves for raw materials and tool cribs that exceed these ages. Finished goods obsolescence reserves are
either based on product age limits determined by market requirements, and/or based on excess quantities that exceed product
orders and historical product sales.
Inventory costs include material, labor and manufacturing overhead and most inventory costs are determined by the
“first-in, first-out” (“FIFO”) method. For tool crib, a component of the Company’s raw material inventory, cost is determined
under the average cost method. The Company has consigned inventory at certain customer locations totaling $9.5 million and
$8.1 million at March 31, 2019 and 2018, respectively.
Property, Plant and Equipment
Property, plant, and equipment are stated at cost. Depreciation is calculated principally using the straight-line method
over the estimated useful lives of the respective assets. Leasehold improvements are amortized using the straight-line method
over the shorter of the estimated useful lives of the assets or the terms of the respective leases. Maintenance costs are expensed
and expenditures for renewals and improvements are generally capitalized. Upon sale or retirement of property and equipment,
the related cost and accumulated depreciation are removed, and any gain or loss is recognized. A long-lived asset classified as
held for sale is initially measured and reported at the lower of its carrying amount or fair value less cost to sell. Long-lived
assets to be disposed of other than by sale are classified as held and used until the long-lived asset is disposed of. Depreciation
78
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
expense, including amortization of capital leases, was $46.7 million, $45.5 million and $35.0 million for the fiscal years ended
March 31, 2019, 2018 and 2017, respectively.
The Company evaluates long-lived assets for impairment whenever certain events or changes in circumstances may
indicate that the recoverability of the carrying amount of property, plant, and equipment should be assessed, including, among
others, a significant decrease in market value, a significant change in the business climate in a particular market, or a current
period operating or cash flow loss combined with historical losses or projected future losses. Reviews are regularly performed
to determine whether facts and circumstances exist which indicate the carrying amount of assets may not be recoverable. If any
impairment indicators are determined to exist, the Company assesses the recoverability of its assets by comparing the projected
undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their
respective carrying amounts. If it is determined that the book value of a long-lived asset or asset group is not recoverable, an
impairment loss would be calculated equal to the excess of the carrying amount of the long-lived asset over its fair value. The
Company must make certain assumptions as to the future cash flows to be generated by the underlying assets. Those
assumptions include the amount of volume increases, average selling price decreases, anticipated cost reductions, and the
estimated remaining useful life of the equipment. Future changes in assumptions may negatively impact future valuations. Fair
market value is based on the discounted cash flows that the assets will generate over their remaining useful lives or other
valuation techniques. See Note 8, “(Gain) loss on write down and disposal of long-lived assets” for further discussion of
property, plant and equipment impairment charges.
Goodwill and Other Intangible Assets
Goodwill and other intangible assets with indefinite useful lives are not amortized but are subject to annual impairment
tests during the fourth quarter of each fiscal year and when otherwise warranted. The Company evaluates its goodwill on a
reporting unit basis, which requires the Company to estimate the fair value of the reporting unit. The impairment test involves a
comparison of the fair value of each reporting unit, with the corresponding carrying amounts. If the reporting unit’s carrying
amount exceeds its fair value, then an indication exists that the reporting unit’s goodwill and intangible assets with indefinite
useful lives may be impaired. The impairment to be recognized is measured by the amount by which the carrying value of the
reporting unit’s goodwill being measured exceeds its implied fair value. The implied fair value of goodwill is the excess of the
fair value of the reporting unit over the sum of the amounts assigned to identified net assets. As a result, the implied fair value
of goodwill is generally the residual amount that results from subtracting the value of net assets, including all tangible assets
and identified intangible assets, of the reporting unit’s fair value. The Company determines the fair value of its reporting units
using an income-based, discounted cash flow (“DCF”) analysis, and market-based approaches (Guideline Publicly Traded
Company Method and Guideline Transaction Method) which examine transactions in the marketplace involving the sale of the
stocks of similar publicly owned companies, or the sale of entire companies engaged in operations similar to KEMET. The
Company evaluates the value of its other indefinite-lived intangible assets (trademarks) using an income-based, relief from
royalty analysis. In addition to the previously described reporting unit valuation techniques, the Company’s goodwill and
intangible assets with indefinite useful lives impairment assessment also considers the Company’s aggregate fair value based
upon the value of the Company’s outstanding shares of common stock.
The impairment review of goodwill and intangible assets with indefinite useful lives are subjective and involve the use
of estimates and assumptions. Estimates of business enterprise fair value use discounted cash flow and other fair value appraisal
models and involve making assumptions for future sales trends, market conditions, growth rates, cost reduction initiatives and
cash flows for the next several years. Future changes in assumptions may negatively impact future valuations.
Equity Method Investments
Investments and ownership interests are accounted for under the equity method of accounting if the Company has the
ability to exercise significant influence, but not control, over the entity. Investments accounted for under the equity method are
initially recorded at cost, and the difference between the basis of the Company’s investment and the underlying equity in the net
assets of the company at the investment date, is amortized over the lives of the related assets that gave rise to the difference.
The Company’s share of earnings or losses under the equity method investments and basis difference amortization is reported in
the consolidated statements of operations as “Equity income (loss) from equity method investments.” The Company reviews its
investments and ownership interests accounted for under the equity method of accounting for impairment whenever events or
changes in circumstances indicate a loss in the value of the investment may be other than temporary.
79
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Deferred Income Taxes
The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are
recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of
existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets
and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those
temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax
rates is recognized in income in the period that includes the enactment date. The Company periodically evaluates its net
deferred tax assets based on an assessment of historical performance, ability to forecast future events, and the likelihood that the
Company will realize the benefits through future taxable income. Valuation allowances are recorded to reduce the net deferred
tax assets to the amount that is more likely than not to be realized. The Company makes certain estimates and judgments in the
calculation for the provision for income taxes, in the resulting tax liabilities, and in the recoverability of deferred tax assets. All
deferred tax assets are reported as noncurrent in the Consolidated Balance Sheets.
Stock-based Compensation
Stock-based compensation for stock options is estimated on the date of grant using the Black-Scholes option-pricing
model. The Black-Scholes model considers volatility in the price of the Company’s stock, the risk-free interest rate, the
estimated life of the equity-based award, the closing market price of the Company’s stock on the grant date and the exercise
price. The estimates utilized in the Black-Scholes calculation involve inherent uncertainties and the application of management
judgment. The Company's stock options were fully expensed during the fiscal year ended March 31, 2017. Upon adoption of
Accounting Standard Update (“ASU”) No. 2016-09, Compensation Stock-Compensation, the Company elected to discontinue
estimating forfeitures. Stock-based compensation cost for restricted stock is measured based on the closing fair market value of
the Company’s common stock on the date of grant. The Company recognizes stock-based compensation cost for arrangements
with cliff vesting as expense ratably on a straight-line basis over the requisite service period. The Company recognizes stock-
based compensation cost for arrangements with graded vesting as expense on an accelerated basis over the requisite service
period.
Concentrations of Credit and Other Risks
The Company sells to customers globally. Credit evaluations of its customers’ financial condition are performed
periodically, and the Company generally does not require collateral from its customers. There were no customers’ accounts
receivable balances exceeding 10% of gross accounts receivable at March 31, 2019 or March 31, 2018.
Consistent with industry practice, the Company utilizes electronics distributors for a large percentage of its sales.
Electronics distributors are an effective means to distribute the products to end-users. For fiscal years ended March 31, 2019,
2018, and 2017, net sales to electronics distributors accounted for 42.2%, 39.2% and 46.8%, respectively, of the Company’s
total net sales. One distributor, TTI, Inc., accounted for $184.3 million, $133.5 million and $104.4 million of the Company’s net
sales in fiscal years ended March 31, 2019, 2018, and 2017, respectively.
Foreign Subsidiaries
The Company translates the assets and liabilities of its foreign subsidiaries from their respective functional currencies
to U.S. dollars at the appropriate spot rates as of the balance sheet date. Generally, our foreign subsidiaries use the local
currency as their functional currency. Changes in the carrying value of these assets and liabilities attributable to fluctuations in
spot rates are recognized as a component of equity in accumulated other comprehensive income ("AOCI"). Results of
operations accounts are translated using average exchange rates for the year.
Assets and liabilities denominated in a currency that is different from a reporting entity's functional currency must first
be remeasured from the applicable currency to the legal entity's functional currency. The effect of this remeasurement process is
recognized in the Consolidated Statements of Operations.
80
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Comprehensive Income (Loss)
Comprehensive income (loss) consists of net income, foreign currency translation gains (losses), post-retirement and
defined benefit plan adjustments including those adjustments which result from changes in net prior service credit and actuarial
gains (losses), equity interest in investee’s other comprehensive income (loss), gains (losses) on foreign exchange contracts, and
gains (losses) on the excluded component of fair value hedges. Comprehensive income is presented in the Consolidated
Statements of Comprehensive Income (Loss).
The following summary sets forth the components of accumulated other comprehensive income (loss) contained in the
stockholders’ equity section of the Consolidated Balance Sheets (amounts in thousands):
Foreign
Currency
Translation,
net of Tax (1)(2)
Post-
Retirement
Benefit
Plan
Adjustments,
net of Tax
Defined
Benefit
Pension
Plans, net of
Tax (3)(4)
Ownership Share
of Equity Method
Investees’ Other
Comprehensive
Income (Loss),
net of Tax
Foreign
Exchange
Contracts,
net of Tax
Excluded
Component
of Fair
Value
Hedges, net
of Tax
Net
Accumulated
Other
Comprehensive
Income (Loss)
$
(25,556) $
1,134
$ (14,998) $
(5,299) $ 2,907
$
— $
(41,812)
35,271
(64)
409
5,584
667
—
35,271
(191)
(255)
(242)
167
—
(2,420)
5,584
(1,753)
9,715
879
(14,831)
285
1,154
—
—
—
—
41,867
(2,853)
39,014
(2,798)
(19,835)
81
(1,525)
(11)
(1,286)
(6,383)
(28,959)
(4,230)
(167)
598
—
698
4,134
1,033
(24,065)
(86)
(927)
(11)
(588)
(2,249)
(27,926)
$
(14,350) $
793
$ (15,758) $
274
$
566
$
(2,249) $
(30,724)
Balance at March 31,
2017
Other comprehensive
income (loss) before
reclassifications
Amounts reclassified out
of AOCI
Other comprehensive
income (loss)
Balance at March 31,
2018
Other comprehensive
income (loss) before
reclassifications (5)
Amounts reclassified out
of AOCI
Other comprehensive
income (loss)
Balance at March 31,
2019
_______________________________________________________________________________
(1) There were no significant tax effects associated with the cumulative currency translation gains and losses as of March 31, 2019, 2018, and 2017.
(2) Other comprehensive income (loss) before reclassifications for the year ended March 31, 2018 and the balance at March 31, 2018 adjusted due to the
adoption of ASC 606.
(3) Ending balance is net of a tax benefit of $2.4 million, $2.3 million, and $2.7 million as of March 31, 2019, 2018, and 2017, respectively.
(4) Activity for the years ended March 31, 2019 and 2018 are net of a tax expense of $0.2 million and $0.4 million, respectively.
(5) Foreign currency translation includes gains of $5.0 million related to a derivative instrument accounted for as a net investment hedge. Refer to Note 12,
Derivatives, for further information.
Fair Value Measurement
The Company utilizes three levels of inputs to measure the fair value of (a) nonfinancial assets and liabilities that are
recognized or disclosed at fair value in the Company’s consolidated financial statements on a recurring basis (at least annually)
and (b) all financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid
to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly
transaction between market participants on the measurement date. Valuation techniques used to measure fair value must
maximize the use of observable inputs and minimize the use of unobservable inputs.
The first two inputs are considered observable and the last is considered unobservable. The levels of inputs are as
follows:
•
Level 1—Quoted prices in active markets for identical assets or liabilities.
81
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
•
•
Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for
similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or
can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the
fair value of the assets or liabilities.
Assets and liabilities are measured at fair value on a recurring basis as of March 31, 2019 and 2018 are as follows
(amounts in thousands):
Carrying
Value
March
31,
Fair
Value
March
31,
Fair Value Measurement
Using
Carrying
Value
March
31,
Fair
Value
March
31,
Fair Value Measurement
Using
2019
2019
Level 1
Level 2 (3)
Level 3
2018
2018
Level 1
Level 2 (3)
Level 3
Assets (Liabilities):
Money markets (1)(2)
Derivative assets
Derivative liabilities
$ 60,687
$
60,687
$ 60,687
$
— $
— $ 83,891
$ 83,891
$ 83,891
$
— $
Total debt
(294,471)
(303,170)
5,141
—
5,141
—
—
—
—
5,141
—
—
—
1,154
1,154
—
—
(303,170)
— (324,623)
(343,125)
—
—
—
1,154
—
(343,125)
—
—
—
—
_______________________________________________________________________________
(1) Included in the line item “Cash and cash equivalents” on the Consolidated Balance Sheets.
(2) Certificates Deposits of $32.2 million and $33.9 million that mature in three months or less are included within the balance as of March 31, 2019 and 2018,
respectively.
(3) Fair value for derivative assets and liabilities was determined by using a third-party matrix-pricing model that uses significant inputs derived from or
corroborated by observable market data. Where applicable, these models discount future cash flow amounts using market-based observable inputs, including
interest rate yield curves, and forward and spot prices for currencies. Fair value for total debt was determined by using a discounted cash flow based on
current market interest rates.
Revenue Recognition
The Company recognizes revenue under the guidance provided in ASC 606. Consistent with the terms of ASC 606, the
Company records revenue on product sales in the period in which the Company satisfies its performance obligation by
transferring control over a product to a customer. The amount of revenue recognized reflects the consideration the Company
expects to receive in exchange for transferring products to a customer. The Company has elected the practical expedient under
ASC 606-10-32-18 and does not consider the effects of a financing component on the promised amount of consideration
because the period between when the Company transfers a product to a customer and when the customer pays for that product
is one year or less. As performance obligations are expected to be fulfilled in one year or less, the Company has elected the
practical expedient under ASC 606-10-50-14 and has not disclosed information relating to remaining performance obligations.
The Company sells its products to distributors, original equipment manufacturers (“OEM”), and electronic
manufacturing services providers (“EMS”), and the sales price may include adjustments for sales discounts, price adjustments,
and sales allowances. The Company has elected the practical expedient under ASC 606-10-10-4 and evaluates these sales-
related adjustments on a portfolio basis. The principle forms of these adjustments include:
•
Inventory price protection and ship-from stock and debit (“SFSD”) programs,
• Distributor rights of returns,
•
Sales allowances, and
• Limited assurance warranties
The Company's inventory price protection and SFSD programs provide authorized distributors with the flexibility to
meet marketplace prices by allowing them, upon a pre-approved case-by-case basis, to adjust their purchased inventory cost to
correspond with current market demand. KEMET's SFSD program is specific to certain distributors within the Americas and
EMEA regions. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment
quote from their local KEMET sales representative, and apply only to a specific customer, part, specified special price amount,
specified quantity, and are only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with
82
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain
accounting assumptions, all of which are reviewed quarterly.
Select distributors have the right to return a certain portion of their purchased inventory to KEMET from the previous
fiscal quarter. The Company estimates future returns based on historical return patterns and records a corresponding right of
return asset and refund liability as a component of the line items, “Inventories, net” and “Accrued expenses,” respectively, on
the Condensed Consolidated Balance Sheets. The Company also offers volume-based rebates on a case-by-case basis to certain
customers in each of the Company’s sales channels.
The Company's sales allowances are recognized as a reduction in the line item “Net sales” on the Consolidated
Statements of Operations, while the associated reserves are included in the line item “Accounts receivable, net” on the
Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but
is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the
effects of technological change, and other variables that might result in changes to the Company’s estimates.
The Company provides a limited assurance warranty on products that meet certain specifications to select customers.
The warranty coverage period is generally limited to one year for United States based customers and a length of time
commensurate with regulatory requirements or industry practice outside the United States. A warranty cannot be purchased by
the customer separately and, as a result, product warranties are not considered to be separate performance obligations. The
Company’s liability under these warranties is generally limited to a replacement of the product or refund of the purchase price
of the product. The Company recognizes warranty costs when losses are both probable and reasonably estimable. Warranty
costs were not material for the fiscal years ended March 31, 2019, 2018 and 2017.
Disaggregation of Revenue
Refer to Note 7, “Reportable Segment and Geographic Information” for revenue disaggregated by primary
geographical market, sales channel, and major product line.
Contract liabilities
Contract liabilities consist of advance payments from certain customers within the OEM channel for the development
of additional production capacity. The current and noncurrent portions of these liabilities are included as a component of the
line items, “Accrued expenses” and “Other non-current obligations,” respectively, on the Consolidated Balance Sheets.
The balance of net contract liabilities consisted of the following at March 31, 2019 and 2018 (amounts in thousands):
Contract liabilities - current (Accrued expenses)
Contract liabilities - noncurrent (Other non-current obligations)
Total contract liabilities
March 31, 2019
March 31, 2018
$
$
256
—
256
$
$
256
513
769
For the fiscal years ended March 31, 2019, 2018 and 2017, the Company recognized revenue of $0.9 million, $0.3
million, and $0.2 million, respectively, related to contract liabilities. Revenue related to contract liabilities is recorded on the
Consolidated Statements of Operations in the line item, "Net sales."
83
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Contract assets
The Company recognizes an asset from the costs incurred to fulfill a contract if those costs directly relate to an
existing or anticipated contract or specific business opportunity, if the costs enhance our own resources that will be used in
satisfying performance obligations in the future, and the costs are expected to be recovered through subsequent sale of product
to the customer. The Company has determined that certain direct labor, materials, and allocations of overhead incurred within
research and development activities meet the requirements to be capitalized. As most of our contracts and customer specific
business opportunities do not include a stated term, the Company amortizes these capitalized costs over the expected product
life cycle, which is consistent with the estimated transfer of goods to the customer. Capitalized contract costs were $1.6 million
and $2.2 million at March 31, 2019 and 2018, respectively. Capitalized contracts costs are recorded on the Consolidated
Balance Sheets in the line item, “Other assets.” Amortization expense related to contract costs for the fiscal years ended
March 31, 2019, 2018 and 2017 was $0.8 million, $0.9 million, and $0.8 million, respectively. There was no impairment loss in
relation to the costs capitalized for the fiscal years ended March 31, 2019, 2018 and 2017. Amortization expense related to
contract assets is recorded on the Consolidated Statements of Operations line item "Cost of sales."
Allowance for Doubtful Accounts
The Company evaluates the collectability of trade receivables through the analysis of customer accounts. When the
Company becomes aware that a specific customer has filed for bankruptcy, has begun closing or liquidation proceedings, has
become insolvent or is in financial distress, the Company records a specific allowance for the doubtful account to reduce the
related receivable to the amount the Company believes is collectible. If circumstances related to specific customers change, the
Company’s estimates of the recoverability of receivables could be adjusted. Accounts are written off after all means of
collection, including legal action, have been exhausted.
Shipping and Handling Costs
The Company’s shipping and handling costs are reflected in the line item “Cost of sales,” on the Consolidated
Statements of Operations. Shipping and handling costs were $31.0 million, $21.4 million, and $16.4 million in the fiscal years
ended March 31, 2019, 2018 and 2017, respectively.
Advertising Costs
The Company expenses advertising costs in the period in which the expenditures are incurred. Advertising costs
reflected in the line item "Selling, general and administrative expenses" in our Consolidated Statements of Operations were
$2.5 million, $2.4 million, and $1.3 million in fiscal years ended March 31, 2019, 2018 and 2017, respectively.
Income per Share
Basic income per share is computed using the weighted-average number of shares outstanding. Diluted income per
share is computed using the weighted-average number of shares outstanding adjusted for the incremental shares attributed to the
warrant issued in May 2009 to K Financing, LLC by the Company (the “Platinum Warrant”) and outstanding employee stock
grants if such effects are dilutive. On September 11, 2017, the Platinum Warrant was exercised in full.
Grants Income
The Company from time to time enters into contracts to perform projects in which governmental agencies agree to
reimburse the Company for certain expenses incurred on the projects. The Company recognizes revenue from government
grants when it is probable that the Company will comply with the conditions attached to the grant agreement and the grant
proceeds will be received. Additionally, from time to time the Company receives interest free loans from governmental agencies
in consideration of the Company making investments in operations in certain locations. As the loans are interest free, the
Company records deferred grant income for the difference between the gross loan proceeds and the present value of the debt at
the time it is issued. The deferred grant income is amortized over the life of the loans. During the fiscal years ended March 31,
2019 and 2018, the Company recognized $4.6 million and $0.8 million, respectively, as grant income within other (income)
expense, net.
84
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Environmental Cost
The Company recognizes liabilities for environmental remediation when it is probable that a liability has been incurred
and can be reasonably estimated. The Company determines its liability on a site-by-site basis, and it is not discounted or
reduced for anticipated recoveries from insurance carriers. In the event of anticipated insurance recoveries, such amounts would
be presented on a gross basis in other current or non-current assets, as appropriate. Expenditures that extend the life of the
related property or mitigate or prevent future environmental contamination are capitalized.
Derivative Financial Instruments
The Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact
of certain market risks. The primary market risk managed by the Company through the use of derivative financial instruments is
foreign currency exchange risk. All derivatives are carried at fair value in our Consolidated Balance Sheets. See Note 12,
"Derivatives," for further discussion of derivative financial instruments.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles
(“GAAP”) requires management to make a number of estimates and assumptions. These estimates and assumptions affect the
reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial
statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period. Significant
items subject to such estimates and assumptions include impairment of property and equipment, intangibles and goodwill,
allowances for doubtful accounts, price protection and customers’ returns, deferred income taxes, and assets and obligations
related to employee benefits. Actual results could differ from these estimates and assumptions.
Impact of Recently Issued Accounting Standards
In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2018-15, Customer's
Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. This ASU
amends the definition of a hosting arrangement and requires a customer in a hosting arrangement that is a service contract to
capitalize certain implementation costs as if the arrangement was an internal-use software project. Under this ASU, a customer
will apply ASC 350-40 to determine whether to capitalize implementation costs of the cloud computing arrangement that is a
service contract or expense them as incurred. This ASU is effective for fiscal years beginning after December 15, 2019, and
interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the
adoption of this guidance on the Company’s Consolidated Financial Statements.
In March 2018, the FASB issued ASU No. 2018-05, Amendments to SEC Paragraphs Pursuant to SEC Staff
Accounting Bulletin (“SAB”) No. 118. The amendments in this update provide guidance on when to record and disclose
provisional amounts for certain income tax effects of the Tax Cuts and Jobs Act (the “Act”). The amendments also require any
provisional amounts or subsequent adjustments to be included in net income from continuing operations. Additionally, this ASU
discusses required disclosures that an entity must make with regard to the Act. This ASU is effective immediately as new
information is available to adjust provisional amounts that were previously recorded. The Company has adopted this ASU and
has finalized its accounting for the Act. See Note 11, “Income Taxes” for additional information on the Act.
In August 2017, the FASB issued ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities
(“ASU 2017-12”). This ASU amends and simplifies existing guidance to allow companies to more accurately present the
economic effects of risk management activities in the financial statements. For cash flow hedges existing on the date of
adoption, an entity is required to eliminate the separate measurement of ineffectiveness in earnings by means of a cumulative-
effect adjustment to accumulated other comprehensive income (“AOCI”) with a corresponding adjustment to the opening
balance of retained earnings. ASU 2017-12 becomes effective for fiscal years and interim periods beginning after December 15,
2018 and early adoption is permitted. In the third quarter of fiscal year 2019, the Company entered into new derivative
contracts and elected to early adopt the ASU effective as of October 1, 2018. The adoption of the standard did not result in a
cumulative-effect adjustment since the Company has not previously had any ineffectiveness associated with its cash flows
hedges.
In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain
Cash Receipts and Cash Payments. This ASU clarifies how cash receipts and cash payments in certain transactions are
presented and classified in the statement of cash flows. The effective date of this update is for fiscal years, and interim periods
85
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires retrospective
application to all periods presented but may be applied prospectively if retrospective application is impracticable. The Company
adopted this guidance as of April 1, 2018. In connection with the adoption of this ASU, the Company elected to account for
distributions received from equity method investees using the nature of distributions approach, under which distributions are
classified based on the nature of activity that generated them. The other provisions of this ASU did not have an impact on the
Company's Condensed Consolidated Cash Flows.
In February 2016, the FASB issued ASU No. 2016-02 (“ASU 2016-02”), Leases, as modified by ASU 2017-03,
Transition and Open Effective Date Information, requiring lessees to recognize a right-of-use asset and a lease liability for all
leases. This ASU also requires expanded disclosures to help financial statement users better understand the amount, timing, and
uncertainty of cash flows arising from leases. The standard is effective for fiscal years beginning after December 15, 2018, and
interim periods within those fiscal years and the Company will adopt ASU 2016-02 on April 1, 2019. The Company has
substantially completed its preparation for the adoption of this ASU, and the ASU is expected to have a material impact on lease
assets and lease liabilities on its Consolidated Balance Sheets upon adoption. This ASU is not expected to have a material effect
on the amount of expense recognized in connection with the Company's current practice. The Company plans to elect the
optional transition method that will give companies the option to use the effective date as the date of initial application on
transition, and as a result, we will not adjust our comparative period financial information or make the new required lease
disclosures for periods before the effective date. For information about the Company's future lease commitments as of March
31, 2019, see Note 15, "Commitments and Contingencies."
In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which superseded existing
GAAP for revenue recognition and created a single framework. ASU 2014-09 and its amendments were included primarily in
ASC 606. The core principle of ASC 606 is that an entity should recognize revenue for the transfer of goods or services equal to
an amount that it expects to be entitled to receive for those goods or services. ASC 606 also requires additional disclosures
about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including
significant judgments and changes in judgments. The Company adopted the requirements of ASC 606 effective in the first
quarter of fiscal year 2019, using the full retrospective method, which required us to restate each prior reporting period
presented. The Company has applied practical expedient ASC 606-10-65-1(f)(3) and notes that all previously reported historical
amounts are adjusted for the impact of ASC 606.
Adoption of the requirements in ASC 606 impacted our previously reported Consolidated Balance Sheet as of March
31, 2018 and our Consolidated Statements of Operations, Statements of Comprehensive Income, Statements of Changes in
Stockholders' Equity, and Statements of Cash Flows for the fiscal years ended March 31, 2018 and 2017 as follows (amounts in
thousands, except per share data):
86
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Consolidated Balance Sheet
Assets
Account receivable, net
Total current assets
Other assets
Total assets
Liabilities and Stockholders' Equity
Accrued expenses
Total current liabilities
Deferred income taxes
Other non-current obligations
Total liabilities
Retained earnings (deficit)
Accumulated other comprehensive income
Total stockholders' equity
As of March 31, 2018
As Previously
Reported
ASC 606
Adjustments
As Adjusted
$
$
$
144,076
$
2,485
$
$
$
676,468
10,431
1,218,269
122,377
284,916
14,571
151,736
755,306
2,675
(3,015)
462,963
$
$
2,485
2,169
4,654
2,742
2,742
487
513
3,742
695
217
912
146,561
678,953
12,600
1,222,923
125,119
287,658
15,058
152,249
759,048
3,370
(2,798)
463,875
Total liabilities and stockholders' equity
$
1,218,269
$
4,654
$
1,222,923
Consolidated Statements of Operations
Net sales
Operating costs and expenses:
Cost of sales
Research and development
Operating income
Income tax expense
Net income
Net income per basic share
Net income per diluted share
As Previously
Reported
Fiscal Year 2018
ASC 606
Adjustments
As Adjusted
$
1,199,926
$
255
$
1,200,181
859,533
39,619
113,303
9,181
254,529
4.82
4.34
$
$
$
$
$
$
1,211
(505)
(451)
(49)
(402) $
(0.01) $
(0.01) $
860,744
39,114
112,852
9,132
254,127
4.81
4.33
87
Net sales
Operating costs and expenses:
Cost of sales
Research and development
Operating income
Income tax expense
Net income
Net income per basic share
Net income per diluted share
Consolidated Statements of Comprehensive Income
Net income
Foreign currency translation gains (losses)
Other comprehensive income
Total comprehensive income
Net income
Total comprehensive income
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
As Previously
Reported
Fiscal Year 2017
ASC 606
Adjustments
As Adjusted
$
757,791
$
(453) $
757,338
570,864
27,398
35,796
4,290
47,989
1.03
0.87
$
$
$
1,080
(705)
(828)
4
(832) $
(0.02) $
(0.02) $
571,944
26,693
34,968
4,294
47,157
1.01
0.85
As Previously
Reported
Fiscal Year 2018
ASC 606
Adjustments
254,529
$
35,054
38,797
293,326
$
(402) $
217
217
(185) $
As Adjusted
254,127
35,271
39,014
293,141
As Previously
Reported
Fiscal Year 2017
ASC 606
Adjustments
As Adjusted
47,989
37,602
$
$
(832) $
(832) $
47,157
36,770
$
$
$
$
$
$
$
88
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Consolidated Statements of Changes in Stockholders' Equity
Net income
Retained earnings
Other comprehensive income
Accumulated other comprehensive income (loss)
Total stockholders' equity
Net income
Adoption of ASU's
Retained earnings
Total stockholders' equity
Consolidated Statement of Cash Flows
Operating activities
Net income
Depreciation and amortization
Change in deferred income taxes
Other, net
Accounts receivable
Other operating liabilities
Net cash provided by (used in) operating activities
Effect of foreign currency fluctuations on cash
Operating activities
Net income
Depreciation and amortization
Change in deferred income taxes
Other, net
Accounts receivable
Other operating liabilities
Net cash provided by (used in) operating activities
As of and for the Fiscal Year Ended March 31, 2018
As Previously
Reported
ASC 606
Adjustments
As Adjusted
254,529
$
2,675
38,797
(3,015)
462,963
$
(402) $
695
217
217
912
$
254,127
3,370
39,014
(2,798)
463,875
As of and for the Fiscal Year Ended March 31, 2017
As Previously
Reported
ASC 606
Adjustments
As Adjusted
47,989
(333)
(251,854)
154,472
$
$
(832) $
1,929
1,097
1,097
$
47,157
1,596
(250,757)
155,569
$
$
$
$
Fiscal Year 2018
As Previously
Reported
ASC 606
Adjustments
As Adjusted
$
254,529
$
49,755
613
(71)
30,084
113
120,860
9,646
(402) $
906
(49)
(609)
133
84
(99)
99
254,127
50,661
564
(680)
30,217
197
120,761
9,745
Fiscal Year 2017
As Previously
Reported
ASC 606
Adjustments
As Adjusted
$
47,989
$
37,338
(19)
(327)
(12)
(1,068)
71,667
(832) $
813
4
(65)
(2,618)
2,762
—
47,157
38,151
(15)
(392)
(2,630)
1,694
71,667
89
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 2: Acquisitions
Sale of Electro-Mechanical Business and Acquisition of Remaining Interest in TOKIN
Between February 1, 2013 and April 19, 2017, KEMET, through its wholly-owned subsidiary, KEMET Electronics
Corporation (“KEC”), held a 34% economic interest in TOKIN Corporation (“TOKIN”) pursuant to a Stock Purchase
Agreement (the “Stock Purchase Agreement”) by and among KEC, TOKIN and NEC Corporation (“NEC”), as calculated based
on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and
preferred shares of TOKIN outstanding as of such date. TOKIN was established in Japan in 1938 and is engaged in production
and distribution of tantalum capacitors, transmitting communication devices, magnetic devices, piezoelectric devices and
sensors. TOKIN has six manufacturing locations throughout Asia and was previously operating as a joint venture with NEC.
On April 14, 2017, TOKIN closed on the sale of its electro-mechanical devices (“EMD”) business to NTJ Holdings 1
Ltd. (“NTJ”), a special purpose entity that is owned by funds managed or operated by Japan Industrial Partners, Inc. (“JIP”),
pursuant to a master sale and purchase agreement (the “EMD Master Sale and Purchase Agreement”) previously entered into
between TOKIN, NTJ and JIP (“Sale of EMD”). The initial selling price for EMD was JPY 48.2 billion, or approximately
$431.0 million, using the March 31, 2017 exchange rate of 111.823 Japanese Yen to 1.00 U.S. Dollar, and was subject to certain
working capital adjustments. In the third quarter of fiscal year 2018, the selling price was adjusted by JPY 1.1 billion or
approximately $10.1 million (using the December 31, 2017 exchange rate of 112.574 Japanese Yen to 1.00 U.S. Dollar) related
to working capital and other adjustments in accordance with the EMD Master Sale and Purchase Agreement. At the closing of
the Sale of EMD, TOKIN used a portion of the sale proceeds to repay debt related to a shareholder loan from NEC. The TOKIN
historical balance sheet was adjusted to reflect the removal of net assets sold and other items directly impacted by the Sale of
EMD. Additionally, due to KEMET’s 34% equity interest in TOKIN held as of the closing, adjustments have been made to
reflect KEMET’s accounting for the Sale of EMD in accordance with the equity method of accounting.
On April 19, 2017, pursuant to a stock purchase agreement (the “TOKIN Purchase Agreement”) dated February 23,
2017 between KEC and NEC, KEC completed its acquisition, subject to final purchase price adjustment, of the remaining 66%
economic interest in TOKIN, and as a result, TOKIN is now a 100% owned indirect subsidiary of KEMET (the “TOKIN
Acquisition”). Under the terms of the TOKIN Purchase Agreement, KEC paid NEC JPY 16.2 billion, or approximately $148.6
million (using the April 19, 2017 exchange rate of 109.007 Japanese Yen to 1.00 U.S. Dollar), for all of the outstanding shares
of TOKIN it did not already own. The preliminary purchase price was comprised of JPY 6.0 billion, or approximately $55.0
million (using the April 19, 2017 exchange rate of 109.007 Japanese Yen to 1.00 U.S. Dollar) plus JPY 10.2 billion, or
approximately $93.6 million, which represented one-half of the estimated excess net cash proceeds (“Excess Cash”) from the
Sale of EMD. The acquisition price was subject to working capital adjustments pursuant to the EMD Master Sale and Purchase
Agreement. As a result of these working capital adjustments, the acquisition price was increased by JPY 0.3 billion, or
approximately $3.0 million (using the September 30, 2017 exchange rate of 112.502 Japanese Yen to 1.00 U.S. Dollar) in the
second quarter of fiscal year 2018. There will be no more working capital adjustments under the purchase agreement.
The acquisition of TOKIN has expanded KEMET’s geographic presence, combining KEMET’s presence in the
western hemisphere and TOKIN’s excellent position in Asia to enhance customer reach and created an entrance into Japan for
KEMET. The Company believes TOKIN’s product portfolio is a strong complement to KEMET’s existing product portfolio and
believes the combination has created a leader in the combined polymer and tantalum capacitors market. The acquisition also
enhanced KEMET’s product diversification with entry into EMC devices, as well as sensors and actuators. With the increased
scale, the Company has achieved synergies by optimizing costs through competitive raw materials sourcing and maximizing
operating efficiencies. Consistent with expectations, the acquisition has been accretive to earnings with improvement in Net
income, Adjusted EBITDA and cash flow. TOKIN’s tantalum capacitor business is included within KEMET’s Solid Capacitor
reportable segment (“Solid Capacitors”) and the remainder of TOKIN’s business formed a new reportable segment for KEMET,
Electro-Magnetic, Sensors, and Actuators (“MSA”).
90
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following table shows the components of the acquisition price (amounts in thousands):
Upfront cash consideration (1)
Excess cash payment (2)
Indemnity asset (3)
Less: Put option (4)
Net consideration transferred
$
148,614
3,144
8,500
(9,900)
150,358
$
_______________________________________________
(1) The upfront cash payment was comprised of JPY 6.0 billion plus one half of Excess Cash in an amount of approximately JPY 10.2 billion, approximately
$55.0 million and $93.6 million (using the April 19, 2017 exchange rate of 109.007 Japanese Yen to 1.00 U.S. Dollar), respectively.
(2) The additional amount paid to NEC Corporation upon the settlement of the adjusted purchase price for the EMD sale.
(3) Pursuant to the Stock Purchase Agreement between KEMET and NEC, NEC was required to indemnify TOKIN and/or KEC for any breaches by TOKIN or
NEC of certain representations, warranties and covenants in the Stock Purchase Agreement. NEC’s aggregate liability for indemnification claims was limited to
$25.0 million. Prior to the acquisition, KEMET's equity method investment balance included an $8.5 million indemnification asset pursuant to this
indemnification arrangement. In connection with the TOKIN Acquisition, NEC was released from its indemnification obligations to KEMET without an
exchange of consideration; as such, this amount of released obligation was included as purchase consideration by KEMET.
(4) Pursuant to the option agreement, dated as of March 12, 2012, by and among NEC and KEMET (the “Option Agreement”), from April 1, 2015 through
May 31, 2018, NEC had the right to require KEC to purchase all outstanding capital stock of TOKIN (the “Put Option”). The fair value of the Put Option of
$9.9 million was reflected as a liability on KEMET’s balance sheet prior to KEMET’s acquisition of the remaining 66% economic interest in TOKIN. The Put
Option was canceled, pursuant to the terms of the TOKIN Purchase Agreement with no exchange of consideration between NEC and KEMET. Accordingly, the
fair value of the Put Option reduced the amount of consideration paid to acquire NEC’s equity in TOKIN.
In accordance with ASC 805, KEMET’s previously held 34% equity interest in TOKIN and the assets acquired and the
liabilities assumed were measured at their fair values based on various estimates. The acquisition-date fair value of KEMET’s
previously held 34% equity interest in TOKIN was approximately $204.1 million, which was derived from 34% of the fair
value of TOKIN as of April 19, 2017 determined under the discounted cash flow method, an income valuation approach.
The following table presents the allocations of the aggregate purchase price based on the estimated fair values of the
assets and liabilities (amounts in thousands):
Cash
Accounts Receivable
Inventory
Other current assets
Property, Plant and equipment
Intangible assets (1)
Equity method investments
Other assets
Current portion of long-term debt
Accounts payable
Accrued expenses
Other non-current obligations
Deferred income taxes
Total net assets acquired
Fair Value
$
315,743
79,295
35,310
20,902
154,744
32,996
11,128
6,512
(3,225)
(81,642)
(44,542)
(105,140)
(5,452)
416,629
$
________________________________________________
(1) Includes trade name for $8.0 million and products and relationships of $25.0 million. TOKIN’s technology, products, and relationships were valued as a
grouped, composite intangible asset due to the Company’s products being dependent on the existing technology, which enabled a product portfolio that
customers found appealing in selecting and designing electronic devices for purchase. The trade name was valued based on the relief from royalty method and
has an indefinite remaining useful life. The products and relationships were valued on the excess earnings method and are amortized over 10 years.
There were $0.9 million of acquisition-related costs, which were all recognized as an expense in the line item “Selling,
general and administrative expenses” on the Consolidated Statements of Operations for the fiscal year ended March 31, 2018.
For the fiscal years ending March 31, 2019 and 2018, the Company's Consolidated Statements of Operations include net sales
91
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
of $370.2 million and $358.2 million, respectively, and operating income of $34.8 million and $36.1 million, respectively,
derived from TOKIN Corporation.
The following table reflects the bargain purchase gain resulting from the TOKIN Acquisition (amounts in thousands):
Net consideration transferred
Fair value of KEMET’s previously held equity interest in TOKIN (1)
Less: fair value of net assets acquired
Bargain purchase gain
______________________________________
(1) Value based in the 34% of the enterprise value determined under the discounted cash flow method.
$
$
150,358
204,112
(416,629)
(62,159)
In performing acquisition accounting procedures, we engaged an internationally recognized independent valuation
firm to assist in the valuation of identifiable net assets acquired. We also performed an extensive review for any unrecorded
assets, liabilities, and contingencies. After identifying and valuing acquired assets and liabilities, we concluded recording a
bargain purchase gain was appropriate and required under ASC 805-30-25-2. We believe the bargain purchase gain resulted
from (1) NEC seeking repayment of its receivables due from TOKIN pursuant to TOKIN’s January 25, 2013 Loan Agreement
with NEC of JPY 25.4 billion, or approximately $233.2 million (using the April 19, 2017 exchange rate of 109.007 Japanese
Yen to 1.00 U.S. Dollar), which the sale transaction achieved, and for which TOKIN did not have the resources to pay prior to
the transaction; and, (2) a predetermined purchase price which, other than certain customary working capital adjustments, was
not subject to amendment irrespective of the amount of proceeds resulting from the sale of TOKIN’s EMD business, which was
a precondition to our acquisition of TOKIN. The bargain purchase gain is recognized in the line item “Acquisition (gain) loss”
in the Consolidated Statements of Operations.
Pro Forma Results
The following table summarizes, on a pro forma basis, the combined results of operations of the Company and TOKIN
as though the acquisition and the Sale of EMD had occurred as of April 1, 2016. The pro forma amounts presented are not
necessarily indicative of either the actual consolidated results had the acquisition occurred as of April 1, 2016, or of future
consolidated operating results (amounts in thousands, except per share data):
Pro forma revenues (3)
Pro forma net income from continuing operations available to common stockholders (3)
Pro forma earnings per common share - basic (3)
Pro forma earnings per common share - diluted (3)
Pro forma common shares - basic
Pro forma common shares - diluted
Fiscal Years Ended March 31,
2018 (1)
2017 (2)
$
1,217,655
$
1,060,777
51,975
0.98
0.89
52,798
58,640
226,086
4.86
4.08
46,552
55,389
___________________________________________
(1) The net income for the fiscal year ended March 31, 2018 excludes the following: 34% of the gain on sale of the EMD business of $75.2 million, the gain
related to the fair value of KEMET’s previous 34% interest in TOKIN of $68.7 million, and the bargain gain on the acquisition of TOKIN of $62.2 million.
(2) The net income for the fiscal year ended March 31, 2017 includes the following: 34% of the gain on sale of the EMD business of $123.4 million (which
includes the release of a valuation allowance that was recorded in the fourth quarter of fiscal year 2017 and the use of the deferred tax asset which was
recorded in the first quarter of fiscal year 2018), the gain related to the fair value of KEMET’s previous 34% interest in TOKIN of $66.7 million, and the
bargain gain on the acquisition of TOKIN of $60.3 million.
(3) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
92
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 3: Debt
A summary of debt is as follows (amounts in thousands):
Term Loan Credit Agreement (1)
TOKIN Term Loan Facility (2)
Customer Advances (3)
Other, net (4)
Total debt
Current maturities
Total long-term debt
March 31,
2019
2018
$
— $
318,782
276,808
11,270
6,393
294,471
(28,430)
266,041
$
—
—
5,841
324,623
(20,540)
304,083
$
______________________________________________________________________________
(1) Amount shown is net of discount, bank issuance costs and other indirect issuance costs of $13.3 million as of March 31, 2018.
(2) Amount shown is net of discount, bank issuance costs and other indirect issuance costs of $8.7 million as of March 31, 2019.
(3) Amount shown is net of discount of $2.1 million as of March 31, 2019.
(4) Amounts shown are net of discounts of $0.6 million and $0.5 million as of March 31, 2019 and 2018, respectively.
The line item “Interest expense” on the Consolidated Statements of Operations for the fiscal years 2019, 2018 and
2017, respectively, is as follows (amounts in thousands):
Contractual interest expense
Capitalized interest
Amortization of debt issuance costs
Amortization of debt (premium) discount
Imputed interest on acquisition related obligations
Interest expense on capital leases
Total interest expense
Term Loan Credit Agreement
$
Fiscal Years Ended March 31,
2019
2018
2017
$
19,471
(232)
334
1,481
57
128
$
30,323
(141)
511
1,843
113
233
38,825
(154)
1,390
(788)
159
323
$
21,239
$
32,882
$
39,755
On November 7, 2018, the Company repaid the full outstanding balance under the Company's prior Term Loan Credit
Agreement dated April 28, 2017 (“Term Loan Credit Agreement”) with Bank of America, N.A. The Company incurred a $15.9
million loss on the debt extinguishment and the loss is included in the line item “Other (income) expense, net” in the
Consolidated Statements of Operations for the fiscal year ended March 31, 2019. Interest payable related to the Term Loan
Credit Agreement included in the line item “Accrued expenses” on the Consolidated Balance Sheets was $0.2 million as of
March 31, 2018.
TOKIN Term Loan Facility
On October 29, 2018, the Company entered into a JPY 33.0 billion Term Loan Agreement (the “TOKIN Term Loan
Facility”) by and among TOKIN, the lenders party thereto (the “Lenders”) and Sumitomo Mitsui Trust Bank, Limited in its
capacity as agent (the “Agent”), arranger and Lender. Funding for the Term Loan facility occurred on November 7, 2018. The
proceeds, which were net of an arrangement fee withheld from the funding amount, were JPY 32.1 billion, or approximately
$283.9 million using the exchange rate as of November 7, 2018. Net of the arrangement fee, bank issuance costs, and other
indirect issuance costs, the Company's net proceeds from the TOKIN Term Loan Facility was $281.8 million.
The proceeds from the TOKIN Term Loan Facility were used by TOKIN to make intercompany loans (the
“Intercompany Loans”) to the Company. The proceeds, along with other cash on hand, were used to prepay in full the
outstanding amounts under the Term Loan Credit Agreement of $323.4 million and a prepayment premium of 1.0%, or $3.2
million.
93
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The TOKIN Term Loan Facility consists of (i) a JPY 16.5 billion (approximately $146.0 million using the exchange
rate as of November 7, 2018) Term Loan A tranche (the “Term Loan A”) and (ii) a JPY 16.5 billion (approximately $146.0
million using the exchange rate as of November 7, 2018) Term Loan B tranche (the “Term Loan B” and, together with the Term
Loan A, collectively, the “Term Loans”). Principal payments under Term Loan A are required semi-annually, in the amount of
JPY 1.4 billion (approximately $12.4 million using the exchange rate as of March 31, 2019), while the principal of Term Loan
B is due in one payment at maturity. At each reporting period, the carrying value of the loan is translated from Japanese Yen to
U.S. Dollars using the spot exchange rate as of the end of the reporting period.
Interest payments are due semi-annually on the Term Loans, with the interest rate based on a margin over the six-
month Japanese TIBOR. The applicable margin for Term Loan A is 2.00% and for Term Loan B is 2.25%. Japanese TIBOR at
March 31, 2019 was 0.13%. Interest payable related to the TOKIN Term Loan Facility included in the line item “Accrued
expenses” on the Consolidated Balance Sheets was $0.1 million as of March 31, 2019. The effective interest rate for the TOKIN
Term Loan Facility was 3.1% for the year ended March 31, 2019.
The Term Loans mature on September 30, 2024. KEMET and certain subsidiaries of TOKIN provided guarantees of
the obligations under the Term Loans, which will also be secured by certain assets, properties and equity interests of TOKIN
and its material subsidiaries. As of March 31, 2019, properties and equipment with a net book value of $50.6 million were
securing the Term Loans. The Term Loans contain customary covenants applicable to both the Company and to TOKIN,
including maintenance of a consolidated net leverage ratio, the absence of two consecutive years of consolidated operating
losses and the maintenance of certain required levels of consolidated net assets. The TOKIN Term Loan Facility also contains
customary events of default. The Company may prepay the Term Loans at any time, subject to certain notice requirements and
reimbursement of loan breakage costs.
Customer Advances
In September, November, and February of fiscal year 2019, the Company entered into agreements with three different
customers (the “Customers”) pursuant to which the Customers agreed to make advances (collectively, the “Advances”) to the
Company in an aggregate amount of up to $72.0 million (collectively, the “Customer Capacity Agreements”). The Company is
using these Advances to fund the purchase of production equipment and to make other investments and improvements in its
business and operations (the “Investments”) to increase overall capacity to produce various electronic components of the type
and part as may be sold by the Company to the Customers from time to time. The Company retains all rights to the production
equipment purchased with the funds from the Advances. The Advances from the Customers are being made in quarterly
installments (“Installments”) over an expected period of 18 to 24 months from the effective date of the Customer Capacity
Agreements.
The Advances will be repaid beginning on the date that production from the Investments is sufficient to meet the
Company's obligations under the agreements with the Customers. Repayments will be made on a quarterly basis as determined
by calculations that generally consider the number of components purchased by the Customers during the quarter. Repayments
based on the calculations will continue until either the Advances are repaid in full, or December 31, 2038 for all three
Customers. The Company has a quarterly repayment cap in the agreement with each of the Customers and is not required to
make any quarterly repayments to the Customers that in the aggregate exceeds $1.8 million. If the Customers do not purchase a
number of components that would require full repayment of the Advances by December 31, 2038, then the Advances shall be
deemed repaid in full. Additionally, if the Customers do not purchase a number of components that would require a payment on
the Advances for a period of 16 consecutive quarters, the Advances shall be deemed repaid in full.
As of March 31, 2019, the Company has received a total of $13.4 million in Advances from these Customers. Since
the debt is non-interest bearing, the Company has recorded debt discounts on the Advances. These discounts are being
amortized over the expected life of the Advances through interest expense. During fiscal year 2019, the Company had $16.3
million in capital expenditures related to the Customer Capacity Agreements.
As of March 31, 2019, the Company had no cash on its Consolidated Balance Sheets that was restricted as far as its
use related to the Customer Capacity Agreements. Restricted cash is recorded within “Prepaid expenses and other current
assets” in the Consolidated Balance Sheets.
94
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Revolving Line of Credit
On September 30, 2010, KEC and KEMET Electronic Marketing Services, Singapore (“KEMS”) entered into a Loan
and Security Agreement (the “Revolver Agreement”), with Bank of America, N.A, as the administrative agent and the initial
lender. The Revolver Agreement provided a $50.0 million revolving line of credit (the “Revolver”), which was bifurcated into a
U.S. facility and a Singapore facility. A portion of the U.S. facility and the Singapore facility can be used to issue letters of
credit. On December 19, 2014, the Revolver Agreement was amended, which increased the facility to $60.0 million, bifurcated
into a U.S. facility and a Singapore facility. The amendment contained an accordion feature permitting the U.S. Borrowers to
increase commitments under the facility by an aggregate principal amount up to $15.0 million (for a total facility of $75.0
million), subject to terms and documentation acceptable to the Agent and/or the Lenders. In addition, KEMET Foil
Manufacturing, LLC (“KFM”), KBP, and The Forest Electric Company were included as Borrowers under the U.S. facility. On
April 28, 2017, the Revolver Agreement was amended to increase the facility to $75.0 million, provided KEC with lower
applicable interest rate margins, and extended the expiration date to April 28, 2022.
In connection with the closing of the TOKIN Term Loan Facility on October 29, 2018, the Company entered into
Amendment No. 10 to the Loan and Security Agreement, Waiver and Consent (the “Revolver Amendment”), by and among
KEMET, KEC, the other borrowers named therein, the financial institutions party thereto as lenders and Bank of America,
N.A., a national banking association, as agent for the lenders. The Revolver Amendment provides the Company with, among
other things, increased flexibility for certain restricted payments (including dividends), and released certain pledges that
allowed the Company to obtain the TOKIN Term Loan Facility to pay down the Term Loan Credit Agreement.
The principal features of the Revolver Agreement as amended are reflected in the description below.
The size of the U.S. facility and Singapore facility can fluctuate as long as the Singapore facility does not exceed $30.0
million and the total facility does not exceed $60.0 million.
Borrowings under the U.S. and Singapore facilities are subject to a borrowing base consisting of:
•
•
In the case of the U.S. facility, (A) 85% of KEC’s accounts receivable that satisfy certain eligibility criteria plus
(B) the lesser of (i) $6.0 million and (ii) (a) on or prior to agent’s receipt of an updated inventory appraisal and
agent’s approval thereof, 40% of the value of Eligible Inventory (as defined in the agreement) and (b) upon
agent’s receipt of an updated inventory appraisal, 85% of the net orderly liquidation value of the Eligible
Inventory (as defined in the agreement) plus (C) the lesser of $5.1 million and 80% of the net orderly
liquidation percentage of the appraised value of equipment that satisfies certain eligibility criteria, as reduced on
the first day of each fiscal quarter occurring after April 30, 2014 in an amount equal to one-twentieth (1/20) of
such appraised value less (D) certain reserves, including certain reserves imposed by the administrative agent in
its permitted discretion; and
In the case of the Singapore facility, (A) 85% of KEMET Singapore’s accounts receivable that satisfy certain
eligibility criteria as further specified in the Revolver Agreement less (B) certain reserves, including certain
reserves imposed by the administrative agent in its permitted discretion.
Interest is payable on borrowings monthly at a rate equal to the London Interbank Offer Rate (“LIBOR”) or the base
rate, plus an applicable margin, as selected by the Borrower. Depending upon the fixed charge coverage ratio of KEMET
Corporation and its subsidiaries on a consolidated basis as of the latest test date, the applicable margin under the U.S. facility
varies between 2.00% and 2.50% for LIBOR advances and 1.00% and 1.50% for base rate advances, and under the Singapore
facility varies between 2.25% and 2.75% for LIBOR advances and 1.25% and 1.75% for base rate advances.
The base rate is subject to a floor that is 100 basis points above LIBOR.
An unused line fee is payable monthly in an amount equal to a per annum rate equal to (a) 0.50%, if the average daily
balance of revolver loans and stated amount of letters of credit was 50% or less of the revolver commitments during the
preceding calendar month, or (b) 0.375%, if the average daily balance of revolver loans and stated amount of letters of credit
was more than 50% of the Revolver commitment during the preceding calendar month. A customary fee is also payable to the
administrative agent on a quarterly basis.
KEC’s ability to draw funds under the U.S. facility and KEMET Singapore’s ability to draw funds under the Singapore
facility are conditioned upon, among other matters:
95
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
•
•
•
the absence of the existence of a Material Adverse Effect (as defined in the Revolver Agreement);
the absence of the existence of a default or an event of default under the Revolver Agreement; and
the representations and warranties made by KEC and KEMS in the Revolver Agreement continuing to be
correct in all material respects.
KEMET and KEC’s 100% owned domestic subsidiaries (“Guarantor Subsidiaries”) guarantee the U.S. facility
obligations and the U.S. facility obligations are secured by a lien on substantially all of the assets of KEC and the Guarantor
Subsidiaries (other than assets that secure the 10.5% Senior Notes due 2018). The collection accounts of the Borrowers and
Guarantor Subsidiaries are subject to a daily sweep into a concentration account and the concentration account will become
subject to full cash dominion in favor of the administrative agent (i) upon an event of default, (ii) if for five consecutive
business days, aggregate availability of all facilities has been less than the greater of (A) 10% of the aggregate revolver
commitments at such time and (B) $7.5 million, or (iii) if for five consecutive business days, availability of the U.S. facility has
been less than $3.75 million (each such event, a “Cash Dominion Trigger Event”).
KEC and the Guarantor Subsidiaries guarantee the Singapore facility obligations. In addition to the assets that secure
the U.S. facility, the Singapore obligations are also secured by a pledge of 100% of the stock of KEMET Singapore and a
security interest in substantially all of KEM's assets. KEMET Singapore’s bank accounts are maintained at Bank of America
and upon a Cash Dominion Trigger Event will become subject to full cash dominion in favor of the administrative agent.
A fixed charge coverage ratio of at least 1.0:1.0 must be maintained as of the last day of each fiscal quarter ending
immediately prior to or during any period in which any of the following occurs and is continuing until none of the following
occurs for a period of at least forty-five consecutive days: (i) an event of default, (ii) aggregate availability of all facilities has
been less than the greater of (A) 10% of the aggregate revolver commitments at such time and (B) $7.5 million, or
(iii) availability of the U.S. facility has been less than $3.75 million. The fixed charge coverage ratio tests the EBITDA and
fixed charges of KEMET and its subsidiaries on a consolidated basis.
In addition, the Revolver Agreement, as amended, includes various covenants that, subject to exceptions, limit the
ability of KEMET and its direct and indirect subsidiaries to, among other things: incur additional indebtedness; create liens on
assets; engage in mergers, consolidations, liquidations and dissolutions; sell assets (including pursuant to sale leaseback
transactions); pay dividends and distributions on or repurchase capital stock; make investments (including acquisitions), loans,
or advances; prepay certain junior indebtedness; engage in certain transactions with affiliates; enter into restrictive agreements;
amend material agreements governing certain junior indebtedness; and change its lines of business. The Revolver Agreement
includes certain customary representations and warranties, affirmative covenants and events of default.
Debt issuance costs related to the Revolver Agreement, net of amortization, were $0.1 million and $0.1 million as of
March 31, 2019 and 2018, respectively. These costs are included in the line item “Other assets” in the Consolidated Balance
Sheets and are amortized over the term of the Revolver Agreement. The Company’s available borrowing capacity under the
Loan and Security Agreement was $66.0 million as of March 31, 2019.
Other Debt
In January 2017, KEMET Electronics Portugal, S.A., (“KEP”) a wholly owned subsidiary, entered into a program with
the Portuguese government where KEP is eligible to receive interest free loans from the Portuguese government if KEP
purchases fixed assets for certain projects approved by the Portuguese government. In January 2017, KEP received the first part
of an interest free loan in the amount of EUR 2.2 million (or $2.5 million). In July 2017, KEP received the second part of the
loan in the amount of EUR 0.3 million (or $0.3 million). The loan has a maturity date of February 1, 2025. The loan will be
repaid through semi-annual payments on August 1 and February 1 of each year beginning on August 1, 2019. The repayments
will be in the amount of EUR 0.2 million (or $0.2 million).
In February 2019, KEP received a second interest free loan from the Portuguese government in the amount of EUR 0.9
million (or $1.1 million). The loan has a maturity date of September 1, 2026 and will be repaid through semi-annual payments
on March 1 and September 1 of each year beginning on March 1, 2021. The repayments will be in the amount of EUR 0.1
million (or $0.1 million).
Since the KEP debt is non-interest bearing, we have recorded debt discounts on the loans. These discounts are being
amortized over the life of the loans through interest expense. If certain conditions are met by KEP, such as increased headcount
at its facility in Evora, Portugal, increased revenue, and increased gross value added, a portion of these loans could be forgiven.
96
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
TOKIN has a short term borrowing pursuant to an agreement with The 77 Bank Limited, located in Japan, in the
amount of 350 million yen (or $3.2 million), at an interest rate of 0.53% (Japanese TIBOR + 40 basis points). The loan was
originally due in September 2018 and was extended to September 2019. The loan agreement automatically renews if both
parties choose not to terminate or modify it.
The following table highlights the Company’s annual cash maturities of debt (amounts in thousands):
TOKIN Term Loan Facility
Customer Advances (1)
Other
Annual Maturities of Debt Fiscal Years Ended March 31,
2020
2021
2022
2023
2024
Thereafter
$
$
24,826
$
24,826
$
24,826
$
24,826
$
24,826
$
161,371
—
3,604
1,800
560
6,850
647
4,028
647
734
647
—
909
28,430
$
27,186
$
32,323
$
29,501
$
26,207
$
162,280
(1) Repayment of the Customer Capacity Agreements assumes the customers purchase products in a quantity sufficient to require the maximum permitted debt
repayment amount per quarter.
Note 4: Restructuring
The Company has implemented restructuring plans which include programs to increase competitiveness by removing
excess capacity, relocating production to lower cost locations, relocating corporate functions to the new headquarters, and
eliminating unnecessary costs throughout the Company. Significant restructuring plans which include personnel reduction costs
that occurred during fiscal year ended March 31, 2019 are summarized below:
• Within the TOKIN legacy group, KEMET took a reduction in force across various operational and overhead functions.
The reduction in force was substantially complete as of March 31, 2019.
• The Solid Capacitors reportable segment is streamlining its vertical integration strategy by relocating its tantalum
powder facility equipment from Carson City, Nevada to its existing Matamoros, Mexico plant. Severance charges and
equipment relocation costs. The relocation is expected to be completed by December 31, 2019. The Solid Capacitors
reportable segment is also reorganizing due to a decline of MnO2 products. The efforts are expected to be completed
by June 30, 2019.
• The Film and Electrolytic reportable segment is streamlining its manufacturing operations by relocating axial
electrolytic production from its plant in Granna, Sweden and to its existing Evora, Portugal plant to consolidate axial
electrolytic production in an effort to further improve gross margins, net income, and cash flow. The relocation is
expected to be completed by June 30, 2019.
97
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Significant restructuring plans in progress or recently completed as of March 31, 2019 are summarized in the table
below (amounts in thousands):
Total expected to be
incurred
Personnel
Reduction
Costs
Relocation
& Exit
Costs
Incurred during year
ended March 31, 2019 (4)
Relocation
Personnel
& Exit
Reduction
Costs
Costs
Cumulative incurred to
date
Personnel
Reduction
Costs
Relocation
& Exit
Costs
Restructuring Plan
Segment
TOKIN operational &
overhead function
reduction in force
MSA, Corporate,
& Solid
Capacitors (1)
Tantalum powder facility
relocation(2) (3)
Axial electrolytic
production relocation from
Granna to Evora
Reorganization due to
decline of MnO2 Products
5,339
—
Solid Capacitors
850
2,468
Film and
Electrolytic
879
3,232
942
—
—
—
5,339
3,355
2,296
—
—
—
3,355
2,296
—
Solid Capacitors
1,798
—
1,585
—
1,585
___________________________________________
(1) Cumulative personnel reduction costs incurred to date are comprised of $3.8 million, $1.4 million, and $0.1 million within the MSA, Corporate, and Solid
Capacitor reportable segments, respectively.
(2) $0.9 million in tantalum reclaim is expected to be recovered as part of this restructuring activity, which will reduce total costs in subsequent periods.
(3) The Company expects to recover approximately $0.9 million related to tantalum reclaim, which would decrease the cumulative expenses incurred to date for
relocation and exit costs upon the completion of reclaim activities.
(4) The Company incurred $0.6 million in restructuring charges for minor projects not included in the table above during fiscal year ended March 31, 2019,
consisting of $0.3 million each in personal reduction costs and relocation and exit costs.
A summary of the expenses aggregated on the Consolidated Statements of Operations line item “Restructuring
charges” in the fiscal years ended March 31, 2019, 2018 and 2017, is as follows (amounts in thousands):
Personnel reduction costs
Relocation and exit costs
Restructuring charges
Fiscal Year Ended March 31, 2019
Fiscal Years Ended March 31,
2019
2018
2017
$
$
2,823
5,956
8,779
$
$
12,587
2,256
14,843
$
$
2,214
3,190
5,404
The Company incurred $8.8 million in restructuring charges in the fiscal year ended March 31, 2019, including $2.8
million in personnel reduction costs and $6.0 million in relocation and exit costs.
The personnel reduction costs of $2.8 million were primarily due to $0.9 million in costs related to headcount
reductions in the TOKIN legacy group across various internal and operational functions, $0.3 million in severance charges
related to personnel reductions in the Film and Electrolytic reportable segment resulting from a reorganization of the segment's
management structure, and $1.6 million in costs related to reorganization in the Solid Capacitors reportable segment due to a
permanent structural change driven by a decline of MnO2 products.
The relocation and exit costs of $6.0 million were primarily due to $3.4 million in costs related to the Company's
relocation of its tantalum powder equipment from Carson City, Nevada to its plant in Matamoros, Mexico and $2.3 million in
costs related to the relocation of axial electrolytic production equipment from Granna, Sweden to its plant in Evora, Portugal.
Fiscal Year Ended March 31, 2018
The Company incurred $14.8 million in restructuring charges in the fiscal year ended March 31, 2018, including $12.6
million related to personnel reduction costs and $2.3 million of relocation and exit costs.
The personnel reduction costs of $12.6 million were due to $5.2 million related to a voluntary reduction in force in the
Film and Electrolytic reportable segment's Italian operations; $4.4 million related to a headcount reduction in the TOKIN
legacy group across various internal and operational functions; $2.7 million in severance charges across various overhead
98
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
functions in the Simpsonville, South Carolina office as these functions were relocated to the Company's new corporate
headquarters in Fort Lauderdale, Florida; and $0.2 million in headcount reductions related to a European sales reorganization.
The relocation and exit costs of $2.3 million included $0.9 million in lease termination penalties related to the
relocation of global marketing, finance and accounting, and information technology functions to the Company's Fort
Lauderdale office, $0.8 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico
plant, $0.4 million in exit costs related to the shut-down of operations for KFM, and $0.1 million related to the transfer of
certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico.
Fiscal Year Ended March 31, 2017
The Company incurred $5.4 million in restructuring charges in the fiscal year ended March 31, 2017, including $2.2
million related to personnel reduction costs and $3.2 million of relocation and exit costs.
The personnel reduction costs of $2.2 million corresponded with the following: $0.3 million related to the
consolidation of certain Solid Capacitor manufacturing in Matamoros, Mexico; $0.4 million for headcount reductions related to
the shut-down of operations for KFM; $0.3 million related to headcount reductions in Europe (primarily Italy and Landsberg,
Germany) corresponding with the relocation of certain production lines and laboratories to lower cost regions; $0.3 million for
overhead reductions in Sweden; $0.3 million in U.S. headcount reductions related to the relocation of global marketing
functions to the Company’s Fort Lauderdale, Florida office; $0.3 million in headcount reductions related to the transfer of
certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico; $0.2 million in overhead reductions for the
relocation of research and development operations from Weymouth, England to Evora, Portugal; and $0.1 million in
manufacturing headcount reductions related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant.
The relocation and exit costs of $3.2 million included $1.9 million in expenses related to contract termination costs
related to the shut-down of operations for KFM; $0.6 million in expenses related to the relocation of the K-Salt operations to
the existing Matamoros, Mexico plant; $0.6 million for transfers of Film and Electrolytic production lines and R&D functions
to lower cost regions; and $0.1 million related to the transfer of certain Tantalum production from Simpsonville, South Carolina
to Victoria, Mexico.
A reconciliation of the beginning and ending liability balances for restructuring charges included in the line items
“Accrued expenses” and “Other non-current obligations” on the Consolidated Balance Sheets were as follows (amounts in
thousands):
Balance at March 31, 2016
Costs charged to expense
Costs paid or settled
Change in foreign exchange
Balance at March 31, 2017
TOKIN opening balance
Costs charged to expense (1)
Costs paid or settled
Change in foreign exchange
Balance at March 31, 2018
Costs charged to expense
Costs paid or settled
Change in foreign exchange
Balance at March 31, 2019
Personnel
Reductions
Relocation and
Exit Costs
$
976
$
2,214
(2,130)
(61)
999
—
12,384
(3,901)
147
9,629
2,823
(10,329)
(258)
1,865
$
$
—
3,190
(2,784)
—
406
312
2,256
(2,662)
18
330
5,956
(5,957)
(13)
316
_________________________________________
(1) Personnel reduction costs charged to expense include $0.2 million of relocation costs expensed as incurred, and therefore not included in accrued expenses
for the fiscal year ended March 31, 2018.
99
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 5: Goodwill and Intangible Assets
The following table highlights the Company’s intangible assets (amounts in thousands):
Indefinite Lived Intangible Assets:
Trademarks
Amortizing Intangibles:
Patents (10 - 18 years)
Customer relationships (10 - 21
years
Other
Total amortizing intangibles
March 31, 2019
March 31, 2018
Carrying
Amount
Accumulated
Amortization
Net Amount
Carrying
Amount
Accumulated
Amortization
Net Amount
$
15,151
$
— $
15,151
$
15,474
$
— $
15,474
26,662
(12,046)
14,616
26,662
(10,625)
16,037
37,850
214
64,726
(13,868)
(214)
(26,128)
(26,128) $
23,982
—
38,598
40,131
238
67,031
53,749
$
82,505
$
(11,735)
(238)
(22,598)
(22,598) $
28,396
—
44,433
59,907
Total intangible assets
$
79,877
$
For fiscal years ended March 31, 2019, 2018, and 2017, amortization related to intangibles was $4.5 million, $4.3
million and $2.1 million, respectively, consisting of amortization related to patents of $1.4 million, $1.4 million, and $1.5
million, respectively, and amortization related to customer relationships of $3.1 million, $2.9 million, and $0.6 million,
respectively.
The weighted-average useful life as of March 31, 2019 and 2018 for patents was 15.8 years and for customer
relationships was 12.3 years. The weighted-average period prior to the next renewal for patents was 2.5 years and 3.5 years as
of March 31, 2019 and 2018, respectively. Estimated amortization of intangible assets for each of the next five fiscal years is
$4.5 million, and thereafter, amortization will total $16.1 million. Estimated amortization of patents for each of the next five
fiscal years is $1.4 million, and thereafter, amortization will total $7.5 million. Estimated amortization of customer relationships
for each of the next five fiscal years is $3.1 million, and thereafter, amortization will total $8.6 million.
For fiscal year 2019, the Company completed its impairment test on goodwill and intangible assets with indefinite
useful lives as of January 1, 2019 and concluded that goodwill and indefinite-lived assets were not impaired. The were no
changes to the carrying amount of goodwill for the years ended March 31, 2019 and 2018. As of March 31, 2019, and 2018, the
carrying amount of goodwill was $40.3 million.
Note 6: Equity Method Investments
The following table provides a reconciliation of equity method investments to the Company's Consolidated Balance
Sheets (amounts in thousands):
Nippon Yttrium Co., Ltd ("NYC")
NT Sales Co., Ltd ("NTS")
Novasentis
KEMET Jianghai Electronics Components Co., Ltd (“KEMET Jianghai”)
March 31,
2019
2018
8,215
$
1,218
977
2,515
8,148
998
2,870
—
12,925
$
12,016
$
$
TOKIN's Joint Ventures - NYC and NTS
As noted in Note 2, “Acquisitions,” on April 19, 2017, the Company completed its acquisition of the remaining 66%
economic interest in TOKIN and TOKIN became a 100% owned subsidiary of KEMET. TOKIN had two investments at the
time of acquisition: NYC and NTS. The Company accounts for both investments using the equity method due to the related
nature of operations and the Company's ability to influence management decisions.
100
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
NYC was established in 1966 by TOKIN and Mitsui Mining and Smelting Co., Ltd (“Mitsui”). NYC was established
to commercialize yttrium oxides and the Company owns 30% of NYC's stock. The carrying amount of the Company's equity
investment in NYC was $8.2 million and $8.1 million as of March 31, 2019 and 2018, respectively.
NTS was established in 2004 by TOKIN, however subsequent to its formation, TOKIN sold 67% of its stock. NTS
provides world-class electronic devices by utilizing global procurement networks and the Company owns 33% of NTS' stock.
During the year ended March 31, 2019, a significant portion of NTS' sales were TOKIN’s products. The carrying amount of the
Company's equity investment in NTS was $1.2 million and $1.0 million as of March 31, 2019 and 2018, respectively.
Summarized transactions between TOKIN and NTS are as follows (amounts in thousands):
KEMET's sales to NTS
NTS' sales to KEMET
Investment in Novasentis
Fiscal Year Ended March 31,
2019
2018
$
49,740
$
2,501
52,883
1,616
During fiscal year 2018, KEMET invested in the Series-D round of funding of Novasentis, a leading developer of film-
based haptic actuators. Novasentis produces the world’s thinnest electro mechanical polymer-based actuators that provide rich
haptic feedback for a variety of applications, including augmented/virtual reality and wearables. Novasentis supplies its “smart”
film and KEMET applies its expertise in manufacturing film capacitors to the development and commercial production of the
actuators. The Company's ownership percentage in Novasentis is 27.9% and has 1 of 3 seats on Novasentis’ board of directors.
Additionally, KEMET has an exclusive manufacturing supply agreement, whereby Novasentis (the “Buyer”) will purchase
goods exclusively from KEMET (the “Seller”) and the Seller shall manufacture and sell goods exclusively to the Buyer.
While the Company determined that Novasentis is a variable interest entity, the Company concluded that it is not the
primary beneficiary of Novasentis. Accordingly, the Company accounts for its investment in Novasentis under
the equity method of accounting.
Under the equity method, the Company's share of profits and losses and impairment charges on investments in
affiliates are included in “Equity income (loss) from equity method investments” in the Consolidated Statements of Operations.
During the fourth quarter of fiscal year 2019, the Company recorded $2.7 million of impairment on its investment in
Novasentis. The carrying amount of the Company's equity investment in Novasentis was $1.0 million and $2.9 million as of
March 31, 2019 and 2018, respectively.
KEMET JIANGHAI Joint Venture
On January 29, 2018, KEC entered into a joint venture agreement (the “Agreement”) with Jianghai (Nantong) Film
Capacitor Co., Ltd (“Jianghai Film”), a subsidiary of Nantong Jianghai Capacitor Co., Ltd (“Jianghai”) for the formation of
KEMET Jianghai Electronic Components Co. Ltd., a limited liability company located in Nantong, China. KEMET Jianghai
was officially formed on May 16, 2018 to manufacture axial electrolytic capacitors and (H)EV Film DC brick capacitors, for
distribution through the KEMET and Jianghai Film sales channels. During fiscal year 2019 the Company signed an amendment
to the Agreement with Jianghai Film to expand the scope of KEMET Jianghai to also produce solid aluminum capacitors and
aluminum electrolytic capacitors. The Company's ownership percentage is 50.0% and the Company and Jianghai Film are
equally represented on the joint venture’s board of directors.
The Company's initial capital contribution to KEMET Jianghai was made during the second quarter of fiscal year
2019, and the Company accounts for its investment using the equity method due to the related nature of operations and its
ability to influence the joint venture's decisions. As of March 31, 2019, the carrying amount of the Company's equity
investment in KEMET Jianghai was $2.5 million.
Investment in TOKIN
As noted in Note 2, “Acquisitions,” the Company held a 34% economic interest in TOKIN from February 1, 2013
through April 19, 2017. The Company completed its acquisition of the remaining 66% economic interest in TOKIN on April 19,
2017. During the time period that the Company held its 34% economic interest in TOKIN, the Company accounted for its
investment using the equity method for a non-consolidated variable interest entity since KEMET did not have the power to
101
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
direct significant activities of TOKIN. Prior to the acquisition, the Company had a put option that could have required KEMET
to purchase all of the outstanding capital stock of TOKIN from its shareholders (the “Put Option”). The Put Option was
canceled as part of the TOKIN acquisition and accounted for as a reduction in the purchase price of TOKIN. In fiscal years
prior to the TOKIN acquisition, the Put Option was marked to fair value as of the end of each reporting period with the change
in fair value included in the line item “Change in the value of TOKIN options” in the Consolidated Statements of Operations.
For the fiscal year ended March 31, 2017, the Company recognized a $10.7 million gain related to the change in the fair value
of the Put Option.
Summarized financial information for TOKIN for fiscal years 2018 and 2017 are as follows (amounts in thousands):
Net sales
Gross profit
Net income
19 Day Period Ended
April 19, 2017
Fiscal Year March
31, 2017
$
23,649 $
6,647
247,786
328,822
74,465
128,502
A reconciliation between TOKIN’s net income and KEMET’s equity investment income for fiscal years 2018 and 2017
are as follows (amounts in thousands):
TOKIN net income
KEMET’s equity ownership %
Equity income from TOKIN before Adjustments
Adjustments:
Amortization and depreciation
Removal of EMD memo accounts
Inventory profit elimination
Equity income from TOKIN
Acquired equity method investment income
Equity income from equity method investments
19 Day Period Ended
April 19, 2017
Fiscal Year March
31, 2017
$
$
247,786
34%
84,247
$
$
128,502
34%
43,691
(113)
(8,981)
24
75,177
1,015
$
76,192
$
(2,210)
—
162
41,643
—
41,643
Summarized transactions between KEC and TOKIN are as follows (amounts in thousands):
KEC’s sales to TOKIN
TOKIN’s sales to KEMET
Note 7: Reportable Segment and Geographic Information
19 Day Period Ended
April 19, 2017
Fiscal Year March
31, 2017
$
$
727
356
17,100
8,341
The Company is organized into three reportable segments: Solid Capacitors, Film and Electrolytic, and MSA based
primarily on product lines.
The reportable segments are responsible for their respective manufacturing sites as well as their research and
development efforts. The Company does not allocate corporate indirect selling, general and administrative (“SG&A”) or shared
R&D expenses to the segments.
102
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Solid Capacitors
Solid Capacitors operates in ten manufacturing sites in the United States, Mexico and Asia, and operates innovation
centers in the United States and Japan. Solid Capacitors primarily produces tantalum, aluminum, polymer and ceramic
capacitors which are sold globally. Solid Capacitors also produces tantalum powder used in the production of tantalum
capacitors.
Film and Electrolytic
Film and Electrolytic operates in nine manufacturing sites throughout Europe and Asia, and maintain product
innovation centers in Italy, Portugal, and Sweden. Film and Electrolytic primarily produces film, paper, and wet aluminum
electrolytic capacitors, which are sold globally. In addition, the Film and Electrolytic reportable segment designs and produces
electromagnetic interference filters.
MSA
MSA operates in four manufacturing sites throughout Asia and operates a product innovation center in Japan. MSA
primarily produces EMC materials and devices, piezo materials and actuators, and various types of sensors, which are sold
globally.
In the following tables, revenue is disaggregated by primary geographical market, sales channel, and major product
lines. The tables also include reconciliations of the disaggregated revenue with the reportable segments for the fiscal years
ended 2019, 2018 and 2017 (amounts in thousands):
Primary geographical markets
Asia and the Pacific Rim ("APAC")
Europe, the Middle East, and Africa ("EMEA")
North and South America ("Americas")
Japan and Korea ("JPKO")
Sales channel
OEM
Distributor
EMS
Major product lines
Tantalum
Ceramics
Film and Electrolytic
MSA
Fiscal Year Ended March 31, 2019
Solid
Capacitors
Film and
Electrolytic
MSA
Total
$
411,183
$
51,923
$
70,234
$
533,340
189,992
297,167
37,496
122,956
30,462
2,587
10,213
899
157,706
315,535
337,842
196,101
$
935,838
$
206,240
$
240,740
$ 1,382,818
$
$
290,058
475,190
170,590
81,704
100,113
24,423
$
226,544
9,315
4,881
$
598,306
584,618
199,894
$
935,838
$
206,240
$
240,740
$ 1,382,818
$
563,255
$
372,583
— $
—
206,240
—
—
—
240,740
— $
563,255
—
—
372,583
206,240
240,740
$
935,838
$
206,240
$
240,740
$ 1,382,818
103
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Primary geographical markets
Asia and the Pacific Rim
Europe, the Middle East, and Africa
North and South America
Japan and Korea
Sales channel
OEM
Distributor
EMS
Major product lines
Tantalum
Ceramics
Film and Electrolytic
MSA
Fiscal Year Ended March 31, 2018
Solid
Capacitors
Film and
Electrolytic
MSA
Total
$
350,791
$
58,922
$
70,274
$
479,987
156,169
227,582
36,698
119,649
22,634
2,080
8,889
772
145,721
277,898
259,105
183,191
$
771,240
$
201,977
$
226,964
$ 1,200,181
$
262,097
$
86,049
$
215,349
$
563,495
366,569
142,574
92,708
23,220
11,047
568
470,324
166,362
$
771,240
$
201,977
$
226,964
$ 1,200,181
$
495,114
$
276,126
— $
—
201,977
—
—
—
226,964
— $
495,114
—
—
276,126
201,977
226,964
$
771,240
$
201,977
$
226,964
$ 1,200,181
104
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Primary geographical markets
Asia and the Pacific Rim
Europe, the Middle East, and Africa
North and South America
Japan and Korea
Sales channel
OEM
Distributor
EMS
Major product lines
Tantalum
Ceramics
Film and Electrolytic
MSA
Fiscal Year Ended March 31, 2017
Solid
Capacitors
Film and
Electrolytic
MSA
Total
$
237,847
$
50,917
$
— $
288,764
128,617
202,812
5,834
108,820
21,244
1,247
—
—
—
237,437
224,056
7,081
$
575,110
$
182,228
$
— $
757,338
$
162,411
$
83,986
$
— $
246,397
275,591
137,108
79,048
19,194
—
—
354,639
156,302
$
575,110
$
182,228
$
— $
757,338
$
342,184
232,926
182,228
—
—
$
342,184
232,926
182,228
—
—
—
$
575,110
$
182,228
$
— $
757,338
105
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following highlights net sales by geographic location (amounts in thousands):
United States
Hong Kong
Germany
Europe (2) (3)
China
Taiwan
Asia Pacific (2)
Japan
United Kingdom
Netherlands
Malaysia
Singapore
Italy
Hungary
Mexico
Other Countries (2)
Total Non-United States (3)
Fiscal Years Ended March 31,(1)
2018
2019
2017
$
$
292,980
188,102
124,805
76,149
173,148
88,853
47,233
178,502
42,472
44,065
33,748
19,417
15,551
12,245
44,267
1,281
1,089,838
1,382,818
$
$
233,133
169,073
105,548
64,248
163,016
78,728
36,647
170,282
37,038
39,684
28,165
17,267
17,905
13,254
23,915
2,278
967,048
1,200,181
$
$
198,250
121,813
104,755
63,863
71,223
9,147
26,878
3,565
33,837
32,478
15,177
15,565
15,376
18,856
22,424
4,131
559,088
757,338
______________________________________________________________________________
(1) Revenues are attributed to countries or regions based on the location of the customer. Net Sales to one customer, TTI, Inc., exceeded 10% of total net sales as
follows: $184.3 million, $133.5 million and $104.4 million in fiscal years 2019, 2018 and 2017, respectively.
(2) No country included in this caption exceeded 3% of consolidated net sales for fiscal years 2019, 2018 and 2017.
(3) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
106
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following tables summarize information for operating income (loss), depreciation and amortization, restructuring
charges, gain (loss) on write down and disposal of long-lived assets, and capital expenditures by reportable segment for the
fiscal years ended 2019, 2018 and 2017 and total assets by reportable segment for the fiscal years ended 2019 and 2018
(amounts in thousands):
Operating income (loss): (1)
Solid Capacitors
Film and Electrolytic (1)
MSA
Corporate
Depreciation and amortization expense: (1)
Solid Capacitors
Film and Electrolytic (1)
MSA
Corporate
Restructuring charges:
Solid Capacitors
Film and Electrolytic
MSA
Corporate
(Gain) loss on write down and disposal of long-lived assets
Solid Capacitors
Film and Electrolytic
MSA
Corporate
Capital expenditures:
Solid Capacitors
Film and Electrolytic
MSA
Corporate
Fiscal Years Ended March 31,
2019
2018
2017
$
348,150
$
234,473
$
$
$
$
$
$
$
$
$
8,183
22,546
(178,030)
200,849
28,795
9,763
5,226
8,844
52,628
4,922
2,717
452
688
8,779
235
(93)
—
$
$
$
$
$
$
3,622
15,694
(140,937)
112,852
27,329
10,918
4,407
8,007
50,661
983
5,788
3,343
4,729
14,843
689
(3,356)
1,272
$
$
$
$
$
$
1,518
1,660
$
403
(992) $
80,700
$
31,249
$
16,000
13,400
35,956
12,651
8,481
12,623
$
146,056
$
65,004
$
147,662
(9,028)
—
(103,666)
34,968
20,824
11,766
—
5,561
38,151
1,333
3,738
—
333
5,404
2,303
8,339
—
29
10,671
12,300
7,955
—
5,362
25,617
_______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
107
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Total assets:
Solid Capacitors
Film and Electrolytic (1)
MSA
Corporate
March 31,
2019
2018
$
794,402
$
219,711
234,419
69,563
704,851
240,968
254,193
22,911
$
1,318,095
$
1,222,923
_______________________________________________________________________________
(1) March 31, 2018 adjusted due to the adoption of ASC 606.
The following geographic information includes Property, plant and equipment, net, based on physical location
(amounts in thousands):
United States
Japan
Thailand
Mexico
Italy
China
Portugal
Macedonia
Bulgaria
Sweden
Other (1)
Total Non-United States
March 31,
2019
2018
$
57,095
$
89,602
82,389
121,147
35,197
45,815
31,872
12,906
5,480
4,800
8,977
438,185
$
495,280
$
49,530
79,855
74,100
62,503
39,398
36,396
29,073
13,723
5,597
6,005
9,136
355,786
405,316
_______________________________________________________________________________
(1) No country included in this caption exceeded 1% of consolidated Property, plant and equipment net for fiscal years 2019 and 2018.
Note 8: (Gain) Loss on Write Down and Disposal of Long-Lived Assets
During fiscal year 2019, KEMET recorded a net loss on the write down and disposal of long-lived assets of $1.7
million, which was comprised of $0.7 million in impairment charges and $1.0 million in net losses on the sale and disposal of
long-lived assets. The impairment charges were primarily related to the write down of idle land and machinery of $0.5 million
and $0.2 million, respectively, at TOKIN. The $1.0 million net loss on write down and disposal of long-lived assets primarily
consisted of the disposal of furniture and fixtures resulting from the Company relocation of its corporate headquarters to Fort
Lauderdale, Florida and the disposal of old machinery throughout the Company that was no longer being used. These activities
are recorded on the Consolidated Statements of Operations line item "(Gain) loss on write down and disposal of long-lived
assets."
During fiscal year 2018, the Company recorded a net gain on the write down and disposal of long-lived assets of $1.0
million, which was comprised of $1.2 million in net gains on the sale and disposal of long-lived assets offset by $0.2 million in
impairment charges. The net gains on the sale and disposal of long-lived assets were primarily related to the sale of equipment,
land, and buildings from KFM, which was shut down in fiscal year 2017. On March 13, 2018, the Company sold KFM's land
and buildings to a third party for a gross sales price of $3.6 million. The net proceeds realized by the Company were
approximately $3.4 million after payment of $0.2 million in closing costs. The Company realized a gain on the sale of the land
and buildings of approximately $1.9 million during the year ended March 31, 2018 as a result of the sale. In addition, the
Company sold KFM's equipment for a $1.4 million gain. These gains were partially offset by MSA's loss on disposals of assets
108
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
of $1.3 million primarily related to equipment and buildings used for discontinued products and Solid Capacitors' loss of
approximately $0.6 million related to the relocation of its K-Salt operations from a leased facility to its existing Matamoros,
Mexico facility.
During fiscal year 2017, the Company recorded a net loss on write down and disposal of long-lived assets of $10.7
million, which was comprised of $10.3 million in impairment charges and $0.4 million in net losses on the sale and disposal of
long-lived assets. In fiscal year 2017, Film and Electrolytic incurred impairment charges totaling $8.2 million. The impairment
charges consisted of the following two actions.
On August 31, 2016, KEMET Electronics Corporation, a wholly-owned subsidiary of KEMET made the decision to
shut-down operations of its wholly-owned subsidiary, KFM. Operations at KFM’s Knoxville, Tennessee plant ceased as of
October 31, 2016. The Company recorded impairment charges related to KFM totaling $4.1 million comprised of $3.0 million
for the write down of property plant and equipment and $1.1 million for the write down of intangible assets.
The Company also recorded impairment charges of $4.1 million related to a decline in real estate market conditions
surrounding its vacated Sasso Marconi, Italy manufacturing facility.
In fiscal year 2017, Solid Capacitors incurred impairment charges totaling $2.1 million related to the relocation of its
leased K-salt facility to the existing Matamoros, Mexico facility.
Note 9: Pension and Other Post-retirement Benefit Plans
The Company sponsors twelve defined benefit pension plans: six in Europe, one in Singapore, two in Mexico, two in
Japan, and one in Thailand. The Company funds the pension liabilities in accordance with laws and regulations applicable to
those plans.
In addition, the Company maintains two frozen post-retirement benefit plans: health care and life insurance benefits
for certain retired United States employees who reached retirement age while working for the Company. The health care plan is
contributory, with participants’ contributions adjusted annually. The life insurance plan is non-contributory.
109
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
A summary of the changes in benefit obligations and plan assets at March 31, 2019 and 2018 is as follows (amounts in
thousands):
Change in Benefit Obligation
Benefit obligation at beginning of the year
$
161,673
$
45,171
$
367
$
Pension
Other Benefits
2019
2018
2019
2018
Service cost
Interest cost
Plan participants’ contributions
Actuarial (gain) loss
Foreign currency exchange rate change
Gross benefits paid
Curtailments and settlements
Acquisitions
Benefit obligation at end of year
Change in Plan Assets
Fair value of plan assets at beginning of year
Actual return on plan assets
Foreign currency exchange rate changes
Employer contributions
Settlements
Plan participants’ contributions
Gross benefits paid
Acquisitions
Fair value of plan assets at end of year
Funded status at end of year
Fair value of plan assets
Benefit obligations
Amount recognized at end of year
4,716
1,815
—
1,146
(8,402)
(1,097)
(11,411)
—
148,440
71,491
1,165
(3,161)
7,882
(12,379)
—
(1,096)
—
$
$
4,585
1,750
—
437
9,934
(1,128)
(5,642)
106,566
161,673
10,004
2,594
3,831
4,766
(5,659)
—
(1,128)
57,083
$
$
—
11
641
(81)
—
(626)
—
—
312
$
— $
—
—
(15)
—
641
(626)
—
63,902
$
71,491
$
— $
$
63,902
(148,440)
(84,538) $
$
71,491
(161,673)
(90,182) $
— $
(312)
(312) $
$
$
$
$
$
386
—
12
536
64
—
(631)
—
—
367
—
—
—
95
—
536
(631)
—
—
—
(367)
(367)
The Company expects to contribute $5.1 million to the pension plans in fiscal year 2020, which includes direct
contributions to be made for funded plans and benefit payments to be made for unfunded plans.
The Company does not pre-fund its post-retirement health care and life insurance benefit plans. As a result, the
Company is responsible annually for the payment of benefits as incurred by the plans. The Company anticipates making
payments of $0.1 million during fiscal year 2020.
Amounts recognized in the Consolidated Balance Sheets at March 31, 2019 and 2018 consist of the following
(amounts in thousands):
Noncurrent asset
Current liability
Noncurrent liability
Net Amount recognized, end of year
Pension
Other Benefits
2019
2018
2019
2018
$
$
$
$
670
(2,753) $
(82,455)
(84,538) $
— $
(7,000) $
(83,182)
(90,182) $
— $
(50) $
(262)
(312) $
—
(54)
(313)
(367)
110
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Amounts recognized in Accumulated other comprehensive income (loss) at March 31, 2019 and 2018 consist of the
following (amounts in thousands):
Net actuarial loss (gain)
Prior service cost
Accumulated other comprehensive (income) loss
Pension
Other Benefits
2019
2018
2019
2018
$
$
16,864
1,325
18,189
$
$
15,691
1,413
17,104
$
$
(793) $
—
(793) $
(879)
—
(879)
Although not reflected in the table above, the tax effect on the pension balances was $2.4 million and $2.3 million as
of March 31, 2019 and 2018, respectively.
The components of net periodic benefit (income) costs for the fiscal years ended March 31, 2019, 2018 and 2017 are
as follows (amounts in thousands):
2019
Pension
2018
2017
2019
2018
2017
Other Benefits
Net service cost
$
4,716
$
4,585
$
1,298
$
— $
— $
Interest cost
Expected return on plan assets (1)
Amortization:
Actuarial (gain) loss (2)
Prior service cost
Recurring activity
One time expense (income)
1,815
(2,037)
1,750
(1,956)
396
87
4,977
115
393
87
4,859
(71)
4,788
$
1,297
(346)
419
82
2,750
(11)
2,739
$
11
—
12
—
(167)
—
(156)
—
(156) $
(191)
—
(179)
—
(179) $
—
11
—
(207)
—
(196)
—
(196)
Net periodic benefit cost (credit)
$
5,092
$
_______________________________________________________________________________
(1) The Company has elected to use the actual fair value of plan assets as the market-related value of assets in the determination of the expected return on plan
assets.
(2) Actuarial gains and losses are amortized using a corridor approach. The total unrecognized amount of cumulative actuarial gain or loss in excess of 10% of
the greater of the market value of assets or the projected benefit obligation is amortized over the average remaining service of active employees/lifetime of plan
participants for plans with no active participants.
All of the amounts in the table above, other than net service cost, were recorded in the line item “Other (income)
expense, net” in the Consolidated Statements of Operations.
The estimated amounts related to pensions that will be amortized from accumulated other comprehensive income into
net periodic benefit costs in fiscal year 2020 are actuarial losses of $0.5 million, and prior service costs of $0.1 million. The
estimated amounts related to other benefits that will be amortized from accumulated other comprehensive income into net
periodic benefit costs in fiscal year 2020 are actuarial gains of $0.1 million.
111
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The asset allocation for the Company’s defined benefit pension plans at March 31, 2019 and the target allocation for
2019, by asset category, are as follows:
Asset Category
Insurance (1)
International equities
International bonds
Other
Total
Target
Allocation
(%)
Plan Assets at
March 31, 2019
(%)
1
34
61
4
100
1
31
61
7
100
_______________________________________________________________________
(1) Comprised of assets held by the defined benefit pension plan in Germany.
The Company’s investment strategy for its defined benefit pension plans is to maximize long-term rate of return on
plan assets within an acceptable level of risk to minimize the cost of providing pension benefits. The investment policy
establishes a target allocation range for each asset class and the fund is managed within those ranges. The plans use a number of
investment approaches including insurance products, equity and fixed income funds in which the underlying securities are
marketable in order to achieve this target allocation. Certain plans invest solely in insurance products. The Company
continuously monitors the performance of the overall pension asset portfolio, asset allocation policies, and the performance of
individual pension asset managers and makes adjustments and changes, as required. The Company does not manage any assets
internally, does not have any passive investments in index funds, and does not directly utilize futures, options, or other
derivative instruments or hedging strategies with regard to the pension plans; however, the investment mandate of some pension
asset managers allows the use of the foregoing as components of their portfolio management strategies.
The expected rate of return was determined by modeling the expected long-term rates of return for broad categories of
investments held by the plan against a number of various potential economic scenarios.
Other changes in plan assets and benefit obligations recognized in Accumulated other comprehensive income (loss) are
as follows (amounts in thousands):
2019
Pension
2018
2017
2019
2018
2017
Other Benefits
Current year actuarial (gain) loss
Amortization of actuarial gain (loss)
Current year prior service cost
Amortization of prior service cost
Total recognized in other comprehensive income
Total recognized in net periodic benefit cost and
other comprehensive income (loss)
$
$
$
1,684
(511)
—
(87)
1,086
6,178
$
$
$
(184) $
(322)
—
(87)
(593) $
1,229
(619)
—
(82)
528
4,195
$
3,267
$
$
$
(81) $
167
—
—
86
$
255
(70) $
76
64
$
191
—
—
$
$
(228)
208
—
—
(20)
(216)
Each of these changes has been factored into the following benefit payments schedule for the next ten fiscal years. The
Company expects to have benefit payments in the future as follows (amounts in thousands):
Pension benefits
Other benefits
Total
Expected benefit payments
2020
2021
2022
2023
2024
2025- 2029
$
$
6,707
51
6,758
$
$
6,679
47
6,726
$
$
8,416
42
8,458
$
$
8,126
37
8,163
$
$
9,828
33
9,861
$
$
54,107
105
54,212
112
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following weighted-average assumptions were used to determine the projected benefit obligation at the
measurement date and the net periodic cost for the pension and post-retirement plan (amounts in thousands except percentages):
Projected benefit obligation:
Discount rate
Rate of compensation increase
Health care cost trend on covered charges
Net periodic benefit cost:
Discount rate
Rate of compensation increase
Expected return on plan assets
Health care cost trend on covered charges
Pension
Other Benefits
2019
2018
2019
2018
1.2%
3.5%
1.3%
3.5%
3.0%
1.2%
3.5%
1.2%
3.5%
3.0%
3.3%
—%
3.5%
—%
6.5%
decreasing to
ultimate trend
of 5.0% in 2025
7.0%
decreasing to
ultimate trend
of 5.0% in 2022
3.5%
—%
—%
3.2%
—%
—%
7.0%
decreasing to
ultimate trend
of 5.0% in 2022
7.0%
decreasing to
ultimate trend
of 5.0% in 2021
The measurement date used to determine pension and post-retirement benefits is March 31.
The Company evaluated input from its third-party actuary to determine the appropriate discount rate. The
determination of the discount rate is based on various factors such as the rate on bonds, term of the expected payouts, and long-
term inflation factors.
The following table sets forth by level, within the fair value hierarchy as described in Note 1, the pension plan’s assets,
required to be carried at fair value on a recurring basis as of March 31, 2019 and March 31, 2018 (amounts in thousands):
Cash and cash equivalents
$
319
$
319
$ — $ — $
193
$
193
$ — $ —
Fair Value
March 31,
2019
Fair Value Measurement Using
Level 1
Level 2 (1)
Level 3 (2)
Fair Value
March 31,
2018
Fair Value Measurement Using
Level 1
Level 2
Level 3
Equity securities:
International equities
Fixed income securities:
International bonds
Insurance contracts
Diversified growth funds
19,965
— 19,965
—
22,391
— 22,391
39,030
642
3,946
— 39,030
—
—
—
3,946
—
642
—
43,742
697
4,468
— 43,742
—
—
—
4,468
$
63,902
$
319
$ 62,941
$
642
$
71,491
$
193
$ 70,601
$
—
—
697
—
697
___________________________________________
(1) Level 2 plan assets consist of pooled investment funds which are unquoted and have no restriction on redemption. Fair value was determined using daily,
weekly, or monthly trading activity which derives the unit price of the pooled fund.
(2) Level 3 plan assets are invested in reinsurance contracts whose value is the sum of the actuarial reserve and the profit participation of each contract. The
actuarial reserve is the sum of discounted cash flows associated with future benefits and premiums.
The table below sets forth a summary of changes in the fair value of the defined benefit pension plan’s Level 3 assets
for the fiscal years ended March 31, 2018 and March 31, 2019 (amounts in thousands):
113
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Balance at March 31, 2017
Actual return on plan assets
Employer contributions
Benefits paid
Foreign currency exchange rate change
Balance at March 31, 2018
Actual return on plan assets
Employer contributions
Benefits paid
Foreign currency exchange rate change
Balance at March 31, 2019
$
$
$
580
41
219
(233)
90
697
20
233
(247)
(61)
642
The Company also sponsors a deferred compensation plan for highly compensated employees. The plan is non-
qualified and allows certain employees to contribute to the plan. Company matches, net of gains (losses) related to the deferred
compensation plan, were $0.1 million in fiscal year 2019, $0.2 million in fiscal year 2018, and $0.2 million in fiscal year 2017.
Total benefits accrued under this plan were $2.3 million and $2.1 million at March 31, 2019 and March 31, 2018, respectively.
In addition, the Company has a defined contribution retirement plan (the “Savings Plan”) in which all United States
employees who meet certain eligibility requirements may participate. A participant may direct the Company to contribute
amounts, based on a percentage of the participant’s compensation, to the Savings Plan through the execution of salary reduction
agreements. In addition, the participants may elect to make after-tax contributions. The Company matches contributions to the
Savings Plan up to 6% of the employee’s salary. The Company made matching contributions of $2.8 million, $2.2 million and
$2.4 million in fiscal years 2019, 2018, and 2017, respectively.
Note 10: Stock-Based Compensation
The Company’s stock-based compensation plans are broad-based, long-term retention programs intended to attract and
retain talented employees and align stockholder and employee interests.
The major components of stock-based compensation expense are as follows (amounts in thousands):
Fiscal year ended March 31, 2019
Fiscal year ended March 31, 2018
Fiscal year ended March 31, 2017
Stock
Options
Restricted
Stock
LTIPs
Stock
Options
Restricted
Stock
LTIPs
Stock
Options
Restricted
Stock
LTIPs
Cost of sales
$ — $ 1,502
$ 1,254
$ — $
865
$
654
$
21
$
634
$
729
Selling, general and
administrative expenses
Research and development
Employee Stock Options
—
—
7,338
88
2,413
271
—
—
4,195
46
1,695
202
$ — $ 8,928
$ 3,938
$ — $ 5,106
$ 2,551
$
20
1
42
1,490
26
1,620
179
$ 2,150
$ 2,528
As of March 31, 2019, the KEMET Corporation Omnibus Incentive Plan (the “Incentive Plan”), which amended and
restated the KEMET Corporation 2014 Amendment and Restatement of the KEMET Corporation 2011 Omnibus Equity Incentive
Plan, approved by the Company’s stockholders on August 2, 2017, is the only plan the Company has to issue equity-based awards
to executives and key employees. Upon adoption of the Incentive Plan, no further awards were permitted to be granted under the
Company’s prior plans, including the 1992 Key Employee Stock Option Plan, the 1995 Executive Stock Option Plan, and the
2004 Long-Term Equity Incentive Plan (collectively, the “Prior Plans”).
The Incentive Plan has authorized, in the aggregate, the grant of up to 12.2 million shares of the Company’s Common
Stock, comprised of 11.4 million shares under the Incentive Plan and 0.8 million shares remaining from the Prior Plans and
authorizes the Company to provide equity-based compensation in the form of:
114
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
•
•
•
•
•
stock options, including incentive stock options, entitling the optionee to favorable tax treatment under Section 422 of
the Code;
stock appreciation rights;
restricted stock and restricted stock units ("RSUs");
other share-based awards; and
performance awards.
Options issued under these plans vest within one to three years and expire ten years from the grant date.
If available, the Company issues shares of Common Stock from treasury stock upon exercise of stock options and
vesting of restricted stock units. The Company has no plans to purchase additional shares in conjunction with its employee stock
option plans in the near future.
Employee stock option activity for fiscal year 2019 is as follows:
Outstanding at April 1, 2018
Exercised
Expired
Outstanding at March 31, 2019
Exercisable at March 31, 2019
Remaining weighted average contractual life of options exercisable (years)
Remaining weighted average contractual life of options outstanding (years)
Options
(in thousands)
Weighted-
Average
Exercise
Price
$
230
(74)
(1)
155
155
$
6.36
6.42
1.92
6.37
6.37
2.84
2.84
115
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Amounts included in the following table are in thousands, except weighted average fair value and weighted average
exercise price:
Weighted average grant-date fair value of non-vested shares
$
— $
— $
2.72
Weighted average grant-date fair value of shares
Fiscal Years Ended
March 31,
2019
2018
2017
Granted
Vested
Forfeited
Total estimated fair value of shares vested
Intrinsic value
Stock options exercised
Options outstanding
Options currently exercisable
Total unrecognized compensation cost, non-vested options
Weighted-average period of recognition for unrecognized compensation cost (in
years)
Weighted average exercise price of stock options expected to vest
—
2.72
2.72
223
890
—
—
—
—
6,914
2,713
2,713
—
—
—
—
1,296
1,644
1,644
—
N/A
N/A
All option plans provide that options to purchase shares be supported by the Company’s authorized but unissued
common stock or treasury stock. All restricted stock and performance awards are also supported by the Company’s authorized but
unissued common stock or treasury stock. The prices of the options granted pursuant to these plans are not less than 100% of the
value of the shares on the date of the grant.
Restricted Stock Units (“RSU’s”) and Long-term Incentive Plans (“LTIP”)
The Company grants RSUs to members of the Board of Directors (“Board”), the Chief Executive Officer and a limited
group of executives. In fiscal year 2019, RSUs granted to the Board vested immediately and RSUs granted to certain officers
under the key manager stock program vest over 3 years. Once vested, RSUs are converted into restricted shares of common stock,
except for RSUs granted to members of the Board, who can elect to defer settlement of the RSUs to a later date. Restricted shares
cannot be sold until 90 days after the Chief Executive Officer, executive, key manager, or member of the Board, as applicable,
resigns from his or her position, or until the KEMET employee achieves the targeted ownership under the Company’s stock
ownership guidelines, and only to the extent that such ownership exceeds the target. As of March 31, 2019, and 2018,
unrecognized compensation costs related to the non-vested restricted stock share-based compensation arrangements granted were
$8.0 million and $8.1 million, respectively. The expense is being recognized over the respective vesting periods.
Historically the Board of the Company has approved annual LTIPs which cover two-year periods and are primarily based
upon the achievement of an adjusted EBITDA range for the two-year period. At the time of the award, the individual plans entitle
the participants to receive cash or RSUs, or a combination of both as determined by the Company's Board. The Company assesses
the likelihood of meeting the Adjusted EBITDA financial metric on a quarterly basis and adjusts compensation expense to match
expectations. The 2016/2017 LTIP, 2017/2018 LTIP, 2018/2019 LTIP and 2019/2020 LTIP also awarded time-based RSUs which
vest over the course of three years from the anniversary of the establishment of the plan and are not subject to a performance
metric. Any related liability (for the cash portion of the LTIP) is reflected in the line item “Accrued expenses” on the Consolidated
Balance Sheets and any restricted stock commitment is reflected in the line item “Additional paid-in capital” on the Consolidated
Balance Sheets. As of March 31, 2019 and 2018, unrecognized compensation costs related to the cash portion of LTIP
arrangements granted were $2.4 million and $0.1 million, respectively. As of March 31, 2019 and 2018, unrecognized
compensation costs related to the stock portion of LTIP arrangements granted were $4.1 million and $1.6 million, respectively.
The expense is being recognized over the respective vesting periods.
116
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following is the performance-based vesting schedule of RSUs under each respective LTIP, subject to the respective
participant’s continued employment with KEMET (shares in thousands):
Performance-based award vested fiscal year 2019
Performance-based award vesting fiscal year 2020
Potential performance-based award vesting fiscal year 2021 (2)
2019/2020
—
104
104
2018/2019 (1)
—
2017/2018 (1)
—
—
—
—
—
2016/2017
173
—
—
___________________________________________
(1) The performance portion of the 2018/2019 and 2017/2018 LTIP are payable in cash.
(2) Estimated shares to vest based upon current performance expectations. The final number of shares depends on the achievement of performance metrics.
The following is the time-based vesting schedule of RSUs under each respective LTIP, subject to the respective
participant’s continued employment with KEMET (shares in thousands):
Time-based award vested fiscal year 2019
Time-based award vesting fiscal year 2020
Time-based award vesting fiscal year 2021
Time-based award vesting fiscal year 2022
2019/2020
2018/2019
2017/2018
2016/2017
13
53
53
54
85
58
60
—
224
156
—
—
191
—
—
—
RSU activity, including performance-based and time-based LTIP activity, for fiscal year 2019 is as follows (amounts in
thousands except fair value):
Non-vested restricted stock at April 1, 2018
Granted
Vested (1)
Forfeited (2)
Non-vested restricted stock at March 31, 2019
Weighted-
average
Fair Value on
Grant Date
7.96
19.43
7.67
12.68
15.19
Shares
2,452
$
910
(1,789)
(158)
1,415
$
__________________________________________
(1) 33,292 in RSUs were settled for $0.2 million in cash.
(2) 85,956 in RSUs were forfeited by Per-Olof Loof, the Company's former Chief Executive Officer upon his resignation in December 2018.
Vested shares in the table above include the acceleration of 275,000 shares related to the April 18, 2018 Amended and
Restated Employment Agreement for the former Chief Executive Officer, which amended and restated Mr. Loof's prior
employment agreement with the Company dated June 29, 2015. Upon the signing of the Amended and Restated Employment
Agreement, certain RSUs previously granted to Mr. Loof on June 29, 2015, totaling 175,000 shares, and on September 6, 2017,
totaling 100,000 shares, both of which were scheduled to vest over time, became fully vested. Incremental compensation cost
resulting from the modification totaled $1.7 million.
Additionally, vested shares in the table above include the acceleration of 44,302 shares related to the March 20, 2019
Employment Agreement for the current Chief Executive Officer William Lowe. Upon the signing of the Employment Agreement,
certain RSUs previously granted to Mr. Lowe on May 18, 2016, totaling 20,220 shares, May 18, 2017, totaling 11,237 shares, and
May 18, 2018, totaling 12,845 shares, each of which were scheduled to vest over time, became fully vested. Incremental
compensation cost resulting from the modification totaled $0.2 million.
In the Operating activities section of the Consolidated Statements of Cash Flows, stock-based compensation expense was
treated as an adjustment to net income for fiscal years 2019, 2018 and 2017.
117
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Note 11: Income Taxes
The components of income before income taxes and equity income (loss) from equity method investments are as
follows (amounts in thousands):
Domestic (U.S.) (1)
Foreign (Outside U.S.) (1)
Total (1)
______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
$
$
Fiscal Years Ended March 31,
2019
95,639
74,792
170,431
$
$
2018
141,582
45,485
187,067
$
$
2017
(67)
9,875
9,808
The provision for income tax expense (benefit) is as follows (amounts in thousands):
Current:
Federal
State and local
Foreign
$
Total current income tax expense from continuing operations
Deferred:
Federal
State and local
Foreign (1)
Deferred tax expense (benefit) from continuing operations (1)
Provision for income tax expense (benefit) (1)
______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
$
Fiscal Years Ended March 31,
2019
2018
2017
$
170
161
9,966
10,297
(43,804)
(773)
(5,180)
(49,757)
(39,460) $
223
$
50
8,295
8,568
(807)
(96)
1,467
564
9,132
$
—
62
4,247
4,309
(6)
(97)
88
(15)
4,294
The Company realized a deferred tax expense (benefit) for fiscal years ended 2019, 2018 and 2017 of ($50.1) million,
$0.6 million and $1.2 million, respectively, in U.S. and certain foreign jurisdictions based on changes in judgment about the
realizability of deferred tax assets in future years.
118
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Differences between the provision for income taxes on earnings from continuing operations and the amount computed
using the U.S. Federal statutory income tax rate are as follows (amounts in thousands):
Amount computed using the statutory rate (1)
Change in U.S. valuation allowance
Unremitted earnings of foreign subsidiaries
Effect of prior year adjustments (2)
IRC section 162(m) limitation (3)
Expired foreign tax credits
Taxable foreign source income
(Put)/call option valuation impact
Non-taxable gain from bargain purchase
Deduction related to APA settlement
Tax-deductible equity compensation
Other non-deductible expenses
Differences due to U.S. tax law changes (4)
State income taxes, net of federal taxes (5)
Change in foreign operations tax exposure reserves
Foreign tax rate differential
Change in foreign tax law
Change in foreign operations valuation allowance (6)
Nondeductible expenses related to antitrust litigation
Other effect of foreign operations
Provision for income tax expense (benefit)
Fiscal Years Ended March 31,
2019
2018
2017
$
$
35,791
(67,761)
—
2,450
4,553
—
3,502
—
—
(2,309)
(4,215)
(44)
—
(695)
132
6,501
(1,956)
(41,133)
14,360
11,364
(39,460) $
$
$
59,162
(66,948)
—
(1,337)
—
407
22,238
—
(41,292)
—
(5,699)
220
50,420
(3,325)
1,059
(400)
251
(6,676)
488
564
3,722
(7,080)
2,127
1,789
—
4,766
1,835
(3,745)
—
—
(44)
(893)
—
(35)
108
587
144
983
—
30
9,132
$
4,294
___________________________________________
(1) The statutory income tax rate for the fiscal year ended March 31, 2017 is 35%. The Tax Cuts and Jobs Act enacted on December 22, 2017 reduced the U.S.
federal corporate tax rate from 35% to 21%, effective January 1, 2018. Based on the fiscal year of the Company ending on March 31, the statutory income tax
rate for the fiscal year ended March 31, 2018 is a blended rate of 31.6% based on the number of days in the fiscal year before January 1, 2018 and the number
of days in the fiscal after December 31, 2017. The statutory income tax rate for the fiscal year ended March 31, 2019 is 21%.
(2) The effect of prior year adjustments was offset by a full valuation allowance resulting in no impact on the provision for income taxes.
(3) Fiscal year ended March 31, 2019 difference consist of $1.5 million related to the expansion of the Sec. 162(m) limitation due to tax law changes.
(4) Fiscal year end March 31, 2018 differences due to tax law changes consists of $4.8 million related to foreign earnings and $45.6 million related to tax rate
adjustment. $45.6 million related to tax rate adjustment is the gross deferred rate change, which is offset by valuation allowance adjustment, resulting in a net
benefit of $0.8 million.
(5) Fiscal year ended March 31, 2018 difference consists mainly of $3.7 million related to the revaluation of state net operating loss carryforwards as a result of
the change in the federal tax rate.
(6) The change in foreign operations valuation allowance excludes other comprehensive income and currency translation adjustments of $3.8 million, $(3.4)
million, and $0.9 million for fiscal years ended 2019, 2018 and 2017, respectively, which has no impact on the provision for income taxes.
The foreign jurisdictions having the greatest effect on the provision for income taxes are China and Mexico. The
statutory tax rates for China and Mexico are 25% and 30%, respectively. The combined provision for income taxes for China
and Mexico for fiscal years ended 2019, 2018 and 2017 is $5.7 million, $3.8 million, and $3.1 million, respectively.
119
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The components of deferred tax assets and liabilities are as follows (amounts in thousands):
Deferred tax assets:
Net operating loss carry forwards
Sales allowances and inventory reserves
Medical and employee benefits
Depreciation and differences in basis
Accrued restructuring
Anti-trust fines and settlements
Tax credits
Stock-based compensation
Other(1)
Total deferred tax assets before valuation allowance
Less valuation allowance
Total deferred tax assets
Deferred tax liabilities:
Unremitted earnings of subsidiaries
Amortization of intangibles and debt discounts
Non-amortized intangibles
Total deferred tax liabilities
Net deferred tax assets (liabilities)
__________________________________________________________________
(1) March 31, 2018 adjusted due to the adoption of ASC 606.
March 31,
2019
2018
$
78,986
$
115,064
10,967
35,298
5,318
469
910
3,394
5,589
1,342
142,273
(58,658)
83,615
(21,850)
(11,996)
(1,551)
(35,397)
48,218
$
$
9,675
38,572
6,241
2,551
16,575
4,208
1,765
2,812
197,463
(171,401)
26,062
(11,678)
(14,054)
(1,551)
(27,283)
(1,221)
The following table presents the annual activities included in the deferred tax valuation allowance (amounts in
thousands):
Balance at March 31, 2016
Charge (benefit) to costs and expenses
Deductions
Balance at March 31, 2017
Charge to costs and expenses
Deductions
Balance at March 31, 2018
Charge (benefit) to costs and expenses
Deductions
Balance at March 31, 2019
Valuation Allowance for
Deferred Tax Assets
$
$
170,917
(2,094)
(4,925)
163,898
8,647
(1,144)
171,401
(112,080)
(663)
58,658
In fiscal year 2019, the valuation allowance decreased $112.7 million, of which $44.9 million related to a valuation
allowance decrease for the foreign group and $67.8 million related to a valuation allowance decrease for the U.S. group. The
$44.9 million decrease in valuation allowance related to the foreign group primarily is comprised of a $35.5 million decrease
related to changes in temporary differences and net operating utilizations and a $5.5 million release in valuation allowance. The
$67.8 million decrease in the valuation allowance related to the U.S. group primarily is comprised of a $26.9 million decrease
related to utilization of net operating loss carryforwards and a $44.2 million release in valuation allowance.
120
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
In fiscal year 2018, the valuation allowance increased $7.5 million, of which $74.4 million related to a valuation
allowance increase for the foreign group and $66.9 million related to a valuation allowance decrease for the U.S. group. The
$66.9 million decrease in valuation allowance related to the U.S. group primarily is comprised of a $49.4 million decrease from
the repricing of deferred tax assets under U.S. tax reform, and a $21.1 million decrease from the additional investment in
TOKIN. The $74.4 million increase in valuation allowance related to the foreign group is comprised of a $78.2 million increase
due to opening balance sheet adjustments from the acquisition of TOKIN, and a decrease of $3.8 million from other foreign
operations.
In fiscal year 2017, the valuation allowance decreased $7.0 million, primarily of which $4.8 million is related to the
expiration of foreign tax credit carryovers that were held by the U.S. group and $1.2 million related to the investment in
TOKIN.
The change in net deferred income tax asset (liability) for the current year is presented below (amounts in thousands):
Balance at March 31, 2018 (1)
Deferred income taxes related to continuing operations
Deferred income taxes related to other comprehensive income
Foreign currency translation
Balance at March 31, 2019
___________________________________________________________
(1) March 31, 2018 adjusted due to the ASC 606.
$
$
(1,221)
49,757
(223)
(95)
48,218
As of March 31, 2019, and 2018, the Company’s gross deferred tax assets were reduced by a valuation allowance of
$58.7 million and $171.4 million, respectively. A remaining valuation allowance on a portion of U.S. deferred tax assets was
determined to be necessary based on the existence of significant negative evidence. The amount of future income required for
the Company to realize its net deferred tax assets is $227.1 million.
In assessing the realizability of deferred tax assets in foreign jurisdictions, management considers whether it is more
likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax
assets is dependent upon the generation of future taxable income during the periods in which those temporary differences
become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income,
and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projections for
future taxable income over the periods in which the deferred tax assets are deductible, management believes it is more likely
than not that the Company will realize the benefits of these deductible differences, net of the existing valuation allowances as of
March 31, 2019. However, the amount of deferred tax assets considered realizable could be reduced in the near term if
estimates of future taxable income during the carryforward period are reduced.
As of March 31, 2019, the Company had U.S. federal net operating loss carryforwards of $114.3 million. These U.S.
federal net operating losses were incurred from fiscal years 2006 through 2018 and are available to offset future federal taxable
income, if any, through 2037. The Company had state net operating losses of $525.1 million, of which $3.6 million will expire
in one year if unused. These state net operating losses are available to offset future state taxable income, if any, through 2039.
Foreign subsidiaries, primarily in Japan, Italy, Thailand, Hong Kong, United Kingdom, and Sweden, had net operating loss
carryforwards totaling $135.3 million of which none will expire within one year if unused. The net operating losses in Thailand
and Japan are available to offset future taxable income through 2025 and 2029, respectively. The net operating losses in Italy,
Hong Kong, United Kingdom, and Sweden are available indefinitely to offset future taxable income. For a portion of the U.S.
federal and some state jurisdictions there is a greater likelihood of not realizing the future tax benefits of these deferred tax
assets, and, accordingly, the Company has recorded valuation allowances of $16.9 million related to the net deferred tax assets
in these jurisdictions. For the foreign jurisdictions with net operating loss carryforwards, a valuation allowance has been
recorded where the Company does not expect to fully realize the deferred tax assets in the future.
Utilization of the Company’s net operating loss carryforwards may be subject to substantial annual limitation due to
the ownership change limitations provided by the Internal Revenue Code of 1986, as amended (the “Code”) and similar state
provisions. Such an annual limitation could result in the expiration of the net operating loss and tax credit carryforwards before
utilization. If such an ownership change were deemed to have occurred, the amount of our taxable income that could be offset
by the Company’s net operating loss carryovers in taxable years after the ownership change would be severely limited. KBP
was acquired which has substantial federal net operating losses that are limited due to the ownership change which occurred.
121
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
At March 31, 2019, the U.S. consolidated group of companies had the following tax credit carryforwards available
(amounts in thousands):
U.S. research credits
Texas franchise tax credits
Tax
Credits ($)
Fiscal Year
of Expiration
$
1,253
2,141
2024
2026
The Company conducts business in Macedonia and Thailand through subsidiaries that qualify for a tax holiday. The
tax holiday for Macedonia will terminate on January 1, 2023. For calendar years 2017, 2018, and 2019, the statutory rate of
10% was reduced to zero. The tax holiday for Thailand will terminate on June 15, 2020. For the 2019 fiscal year, the statutory
rate of 20% was reduced to zero. For the fiscal year ended March 31, 2019 the Company realized no income tax benefit from
the tax holidays.
Prior to the Tax Cuts and Jobs Act of 2017, earnings of a foreign subsidiary were taxed when remitted to the U.S.
With the Tax Cuts and Jobs Act of 2017, the Company is permitted a 100% exemption from U.S. tax on foreign earnings
remitted to the U.S. and the U.S group recognizes no deferred tax liability at March 31, 2019 relating to unremitted foreign
earnings. The Company asserts that no foreign earnings subject to a withholding tax will be remitted to the U.S.
At March 31, 2019, the Company had $7.7 million of unrecognized tax benefits. A reconciliation of gross
unrecognized tax benefits (excluding interest and penalties) is as follows (amounts in thousands):
Beginning of fiscal year
Additions from business combinations
Additions for tax positions of the current year
Additions for tax positions of prior years
Reductions for tax positions of prior years
Lapse in statute of limitations
Settlements
End of fiscal year
Fiscal Years Ended March 31,
2019
2018
2017
$
8,680
$
7,390
$
7,103
—
2,027
519
(633)
(9)
(2,923)
7,661
$
1,270
1,078
—
(1,058)
—
—
—
762
—
(64)
(411)
—
$
8,680
$
7,390
At March 31, 2019, $1.9 million of the $7.7 million of unrecognized income tax benefits would affect the Company’s
effective income tax rate, if recognized. It is reasonably possible that the total unrecognized tax benefit could decrease by $1.0
million in fiscal year 2020 if the advanced pricing arrangement for one of the Company’s foreign subsidiaries is agreed to by
the foreign tax authority and an ongoing audit in one of the Company’s foreign jurisdictions is settled.
The Company files income tax returns in the U.S. and multiple foreign jurisdictions, including various state and local
jurisdictions. The U.S. Internal Revenue Service concluded its examinations of the Company’s U.S. federal tax returns for all
tax years through 2003. Because of net operating losses, the Company’s U.S. federal returns for 2003 and later years will
remain subject to examination until the losses are utilized. The Company is subject to income tax examinations in various
foreign and U.S. state jurisdictions for the years 2014 and forward. The Company records potential interest and penalty
expenses related to unrecognized income tax benefits within its global operations in income tax expense. The Company had
$0.5 million and $0.9 million of accrued interest and penalties respectively at March 31, 2019 and 2018, which are included as
a component of income tax expense. To the extent interest and penalties are not assessed with respect to uncertain tax positions,
amounts accrued will be reduced and reflected as a reduction of the overall income tax provision.
122
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Tax Cuts and Jobs Act
The Tax Cuts and Jobs Act (the “Act”) was enacted on December 22, 2017. The Act reduced the US federal corporate
tax rate from 35% to 21%, required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that
were previously tax deferred, and created new taxes on certain foreign-sourced earnings.
In fiscal year 2018, the Company recorded provisional amounts for certain enactment-date effects of the Act by
applying the guidance in SAB 118, because the Company had not yet completed its accounting for all of the tax effects of the
Act. Certain provisions of the Act did not impact the Company until fiscal year 2019. These provisions include, but are not
limited to, the base erosion anti-abuse tax (“BEAT”), the provision designed to tax global intangible low-taxed income
(“GILTI”), the foreign-derived intangible income (“FDII”) provision, the expansion of the IRC Sec. 162(m) limitation, and the
provision designed to limit interest expense deductions.
In fiscal year 2019, the Company completed its accounting for the enactment-date income tax effects of the Act, based
on legislative updates relating to the Act currently available. These tax effects related to the one-time transition tax, the reduced
corporate tax rate, and an additional limitation for executive compensation under IRC Sec. 162(m). The Company recognized
the below adjustments as a component of income tax expense.
One-time Transition Tax
The one-time transition tax is based on the Company’s total post-1986 earnings and profits which were previously
deferred from U.S. income taxes under U.S. law. In previous periods, the Company recorded provisional amounts for its one-
time transition tax liability for each of its foreign subsidiaries, and the amounts were offset by utilizing net operating losses that
had been carried forward from prior years.
Upon further analysis of the Act and notices and regulations issued and proposed under Internal Revenue Code
(“IRC”) Section 965 by the U.S. Department of Treasury and the Internal Revenue Service, the Company finalized its
calculations of the transition tax liability during the current reporting period. The final net taxable income the Company
reported on its 2018 federal income tax return under IRC Section 965, after allowable deductions under IRC Section 965(c),
was $34.3 million. The amount was included as a component of income tax expense and offset by federal net operating loss
carryover utilizations, resulting in a net income tax expense of zero. There is no impact to foreign locations.
Deferred tax assets and liabilities
During the period ended March 31, 2018, the Company had recognized a $0.8 million tax benefit related to the US
federal corporate tax rate change to its existing deferred tax balances. The amount was included as a component of income tax
expense for fiscal year 2018.
Global intangible low-taxed income
The Act subjects a U.S. shareholder to tax on GILTI earned by certain foreign subsidiaries. The Financial Accounting
Standards Board (“FASB”) Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed income, states that an
entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to
reverse as GILTI in future years, or to provide for the tax expense related to GILTI in the year the tax is incurred as a period
expense. The Company has elected to account for GILTI as a period cost in the year the tax is incurred. At March 31, 2019, the
Company estimates that it will have no additional taxable income from GILTI for the 2019 fiscal year.
Foreign-Derived Intangible Income
The Act provides tax incentives to U.S. companies to earn income from the sale, lease, or license of goods and services
abroad in the form of a deduction for foreign-derived intangible income. The tax law limits the amount of the FDII deductions
to the U.S. shareholder’s taxable income. At March 31, 2019, the Company estimates to utilize net operating loss carryovers to
absorb its taxable income for the fiscal year 2019. As a result, the Company is not estimating any taxable income deduction
related to FDII.
123
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Base Erosion Anti-Abuse Tax
Under the Act, an entity must pay a BEAT tax, if the BEAT is greater than its regular tax liability. The BEAT
calculation eliminates the deduction of certain payments made to foreign affiliates, referred to as base erosion payments, but
applies a lower tax rate on the resulting BEAT income. During the fiscal year ended March 31, 2019, the Company's Base
Erosion Percentage was below the 3.0% threshold, and as a result, the Company estimated no additional tax expense related to
the BEAT for the 2019 fiscal year.
Interest Expense Deduction Limits
The Act limits the deduction for net interest expense incurred by U.S. corporations for amounts that exceed 30% of the
corporation’s adjusted taxable income for the year. The adjusted taxable income is computed initially excluding depreciation,
amortization, or depletion and includes these items beginning in the year 2022. The Act permits an indefinite carryforward of
any disallowed business interest expense. At March 31, 2019, the Company estimates that its net interest expense deductions for
the fiscal year 2019 will not be limited.
Executive Compensation Limits
The Act made significant changes to the $1.0 million tax deduction limitation for publicly held corporations under IRC
Sec. 162(m). The changes included the repeal of an exclusion for qualified performance-based compensation and broadened the
group of possible covered employees subject to the deduction limit. For the fiscal year 2019, the Company estimates an
additional deduction limitation of $7.0 million as a result of this law change.
Note 12: Derivatives
Certain of the Company’s foreign operations expose the Company to fluctuations in currency exchange rates. These
fluctuations may impact the value of the Company’s cash payments, assets, and liabilities in terms of the Company’s functional
currency. The Company enters into derivative financial instruments to protect the value of certain obligations and its net
investment in its TOKIN subsidiary in terms of its functional currency, the U.S. dollar. The Company’s primary exposure to
foreign currency exchange rate risk relates to (i) intercompany financings with TOKIN, (ii) its net investment in TOKIN, and
(iii) certain operating expenses at the Company’s Mexican facilities.
The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s
operating and financial structure as well as to hedge specific anticipated transactions. The Company does not utilize derivatives
for speculative or other purposes other than currency risk management. The use of derivative financial instruments carries
certain risks, including the risk that any counterparty to a contractual arrangement may not be able to perform under the
agreement. To mitigate this risk, the Company only enters into derivative financial instruments with a counterparty that is a
major financial institution with a high credit rating. The Company does not anticipate that the counterparty will fail to meet its
obligations.
Each derivative instrument that qualifies for hedge accounting is expected to be highly effective at reducing the risk
associated with the exposure being hedged, and the Company monitors each instrument for effectiveness on a quarterly basis.
The Company formally documents all relationships between hedging instruments and hedged items, as well as risk management
objectives and strategies for undertaking various hedge transactions.
Changes in fair value of all its derivative instruments are reported in earnings or in AOCI, depending on whether the
derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction. The Company records all
derivative financial instruments on its Consolidated Balance Sheets at fair value. Certain of the derivative instruments are
subject to master netting agreements and are presented in the Consolidated Balance Sheets on a net basis. If the Company were
to account for the asset and liability balances of those derivative contracts on a gross basis, the amounts presented in the
Consolidated Balance Sheets would be adjusted from the current net presentation to the gross amounts as detailed in the table
below.
124
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The balance sheet classifications and fair value of derivative instruments designated as hedges as of March 31, 2019
and 2018 are as follows (amounts in thousands):
Fair Value of Derivative Instruments
March 31, 2019
March 31, 2018
Hedge
Designation
Balance Sheet
Location
As
Presented
Offset
Gross
As
Presented
Offset
Gross
Derivative assets
Cross-currency swaps
Fair Value Other assets
$ 3,485
$ — $ 3,485
$ — $ — $ —
Cross-currency swaps
Net
Investment Other assets
Foreign exchange
contracts
Cash Flow
Prepaid and other
current assets
1,092
—
1,092
—
564
645
1,209
1,154
—
—
—
1,154
Derivative liabilities
Foreign exchange
contracts
Cash Flow Accrued expenses
—
645
645
—
—
—
Fair Value Hedging Strategy
The Company entered into two cross-currency swaps designated as fair value hedges on November 7, 2018 to hedge
the foreign currency risk on the Intercompany Loans. These agreements are contracts to exchange floating-rate payments in one
currency with floating-rate payments in another currency. These swaps are intended to offset in the same period the
remeasurement of the carrying value of the underlying foreign currency Intercompany Loans. Changes in the fair value of these
cross-currency swaps due to changes in foreign currency exchange rates are recognized in earnings upon the recognition of the
change in the fair value of the hedged intercompany financings. The Company excludes the change in the fair value of these
cross-currency swaps due to changes in interest rates from the assessment of hedge effectiveness. Changes in fair value of the
swaps associated with changes in interest rates are initially recorded as a component of AOCI and recognized into other
(income) expense, net in the Consolidated Statement of Operations using a systematic and rational method over the
instrument’s term. The terms of the two cross-currency swaps designated as fair value hedges are as follows:
• An amortizing cross-currency swap with an initial notional value of JPY 16.5 billion. The notional value is amortized
by approximately JPY 1.4 billion every six months and matures on September 30, 2024. The Company receives
interest in JPY on March 31 and September 30 of each year based on the JPY notional value and JPY Libor plus
2.00%. Interest payments are made in USD on March 31 and September 30 of each year based on the USD equivalent
of the JPY notional value and USD Libor plus 2.70%.
• A non-amortizing cross-currency swap with a notional value of JPY 16.5 billion maturing on September 30, 2024. The
Company receives interest in JPY on March 31 and September 30 of each year based on the JPY notional value and
JPY Libor plus 2.25%. Interest payments are made in USD on March 31 and September 30 of each year based on the
USD equivalent of the JPY notional value and USD Libor plus 3.15%.
The notional value of these contracts were JPY 31.6 billion or $279.7 million at March 31, 2019.
125
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Hedges of Net Investments in Foreign Operations Strategy
The Company entered into a cross-currency swap designated as a net investment hedge on November 7, 2018 to hedge
the JPY currency exposure of the Company’s net investment in TOKIN. This agreement is a contract to exchange fixed-rate
payments in one currency for fixed-rate payments in another currency. Changes in the fair value of this swap are recorded in
equity as a component of AOCI in the same manner as foreign currency translation adjustments. In assessing the effectiveness
of this hedge, the Company uses a method based on changes in spot rates to measure the impact of the foreign currency
exchange rate fluctuations on both its foreign subsidiary net investment and the related swap. Under this method, changes in the
fair value of the hedging instrument other than those due to changes in the spot rate are initially recorded in AOCI as a
translation adjustment, and then are amortized into other (income) expense, net in the Consolidated Statement of Operations
using a systematic and rational method over the instrument’s term. Changes in the fair value associated with the effective
portion (i.e. those changes due to the spot rate) are recorded in AOCI as a translation adjustment and are released and
recognized in earnings only upon the sale or liquidation of the hedged net investment. The terms of this cross-currency swap are
as follows:
• An amortizing cross-currency swap with an initial notional value of JPY 33.0 billion. The notional amount is
amortized by approximately JPY 1.4 billion every six months and matures on September 30, 2024. Interest payments
are made by the Company in JPY on March 31 and September 30 of each year based on the JPY notional value and a
fixed rate of 2.61%. The Company receives interest in USD on March 31 and September 30 of each year based on the
USD equivalent of the JPY notional value and a fixed rate of 6.25%.
The notional value of this contract was JPY 31.6 billion or $279.7 million at March 31, 2019.
Cash Flow Hedging Strategy
Certain operating expenses at the Company’s Mexican facilities are paid in Mexican Pesos. In order to hedge a portion
of these forecasted cash flows, the Company purchases foreign exchange contracts, with terms generally less than twelve
months, to buy Mexican Pesos for periods and amounts consistent with underlying cash flow exposures. These contracts are
designated as cash flow hedges at inception.
Unrealized gains and losses associated with the change in fair value of the foreign exchange contracts are recorded in
AOCI. Changes in the derivatives’ fair values are deferred and recorded as a component of AOCI until the underlying
transaction is settled and recorded to the Consolidated Statement of Operations. When the hedged item affects income, gains or
losses are reclassified from AOCI to the Consolidated Statement of Operations as Cost of Sales for foreign exchange contracts
to purchase such foreign currency. The notional value of outstanding Peso contracts was $74.3 million and $70.6 million as of
March 31, 2019 and 2018, respectively.
126
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
Hedging Strategy Impact on Statements of Operations
The following tables present gain and loss activity for the fiscal years ended March 31, 2019, 2018, and 2017 for
derivative instruments designated as hedges (amounts in thousands):
Derivative Instrument
Cross-currency swaps (1)
Cross-currency swaps (2)
Foreign exchange contracts (3) Cash Flow
Hedge Designation
Fair Value
Other income/expense, net
Net Investment Other income/expense, net
Cost of sales
Location of Gain (Loss)
Recognized in Statements of
Operations
Derivative Instrument
Cross-currency swaps (1)
Cross-currency swaps (2)
Foreign exchange contracts (3) Cash Flow
Hedge Designation
Fair Value
Other income/expense, net
Net Investment Other income/expense, net
Cost of sales
Location of Gain (Loss)
Recognized in Statements of
Operations
Fiscal Year Ended March 31, 2019
Gain (Loss)
Reclassified
from AOCI to
Income
Recorded
Directly to
Income
Recognized in
AOCI
$
(6,383) $
5,009
(1,286)
(4,134) $
4,230
(698)
6,034
—
—
Fiscal Year Ended March 31, 2018
Gain (Loss)
Reclassified
from AOCI to
Income
Recorded
Directly to
Income
Recognized in
AOCI
$
— $
— $
—
667
—
2,420
—
—
—
Fiscal Year Ended March 31, 2017
Gain (Loss)
Location of Gain (Loss)
Recognized in Statements of
Operations
Recognized in
AOCI
Reclassified
from AOCI to
Income
Recorded
Directly to
Income
Hedge Designation
Fair Value
Other income/expense, net
Net Investment Other income/expense, net
Derivative Instrument
Cross-currency swaps (1)
Cross-currency swaps (2)
Foreign exchange contracts (3) Cash Flow
______________________________________________________________________________
(1) Amounts recognized in AOCI represent the change in the fair value of the derivative instruments related to the excluded components. Amounts reclassified
from AOCI to income represent amortization of excluded components based upon the instruments' periodic coupons. Amounts recorded directly to income
represent the change in the fair value of the derivative instruments related to the effective portion of the qualifying hedge.
(2) Amounts recognized in AOCI represent the total change in the fair value of the derivative instrument. Amounts recorded to AOCI are recorded within foreign
currency translation. Amounts reclassified from AOCI to income represent amortization of excluded components based on the instrument's periodic coupon.
(3) Amounts recognized in AOCI represent the total change in the fair value of the derivative instruments. Amounts reclassified from AOCI to income represent
the change in the fair value of the derivative instruments pertaining to the settlement of the qualifying hedged item (effective portion).
—
(5,170)
—
(1,896)
Cost of sales
— $
— $
—
—
—
$
127
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following tables present the total amount of each income and expense line item presented in the Consolidated
Statements of Operations in which the results of fair value and cash flow hedges are recorded and the effects of those hedging
strategies on income (amounts in thousands):
Total income (expense) in Statements of Operations (1)
Cash flow hedging impact
Foreign exchange contracts:
Cost of sales
Fiscal Year Ended March 31,
2019
(924,276) $
2018
(860,744) $
2017
(571,944)
$
Gain (loss) reclassified from AOCI to income (2)
(698)
2,420
(5,170)
Other income (expense), net
Fiscal Year Ended March 31,
2019
2018
2017
Total income (expense) in Statements of Operations
$
(11,214) $
(24,592) $
3,871
Fair value hedging impact
Cross-currency swaps:
Gain (loss) on hedged item
Gain (loss) on derivative instrument (3)
(6,034)
1,900
—
—
—
—
_______________________________________________________________________________
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
(2) Net gains of $1.1 million are expected to be reclassified from AOCI into income within the next 12 months.
(3) Amounts recognized in income include the change in the fair value of the derivative instruments related to the effective portion of the qualifying hedges and
amortization of the excluded components.
Note 13: Supplemental Balance Sheets and Statements of Operations Detail
(amounts in thousands)
Accounts receivable:
Trade
Allowance for doubtful accounts reserve
Ship-from-stock and debit (“SFSD”) reserve
Returns reserves (1)
Rebates reserves
Price protection reserves
Other
Accounts receivable, net (1)
_______________________________________________________________________________
(1) Fiscal year ended March 31, 2018 adjusted due to the adoption of ASC 606.
March 31,
2019
2018
$
$
176,715
(1,206)
(18,862)
(964)
(967)
(657)
—
$
154,059
$
166,459
(1,210)
(17,362)
(131)
(446)
(420)
(329)
146,561
128
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The Company has agreements with distributors and certain other customers that, under certain conditions, allow for
returns of overstocked inventory, provide protection against price reductions initiated by the Company and grant other sales
allowances. Allowances for these commitments are included in the Consolidated Balance Sheets as reductions in trade accounts
receivable. The Company adjusts sales based on historical experience.
The following table presents the annual activities included in the allowance for these commitments (amounts in
thousands):
Balance at March 31, 2016
Reduction in sales
Actual adjustments applied
Other
Balance at March 31, 2017
Reduction in sales
Actual adjustments applied (1)
Other
Balance at March 31, 2018
Reduction in sales
Actual adjustments applied
Other
Balance at March 31, 2019
_______________________________________________________________________________
(1) Adjusted due to the adoption of ASC 606.
(amounts in thousands)
Inventories:
Raw materials and supplies
Work in process
Finished goods
Inventory gross
Inventory reserves
Inventory, net
$
$
22,978
87,739
(90,365)
62
20,414
94,660
(95,444)
268
19,898
99,538
(96,775)
(5)
22,656
March 31,
2019
2018
$
97,119
$
71,374
88,175
256,668
(15,539)
241,129
$
$
88,408
65,417
66,907
220,732
(16,346)
204,386
129
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following table presents the annual activities included in the inventory reserves (amounts in thousands):
Balance at March 31, 2016
Costs charged to expense
Write-offs
Other
Balance at March 31, 2017
Costs charged to expense
Write-offs
Other (1)
Balance at March 31, 2018
Costs charged to expense
Write-offs
Other
Balance at March 31, 2019
_______________________________________________________________________________
(1) Includes $1.9 million in inventory reserves from TOKIN.
(amounts in thousands, except years)
Property, plant and equipment:
Land and land improvements
Buildings
Machinery and equipment
Furniture and fixtures
Construction in progress
Other
Total property and equipment
Accumulated depreciation
Property, plant and equipment, net
(amounts in thousands)
Accrued expenses:
$
$
16,101
6,163
(6,125)
(198)
15,941
4,994
(6,954)
2,365
16,346
6,019
(6,826)
—
15,539
Useful life
(years)
20
20 - 40
10
4 - 10
March 31,
2019
2018
$
62,232
$
199,319
916,737
82,306
105,857
9,280
66,150
186,207
895,914
72,811
46,391
4,457
1,375,731
(880,451)
495,280
$
$
1,271,930
(866,614)
405,316
March 31,
2019
2018
Salaries, wages, and related employee costs
$
61,880
$
62,778
Interest
Restructuring
Vacation
Anti-trust fines and settlements
Stock Returns (1)
Property, sales, and other taxes
Other (1)
Total accrued expenses (1)
_______________________________________________________________________________
(1) March 31, 2018 adjusted due to the adoption of ASC 606.
130
211
1,869
10,364
9,517
2,539
1,854
5,527
396
8,719
10,364
33,696
2,485
1,571
5,110
$
93,761
$
125,119
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
(amounts in thousands)
Other non-current obligations:
Pension plans
Employee separation liability
Deferred compensation
Customer deposits
Anti-trust fines and settlements
Uncertain tax positions
Deferred rent
Government subsidies
Deferred interest income-customer capacity agreements
Restructuring
Other (1)
Total other non-current obligations (1)
_______________________________________________________________________________
(1) March 31, 208 adjusted due to the adoption of ASC 606.
(amounts in thousands)
Other (income) expense, net:
Net foreign exchange (gains) losses
Legal fines related to anti-trust class actions
Post retirement and pension plan non-service costs
Insurance proceeds
Loss on early extinguishment of debt
Grant (income)
Other
Total other (income) expense, net
$
$
March 31,
2019
2018
$
82,717
$
83,495
7,640
2,285
3,689
13,168
2,415
5,366
1,247
2,142
312
4,379
8,539
2,057
3,800
35,263
5,704
3,840
4,739
—
1,240
3,572
$
125,360
$
152,249
Fiscal Years Ended March 31,
2019
2018
2017
(7,230) $
6,701
366
—
15,946
(4,559)
(10)
11,214
13,145
$
9,900
210
—
486
(787)
1,638
$
24,592
$
(3,758)
—
1,256
(423)
—
—
(946)
(3,871)
Note 14: Basic and Diluted Net Income Per Common Share
Basic earnings per share calculation is based on the weighted-average number of common shares outstanding. Diluted
earnings per share calculation is based on the weighted-average number of common shares outstanding adjusted by the number
of additional shares that would have been outstanding had the potentially dilutive common shares been issued. Potentially
dilutive shares of common stock include stock options and Platinum Warrant.
131
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
The following table presents the basic and diluted weighted-average number of shares of common stock (amounts in
thousands, except per share data):
Numerator
Net income (1)
Denominator:
Weighted-average common shares outstanding:
Basic
Assumed conversion of employee stock grants
Assumed conversion of warrants
Diluted
Net income per basic share (1)
Net income per diluted share (1)
Fiscal Years Ended March 31,
2019
2018
2017
$
206,587
$
254,127
$
47,157
57,840
1,242
—
59,082
3.57
3.50
$
$
$
52,798
2,291
3,551
58,640
4.81
4.33
$
$
$
46,552
2,235
6,602
55,389
1.01
0.85
$
$
$
______________________________________________________________________________
(1) Fiscal years ending March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
Common stock equivalents that could potentially dilute net income per basic share in the future, but were not included
in the computation of diluted earnings per share because the impact would have been anti-dilutive, were as follows (amounts in
thousands):
Assumed conversion of employee stock grants
Note 15: Commitments and Contingencies
Fiscal Years Ended
March 31,
2019
2018
2017
—
71
771
The Company leases office space for its headquarters in Fort Lauderdale, Florida under a 12 year lease agreement
expiring in January 2030 . The annual rent expense under this agreement is $2.4 million, and allows for one renewal option for
a five year term expiring in January 2035, exercisable at the option of the Company. The Company’s remaining operating leases
are primarily for distribution facilities or sales and administrative offices that expire principally between 2019 and 2061. A
number of leases require the Company to pay certain executory costs (taxes, insurance, and maintenance) and contain certain
renewal and purchase options. Annual rental expenses for operating leases were included in results of operations and were
$13.3 million, $10.7 million and $6.7 million in fiscal years 2019, 2018, and 2017, respectively.
Future minimum lease payments over the next five fiscal years and thereafter under non-cancellable operating leases at
March 31, 2019, are as follows (amounts in thousands):
Minimum lease payments
$
10,898
$
8,536
$
5,766
$
5,322
$
4,080
$
13,709
2020
2021
2022
2023
2024
Thereafter
Fiscal Years Ended March 31,
Legal Update
The Company or its subsidiaries are at any one-time parties to a number of lawsuits arising out of our respective
operations, including workers’ compensation or work place safety cases, some of which involve claims of substantial damages.
Although there can be no assurance, based upon information known to the Company, the Company does not believe that any
liability which might result from an adverse determination of such lawsuits would have a material adverse effect on the
Company’s financial condition or results of operations.
132
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
As previously reported, KEMET and KEC, along with more than 20 other capacitor manufacturers and subsidiaries
(including TOKIN, as described below), are defendants in a purported antitrust class action complaint, In re: Capacitors
Antitrust Litigation, No. 3:14-cv-03264-JD, filed on December 4, 2014 with the United States District Court, Northern District
of California (the “U.S. Class Action Complaint”). The complaint alleges a violation of Section 1 of the Sherman Act, for which
it seeks injunctive and equitable relief and money damages. The complaint is currently nearing the end of the expert merits
discovery phase. In addition, KEMET and KEC, along with more than 20 other capacitor manufacturers and subsidiaries, have
been named as defendants in two suits by plaintiffs who have chosen not to participate in the U.S. Class Action Complaint
(collectively with the U.S. Class Action Complaint, the “U.S. Complaints”): AASI Beneficiaries’ Trust v. AVX Corporation, et
al., filed on August 29, 2016 in the United States District Court, Southern District of Florida, and Benchmark Electronics, Inc.,
et al. v. AVX Corporation, et al., filed on April 18, 2017 in the United States District Court, Southern District of Texas. The
AASI and Benchmark complaints allege generally the same violations as the U.S. Class Action Complaint.
In addition, as previously reported, KEMET and KEC, along with certain other capacitor manufacturers and
subsidiaries (including TOKIN, as described below), were named as defendants in several additional suits that were filed in
Canada (collectively, the “Canadian Complaints”): Badamshin v. Panasonic Corporation, et al., filed August 6, 2014 in the
Superior Court, Province of Quebec, District of Montreal; Herard v. Panasonic Corporation, et al., filed August 6, 2014 in the
Superior Court, Province of Quebec, District of Montreal; Cygnus Electronics Corporation v. Panasonic Corporation, et al.,
filed August 6, 2014 in the Superior Court of Justice, Province of Ontario; LeClaire v. Panasonic Corporation, et al., filed
August 6, 2014 in the Superior Court, Province of Quebec, District of Montreal; Taylor v Panasonic Corporation, et al., filed
August 11, 2014 in the Superior Court of Justice, Province of Ontario; Ramsay v. Panasonic Corporation, et al., filed August
14, 2014 in the Supreme Court, Province of British Columbia; Martin v. Panasonic Corporation, et al., filed September 25,
2014 in the Superior Court, Province of Quebec, District of Montreal; Parikh v. Panasonic Corporation, et al., filed October 3,
2014 in the Superior Court of Justice, Province of Ontario; Fraser v. Panasonic Corporation, et al., filed October 3, 2014 in the
Court of Queen’s Bench, Province of Saskatchewan; Pickering v. Panasonic Corporation, et al., filed October 6, 2014 in the
Supreme Court, Province of British Columbia; McPherson v Panasonic Corporation et al., filed on November 6, 2014 in the
Court of Queen’s Bench, Province of Manitoba; and Allott v AVX Corporation, et al., filed on May 13, 2016 in the Superior
Court of Justice, Province of Ontario. The Canadian Complaints generally allege the same unlawful acts as in the U.S.
Complaints, assert claims under Canada’s Competition Act as well as various civil and common law causes of action, and seek
injunctive and equitable relief and money damages.
There have been no material updates to the proceedings described in the immediately preceding paragraph except that
the claims against KEMET and KEC in Leclaire were dismissed on December 6, 2018. In addition, Parikh and Taylor have
been stayed in favor of Cygnus, and Badamshin, Martin and Herard have been stayed in favor of LeClaire. Further, on
November 18, 2018, the Ontario Supreme Court of Justice temporarily stayed Cygnus pending the outcome of a matter on
appeal concerning class certification, and the Ramsay plaintiffs voluntarily suspended that proceeding until class certification
for Cygnus has been determined.
Except for the TOKIN accrual described below and certain attorneys’ fees, the Company has not recorded any accrual
concerning the U.S. Complaints and the Canadian Complaints.
TOKIN-Specific Legal Proceedings
In July 2013, TOKIN was named as one of eight defendants in two purported U.S. class action antitrust lawsuits (In
Re: Lithium Ion Batteries Antitrust Litigation, 13-MD-02420-YGR, United States District Court, Northern District of
California) (the “Battery Class Action Suits”) regarding the sale of lithium ion batteries brought on behalf of direct product
purchasers and indirect product purchasers. On March 2, 2018, TOKIN entered into a settlement agreement, which, subject to
court approval, provides for the release of TOKIN and its subsidiaries from claims asserted in the Battery Class Action Suits, in
consideration of which, TOKIN agreed to pay $2.0 million to the settlement class of indirect product purchasers. TOKIN paid
the settlement amount into an escrow account on January 25, 2019. On May 16, 2018, the Court granted final approval to a
settlement agreement by which, in consideration of the release of TOKIN and its subsidiaries from claims asserted in the
Battery Class Action Suits, TOKIN agreed to pay $4.95 million to the settlement class of direct product purchasers. Prior to
final court approval, TOKIN had paid the settlement amount into an escrow account on January 18, 2018.
Beginning in March 2014, TOKIN and certain of its subsidiaries received inquiries, requests for information and other
communications from government authorities in China, the United States, the European Commission, Japan, South Korea,
Taiwan, Singapore, and Brazil concerning alleged anti-competitive activities within the capacitor industry.
133
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
On September 2, 2015, the United States Department of Justice announced a plea agreement with TOKIN in which
TOKIN agreed to plead guilty to a one-count felony charge of unreasonable restraint of interstate and foreign trade and
commerce in violation of Section 1 of the Sherman Act, and to pay a criminal fine of $13.8 million. The plea agreement was
approved by the United States District Court, Northern District of California, on January 21, 2016. The fine is payable over 5
years in six installments of $2.3 million each, plus accrued interest. The first four payments were made in February 2016,
January 2017, January 2018, and January 2019, while the next payment is due in January 2020.
On December 9, 2015, the Taiwan Fair Trade Commission (“TFTC”) publicly announced that TOKIN would be fined
1.2 billion New Taiwan dollars (“NTD”) (approximately $39.5 million) for violations of the Taiwan Fair Trade Act.
Subsequently, the TFTC indicated the fine would be reduced to NTD 609.1 million (approximately $19.8 million). In February
2016, TOKIN commenced an administrative suit in Taiwan, challenging the validity of the amount of the fine. On August 23,
2018, the Taipei High Administrative Court revoked the TFTC decision, finding that the decision had been time-barred by
applicable statute. On September 21, 2018, the TFTC filed an appeal against the High Administrative Court's decision. Payment
of the TFTC fine is not stayed during the administrative appeals; TOKIN has made installment payments of the fine aggregating
to approximately NTD 152.3 million (approximately $4.9 million) as of March 31, 2019.
On March 29, 2016, the Japan Fair Trade Commission published an order by which TOKIN was fined JPY 127.2
million (approximately U.S. $1.1 million) for violation of the Japanese Antimonopoly Act. Payment of the fine was made on
October 31, 2016.
On July 15, 2016, TOKIN entered into definitive settlement agreements in two antitrust suits filed with the United
States District Court, Northern District of California as In re: Capacitors Antitrust Litigation, No. 3:14-cv-03264-JD (the
“Capacitor Class Action Suits”). Pursuant to the terms of the settlement, in consideration of the release of TOKIN and its
subsidiaries (including TOKIN America, Inc.) from claims asserted in the Capacitor Class Action Suits, TOKIN will pay an
aggregate $37.3 million to a settlement class of direct purchasers of capacitors and a settlement class of indirect purchasers of
capacitors. Each of the respective class payments is payable in five installments, four of which were paid on or before the
respective due dates of July 29, 2016, May 15, 2017, May 15, 2018, and May 15, 2019. The final payment is due by December
31, 2019.
On July 27, 2016, Brazil’s Administrative Council for Economic Defense approved a cease and desist agreement with
TOKIN in which TOKIN made a financial contribution of Brazilian Real 0.6 million (approximately $0.2 million) to Brazil’s
Fund for Defense of Diffuse Rights.
On March 21, 2018, the European Commission announced a decision by which TOKIN was fined EUR 8.8 million
directly (approximately $10.3 million) and EUR 5.0 million (approximately $5.9 million) jointly and severally with NEC
Corporation, for violation of the competition laws of the European Union. Payment of the fines were made on June 28, 2018.
On June 4, 2018, TOKIN filed an appeal with the General Court of the European Union, seeking annulment and/or reduction of
the fines.
As noted above, TOKIN, along with KEMET and certain of its other subsidiaries, were named as defendants in the
Canadian Complaints. On May 30, 2018, TOKIN entered into definitive settlement agreement with the plaintiffs in the
Canadian Complaints Pursuant to the terms of the settlement, in consideration of the release of TOKIN and its subsidiaries
(including TOKIN America, Inc.) from claims asserted in the Canadian Complaints, TOKIN paid CAD 2.9 million
(approximately $2.2 million) to a settlement class of purchasers of aluminum and tantalum electrolytic capacitors and
purchasers of products containing such capacitors. The settlement payment was made on June 27, 2018. The settlement
agreement has been approved by the Quebec and Ontario courts; approval by the Supreme Court of British Columbia is
pending.
On November 30, 2018, the Korean Fair Trade Commission (“KFTC”) notified TOKIN of its decision to impose an
administrative fine on TOKIN of KRW 8.1 billion (approximately $7.2 million) for violation of South Korea's Monopoly
Regulation and Fair Trade Law. TOKIN filed its appeal of the KFTC's decision with the Seoul High Court on December 28,
2018. Payment of the fine is not stayed during appeal; TOKIN paid the full fine amount on February 1, 2019.
On July 2, 2018, TOKIN and TOKIN America Inc. were named as two of 20 defendants in a purported U.S. class
action antitrust lawsuit, In re: Inductors Antitrust Litigation, No. 5:18-cv-00198-EJD-NC, filed in the United States District
Court, Northern District of California, regarding the sale of inductors brought on behalf of direct product purchasers and
134
KEMET CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements (Continued)
indirect product purchasers. The complaint alleges violations of Sections 1 and 3 of the Sherman Act, for which it seeks
injunctive and equitable relief and money damages.
As of March 31, 2019, TOKIN’s accrual for antitrust and civil litigation claims totaled $37.7 million which is stated in
the following line items, “Account payable” ($15.0 million), “Accrued expenses” ($9.5 million) and “Other non-current
obligations” ($13.2 million) on the Consolidated Balance Sheets. This amount includes the best estimate of losses which may
result from the ongoing antitrust investigations, civil litigation and claims. However, the actual outcomes could differ from
what has been accrued. Additionally, under the terms of the TOKIN Purchase Agreement, KEMET will be responsible for
defending all suits brought against TOKIN, paying all expenses and satisfying all judgments to the extent incurred by or
rendered against TOKIN arising out of or related the capacitor antitrust investigations and related litigation described above.
Note 16: Quarterly Results of Operations (Unaudited)
The following table sets forth certain quarterly information for fiscal years 2019 and 2018. This information, in the
opinion of the Company’s management, reflects all adjustments (consisting only of normal recurring adjustments) necessary to
present fairly this information when read in conjunction with the Consolidated Financial Statements and notes thereto included
elsewhere herein (amounts in thousands except per share data):
Net sales
Gross margin
Operating income (1)
Net income
Net income per basic share
Net income per diluted share
Net sales (2)
Gross margin (2)
Operating income (1) (2)
Net income (2)
Net income per basic share (2)
Net income per diluted share (2)
Fiscal Year 2019 Quarters Ended
Jun-30
Sep-30
Dec-31
Mar-31
327,616
$
349,233
$
350,175
$
94,821
35,176
35,220
0.61
0.60
$
$
$
113,565
50,000
37,141
0.64
0.63
$
$
$
123,750
61,616
40,806
0.70
0.69
$
$
$
355,794
126,406
54,057
93,420
1.60
1.58
Fiscal Year 2018 Quarters Ended
Jun-30
Sep-30
Dec-31
Mar-31
273,946
$
301,568
$
306,576
$
318,091
74,117
27,607
220,439
4.65
3.82
$
$
$
84,904
31,597
12,819
0.26
0.22
$
$
$
92,288
32,002
18,589
0.33
0.32
$
$
$
88,128
21,646
2,280
0.04
0.04
$
$
$
$
$
$
$
$
___________________________________________
(1) Operating income (loss) as a percentage of net sales fluctuates from quarter to quarter due to a number of factors, including net sales fluctuations, foreign
currency exchange, restructuring charges, product mix, the timing and expense of moving product lines to lower-cost locations, the write-down of long lived
assets, the net gain/loss on sales and disposals of assets and the relative mix of sales among distributors, original equipment manufacturers, and electronic
manufacturing service providers.
(2) Fiscal year 2018 figures adjusted due to the adoption of ASC 606.
Note 17: Subsequent Events
The Company has evaluated events from March 31, 2019 through the date the financial statements were issued and
there have not been any subsequent events that require disclosure.
135
ITEM 16. FORM 10-K SUMMARY.
None.
136
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SIGNATURES
KEMET CORPORATION
(Registrant)
Date: May 30, 2019
By:
/s/ GREGORY C. THOMPSON
Gregory C. Thompson
Executive Vice President and Chief Financial Officer
________________________________________________________________________________________________________________________
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on the dates indicated.
137
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
Date: May 30, 2019
/s/ WILLIAM M. LOWE, JR.
William M. Lowe, Jr.
Chief Executive Officer and Director (Principal Executive
Officer)
/s/ GREGORY C. THOMPSON
Gregory C. Thompson
Executive Vice President and Chief Financial Officer
(Principal Accounting and Financial Officer)
/s/ FRANK G. BRANDENBERG
Frank G. Brandenberg
Chairman and Director
/s/ DR. WILFRIED BACKES
Dr. Wilfried Backes
Director
/s/ GURMINDER S. BEDI
Gurminder S. Bedi
Director
/s/ JACOB T. KOTZUBEI
Jacob T. Kotzubei
Director
/s/ E. ERWIN MADDREY, II
E. Erwin Maddrey, II
Director
/s/ YASUKO MATSUMOTO
Yasuko Matsumoto
Director
/s/ ROBERT G. PAUL
Robert G. Paul
Director
/s/ KAREN M. ROGGE
Karen M. Rogge
Director
138
(This page intentionally left blank.)
(This page intentionally left blank.)
BOARD OF
DIRECTORS
OTHER KEY
EMPLOYEES
Frank G. Brandenberg
(cid:38)(cid:75)(cid:68)(cid:76)(cid:85)(cid:80)(cid:68)(cid:81)
(cid:41)(cid:82)(cid:85)(cid:80)(cid:72)(cid:85)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)
Vice President &
Sector President
(cid:49)(cid:82)(cid:85)(cid:87)(cid:75)(cid:85)(cid:82)(cid:83)(cid:3)(cid:42)(cid:85)(cid:88)(cid:80)(cid:80)(cid:68)(cid:81)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)
Dr. Wilfried Backes
(cid:41)(cid:82)(cid:85)(cid:80)(cid:72)(cid:85)(cid:3)(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)
(cid:40)(cid:51)(cid:38)(cid:50)(cid:54)(cid:3)(cid:36)(cid:42)
Gurminder S. Bedi
(cid:41)(cid:82)(cid:85)(cid:80)(cid:72)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)
(cid:41)(cid:82)(cid:85)(cid:71)(cid:3)(cid:48)(cid:82)(cid:87)(cid:82)(cid:85)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)
Jacob T. Kotzubei
Partner
(cid:51)(cid:79)(cid:68)(cid:87)(cid:76)(cid:81)(cid:88)(cid:80)(cid:3)(cid:40)(cid:84)(cid:88)(cid:76)(cid:87)(cid:92)(cid:3)(cid:36)(cid:71)(cid:89)(cid:76)(cid:86)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)(cid:47)(cid:47)(cid:38)
(cid:36)(cid:3)(cid:85)(cid:72)(cid:74)(cid:76)(cid:86)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:76)(cid:81)(cid:89)(cid:72)(cid:86)(cid:87)(cid:80)(cid:72)(cid:81)(cid:87)(cid:3)(cid:68)(cid:71)(cid:89)(cid:76)(cid:86)(cid:82)(cid:85)
William M. Lowe, Jr.
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)(cid:3)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)
E. Erwin Maddrey, II
(cid:41)(cid:82)(cid:85)(cid:80)(cid:72)(cid:85)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:9)(cid:3)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)
(cid:39)(cid:72)(cid:79)(cid:87)(cid:68)(cid:3)(cid:58)(cid:82)(cid:82)(cid:71)(cid:86)(cid:76)(cid:71)(cid:72)(cid:3)(cid:44)(cid:81)(cid:71)(cid:88)(cid:86)(cid:87)(cid:85)(cid:76)(cid:72)(cid:86)
Yasuko Matsumoto
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)
(cid:36)(cid:85)(cid:88)(cid:75)(cid:76)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)
Robert G. Paul
(cid:41)(cid:82)(cid:85)(cid:80)(cid:72)(cid:85)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)
(cid:37)(cid:68)(cid:86)(cid:72)(cid:3)(cid:54)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:54)(cid:88)(cid:69)(cid:86)(cid:92)(cid:86)(cid:87)(cid:72)(cid:80)(cid:86)(cid:3)(cid:56)(cid:81)(cid:76)(cid:87)
(cid:36)(cid:81)(cid:71)(cid:85)(cid:72)(cid:90)(cid:3)(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)
Karen M. Rogge
President
(cid:53)(cid:60)(cid:49)(cid:3)(cid:42)(cid:85)(cid:82)(cid:88)(cid:83)(cid:3)(cid:47)(cid:47)(cid:38)
EXECUTIVE
OFFICERS
William M. Lowe, Jr.
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)(cid:3)(cid:9)(cid:3)(cid:39)(cid:76)(cid:85)(cid:72)(cid:70)(cid:87)(cid:82)(cid:85)
Gregory C. Thompson
(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:9)(cid:3)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:41)(cid:76)(cid:81)(cid:68)(cid:81)(cid:70)(cid:76)(cid:68)(cid:79)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)
Charles C. Meeks, Jr.
(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)
(cid:54)(cid:82)(cid:79)(cid:76)(cid:71)(cid:3)(cid:38)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:177)(cid:3)(cid:55)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)
Shigenori Oyama
(cid:40)(cid:91)(cid:72)(cid:70)(cid:88)(cid:87)(cid:76)(cid:89)(cid:72)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)
(cid:48)(cid:68)(cid:74)(cid:81)(cid:72)(cid:87)(cid:76)(cid:70)(cid:86)(cid:15)(cid:3)(cid:54)(cid:72)(cid:81)(cid:86)(cid:82)(cid:85)(cid:86)(cid:3)(cid:9)(cid:3)(cid:36)(cid:70)(cid:87)(cid:88)(cid:68)(cid:87)(cid:82)(cid:85)(cid:86)
R. James Assaf
Senior Vice President
(cid:42)(cid:72)(cid:81)(cid:72)(cid:85)(cid:68)(cid:79)(cid:3)(cid:38)(cid:82)(cid:88)(cid:81)(cid:86)(cid:72)(cid:79)(cid:3)(cid:9)(cid:3)(cid:54)(cid:72)(cid:70)(cid:85)(cid:72)(cid:87)(cid:68)(cid:85)(cid:92)
Claudio Lollini
Senior Vice President
(cid:42)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)(cid:3)(cid:54)(cid:68)(cid:79)(cid:72)(cid:86)(cid:3)(cid:9)(cid:3)(cid:48)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:76)(cid:81)(cid:74)
Stefano Vetralla
Senior Vice President &
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:43)(cid:88)(cid:80)(cid:68)(cid:81)(cid:3)(cid:53)(cid:72)(cid:86)(cid:82)(cid:88)(cid:85)(cid:70)(cid:72)(cid:86)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)
Robert S. Willoughby
Senior Vice President
(cid:54)(cid:82)(cid:79)(cid:76)(cid:71)(cid:3)(cid:38)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:177)(cid:3)(cid:38)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:86)
Susan B. Barkal
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:52)(cid:88)(cid:68)(cid:79)(cid:76)(cid:87)(cid:92)(cid:3)
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:79)(cid:76)(cid:68)(cid:81)(cid:70)(cid:72)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)(cid:3)
(cid:9)(cid:3)(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:82)(cid:73)(cid:3)(cid:54)(cid:87)(cid:68)(cid:73)(cid:73)(cid:3)
Dr. Philip M. Lessner
Senior Vice President &
(cid:38)(cid:75)(cid:76)(cid:72)(cid:73)(cid:3)(cid:55)(cid:72)(cid:70)(cid:75)(cid:81)(cid:82)(cid:79)(cid:82)(cid:74)(cid:92)(cid:3)(cid:50)(cid:73)(cid:191)(cid:70)(cid:72)(cid:85)(cid:3)
Andreas Meier
Senior Vice President
(cid:41)(cid:76)(cid:79)(cid:80)(cid:3)(cid:9)(cid:3)(cid:40)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:79)(cid:92)(cid:87)(cid:76)(cid:70)
Michael L. Raynor
Vice President &
(cid:38)(cid:82)(cid:85)(cid:83)(cid:82)(cid:85)(cid:68)(cid:87)(cid:72)(cid:3)(cid:38)(cid:82)(cid:81)(cid:87)(cid:85)(cid:82)(cid:79)(cid:79)(cid:72)(cid:85)
Richard J. Vatinelle
(cid:57)(cid:76)(cid:70)(cid:72)(cid:3)(cid:51)(cid:85)(cid:72)(cid:86)(cid:76)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)(cid:9)(cid:3)(cid:55)(cid:85)(cid:72)(cid:68)(cid:86)(cid:88)(cid:85)(cid:72)(cid:85)
KEY
SUBSIDIARIES
KEMET Electronics
Corporation
(cid:41)(cid:82)(cid:85)(cid:87)(cid:3)(cid:47)(cid:68)(cid:88)(cid:71)(cid:72)(cid:85)(cid:71)(cid:68)(cid:79)(cid:72)(cid:15)(cid:3)(cid:41)(cid:79)(cid:82)(cid:85)(cid:76)(cid:71)(cid:68)(cid:15)(cid:3)(cid:56)(cid:54)(cid:36)
TOKIN Corporation
(cid:54)(cid:75)(cid:76)(cid:85)(cid:82)(cid:76)(cid:86)(cid:75)(cid:76)(cid:15)(cid:3)(cid:45)(cid:68)(cid:83)(cid:68)(cid:81)(cid:3)
KEMET Electronics
Bulgaria EAD
(cid:46)(cid:92)(cid:88)(cid:86)(cid:87)(cid:72)(cid:81)(cid:71)(cid:76)(cid:79)(cid:15)(cid:3)(cid:37)(cid:88)(cid:79)(cid:74)(cid:68)(cid:85)(cid:76)(cid:68)
KEMET Electronics
(Suzhou) Co., Ltd.
(cid:54)(cid:88)(cid:93)(cid:75)(cid:82)(cid:88)(cid:15)(cid:3)(cid:51)(cid:72)(cid:82)(cid:83)(cid:79)(cid:72)(cid:182)(cid:86)(cid:3)(cid:53)(cid:72)(cid:83)(cid:88)(cid:69)(cid:79)(cid:76)(cid:70)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:75)(cid:76)(cid:81)(cid:68)
TOKIN Electronics
(Xiamen) Corporation
(cid:59)(cid:76)(cid:68)(cid:80)(cid:72)(cid:81)(cid:15)(cid:3)(cid:51)(cid:72)(cid:82)(cid:83)(cid:79)(cid:72)(cid:182)(cid:86)(cid:3)(cid:53)(cid:72)(cid:83)(cid:88)(cid:69)(cid:79)(cid:76)(cid:70)(cid:3)(cid:82)(cid:73)(cid:3)(cid:38)(cid:75)(cid:76)(cid:81)(cid:68)
KEMET Electronics Oy
(cid:40)(cid:86)(cid:83)(cid:82)(cid:82)(cid:15)(cid:3)(cid:41)(cid:76)(cid:81)(cid:79)(cid:68)(cid:81)(cid:71)
KEMET Electronics
GmbH
(cid:47)(cid:68)(cid:81)(cid:71)(cid:86)(cid:69)(cid:72)(cid:85)(cid:74)(cid:15)(cid:3)(cid:42)(cid:72)(cid:85)(cid:80)(cid:68)(cid:81)(cid:92)
PT KEMET Electronics
Indonesia
(cid:37)(cid:68)(cid:87)(cid:68)(cid:80)(cid:15)(cid:3)(cid:44)(cid:81)(cid:71)(cid:82)(cid:81)(cid:72)(cid:86)(cid:76)(cid:68)
KEMET Electronics
Italia, S.r.l.
(cid:51)(cid:82)(cid:81)(cid:87)(cid:72)(cid:70)(cid:70)(cid:75)(cid:76)(cid:82)(cid:15)(cid:3)(cid:44)(cid:87)(cid:68)(cid:79)(cid:92)
KEMET Electronics
Japan Co., Ltd.
(cid:55)(cid:82)(cid:78)(cid:92)(cid:82)(cid:15)(cid:3)(cid:45)(cid:68)(cid:83)(cid:68)(cid:81)
KEMET Electronics
Macedonia
DOOEL Skopje
(cid:54)(cid:78)(cid:82)(cid:83)(cid:77)(cid:72)(cid:15)(cid:3)(cid:48)(cid:68)(cid:70)(cid:72)(cid:71)(cid:82)(cid:81)(cid:76)(cid:68)
KEMET de Mexico,
S.A. de C.V.
(cid:48)(cid:68)(cid:87)(cid:68)(cid:80)(cid:82)(cid:85)(cid:82)(cid:86)(cid:15)(cid:3)(cid:55)(cid:68)(cid:80)(cid:68)(cid:88)(cid:79)(cid:76)(cid:83)(cid:68)(cid:86)(cid:15)(cid:3)(cid:48)(cid:72)(cid:91)(cid:76)(cid:70)(cid:82)
KEMET Electronics
Portugal, S.A.
(cid:40)(cid:89)(cid:82)(cid:85)(cid:68)(cid:15)(cid:3)(cid:51)(cid:82)(cid:85)(cid:87)(cid:88)(cid:74)(cid:68)(cid:79)
KEMET Electronics
Marketing (S) Pte Ltd.
(cid:54)(cid:76)(cid:81)(cid:74)(cid:68)(cid:83)(cid:82)(cid:85)(cid:72)
TOKIN Electronics
(Thailand) Co., Ltd.
(cid:38)(cid:75)(cid:68)(cid:70)(cid:75)(cid:82)(cid:72)(cid:81)(cid:74)(cid:86)(cid:68)(cid:82)(cid:15)(cid:3)(cid:55)(cid:75)(cid:68)(cid:76)(cid:79)(cid:68)(cid:81)(cid:71)
KEMET Blue Powder
Corporation
(cid:48)(cid:82)(cid:88)(cid:81)(cid:71)(cid:3)(cid:43)(cid:82)(cid:88)(cid:86)(cid:72)(cid:15)(cid:3)(cid:49)(cid:72)(cid:89)(cid:68)(cid:71)(cid:68)(cid:15)(cid:3)(cid:56)(cid:54)(cid:36)
TOKIN Electronics
(Vietnam) Co., Ltd.
(cid:37)(cid:76)(cid:72)(cid:81)(cid:3)(cid:43)(cid:82)(cid:68)(cid:3)(cid:38)(cid:76)(cid:87)(cid:92)(cid:15)(cid:3)(cid:39)(cid:82)(cid:81)(cid:74)(cid:3)(cid:49)(cid:68)(cid:76)(cid:3)(cid:51)(cid:85)(cid:82)(cid:89)(cid:76)(cid:81)(cid:70)(cid:72)
(cid:57)(cid:76)(cid:72)(cid:87)(cid:81)(cid:68)(cid:80)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:75)(cid:72)(cid:68)(cid:71)(cid:84)(cid:88)(cid:68)(cid:85)(cid:87)(cid:72)(cid:85)(cid:86)(cid:17)(cid:3)
(cid:49)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:68)(cid:79)(cid:3)(cid:38)(cid:68)(cid:85)(cid:69)(cid:82)(cid:81)(cid:3)(cid:38)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:3)
(cid:47)(cid:68)(cid:78)(cid:72)(cid:90)(cid:82)(cid:82)(cid:71)(cid:15)(cid:3)(cid:50)(cid:43)(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:87)(cid:85)(cid:68)(cid:70)(cid:72)(cid:86)(cid:3)(cid:76)(cid:87)(cid:86)(cid:3)(cid:82)(cid:85)(cid:76)(cid:74)(cid:76)(cid:81)(cid:3)(cid:69)(cid:68)(cid:70)(cid:78)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:20)(cid:28)(cid:20)(cid:28)(cid:3)(cid:90)(cid:75)(cid:72)(cid:81)(cid:3)(cid:43)(cid:88)(cid:74)(cid:75)(cid:3)(cid:38)(cid:82)(cid:82)(cid:83)(cid:72)(cid:85)(cid:3)
(cid:73)(cid:82)(cid:88)(cid:81)(cid:71)(cid:72)(cid:71)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:47)(cid:68)(cid:69)(cid:82)(cid:85)(cid:68)(cid:87)(cid:82)(cid:85)(cid:76)(cid:72)(cid:86)(cid:17)
(cid:38)(cid:82)(cid:82)(cid:83)(cid:72)(cid:85)(cid:3)(cid:76)(cid:81)(cid:71)(cid:72)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:81)(cid:87)(cid:79)(cid:92)(cid:3)
(cid:83)(cid:68)(cid:87)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:69)(cid:72)(cid:85)(cid:92)(cid:79)(cid:79)(cid:76)(cid:88)(cid:80)(cid:3)
(cid:68)(cid:79)(cid:88)(cid:80)(cid:76)(cid:81)(cid:88)(cid:80)(cid:3)(cid:68)(cid:79)(cid:79)(cid:82)(cid:92)(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:42)(cid:72)(cid:87)(cid:87)(cid:72)(cid:85)(cid:3)(cid:41)(cid:68)(cid:70)(cid:87)(cid:82)(cid:85)(cid:92)
(cid:38)(cid:79)(cid:72)(cid:89)(cid:72)(cid:79)(cid:68)(cid:81)(cid:71)(cid:15)(cid:3)1940s(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:191)(cid:85)(cid:86)(cid:87)(cid:3)(cid:72)(cid:81)(cid:87)(cid:72)(cid:85)(cid:72)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:81)(cid:76)(cid:70)(cid:86)(cid:3)(cid:76)(cid:81)(cid:71)(cid:88)(cid:86)(cid:87)(cid:85)(cid:92)(cid:3)(cid:69)(cid:92)(cid:3)(cid:80)(cid:68)(cid:81)(cid:88)(cid:73)(cid:68)(cid:70)(cid:87)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:74)(cid:72)(cid:87)(cid:87)(cid:72)(cid:85)(cid:86)(cid:3)(cid:73)(cid:82)(cid:85)(cid:3)(cid:89)(cid:68)(cid:70)(cid:88)(cid:88)(cid:80)(cid:3)(cid:87)(cid:88)(cid:69)(cid:72)(cid:86)(cid:17)
(cid:38)(cid:82)(cid:82)(cid:83)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:75)(cid:76)(cid:86)(cid:3)(cid:86)(cid:87)(cid:68)(cid:73)(cid:73)(cid:3)
(cid:72)(cid:91)(cid:83)(cid:72)(cid:85)(cid:76)(cid:80)(cid:72)(cid:81)(cid:87)(cid:72)(cid:71)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:68)(cid:79)(cid:79)(cid:82)(cid:92)(cid:86)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:76)(cid:81)(cid:71)(cid:88)(cid:86)(cid:87)(cid:85)(cid:76)(cid:68)(cid:79)(cid:3)(cid:68)(cid:83)(cid:83)(cid:79)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:15)(cid:3)
1938(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:87)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:3)
(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:71)(cid:72)(cid:89)(cid:72)(cid:79)(cid:82)(cid:83)(cid:72)(cid:71)(cid:3)
(cid:73)(cid:82)(cid:85)(cid:3)(cid:55)(cid:72)(cid:79)(cid:86)(cid:87)(cid:68)(cid:85)(cid:15)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:191)(cid:85)(cid:86)(cid:87)(cid:3)
(cid:70)(cid:82)(cid:80)(cid:80)(cid:88)(cid:81)(cid:76)(cid:70)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:3)(cid:86)(cid:68)(cid:87)(cid:72)(cid:79)(cid:79)(cid:76)(cid:87)(cid:72)(cid:17)
KEMET
(cid:87)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:3)
(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:15)(cid:3)
1959(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:75)(cid:68)(cid:71)(cid:3)(cid:87)(cid:82)(cid:3)(cid:85)(cid:72)(cid:76)(cid:81)(cid:89)(cid:72)(cid:81)(cid:87)(cid:3)
(cid:76)(cid:87)(cid:86)(cid:72)(cid:79)(cid:73)(cid:3)(cid:87)(cid:82)(cid:3)(cid:86)(cid:88)(cid:83)(cid:83)(cid:79)(cid:92)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:81)(cid:72)(cid:72)(cid:71)(cid:86)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:3)(cid:90)(cid:76)(cid:87)(cid:75)(cid:3)(cid:87)(cid:68)(cid:81)(cid:87)(cid:68)(cid:79)(cid:88)(cid:80)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:17)
(cid:38)(cid:72)(cid:85)(cid:68)(cid:80)(cid:76)(cid:70)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)
(cid:80)(cid:68)(cid:81)(cid:88)(cid:73)(cid:68)(cid:70)(cid:87)(cid:88)(cid:85)(cid:76)(cid:81)(cid:74)(cid:15)(cid:3)1968(cid:17)
(cid:54)(cid:72)(cid:81)(cid:76)(cid:82)(cid:85)(cid:3)(cid:80)(cid:68)(cid:81)(cid:68)(cid:74)(cid:72)(cid:85)(cid:86)(cid:3)
(cid:82)(cid:85)(cid:74)(cid:68)(cid:81)(cid:76)(cid:93)(cid:72)(cid:71)(cid:3)(cid:68)(cid:3)(cid:79)(cid:72)(cid:89)(cid:72)(cid:85)(cid:68)(cid:74)(cid:72)(cid:71)(cid:3)
(cid:69)(cid:88)(cid:92)(cid:82)(cid:88)(cid:87)(cid:15)(cid:3)(cid:72)(cid:86)(cid:87)(cid:68)(cid:69)(cid:79)(cid:76)(cid:86)(cid:75)(cid:76)(cid:81)(cid:74)(cid:3)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:68)(cid:86)(cid:3)(cid:68)(cid:81)(cid:3)(cid:76)(cid:81)(cid:71)(cid:72)(cid:83)(cid:72)(cid:81)(cid:71)(cid:72)(cid:81)(cid:87)(cid:3)
(cid:70)(cid:82)(cid:80)(cid:83)(cid:68)(cid:81)(cid:92)(cid:15)(cid:3)1987(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:80)(cid:68)(cid:87)(cid:88)(cid:85)(cid:72)(cid:86)(cid:3)(cid:76)(cid:81)(cid:87)(cid:82)(cid:3)(cid:68)(cid:3)(cid:74)(cid:79)(cid:82)(cid:69)(cid:68)(cid:79)(cid:3)
(cid:86)(cid:88)(cid:83)(cid:83)(cid:79)(cid:76)(cid:72)(cid:85)(cid:3)(cid:82)(cid:73)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:87)(cid:75)(cid:85)(cid:82)(cid:88)(cid:74)(cid:75)(cid:3)
(cid:82)(cid:85)(cid:74)(cid:68)(cid:81)(cid:76)(cid:70)(cid:3)(cid:74)(cid:85)(cid:82)(cid:90)(cid:87)(cid:75)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:86)(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:3)(cid:68)(cid:85)(cid:72)(cid:3)
(cid:68)(cid:81)(cid:3)(cid:76)(cid:81)(cid:87)(cid:72)(cid:74)(cid:85)(cid:68)(cid:79)(cid:3)(cid:83)(cid:68)(cid:85)(cid:87)(cid:3)(cid:82)(cid:73)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:48)(cid:68)(cid:85)(cid:86)(cid:3)(cid:57)(cid:82)(cid:92)(cid:68)(cid:74)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)
(cid:48)(cid:44)(cid:53)(cid:3)(cid:86)(cid:83)(cid:68)(cid:70)(cid:72)(cid:3)(cid:86)(cid:87)(cid:68)(cid:87)(cid:76)(cid:82)(cid:81)(cid:15)(cid:3)1986(cid:17)
(cid:55)(cid:75)(cid:72)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:86)(cid:76)(cid:87)(cid:76)(cid:82)(cid:81)(cid:3)(cid:82)(cid:73)(cid:3)(cid:40)(cid:89)(cid:82)(cid:91)(cid:3)(cid:53)(cid:76)(cid:73)(cid:68)(cid:3)
(cid:68)(cid:81)(cid:71)(cid:3)(cid:36)(cid:85)(cid:70)(cid:82)(cid:87)(cid:85)(cid:82)(cid:81)(cid:76)(cid:70)(cid:86)(cid:3)(cid:80)(cid:68)(cid:71)(cid:72)(cid:3)(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)
(cid:68)(cid:3)(cid:83)(cid:79)(cid:68)(cid:92)(cid:72)(cid:85)(cid:3)(cid:76)(cid:81)(cid:3)(cid:191)(cid:79)(cid:80)(cid:15)(cid:3)(cid:83)(cid:68)(cid:83)(cid:72)(cid:85)(cid:3)(cid:68)(cid:81)(cid:71)(cid:3)
(cid:72)(cid:79)(cid:72)(cid:70)(cid:87)(cid:85)(cid:82)(cid:79)(cid:92)(cid:87)(cid:76)(cid:70)(cid:3)(cid:70)(cid:68)(cid:83)(cid:68)(cid:70)(cid:76)(cid:87)(cid:82)(cid:85)(cid:86)(cid:17)
(cid:46)(cid:40)(cid:48)(cid:40)(cid:55)(cid:3)(cid:68)(cid:70)(cid:84)(cid:88)(cid:76)(cid:85)(cid:72)(cid:86)(cid:3)(cid:55)(cid:50)(cid:46)(cid:44)(cid:49)(cid:3)
(cid:76)(cid:81)(cid:3)(cid:45)(cid:68)(cid:83)(cid:68)(cid:81)(cid:3)(cid:72)(cid:81)(cid:68)(cid:69)(cid:79)(cid:76)(cid:81)(cid:74)(cid:3)(cid:68)(cid:70)(cid:70)(cid:72)(cid:86)(cid:86)(cid:3)
(cid:87)(cid:82)(cid:3)(cid:87)(cid:75)(cid:72)(cid:3)(cid:80)(cid:68)(cid:74)(cid:81)(cid:72)(cid:87)(cid:76)(cid:70)(cid:86)(cid:3)(cid:80)(cid:68)(cid:85)(cid:78)(cid:72)(cid:87)(cid:17)
KEMET Corporation is a leading global supplier of electronic components.
We offer our customers the broadest selection of capacitor technologies
in the industry, along with an expanding range of electromagnetic compatibility
solutions and supercapacitors. Our vision is to be the preferred supplier
of electronic component solutions for customers demanding the highest
standards of quality, delivery and service.
KEMET Worldwide Operations:
Sweden
Taiwan
Thailand
United Kingdom
USA
Vietnam
Bulgaria
China
Finland
France
Germany
Hong Kong
India
Indonesia
Italy
Japan
Macedonia
Malaysia
Mexico
Portugal
Singapore
South Korea
Corporate Office:
KEMET CORPORATION
KEMET Tower, One East Broward Boulevard
Fort Lauderdale, Florida 33301 USA
954.766.2800 | www.kemet.com
©2019 KEMET. All rights reserved.